Acceptance and commitment therapy: cognitive fusion and
personality functioning by Bolderston, Helen
University of Southampton Research Repository
ePrints Soton
Copyright © and Moral Rights for this thesis are retained by the author and/or other 
copyright owners. A copy can be downloaded for personal non-commercial 
research or study, without prior permission or charge. This thesis cannot be 
reproduced or quoted extensively from without first obtaining permission in writing 
from the copyright holder/s. The content must not be changed in any way or sold 
commercially in any format or medium without the formal permission of the 
copyright holders.
  
 When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given e.g.
AUTHOR (year of submission) "Full thesis title", University of Southampton, name 
of the University School or Department, PhD Thesis, pagination
http://eprints.soton.ac.ukUNIVERSITY OF SOUTHAMPTON 
 
FACULTY OF SOCIAL AND HUMAN SCIENCES 
     
 
Psychology 
 
 
 
 
 
Acceptance and Commitment Therapy: Cognitive Fusion and 
Personality Functioning 
 
by 
 
Helen Bolderston 
 
 
 
 
 
 
 
 
Thesis for the degree of Doctor of Philosophy 
 
May 2013 
  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
   
UNIVERSITY OF SOUTHAMPTON 
 
ABSTRACT 
 
FACULTY OF SOCIAL AND HUMAN SCIENCES 
 
PSYCHOLOGY 
 
Doctor of Philosophy 
 
ACCEPTANCE AND COMMITMENT THERAPY: COGNITIVE 
FUSION AND PERSONALITY FUNCTIONING 
  
by Helen Bolderston 
 
Personality disorders (PDs) are common, chronic, mental health problems. The 
majority of treatment outcome research, which has focused specifically on Borderline 
PD, has provided substantial empirical support for Dialectical Behaviour Therapy 
(DBT; Linehan, 1993), particularly in terms of self-harm reduction. Nevertheless, 
DBT graduates can continue to experience poor personality functioning across PD 
diagnostic categories, Axis I disorders, and restricted lives. Acceptance and 
Commitment Therapy (ACT; Hayes, Strosahl, & Wilson, 1999), might be suitable as 
a follow-up intervention for DBT graduates, to address their continued difficulties: to 
date, however, there has been little empirical investigation of its utility in relation to 
PD. This thesis was therefore designed to examine theoretical underpinnings of ACT 
relevant to the development of an ACT intervention for DBT graduates.  
 
Study 1 tested the performance of a new self-report measure of cognitive 
fusion (CF), the Cognitive Fusion Questionnaire (CFQ), with a mental health sample, 
including individuals with PD. CF is a key ACT concept, and the CFQ proved to be a 
psychometrically sound measure of CF with people with mental health problems. 
Study 2 used cross-sectional modelling to show that CF fully mediated the 
relationships between two PD risk factors, negative affectivity and childhood trauma, 
and personality functioning in adulthood. Study 3 used the CFQ to investigate the 
behavioural correlates of CF. These findings strengthened the possibility that an 
ACT-based intervention might prove effective in improving outcomes for DBT 
graduates. To explore this further, Studies 4 and 5 were designed as very small-scale 
uncontrolled treatment development trials for this population. Study 4 suggested that 
ACT had a positive impact on engagement in life, but produced little improvement in 
psychiatric symptomology. Study 5 tested a revised protocol, which yielded more 
consistently positive findings, with improvements in both engagement in life and 
psychiatric symptoms. These findings tentatively suggest that ACT may have a role 
to play as a DBT follow-up intervention.  
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1 
CHAPTER I 
Personality Disorder 
 
1.1 Diagnosis 
  Personality disorder (PD) is defined as: 'an enduring pattern of inner 
experience and behaviour that deviates markedly from the expectations of the 
individual’s culture, is pervasive and inflexible, has an onset in adolescence or early 
adulthood, is stable over time, and leads to distress or impairment' (DSM-IV-TR; 
2000). Within this broad definition, DSM-IV-TR identifies 10 specific PDs (and a 
‘personality disorder not otherwise specified’ diagnostic option), with a wide range of 
presentations and severity, with all diagnoses implying significant emotional and 
interpersonal difficulty. Some diagnoses, such as BPD, involve individuals engaging 
in high-risk behaviours such as self-harm and suicide attempts. 
  DSM-IV groups these 10 PDs into three clusters, as follows: 
Cluster A: Odd or eccentric disorders 
Paranoid PD: characterised as “a pervasive distrust and suspiciousness of others such 
as their motives are interpreted as malevolent” 
Schizoid PD: characterised as “a pervasive pattern of detachment from social 
relationships and a restricted range of expression of emotions in interpersonal 
settings” 
Schizotypal PD: characterised as “a pervasive pattern of social and interpersonal 
deficits marked by acute discomfort with, and reduced capacity for, close 
relationships, as well as by cognitive or perceptual distortions and eccentricities of 
behaviour” 
 
Cluster B: dramatic, emotional or erratic disorders 
Antisocial PD: characterised as “a pervasive pattern of disregard for and a violation 
of the rights of others”, often involving impulsivity, irresponsibility and 
aggressiveness.  
Borderline PD: characterised as “a pervasive pattern of instability of interpersonal 
relationships, self-image, and affects, and marked impulsivity”, often involving self-
damaging urges and actions. CHAPTER I 
   
2 
Histrionic PD: characterised as “a pervasive pattern of excessive emotionality and 
attention seeking” often including self-dramatization, suggestibility and rapidly 
shifting and shallow expression of emotions 
Narcissistic PD: characterised by “a pervasive pattern of grandiosity (in fantasy or 
behaviour), need for admiration, and lack of empathy” 
Cluster C: Anxious or fearful disorders 
Avoidant PD: characterised as “a pervasive pattern of social inhibition, feelings of 
inadequacy, and hypersensitivity to negative evaluation” 
Dependent PD: characterised as “a pervasive and excessive need to be taken care of, 
that leads to submissive and clinging behaviour and fears of separation”, often 
including significant difficulties with making decisions, and going to excessive 
lengths to gain support. 
Obsessive-compulsive PD: characterised as “a pervasive pattern of preoccupation 
with orderliness, perfectionism, and mental and interpersonal control, at the expense 
of flexibility, openness, and efficiency” 
 
Two additional possible PD diagnoses, depressive PD, and passive-aggressive 
PD are included in an appendix to DSM-IV-TR, to encourage further research into 
these particular diagnoses. 
   There have been many criticisms of the categorical approach to PD diagnosis 
(e.g. Skodol & Bender, 2009), due to the high level of comorbidity amongst PD 
diagnoses (including across different clusters), as well as heterogeneity amongst 
patients with the same diagnosis. The arbitrary nature of the cut-off points for 
diagnosis also tends to be a target for criticism, as does the common need to use the 
‘personality disorder not otherwise specified’ diagnosis (Verheul & Widiger, 2004). 
1.1.1 Comorbidity and Dimensionality in PDs 
  Outcome trials testing interventions for PD tend to focus on a single PD 
diagnosis, giving the impression that the study participants only met the criteria for 
that PD. This is extremely misleading, as there is evidence of high levels of 
comorbidity across diagnostic categories. For example, Westen, Shedler, & Bradley 
(2006) found a mean of two diagnoses per patient in a Cluster B PD sample. 
McGlashan et al. (2000) found a mean of one to two additional PD diagnoses with a CHAPTER I 
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sample of patients with a primary diagnosis of schizotypal, avoidant, obsessive-
compulsive, or borderline PD. Not surprisingly, greater levels of comorbidity have 
been found to be associated with poorer quality of life (Cramer, Torgersen, & 
Kringlen, 2006). 
  It has been argued that “human personality varies continuously” (APA, 2012, 
p. 1), and conceptualisations of PD should reflect this, with poor personality 
functioning being described in terms of traits or processes that cut across diagnostic 
categories. Several authors have developed conceptualisations along these lines (e.g. 
Verheul et al., 2008; Lynch & Cheavens, 2008). DSM-V will also be based on 
severity ratings of dysfunctional personality traits, although one of the two 
dimensional assessments included will yield a category-based diagnosis. 
  Clearly, the conceptualisation and diagnosis of PD is currently in a state of 
flux. For the purposes of this thesis I will for the most part use the term ‘personality 
disorder’ (PD), to be in keeping with relevant published literature. The term ‘poor 
personality functioning’ will be used when it is particularly relevant, for example 
when discussing a dimension-based measure of personality functioning, or in relation 
to patients who have personality problems that cut across several PD diagnostic 
categories.  
  Regardless of arguments about the validity of specific categories, PD in 
general appears to be common in the adult population, with prevalence estimates 
ranging from 4% in a UK community sample (Coid, Yang, Tyrer, Roberts, & Ullrich; 
2006) to 15% in a US community sample (Grant et al., 2004). The difference in 
prevalence estimates is thought to be due to methodological differences. It is 
estimated that the prevalence of PDs amongst psychiatric inpatients in the UK ranges 
from 36% - 67%  (NIMHE, 2003). PD is thought to be under-diagnosed in both 
community and in-patient settings (Lamont & Brunero, 2009). According to the 
National Institute for Mental Health in England (NIMHE, 2003), PD diagnosis is 
associated with an increased likelihood to suffer from other difficulties such as 
substance misuse, and in general, there is an extremely high level of Axis-I disorder 
co-morbidity with PDs (McGlashan et al., 2000; Dolan-Sewell, Krueger, & Shea, 
2001). Diagnosis of PD appears to be equal amongst men and women, although there 
is gender-based variation within some specific PD presentations.  
  Given that PDs are typically chronic conditions often experienced over 
decades, and given that they can affect a wide range of intra and inter-personal CHAPTER I 
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experiences, they can have a hugely negative impact on the individual sufferer’s life, 
as well as on the people close to them. Individuals with PD diagnoses are also at risk 
of being stigmatised, by the general public and health and social care staff (Taylor, 
2010). This can lead to further isolation and poor treatment outcomes. Furthermore, 
these common disorders place a significant burden on society in terms of (sometimes 
intensive and repeated) use of health and social care services and lack of engagement 
in paid employment by the sufferer.  
1.2 Aetiology of PD 
Genetic predictors. Recent twin studies have suggested that genetic factors 
contribute to the risk of developing PDs. For example, Kendler et al. (2008) identified 
three genetic factors contributing to PD in their study based on a large, Scandinavian 
sample. These factors did not mirror the three-cluster structure of DSM-IV-TR. In 
fact the first factor identified was a broad factor, which loaded onto PDs from all 
three clusters, and which the authors suggested represents a general PD vulnerability 
factor along the lines of negative emotionality/neuroticism. The remaining two 
factors were much more specific, and seen by the authors as representing impulsive 
aggression (loading onto borderline and antisocial PDs), and inhibition/introversion 
(loading onto avoidant and schizoid PDs). 
  Livesley, Jang, and Vernon, (1998), using different methodology, identified a 
similar genetic factor structure, also involving a broad factor that appeared to 
contribute to a range of PDs, which the authors labelled emotion dysregulation or 
neuroticism. Heritabilities in the Kendler et al. (2008) study were described as 
‘modest’, ranging from 20% for schizotypal PD to 41% for antisocial PD. This 
suggests that environmental factors have an important part to play in the development 
of PDs. 
Environmental predictors In their multivariate twin study, Kendler et al. 
(2008) identified three environmental predictors of PD, which more closely matched 
the three-cluster structure, indicating that environmental factors may have more 
influence than genetic factors on the co-morbidity of PDs within clusters. The authors 
felt unable to label these three environmental factors due to the lack of research 
evidence regarding the influence of environmental risk factors on PDs in general, 
rather than on just one or two diagnoses such as borderline PD (BPD).  CHAPTER I 
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  However, there are some relevant, prospective data available. For example, 
Johnson and colleagues used large, community sample-based, longitudinal studies to 
examine the impact of a range of adverse childhood experiences on the development 
of PDs (e.g. Johnson, Cohen, Brown, Smailes, & Bernstein; 1999; Johnson, Cohen, 
Chen, Kasen, & Brook, 2006). The 2006 study, examining the impact of various 
parental behaviours during childhood on the development of PD in adulthood, found 
that 10 types of parental behaviour were associated with an increased risk of 
developing a PD, included low parental affection or nurturing, which predicted 
increased risk of borderline, antisocial, avoidant, depressive, paranoid, schizoid and 
schizotypal PDs.  
  The 1999 study found that a range of childhood neglect, physical abuse, and 
sexual abuse experiences significantly increased the likelihood of PD diagnosis in 
adulthood, with some specific adverse childhood experiences increasing the risk of 
specific PD diagnoses. For example, neglect by parents was associated with increased 
risk of diagnosis of antisocial, avoidant, borderline, dependent, narcissistic, paranoid, 
passive-aggressive, and schizotypal PDs. More specifically, childhood sexual abuse 
(by parents or other adults) was associated with increased risk of BPD. Overall, a 
childhood experience of neglect or abuse was associated with a four-fold increase in 
risk of developing a PD. 
  Good quality research studies designed to examine genetic or environmental 
predictors of PD are expensive, due to the large numbers of participants involved, and 
the time they take to complete. There are therefore a relatively small number of 
relevant studies currently. It appears that both genetic and environmental factors play 
a role, with both broad genetic (negative emotionality) and environmental (childhood 
neglect) predictors having been identified, along with more specific genetic and 
environmental predictors. Clearly, any theoretical account of PD will need to be 
consistent with these findings.  
  There are significant gaps in the research literature regarding possible 
environmental predictors of PD. For example, childhood experiences such as bullying 
have not been tested as possible risk factors. There is some correlational data linking 
PD and attachment problems, but to date there have been no longitudinal studies 
examining the role of poor childhood attachment in the development of PDs (see 
Mikulincer & Shaver, 2007). Finally, there is no published data concerning the 
possibility of aversive experiences in adulthood increasing the risk of PD diagnosis. CHAPTER I 
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1.3 Treatment of PD 
  Until relatively recently it was generally thought that PDs could not be treated 
successfully (Sperry, 1995; McMain et al., 2009). Indeed, the first RCT testing a 
treatment for a PD (DBT for BPD) was published in 1991 (Linehan, Armstrong, 
Suarez, Allmon, & Heard), indicating the paucity of research evidence guiding 
treatment prior to that point. Few local health and social services provided adequate 
treatment or care, and many health and social care professionals felt unable or 
unwilling to engage with individuals with PD. In the UK, this led to the publication in 
2003 of the NIMHE best practice guidance paper “Personality Disorder: No longer a 
diagnosis of exclusion.” This gave guidance on the development of services for the 
assessment and treatment of PD. It included examples of best practice and addressed 
issues of staff training and supervision. Since this time, evidence-based guidance on 
the treatment of specific PDs (BPD and antisocial PD) has been published (NICE, 
2009; 2010).   
1.3.1 Psychosocial Treatment of PD 
  The treatment of PD is a broad and complex topic. To begin with, there are 10 
or 12 specific PD identified in DSM-IV-TR (2000), depending on whether depressive 
and passive-aggressive PD are included, or not. Many patients present with comorbid 
Axis I (Dolan-Sewell, Kreuger, & Shea, 2001) and/or Axis II (Zimmerman & 
Coryell, 1990) disorders. Prevalence of Axis II co-morbidity in research samples is 
not always described, making it difficult to interpret the impact of an intervention 
(Piper & Joyce, 2001).  
  Many different psychotherapeutic interventions have been applied to PDs, and 
different interventions, based on different theories of psychopathology and healthy 
psychological functioning, may have substantially different aims and treatment 
targets. This range might include the reduction of parasuicidal behaviours in the case 
of DBT (Linehan, 1993) through to a “structural change in patients’ personality” 
(Giesen-Bloo et al., 2006, p. 649), in the cases of Schema Therapy (ST) and 
Transference-Focussed Therapy (TFT).  
  Given these factors, and taking into consideration the relatively high 
prevalence of PDs in the general population and their detrimental impact, it might be 
assumed that there is a substantial, if complex, body of research evaluating CHAPTER I 
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psychosocial interventions for PD. This is not the case. Relative to the volume of 
research evaluating treatment for Axis-I disorders, there are few PD outcome studies, 
with existing research largely focussed on BPD only (Duggan, Huband, Smailagic, 
Ferriter, & Adams, 2007). There are a number of possible explanations for this 
paucity of empirical evidence, and the bias towards BPD, including the high risks 
often associated with BPD, the fact that people with some other PDs do not tend to 
seek help, the under-recognition and diagnosis of PDs in general, particularly those 
other than BPD, and the difficulty of conducting research with people who may 
variously be chaotic, contact avoidant, suspicious and so on. 
  This section will examine a number of psychotherapeutic interventions for 
PDs, limiting the focus (due to space restrictions) to interventions for which there has 
been at least one RCT, which is not to imply that non-RCT studies, particularly 
conducted early in the development of an intervention, are not important. The various 
therapeutic approaches are organised into two broad categories; cognitive and 
behavioural psychotherapies, and psychodynamic and interpersonal psychotherapies. 
The former will be addressed in more detail than the latter, with DBT being paid 
particular attention, partly because there is more empirical evidence relating to DBT 
than to other interventions, and partly because DBT plays a substantial role in this 
thesis (see Chapters VII and VIII).  
The evidence base relating to psychotherapeutic interventions for antisocial 
PD will not be reviewed. The interventions, which are often linked with the treatment 
of substance misuse, and/or on an inpatient basis, are not directly relevant to this 
thesis. They are reviewed in the relevant NICE guidelines (2010).  
1.3.2. Behavioural and Cognitive Behavioural Psychotherapies 
  This group of interventions includes behaviour therapy (BT), cognitive 
behaviour therapy (CBT), and dialectical behaviour therapy (DBT). A summary of 
the main methodological features and results of all of the RCTs evaluating these 
approaches for PD can be found in Appendix A. Acceptance and Commitment 
Therapy (ACT) interventions for PD will be discussed in Chapter II. The 
interventions included in this section address, variously, the problematic behaviours, 
cognitions, schema, emotions, and action urges that are viewed as contributing to the 
development and maintenance of PDs. They each address the specific mechanisms of CHAPTER I 
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change that are hypothesised as being important, within the theoretical context of 
each approach. For example, Lynch, Chapman, Rosenthal, Kuo, and Linehan (2006) 
view the “reduction of ineffective action tendencies linked with dysregulated 
emotions” as being an important mechanism of change in DBT for BPD, based on the 
biosocial theory of BPD. In section 1.3.3 it will be seen that in contrast, the shared 
hypothesised mechanism of change for psychodynamic and interpersonal 
interventions for PD is enactment of some form within the therapeutic relationship. It 
should be noted however that there is little published literature empirically testing 
mechanisms of change in PD interventions. 
1.3.2.1 Behaviour Therapy 
  For a brief overview of behaviour therapy (BT) and the learning theories in 
which BT is rooted, see Chapter II. In the 1970s there was some interest in the 
application of behavioural principles to PD, particularly using behavioural rehearsal 
and reinforcement through social skills training (e.g. Argyle, Trower, & Bryant, 
1974). However, the few empirical studies were severely limited methodologically. In 
fact, there is only one published RCT of a purely behavioural intervention for a PD to 
date (Alden, 1989). The trial tested behavioural interventions that had empirical 
support for the treatment of more general interpersonal difficulties at the time, namely 
exposure (to feared and avoided situations and experiences), and skills training 
(Stravynski & Shahar, 1983). Short-term groups based on graded exposure principles 
significantly improvement engagement in social activities, shyness and other relevant 
variables, compared to a no-treatment control group, though many participants who 
had shown improvement remained within the clinical range on outcome variables.  
  One of the study conditions involved a specific focus on intimacy, 
encouraging participants to move from superficial interactions to closer, more 
satisfying contact with others. This condition was associated with greater 
improvements on some outcome variables than the other conditions, but also had the 
highest attrition rate. This possibly highlights the conflict inherent in attempting to 
offer an intervention that addresses what really matters to patients; there is perhaps 
inevitably greater anxiety and discomfort associated with personally meaningful 
goals than with those that are more superficial and less personal. This theme will be 
revisited in the section of this thesis addressing personal values within psychotherapy CHAPTER I 
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(Chapter II), and the chapters focussed on ACT treatment development for PD 
(Chapters VII and VIII). Unfortunately, this promising, early research has not been 
developed and built on directly, although behavioural principles and interventions are 
evident in other more common PD psychosocial interventions such as CBT and DBT. 
1.3.2.2 Cognitive Behaviour Therapy  
For a general description and overview of cognitive therapy (CT) and 
cognitive behaviour therapy (CBT) see Chapter II. Beck, Freeman and associates 
(1990) first outlined a cognitive approach to PD, in which they described an 
evolutionary basis to the development of such disorders. They argued that behaviours 
and attitudes that might once have had survival value, (for example, excessive help-
seeking), are now problematic as and when they conflict with cultural norms and the 
requirements of current situations. The model suggests that it is the poor fit between 
such genetically determined strategies and the current environmental context that 
causes difficulties. Cognitive theory maintains that schemas develop as a way to 
organise information and experiences, and repeated mismatches between the 
individual’s behaviour and environmental demands, particularly in childhood, can 
lead to the formation of dysfunctional schemas.  
  Core schema are seen as playing a central role in the development and 
maintenance of PDs, and are viewed as being especially rigidly-held, persistent and 
pervasive in the case of PD, compared to those linked to Axis I disorders. Beck and 
associates identified core schema associated with five central areas of human 
experience; love, ability, moral qualities, normality and general worth. These core 
schema, such as ‘I am unlovable’ impact which experiences are attended to, and the 
interpretation of those experiences. This results in conditional and control schema 
such as ‘I must be nice to everyone’, which are designed to cope with core schema. 
These processes of schema-influenced attentional focus and interpretation of 
experience also result in difficult affective experiences such as depression, behaviours 
such as avoidance of social interaction, as well as the core schema itself being 
repeatedly reinforced. According to the model, the particular form the conditional and 
control schema take influences the particular PD that is manifest.  
  The two main CBT-based intervention developments for PD are those of 
Davidson and colleagues (Davidson et al, 2006a; Davidson et al., 2006b), and Blum CHAPTER I 
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and colleagues (Black, Blum, Pfohl, & St. John, 2004; Blum et al., 2008). Schema 
Therapy will be discussed in Section 1.3.3.2. The Davidson et al. protocol involves 
30 one-to-one sessions of modified CBT over a one-year period. Interventions stem 
from a CBT formulation of the individual’s problems, and focus on reducing the 
negative impact of beliefs, schema and behaviours that adversely affect the 
participant’s functioning in life. Patient and therapist jointly prioritise therapeutic 
goals, although high-risk behaviours such as self-harm are given priority.  
  The one published empirical evaluation of this intervention (Davidson et al., 
2006a,b) was designed not only as a test of the intervention, but also as a means of 
improving on the quality of BPD therapy outcome research available at the time. 
There were no between-group differences found on the primary outcome measure, a 
composite of suicidal acts and relevant hospital visits, or indeed on the majority of 
secondary outcome measures. Participants appear to benefit from both conditions, 
though some were still self-harming at the end of the study, and still fell in the 
clinical range on measures such as the Beck Depression Inventory (BDI-II; Beck, 
Steer, & Brown, 1996).   
  Blum and associates (Black et al., 2004; Blum et al., 2008) reported similar 
outcomes from their RCT of Systems Training for Emotional Predictability and 
Problem Solving (STEPPS), a group-based, intervention for BPD that is 
predominantly CBT-based, with an emphasis on skills development. It includes a 
systems element, in that significant others in the patient’s life, including healthcare 
professionals, are educated about BPD and are given guidance on how to most 
effectively interact with the patient. The approach is viewed as an adjunct to TAU 
(which might include one-to-one therapy), rather than as a stand-alone therapeutic 
intervention. The intervention is manualised and consists of 20, highly structured, 
weekly group sessions, and is described by the authors as easy for appropriate 
professionals to learn and to deliver effectively. In the one published RCT of the 
STEPPS approach, (Blum et al., 2008), participants in both the STEPPS and control 
(TAU) conditions improved on all outcome measures, but with no between-group 
differences in terms of self-harm, suicide attempts, or hospital admissions. It is now 
the authors’ view that these important behavioural changes may be unlikely to occur 
within a 20-week intervention. 
  These two relatively recent studies are of better quality than much of the 
published PD research, in terms of sample size and other design issues, and as such, CHAPTER I 
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the results can perhaps be viewed with more confidence than data from less well-
designed studies. It is clear from the existing outcome research that the field of 
cognitive interventions for PD is in its infancy. This is surprising given the 
dominance of cognitive approaches as empirically supported interventions for Axis I 
disorders. Of course, many CBT clinicians treating patients with mood or anxiety 
disorders are likely to be seeing some with co-morbid PDs, and perhaps are achieving 
good therapeutic results. However, there is little research examining the impact of 
these kinds of interventions for people with PD diagnoses.  
1.3.2.3 Dialectical Behaviour Therapy 
Arguably, dialectical behaviour therapy (DBT; Linehan, 1993) is the only 
psychotherapy for PD that currently meets the Division 12 Task Force criteria for a 
well-established psychotherapy (Chambless & Hollon, 1998). It certainly has by far 
the most empirical support amongst treatments for PDs (Lynch, Trost, Salsman, & 
Linehan, 2007). However, it has only been tested to this extent as a treatment for 
BPD, with more limited data available in relation to other diagnoses. For this reason, 
the NICE guidelines (2009) currently recommend considering DBT specifically as an 
intervention for women with BPD who are self-harming.  
 
1.3.2.3.1 Overview of DBT 
  DBT is a manualised psychotherapy originally developed to treat women 
meeting BPD diagnostic criteria, engaging in parasuicidal behaviours (Linehan, 
Armstrong, Suarez, Allmon, & Heard, 1991; Linehan, 1993a, b). It is a cognitive 
behaviour therapy that utilises both change and acceptance strategies, thus sharing 
common ground with other ‘3
rd wave’ CBTs (Hayes, 2004).  
  As its name suggests, DBT is essentially a behaviour therapy, and combines a 
range of behavioural strategies such as on-going functional analysis, behavioural 
experiments, contingency management, skills training, and exposure, with practices 
and principles rooted in dialectical philosophy and Zen Buddhism. The dialectical 
perspective assumes that every event or experience contains polarity, with each 
opposing position (referred to in dialectical philosophy as the ‘thesis’ and 
‘antithesis’) being seen as valid, even if apparently oppositional and contradictory. 
The tension between, and the synthesis of such polarities, is seen as the process CHAPTER I 
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through which change and progress can be made. The fundamental dialectic in DBT 
is between on the one hand, fully accepting the patient as they are, and on the other, 
the urgent need for them to change. This dialectical world-view permeates all of 
DBT, influencing every aspect of the therapy, including the basic structure of DBT, 
the structure and content of skills training modules, how therapist/patient conflict is 
addressed in the therapy, as well as specific therapeutic interventions.  
  DBT integrates a number of features of Zen Buddhism, both in terms of 
therapist assumptions and attitudes, and specific interventions and skills. 
Mindfulness, for example, is seen as a core skill in DBT, and is taught in a specific 
way that is tailored to the capabilities and needs of people with BPD diagnoses. 
  DBT is a comprehensive treatment package, as recommended for example by 
the NICE guidelines for treatment of BPD (2009). DBT interventions are designed to 
serve five functions; enhancing capabilities, increasing motivation, enhancing 
generalisation, structuring the environment, and enhancing therapist motivation and 
capabilities (Lynch et al., 2007). These functions can be addressed in a number of 
ways in DBT, but typical interventions or therapeutic modes that serve the five 
functions are (in turn), a skills training group, one-to-one therapy, out-of-hours 
telephone consultation between patient and therapist, clear DBT service leadership, 
and weekly DBT consultation meetings for therapists. DBT has been outlined in 
terms of four stages in addition to a formal pre-treatment phase, as follows: 
Pre-treatment. Designed to address orientation to the therapy, motivation, and 
commitment. 
Stage 1. Attaining basic capacities in the service of reducing high-risk behaviours. 
Stage 2. Addressing Posttraumatic Stress Disorder and exposure to previously 
avoided emotional experiences. 
Stage 3. Addressing other Axis I disorders, relationship, occupational and other issues 
of ‘”ordinary happiness and unhappiness” (Robins and Chapman, 2004). 
Stage 4. This stage was not described in detail in the original DBT references (e.g. 
Linehan 1993a), but is described by Lynch et al., (2007, p. 185) as “helping the client 
develop the capacity for freedom and joy.” All of the published research to date 
relates to Stage I. This stage of treatment is described in the literature in a great deal 
of detail, which can only serve to guide and support clinicians, and thus perhaps 
contribute to reasonable adherence to the approach in non-research, more typical CHAPTER I 
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clinical settings. There is little published literature delineating the features of later 
stages of the therapy.  
 
1.3.2.3.2 Biosocial Model of BPD 
DBT is based on a biosocial model delineating the aetiology of BPD 
(Linehan, 1993a), in which BPD is conceptualised as a disorder of emotion 
regulation, with consequent emotional difficulties negatively impacting interpersonal, 
behavioural, self and cognitive functioning. The biosocial model describes an on-
going transactional process that can commence early in childhood, through which 
biologically based emotional vulnerabilities on the one hand, and environmental 
invalidation and consequent poor emotion-modulation on the other, interact, 
amplifying emotion dysregulation and its subsequent negative impact on other areas 
of experience.   
  Writing in 1993, Linehan theorised that the emotional vulnerability associated 
with BPD is biologically underpinned. She considered the possible role of problems 
in the limbic system for example, though at the time there was limited relevant 
empirical evidence to develop this aspect of the model. Crowell et al. (2009) have 
revisited the biosocial model, reviewing a range of biological, genetic, and 
psychosocial research, which broadly speaking, offers support to the model.  Taking a 
developmental perspective, they also develop the model by outlining evidence that 
suggests that impulsivity may emerge earlier than emotional dysregulation amongst 
those who go on to develop BPD. Furthermore, impulsivity may contribute to the 
development of problems with emotional dysregulation. Finally, Crowell and 
colleagues outline a series of testable hypotheses related to the aetiology of BPD, 
directly based on the biosocial model.  
  This model has a number of strengths. As outlined above, it can be tested 
empirically, and has some empirical support. It also has clinical utility, in that it 
provides a non-stigmatising explanation for both staff and patients as to why people 
with BPD diagnoses often behave in challenging and anxiety-provoking ways. One 
limitation of the model is that it was originally developed to explain the aetiology of 
just BPD, despite evidence suggesting that there are general genetic and 
environmental factors that contribute to the development of many PD diagnoses, and 
that BPD is rarely a lone PD diagnosis. Lynch and colleagues (e.g. Lynch & CHAPTER I 
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Cheavens, 2008) have however recently adapted the model to address other PD 
presentations (see Section 1.3.2.3.5).  
 
1.3.2.3.3 Supporting Evidence: DBT and BPD 
There is a sufficient body of DBT-related outcome research to have warranted 
a number of review articles (e.g. Robins & Chapman, 2004, and Lynch et al., 2007). 
At the time of the 2007 review, there were seven published RCTs testing DBT as a 
treatment for BPD. An RCT comparing DBT, TFT, and a dynamic supportive 
intervention, (Clarkin, Levy, Lenzenweger, & Kernberg, 2007), and a larger-scale 
RCT comparing DBT with manualised general psychiatric management (McMain et 
al, 2009) have been published since. All trials are based in community/out-patient 
settings (as DBT was originally designed as an out-patient treatment), although 
promising data from a non-randomised trial is available for an in-patient adaptation of 
DBT for BPD (Bohus et al., 2002). 
  The first RCT examining the effectiveness of DBT for BPD (Linehan et al., 
1991; 1993; 1994) showed DBT performing significantly better than TAU in terms of 
reduction in the number of parasuicidal acts, medical risk associated with those acts, 
and the number of psychiatric in-patient days. However, there were no between-group 
differences found for depression, hopelessness or suicidal ideation, with 
improvements on these variables being reported for both conditions. Not all post-
intervention improvements were maintained at 6 and 12-month follow-up, though the 
authors concluded that overall, DBT remained superior to TAU.  
  This general pattern of findings, that is, reduction in high risk behaviours 
compared to a control condition but less impact on Axis I psychopathology and other 
variables, has been replicated in other RCTs of DBT with high risk BPD patients 
(e.g., Linehan et al., 2006). Interestingly the authors of this latter study concluded that 
the lack of a between-group effect for these variables was not due to inadequate 
statistical power, as it might have been in early studies with fewer participants (e.g., 
Linehan et al., 1991). This issue will be discussed in more detail in Section 1.3.3.3.  
  One criticism that has been levelled at the DBT evidence base (Scheel, 2000; 
Brazier et al., 2006) is that the control interventions in the majority of published 
RCTs are of poor quality (see Section 1.3.2.3.6 for a more detailed discussion of this 
and other criticisms). Brazier et al. recommend further trials directly comparing more 
than one established, manualised treatment to address this issue. There has been only CHAPTER I 
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one such RCT to date, comparing DBT, Transference-Focussed Psychotherapy 
(TFP), and Supportive Psychotherapy (SPT), conducted by Clarkin and colleagues 
(Clarkin, et al., 2004; 2007). Ninety patients with BPD diagnoses (history of 
parasuicidal behaviour was not a requirement) were randomly assigned, each 
participant receiving 12 months of psychotherapy. All conditions resulted in 
significant improvements in a number of variables including depression, anxiety, 
global functioning and social adjustment. DBT and TFP were equally associated with 
reduction in suicidality, whilst TFP and SPT were equally associated with 
improvements in anger. Overall, TFP was associated with changes in more variables 
than either DBT or SPT, although data was not reported on several important 
variables that DBT has been shown in the past to positively impact, such as 
hospitalisation rates. 
 
1.3.2.3.4 DBT, BPD and Axis I Disorders 
  There is a high degree of co-morbidity between BPD and Axis I disorders 
such as mood disorders, anxiety disorders, eating disorders and substance misuse 
(Zanarini, Frankenburg, Hennen, Reich, & Silk, 2004; Harned et al., 2008). The 
majority of the RCTs testing the efficacy of DBT for BPD have examined its impact 
on such disorders. In general, where DBT has been used primarily to address high-
risk behaviours, that is as a Stage 1 DBT intervention, (for example Linehan et al., 
1991; McMain et al., 2009), some significant improvements in Axis I disorders such 
as depression, have been demonstrated. However, there tend to be few significant 
differences between DBT and control conditions with regards to impact on Axis I 
symptomology. Furthermore, with these high-risk samples, despite some 
improvements in Axis I symptomology, participants still often fall into the clinical 
range for these disorders. For example, in the McMain et al. study, depression 
reduced from the severe to moderate range for both conditions. 
  In studies where DBT has been used with lower risk BPD patients, arguably 
as a Stage 2/3 DBT intervention, (for example Koons et al., 2001), greater impact on 
Axis I disorders has been reported, with some differences between conditions in 
favour of DBT. In the Koons et al. study, this is the case for depression, hopelessness, 
and anger, where for example, 60% of the DBT condition compared to 20% of the 
control condition met the criterion for clinically significant change for depression.  CHAPTER I 
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  It has been argued (Robins & Chapman, 2004; Linehan et al. 2006) that these 
findings make sense in terms of the DBT treatment model, in that with more risky 
patients, in accordance with the DBT treatment hierarchy, therapists should be 
targeting parasuicidal behaviours rather than Axis I disorders. However, with BPD 
patients who are not engaging in high-risk behaviours, therapy is more likely to be 
focussed on Axis I symptomology. The implication is that DBT is working as it 
should, regardless of the type of disorder it is addressing. However, the data do also 
suggest that DBT does not necessarily bring about clinically significant changes in 
both risky behaviours and Axis I symptomology at the same time. It does appear to be 
the case, for people with BPD diagnoses including parasuicidal behaviours, that they 
are likely to be far more behaviourally stable following 12 months of DBT, but they 
are also still likely to be experiencing considerable Axis I symptomology. To date, 
there is no published DBT-related research indicating how to help patients in this 
position move forward in their lives.  
 
1.3.2.3.5 DBT for Conditions Other Than BPD 
  Adaptations of DBT for the treatment of diagnoses other than PD, such as 
eating disorders and substance misuse will not be examined here (for a review see 
Lynch et al., 2007). However, Lynch and associates have developed and are trialling 
an adapted form of DBT for treatment-resistant depression (TRD) accompanied by 
some cluster A and C PDs (Lynch, 2000; Lynch, Morse, Mendelson, & Robins, 2003; 
Lynch et al., 2006). Lynch notes that individuals with TRD often have co-morbid 
PDs, particularly Paranoid PD, Obsessive-Compulsive PD, and Avoidant PD 
(referred to as emotionally over-controlled PDs), and hypothesises that certain 
maladaptive behaviours, emotional coping strategies, and interpersonal styles 
associated with these PDs are likely to make treatment of TRD more difficult and less 
successful, and should be directly targeted in therapy for TRD. 
  Lynch suggests that these PDs, and indeed TRD, share common features such 
as psychological rigidity, risk aversion, and over-control of emotional expression 
(Lynch, 2000; Lynch & Cheavens, 2008). He has developed an adapted form of 
Linehan’s (1993) biosocial model to account for the development of these personality 
features, hypothesising a genetic vulnerability for increased sensitivity to threat and 
insensitivity to reward, transacting with a childhood environment characterised by 
over-emphasis of performance and evaluation (Lynch & Cheavens). CHAPTER I 
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  This form of DBT shares many structural elements and much content with 
DBT for BPD, but primarily aims to “maximise openness and flexibility to new 
experience as well as to reduce rigid thinking and corresponding behavior” (Lynch & 
Cheavens, 2008, p. 166). A significant adaptation is the introduction of a new skills 
module addressing “Radical Openness”, focussing on openness to new experience 
and loving-kindness/forgiveness. 
Three RCTs testing versions of standard DBT with TRD have been published 
to date (Lynch et al., 2003; Lynch et al., 2006; Harley, Sprich, Safren, Jacobo &, 
Fava, 2008), and can be seen as steps towards the application of a more tailored DBT 
approach for TRD and PD. All three studies have shown DBT plus antidepressant 
medication to be superior to medication alone in the reduction of TRD 
symptomology. Furthermore, Lynch et al. (2006), based on an older adult TRD plus 
PD sample, reported that both conditions were associated with some improvements in 
PD symptomology, with the DBT condition in their study being associated with 
significantly larger reductions in interpersonal variables such as aggression and 
interpersonal sensitivity, which are commonly associated with PDs. The modified 
form of DBT outlined above is currently being trialled (Lynch et al., 2011 – 2016). 
 
1.3.2.3.6 Criticisms of the DBT evidence base 
  Although there are now a number of RCTs providing empirical support for 
DBT as a treatment for BPD, there are weaknesses to this evidence base. For the most 
part, these studies involve small numbers of participants, leading to a lack of 
statistical power to detect treatment effects, and making it difficult to generalise from 
study findings (Scheel, 2000). The majority of the existing RCTs have relatively short 
follow-up periods (typically 6 or 12 months), when the long-term nature of BPD is 
considered. Westen (2000) recommended collecting 3 or even 5-year follow-up data 
in trials of interventions for PDs. The majority of studies have included only female 
participants, making it difficult to generalise from the data. The proportion of women 
to men with a diagnosis of BPD is 3:1 (Widiger & Frances, 1989), thus leaving the 
treatment of a substantial minority of BPD patients without the direct support of the 
data. 
  Writing in 2000, Scheel concluded that the quality of control groups in the 
DBT RCTs for BPD was problematic. Most studies have used TAU as a control 
condition, often resulting in a control intervention significantly less structured, less CHAPTER I 
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coherent, less desirable to participants, and carried out by less experienced clinicians, 
than the DBT intervention. Of course, it could be argued that this is in part a result of 
the lack of alternative manualised psychotherapeutic interventions for BPD. 
However, in recent years, researchers have attempted to address this issue, by 
manualising and improving the quality of TAU (for example Linehan et al., 2006), 
and by beginning to conduct RCTs involving more than one recognised treatment 
(Clarkin et al. 2004; 2007). 
  Overall, Brazier et al. concluded in 2006 that the quality of DBT-related 
RCTs considered in their review was just moderate to poor, although their review was 
written prior to the publication of the more recent, better quality studies outlined 
above. In the same review, they also concluded that their findings did not indicate 
that DBT is a cost-effective intervention, though it might have the potential to be so 
in the future. 
  Since its development approximately two decades ago, DBT has been 
implemented in many health and social care settings internationally, with some 
arguing that the enthusiasm for the approach and the uptake of it ran ahead of the data 
supporting it (Westen, 2000). However, there is now a sizable body of evidence 
indicating that DBT is an effective intervention for reducing risk and hospitalisation 
for BPD patients. DBT can also be seen as having produced important positive effects 
in a more general sense. It has challenged the negative view within mental health 
services that PD, especially BPD, cannot be treated, bringing fresh hope and 
increased willingness to engage, for both staff and patients. This perhaps explains 
why DBT has been taken up with enthusiasm in many treatment settings. 
  Despite the positive impact of DBT, there are of course limitations to what it 
can achieve, as there are for all psychotherapeutic approaches. As outlined in Section 
1.3.2.3.4, it is common for DBT graduates with BPD to continue to have significant 
problems, even after they have ceased engaging in self-harm and other risky 
behaviours. Many continue to experience a range of DSM-IV Axis I disorders, such 
as mood or anxiety disorders. Many DBT graduates also report living restricted lives, 
with little engagement in social or occupational activities, and with little in their lives 
that has meaning for them. Some continue to have a sense of self that is defined by 
self-harm and suicidality, despite the fact that they no longer engaging in those 
behaviours.  CHAPTER I 
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  It would therefore seem important to consider the development of a 
psychotherapeutic intervention that could act as a secondary, post-DBT intervention. 
Such an intervention should be designed to enable DBT graduates to maintain 
progress made during DBT in terms of reduction of behavioural risk, to help them 
address on-going Axis-I disorders, and to offer them the possibility of building and 
engaging in more valued, satisfying lives. It is possible that a suitable post-DBT 
intervention might be found within the broad family of behavioural and cognitive 
behavioural psychotherapies, to which DBT itself belongs. 
 
1.3.3 Psychodynamic and Interpersonal Psychotherapies 
This varied group of psychotherapeutic approaches includes several forms of 
psychodynamic therapy, Cognitive Analytic Therapy (CAT; Ryle, 1990), and Schema 
Therapy (ST; Young, 1990). The latter, with its roots in the cognitive approach to PD 
could equally have been addressed with the cognitive and behavioural approaches 
(Section 1.2.1.1). However, it is included here as it shares important common ground 
with the other therapies in this section. The key unifying aspect of these approaches is 
that they are based on the hypothesis that therapeutic change is primarily achieved 
through enactments in the therapeutic relationship. For example, ST for PD has a 
focus on partial re-parenting (through which, according to the model, changes in 
maladaptive schemas are achieved), while Brief Relational Therapy (Muran, 
Samstag, Safran & Winston, 2005) is designed to address ruptures in the therapeutic 
alliance.  
  In their RCT comparing ST and TFT, Giesen-Bloo et al. (2006, p. 649) 
indicate that both of these approaches were designed to “bring about a structural 
change in the patients’ personality”, rather than just a decrease in parasuicidal 
behaviours. This is in contrast to many of the studies in the cognitive and behavioural 
group of interventions for PD, which tend to have the reduction of high-risk 
behaviours as primary outcome targets. It could be argued that this emphasis on 
impacting aspects of personality functioning, as well as risk (where appropriate), is 
another unifying feature of psychodynamic and interpersonal therapies for PD. See 
Appendix A for a summary of the principal characteristics and results for all relevant 
RCTs. CHAPTER I 
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1.3.3.1 CAT 
CAT (Ryle, 1990) is a time-limited (usually 16 or 24 sessions depending on 
the complexity of presenting problems) psychotherapy, rooted in a theoretical model 
that involves the integration of CBT and psychoanalytic approaches, particularly 
Object Relations Theory. It was developed to address the need in the UK public 
health system for a relatively short-term, empirically supported therapy that could be 
utilised in the treatment of a wide range of psychological difficulties, including more 
complex presentations.  
  Cognitive aspects of the therapy include sharing an explicit problem 
formulation with the patient, the setting of goals, taking a problem-solving stance, 
and the emphasis on a collaborative relationship between therapist and patient, in 
which the patient plays an active role (Denman, 2001). In terms of the analytic 
aspects of the therapy, Ryle has attempted to integrate into CAT a more readily 
understandable interpretation of core analytic concepts such as transference, 
countertransference, and projective identification (Ryle, 1994; 1998). Clarke et al. 
(2012) argue that CAT, with this central positioning of relationship within the 
therapy, may be in a particularly strong position to address the interpersonal 
difficulties with which all people with PD diagnoses, by definition, will struggle.   
  To date, there have been just two RCTs of CAT as an intervention for PD; 
Chanen et al. (2008), and Clarke et al. (2012). Both studies show some promising 
outcomes, with Clarke et al., for example, showing CAT out-performing TAU on 
several outcome measures, including PD diagnosis, with a mixed PD adult sample. In 
the Chanen et al. study, CAT was associated with significant improvements in a 
sample of adolescents with BPD symptomology, although there were no significant 
group differences between the CAT and control conditions. 
However, two small to medium sized studies, addressing different PDs in different 
populations, one of which focussed on participants who did not meet full PD 
diagnostic criteria (Chanen et al., 2008), cannot be regarded as substantial empirical 
support for CAT with PD, particularly as both studies have significant 
methodological shortcomings, such as uncontrolled follow-up and control conditions 
not designed specifically to treat PD. Despite some encouraging, early results from 
these two studies for this relatively brief, low-intensity therapy, much more research 
is needed. CHAPTER I 
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  Clarke et al. raise the interesting possibility that CAT brings about 
improvements in broad PD symptomology by impacting difficulties in interpersonal 
relating, a process that by definition is associated with all PD categories. Larger-scale 
studies would be required to formally investigate such hypothesised mechanisms of 
change, through mediational analyses. However, Clarke et al. did report a significant 
group difference in favour of CAT on a measure of interpersonal problems, a result 
consistent with their view of the role of CAT with PDs. 
 
1.3.3.2 ST 
ST (1990) is rooted in Beck’s original approach to PD, and integrates 
elements of CBT, object relations, humanistic and experiential approaches, 
particularly gestalt. It also has roots in attachment theory, with early adverse 
childhood experiences being seen as central to the development of PD pathology 
(Beckley, 2010). There is thus a developmental aspect to ST, with therapists taking a 
‘partial re-parenting’ role, intended to address emotional needs (directly through the 
therapeutic relationship) that were not met during childhood. It was developed to 
address the kinds of entrenched difficulties associated with PD that more traditional 
CBT appears to be less effective with (Beckley, 2010). 
  Young has identified 18 early maladaptive schema (EMS), such as 
‘unrelenting standards’ and ‘social isolation’, which are seen as having their roots in 
early, aversive experiences, cultural influences, and genetically-underpinned 
temperament. These EMS are not merely beliefs about self and others, but are more 
accurately seen as easily and repeatedly triggered themes that involve not just 
cognition, but memories, emotions and physical sensations.  
  Young sees a greater ‘gap between cognitive and emotive change’ (Young, 
2004) in the treatment of PDs compared with other disorders, and thus ST places 
more emphasis on experiential and interpersonal interventions designed to bring 
about emotional change, than more traditional CBT interventions for Axis I disorders.  
  As is the case with CAT, to date just two ST RCTS have been published, 
Giesen-Bloo et al. (2006), and Farrell, Shaw, & Webber (2009). Both studies tested 
ST as a treatment for BPD in adults, and both showed promising results. For 
example, in a reasonably well-designed study comparing ST and TFT, Giesen-Bloo et CHAPTER I 
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al. the authors reported significant improvements in a range of outcome variables, 
including parasuicidal acts, personality pathology and quality of life measures, for 
both conditions. ST outperformed TFT on all measures apart from quality of life. In a 
small-scale study with a poor quality, TAU control condition, Farrell et al. reported 
significant improvements on all outcome measures for ST, but none for TAU. The 
apparently broad impact of ST in both studies, leading to improvements in risky 
behaviours, PD pathology, general functioning, and quality of life, lends support to 
the view of both groups of authors, that ST addresses PD in a more comprehensive 
manor than some other psychosocial interventions for PD, such as DBT. 
  As is the situation with CAT however, although encouraging, these findings 
should be viewed with caution. The Farrell et al. study in particular is significantly 
flawed, with a small sample, poor control condition, and therapist adherence to ST 
not being independently rated. While Giesen-Bloo et al. is the better study, 
comparing two manualised, adherence-rated psychotherapies, it is also underpowered, 
and did not report follow-up data beyond the 3-year treatment period. The BPD 
sample for this study also appears to be somewhat less severe, in terms of 
parasuicidal behaviour, than is the case in a number of published DBT studies. 
Overall, substantial further research is required, particularly as ST remains untested 
with respect to the majority of PD diagnoses.    
   
1.3.3.3 Psychodynamic Psychotherapy 
The term psychodynamic psychotherapy (PP) is used to describe several 
interventions that share common ground but also differ in significant ways, both in 
terms of the theories on which they are based, and the form that the interventions 
themselves take. A detailed description of each of these approaches is beyond the 
scope of this review, but a brief outline of their shared features follows. In his 2005 
review, Leichsenring uses the Gunderson and Gabbard (1996, p. 685) definition of PP 
as follows: “a therapy that involves careful attention to the therapist-patient 
interaction, with thoughtfully timed interpretation of transference and resistance 
embedded in a sophisticated appreciation of the therapist’s contribution to the two-
person field”. Leichsenring suggests that the different models of PP can be 
conceptualised as operating on an “interpretive-supportive continuum” (Leichsenring, CHAPTER I 
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2005, p. 844). For example, TFT (e.g. Clarkin et al., 2004), with its emphasis on 
“clarification, confrontation, and interpretation within the evolving transference 
relationship” (Clarkin et al., 2004, p.58) could be viewed as being nearer to the 
interpretive end of the continuum. Brief Relational Therapy (BRT; Muran, Samstag, 
Safran & Winston, 2005), focussing on the therapeutic alliance, and repairing 
ruptures in this relationship, would be considered a more supportive therapy.  
  Several RCTs of PPs for PDs have been reported (see Appendix A for a 
summary of methodological features and results), which is encouraging, as there has 
been a commonly held belief that PP is untested and unsupported by empirical 
research (for example see Shedler, 2010; Anestis, 2010). However, as a result of 
several different PP models existing, and researchers targeting differing PD samples, 
there is only one instance of more than one RCT testing a specific intervention with a 
particular PD patient group, making it difficult to summarise the literature and draw 
conclusions about the state of the empirical support for PP as an intervention for PD. 
The one exception is that with the publication of Bateman and Fonagy, 2009, there 
are now two RCTs testing mentalization-based treatment (MBT) as an intervention 
for BPD (the other MBT RCT being Bateman & Fonagy, 1999).  
  In general, results are promising, with (for example) significant between 
group differences on several variables including parasuicidal behaviour and 
psychopathology favouring MBT (Bateman & Fonagy, 1999; 2001; 2009), when 
compared to TAU or structured clinical management, for BPD patients. Unlike 
several of the studies evaluating DBT for high-risk BPD patients (for example 
Linehan, et al., 2006), Bateman and Fonagy report significant greater improvements 
in some Axis I psychopathology compared to a control condition. However, both 
MBT cohorts remained within the clinical range for both depression and anxiety 
following 18 months of treatment. Typical of several studies in this section, Clarkin 
et al. (2004), testing TFT for BPD, report significant improvements on many outcome 
measures, including measures of parasuicidal behaviours, but with few between 
group differences being reported in either study.  
  One of the relative strengths of the PP evidence base is that it includes a 
number of studies that have tested PPs as interventions for non-BPD PDs. For 
example, Svartberg, Stiles & Seltzer (2004), and Muran et al. (2005) tested short-term 
dynamic psychotherapy (STDP) and BRT respectively, as interventions for Cluster C 
PDs. In both studies, significant improvements (maintained at follow-up) were CHAPTER I 
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reported on all outcome measures, although in neither study did the PP condition 
outperform control conditions.  
  As with the CAT and ST evidence bases, there are significant problems with 
the quality of PP-focussed RCTs. The majority of studies are underpowered, many 
have poor quality control conditions, and two studies (Bateman & Fonagy, 1999, and 
Muran, Samstag, Safran & Winston, 2005) have compromised randomisation 
procedures. Follow-up procedures vary from no follow-up data being reported (e.g. 
Gregory et al., 2008) through to relatively long-term, controlled follow-up (Svartberg, 
Stiles & Seltzer, 2004). 
  The conclusions drawn in the literature based on this small collection of 
studies varies considerably. At one extreme, Leichsenring and Leibing (2003) in their 
meta-analysis of the then available PP and CBT data for PDs conclude that both 
approaches are effective treatments for PD, with larger effect sizes reported for PP. 
Referring to this meta-analysis, Shedler (2010), in his review of the general efficacy 
of PP, concludes that there is good empirical support for PP for PDs. At the other 
extreme, Anestis (2010), in his critique of the Shedler review argues that the 
Leichsenring and Leibing meta-analysis is seriously flawed, and that the conclusions 
drawn by the authors and by Shedler are not supported by the data. Suffice it to say, 
despite some promising findings, as a result of the limitations of the research in terms 
of quality, and lack of replication, more studies are required before any PP could 
confidently be viewed as an efficacious treatment for any PD diagnosis. 
 
1.3.4 General Discussion of Psychosocial Treatment Literature 
  Given the widespread negativity in clinical and academic settings about 
treatment outcomes for PDs until relatively recently (e.g., Sperry, 1995), it is 
heartening to note in excess of 20 RCTs evaluating psychosocial interventions for 
PD. The majority of these studies report positive outcomes, at least statistically, 
although whether this implies clinically meaningful changes for patients will be 
discussed below.  
  The vast majority of PD treatment research focuses on BPD, perhaps 
understandably, given the risks and demands associated with this patient group. There 
appears to be a broad pattern of outcomes from these BPD studies. Where high-risk CHAPTER I 
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behaviours have been an inclusion criterion or have been very common in a sample, 
the interventions involved, for example, DBT and MBT, have led to significant 
reductions in these behaviours compared to control conditions. For the most part, 
although DBT has resulted in reductions in Axis I disorders such as depression, with 
these high-risk patients, in several studies it has not outperformed control conditions 
in relation to these disorders. In BPD studies where there appears to be lower 
frequency of recent engagement in parasuicidal behaviours, for example, Koons et al., 
(DBT; 2001) and Giesen-Bloo et al., (ST; TFT; 2006), interventions tend to be 
associated with improvements in both risk behaviours and other PD and Axis I 
psychopathology variables. The partial exceptions to this pattern are the two MBT 
trials (Bateman & Fonagy, 1999; 2001; 2009), where greater reductions in both risk 
behaviours and some Axis I psychopathology compared to the control condition, 
were reported, although many patients still remained within the clinical range for 
depression (for example), following 18-months of treatment. 
  It has been argued (Giesen-Bloo et al., 2006, p. 657) that “DBT and MBT are 
possibly optimal for a subgroup of patients with BPD who have prominent 
parasuicidal abnormalities, whereas SFT and TFP are meaningful for the wide range 
of patients with BPD”. Whilst this speculation is useful in that it draws attention to 
the possibility of matching interventions to specific patient need, a great deal more, 
and better quality research is required before this question can be meaningfully 
addressed. For example, the Giesen-Bloo et al. study is one of just two tests of ST for 
BPD, both of which are underpowered.  
  Compared to BPD, the other PD diagnoses form a neglected majority in terms 
of empirical investigation (Duggan et al., 2007). Studies involving non-BPD patients 
tend to be trials of psychodynamic and interpersonal therapies, all of which report 
improvements on a range of PD and Axis I psychopathology variables, though a 
number (e.g. Vinnars, Barber, Noren, Gallop, & Weinryb, 2005) report no between-
group differences. An exception is Clarke et al. (2012), which indicated CAT to be 
superior to TAU on the majority of their outcome measures. Clarke et al. is also in a 
minority in that the intervention was designed to be effective across PD categories, an 
approach it can be argued should be more common, given the levels of PD 
comorbidity. Although primarily addressing TRD and still under development, the 
work of Lynch and associates (also designed to impact transdiagnostic PD features), CHAPTER I 
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may help shed light on the therapeutic needs of some patients with non-BPD PD 
presentations. 
  Overall, the quality of PD outcome research is improving. More recent studies 
have been based on larger samples (e.g. Doering et al., 2010), and better quality 
control conditions (e.g. Linehan et al., 2006). However, there are still sufficient 
problems with both the limited extent of the empirical literature, and the quality of 
the research, that in 2008, ∅st concluded that DBT, the therapy for PD with the most 
empirical support, could not be considered an empirically supported treatment (EST). 
Other authors (Lynch, et al., 2007) argue that DBT is the only psychosocial 
intervention for BPD that does meet the EST criteria. 
  It is clear from this review that despite some promising outcomes from the 
existing studies, there are many gaps in the PD intervention empirical literature. For 
example, there has been virtually no investigation of mechanisms of change in 
interventions for PD, an essential aspect of psychotherapy development (Kazdin, 
2007). At a more basic level still, there are just a handful of studies that focus on 
treatment of PDs beyond BPD, an issue that could be addressed in two ways. Firstly, 
following the general pattern in the literature to date, further trials could be conducted 
to evaluate interventions with each specific PD diagnosis. However, given the high 
level of comorbidity amongst PD diagnoses and the likely move away from a 
categorical conceptualisation of problematic personality functioning in DSM-V, 
another legitimate option would be to conduct intervention trials with mixed PD 
samples, using general personality functioning as a dependent variable. 
  Finally, even in the case of DBT, the therapy with the most substantial 
empirical support, further research is required. As outlined in Section 1.3.2.3.6, 
patients with histories of parasuicidal behaviours who benefit from DBT, often still 
report substantial psychological difficulties, and may be living unfulfilled lives of 
“quiet desperation” (Dimeff & Linehan, 2001, p. 2). There is a clinical need for the 
development of either an adapted form of DBT that can address risky behaviours and 
address Axis I and engagement in life problems more successfully, or an alternative, 
post-DBT intervention, designed to improve the lives of DBT-graduates, once they 
are behaviourally stable. If a post-DBT intervention were to be developed, basing it 
on a psychosocial intervention that shares common ground with DBT might make the CHAPTER I 
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transition from one therapy to the other easier for patients. This might suggest a 
behavioural or cognitive behavioural intervention 
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CHAPTER II 
 
Behavioural and Cognitive Behavioural Psychotherapies 
 
2.1 First and Second Wave Behavioural and Cognitive Behavioural 
Psychotherapies 
From the 1950s to the 1970s, a range of behavioural psychotherapy 
interventions was developed, based on the respondent and operant conditioning 
principles outlined by Pavlov, Skinner and others. At that time, psychodynamic 
theories and psychotherapies were dominant within psychology and psychiatry, and 
behaviourists such as Eysenck (1966) were critical of the lack of compelling 
empirical support for (typically lengthy) psychodynamic treatments of psychological 
difficulties. Time limited, empirically testable behavioural interventions were 
developed as alternatives (Clark, Beck, & Alford, 1999). It has been argued (Dougher 
& Hayes, 2000) that these behavioural approaches, referred to as first wave behaviour 
therapies (Hayes, 2004), fell into two broad camps; those with their roots in a 
Skinnerian, operant approach, involving behavioural analysis and direct contingency 
management, often focused on children and adults with developmental difficulties 
(e.g. Lovaas et al., 1973), and those rooted in Pavlovian learning theory, applying 
techniques such as systematic desensitisation and extinction to phobias, for example 
(e.g. Wolpe 1958; 1969).  Behaviour analysis has continues to be influential in the 
treatment of people with developmental disorders to this day (e.g. Remington, et al., 
2007). However, the application of behavioural principles to the treatment of adults 
with mental health problems (often referred to as ‘behaviour therapy’) has undergone 
radical change over the last three decades.  
  These changes in behavioural interventions for mental health problems have 
been influenced by a number of factors. Firstly, despite some empirical support, there 
were criticisms of behavioural models, including that behavioural models of 
depression did not satisfactorily account for cognitive and affective symptomology 
(Eastman, 1976). Adults with depression and anxiety appeared to respond according 
to their perceptions of a situation, rather than merely to environmental reinforcers 
(e.g. Bandura, 1969; 1971), and behaviour theory at the time was viewed as being 
unable to give an adequate account of the role of cognition. In fact Skinner (1957; CHAPTER II  
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1969) had written extensively about verbal and rule-governed behaviour, arguing that 
direct operant processes apply to verbal behaviour as much as to non-verbal 
behaviour (Blackledge, 2007). However, neither the behavioural nor cognitive 
academic communities substantially developed this aspect of Skinner’s work at the 
time and Hayes et al. (2006) suggest that Skinner was not able to give an adequate 
account of cognition, a view that has led to the development of relational frame 
theory (RFT; Hayes, Barnes-Holmes, & Roche, 2001. See Section 2.2.1.1). 
  Other criticisms were that supporting evidence for behavioural interventions 
often involved single case studies or was correlational in nature (Blaney, 1977), 
rather than being based on controlled trials. The predominant view in psychology and 
psychiatry was that there were limitations to the effectiveness and appropriateness of 
these kinds of behavioural interventions, particularly in the treatment of complex 
mental health problems.  
  A second wave of therapies (cognitive and cognitive behavioural therapies) 
developed against the backdrop of a shift in the experimental psychology world 
towards cognitive science (Farmer & Chapman, 2008). Despite this, Hayes et al., 
(2006), amongst others, (e.g. Teasdale & Barnard, 1993) suggest that the clinical 
cognitive models developed by Beck and others (Beck 1976; Ellis, 1962) were just 
that, clinically derived models that included cognitive mediators of behaviour, that 
had little in common with basic cognitive science. In fact Beck himself states that the 
most important influence on his development of cognitive theory and intervention for 
depression, his first application of a cognitive perspective, came from his own clinical 
experiences and his attempts to empirically test aspects of the psychodynamic therapy 
he was practicing at the time (Clark, et al., 1999). From this early work Beck (1967) 
concluded that negative judgements about self, the environment and the future (now 
referred to as the negative cognitive triad) appeared to play an important role in 
depression. 
   Ellis, Beck and others developed cognitive therapies designed to treat 
depression initially, though cognitive behaviour therapy (CBT) has now been applied 
to many psychological difficulties. These approaches are based on a cognitive model 
that emphasises the importance of an individual’s perception of themselves and 
events in their lives, thus improving on one of the limitations of first wave 
behavioural theories. Beck’s clinical cognitive model assumes that all human 
cognitive processing is biased; that is, cognitions can only ever be approximate CHAPTER II  
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representations of events. Certain kinds of systematic biases in cognitive processing 
are implicated in the development and maintenance of psychological problems such 
as depression and anxiety. According to the model, meaning-making schemas 
develop though interaction between the individual and their environment (there are 
also genetic influences), and it is the interaction of these schemas with experience of 
events that can lead to the development of unhelpful, negative cognitions. Given the 
central role played by such cognitions and schemas in cognitive theory, bringing 
attention to these cognitive constructions, and addressing the content and accuracy of 
biases in them, is central to the cognitive interventions. 
  CBT is currently the dominant form of psychotherapy for mental health 
problems (Medical Research Council, 2010). There is a large body of outcome data 
supporting CBT-based approaches (see Butler et al., 2006 for a review). CBT is 
recommended in the NICE guidelines for a range of DSM-IV Axis I disorders, 
including depression and anxiety disorders. It is no exaggeration to say that CBT has 
revolutionised the treatment of common psychological problems, making time-
limited, and empirically supported psychological interventions for common mental 
health problems widely available.  
  As happened with the first wave of behaviour therapies, however, second 
wave therapies are now also subject to criticism, both on theoretical and clinical 
effectiveness grounds. A number of ‘dismantling studies’ designed to shed light on 
the effective aspects of CBT have indicated that in fact the behavioural component 
tends to be as or more effective than full CBT in the treatment of depression 
(Jacobson et al., 1996; Dimidjian et al., 2007). These findings, though based on just 
two studies, challenge a central tenet of the cognitive model, namely that “change in 
beliefs is the primary mechanism of change in cognitive therapy” (Hollon & Beck, 
2004, p. 453) and that therefore addressing negative cognitions will reduce depressive 
symptomology. Similarly, Jarrett, Vittengl, Doyle, and Clark (2007) found that 
changes in cognitive content in CBT for depression, were as predicted by the 
cognitive model, but that those changes did not predict therapeutic outcome. In fact, 
improvement in depressive symptomology predicted change in cognition.  
  In terms of treatment outcomes, there are concerns about the proportion of 
patients who do not respond to CBT or who relapse following CBT (e.g. Dimidjian et 
al., 2007). Furthermore, CBT is less effective for individuals with more complex 
presentations, especially those with both Axis I and Axis II disorders (Westbrook & CHAPTER II  
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Kirk, 2004). Indeed, patients with these types of presentations, though clinically 
common, have routinely been excluded from studies testing the effectiveness of CBT 
(Seligman, 1995). In response to these limitations and criticisms, a third wave of 
therapies has been developed. 
 
2.2 Third Wave Psychotherapies 
  Third wave behavioural and cognitive behavioural psychotherapies have been 
described by Hayes (2004) as being “particularly sensitive to the context and 
functions of psychological phenomena, not just their form, and thus they tend to 
emphasise contextual and experiential change strategies in addition to more direct and 
didactic ones. These treatments tend to seek the construction of broad, flexible and 
effective repertoires over an eliminative approach to narrowly defined problems” (p. 
658). These therapies include DBT (Linehan, 1993), mindfulness-based cognitive 
therapy (MBCT; Teasdale et al., 2000), and ACT (Hayes et al., 1999). 
Fundamentally, what these approaches have in common is a recognition that it is not 
necessarily the content of personal experiences such as thoughts and emotions that 
lead to psychological difficulties, but rather the function of these private experiences 
and the way in which an individual relates to them. Patients are therefore enabled to 
develop a different kind of relationship to their private experiences, in which they can 
‘step back’ and observe experiences such as thoughts and emotions, without them 
dominating the individual’s behaviour.  
  Third wave therapeutic approaches have shown clinical promise, particularly 
for people with entrenched mental health problems. As outlined in Chapter I, DBT is 
an effective treatment for people with BPD. MBCT has been shown to be effective in 
preventing relapse in chronic depression (Teasdale et al., 2000). However, both 
therapies were originally developed to address specific clinical diagnoses and, 
although work is underway to test them with other diagnoses, this research is at a 
relatively early stage. Given that people with PD diagnoses tend to present with 
comorbid Axis-I and Axis-II difficulties, and often with more than one PD diagnosis, 
a third wave psychotherapy designed to be more generic in application might be of 
particular relevance to this patient group. CHAPTER II  
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2.2.1 ACT 
ACT is a third wave therapy combining behavioural change and acceptance 
interventions. Philosophically, it is grounded in functional contextualism (Biglan & 
Hayes, 1996), which has the aim of  “the prediction and influence of events, with 
precision, scope and depth”, (Hayes, 1993). As such, private experiences such as 
thoughts and emotions are viewed as not causing other behaviours, except under the 
influence of context, which suggests therefore that it is the context rather than the 
content of such experiences that should be addressed in the therapy. Also related to its 
philosophical basis, ACT emphasises workability (of, for example ‘buying into’ the 
content of a thought), rather than the truth or accuracy of that thought.  
ACT is rooted in Relational Frame Theory (RFT; Hayes, Barnes-Holmes, & 
Roche, 2001), which implicates naturally occurring features of human language and 
cognition in the development of psychological suffering. Hayes, Luoma, Bond, 
Masuda, and Lillis, 2006, described RFT as a contextual theory of cognition. A 
clinical model is used to understand how processes such as cognitive fusion (CF) and 
experiential avoidance (EA) (see Section 2.2.1.2 for definitions) that are hypothesised 
to be the naturally occurring consequences of language (Hayes et al., 1999), lead to 
and maintain such suffering. As ACT is designed to address these processes, it should 
be effective in ameliorating psychological suffering across diagnostic categories. The 
development of this type of transdiagnostic therapeutic approach is encouraged by the 
Medical Research Council Review of Mental Health Research (MRC; 2010). 
 
2.2.1.1 RFT 
	 ﾠ RFT (Hayes et al., 2001) is a contemporary behaviour analytic account of 
human language and cognition. It is a development of earlier work by Hayes and 
colleagues (e.g., Zettle & Hayes, 1982) on stimulus equivalence, which in turn 
addressed perceived limitations in Skinner’s (1959) account of verbal behaviour 
(Gross & Fox, 2009). A detailed examination of RFT is beyond the scope of this 
thesis (see Hayes, et al., 2001, and Tӧrneke, 2010 for comprehensive accounts), but 
there follows a summary of the essential points.   
  ACT is based on the view that human psychological suffering appears to be 
ubiquitous and that specific universal human processes are responsible for this CHAPTER II  
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suffering, despite it taking many different forms. RFT implicates human language 
and cognition, hypothesising that one feature of human language in particular, a form 
of operant conditioning known as derived relational responding, is at the heart of 
both human flourishing and suffering.  
  Relational framing is essentially the learned capacity to arbitrarily relate any 
stimulus with any other stimuli, a capacity that has three main features: 
1. Mutual entailment. This refers to the observation that when a relationship between 
two stimuli, (X is related to Y), is trained in a human with verbal capacity, the 
relationship Y is related to X is derived, without being directly trained. The form of 
these bidirectional relationships can vary. For example, if X is smaller than Y, then Y 
is larger than X, or if X is nearer than Y, then Y is further away than X. 
2. Combintorial mutual entailment. Furthermore, if the relationships between X and 
Y and X and Z are trained, not only are the relationships between Y and X and Z and 
X derived without direct training, but the relationships between Y and Z and Z and Y 
are also derived, without the individual ever having experienced those two stimuli 
together.  
3. Transformation of stimulus functions. Not only are the relationships between 
events and stimuli derived as outlined above, but if one stimulus has a particular 
function, for example as a reinforcer, then this function will be acquired by the other 
stimuli in the same relational frame. Additionally, if X is in a relationship of 
‘opposite’ to Y, and X is a reinforcer, then not only will the stimulus function of X be 
transferred to Y, but Y will have the function of a punisher. This phenomenon 
continues to be observed when several relationships are combined through 
combinatorial mutual entailment. 
  These phenomena begin to be observed as young children start to develop 
language. Initially, relatively simple frames develop, such as frames of co-ordination 
(similarity or sameness). Later, more complex frames emerge, including frames of 
comparison (e.g. bigger/smaller and better/worse), and deictic frames, in which 
stimuli relationships are specified in terms of the perspective of the individual (e.g. 
I/you, here/there, now/then, mine/yours). To date, derived relational responding, also 
known as relational framing, has not been observed in other species. 
  Hayes, Strosahl, and Wilson (2012) argue that what RFT offers that is 
superior to earlier accounts of stimulus equivalence and derived stimulus relations 
(Sidman, 1971, for example), is that it is an attempt to provide a process-based CHAPTER II  
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account of these relations (the process being relational framing), and applies this 
account across many types of stimulus relations, not just equivalence. 
  The ability to learn and apply relational framing offers the possibility of 
solving complex problems, of reasoning, of creativity, and of changing hostile 
environments; abilities that are essential to our survival and that have contributed to 
our becoming the dominant species on the planet. However, these very same 
cognitive capacities, the three features of relational framing described above, give us 
a “broadened interface with pain” (Torneke, 2010, p. 134), compared to non-verbal 
animals. Basically, we have the verbal tools to torment ourselves psychologically. For 
example, through the transfer of stimulus functions, we can become fearful of a 
stimulus even though we have never been in the presence of that stimulus, let alone 
had an aversive experience with it, if it is in a relational frame with a stimulus that 
does have those functions for us. Stimuli can be made psychologically present, 
including those from our pasts or imagined futures, with all that might be entailed 
emotionally, even though those stimuli are physically absent. 
  Hayes et al., (2006) argue that because the same processes that lead to 
psychological pain are also essential for our survival, it is not practical to develop a 
way to end or control relational framing. Therefore, approaches to psychological 
suffering that do not attempt to eliminate framing, but rather are designed to reduce 
its unhelpful effects, might be beneficial. Specifically, it is difficult to control, reverse 
or otherwise avoid relational framing, but it is (according to RFT) possible to 
contextually control the negative functions of relational frames that involve aversive 
stimuli. ACT was developed precisely for this purpose.  
  There is a growing body of research findings supportive of several aspects of 
RFT. For example, there is evidence that various types of framing with abstract tasks 
can be trained in young children (e.g. Barnes-Holmes, Barnes-Holmes, Smeets, 
Strand, & Friman, 2004). Also, transformation of stimulus functions can be 
demonstrated with combintorial mutual entailment (Dougher, Hamilton, Fink, & 
Harrington, 2007). For Hayes and collaborators it is important that ACT is grounded 
in RFT, which has developed out of basic science, rather than ACT being based on a 
clinical theory, a criticism they level at traditional CBT ((Hayes, et al., 2006; Wilson 
& Bolderston, 2011).  
  RFT has been the subject of criticism, with Palmer (2004) for example 
arguing that RFT experiments do not attend to covert verbal behaviour, and that some CHAPTER II  
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account of relational framing could be integrated into Skinner’s original (1957) 
analysis of verbal behaviour. McIlvane (2003) has questioned whether there is a 
substantive difference between RFT and earlier accounts of stimulus equivalence. 
Tonneau (2001) has also criticised RFT for perceived lack of precision and over-
simplification. There has been a vigorous rebuttal of these criticisms (Barnes-Holmes 
& Hayes, 2002; Gross & Fox, 2009). 
 
2.2.1.2 Psychological Inflexibility Model
1 
  As described in Section 2.3.1, RFT suggests that although relational framing 
offers significant survival advantages for humans, it also has less helpful 
psychological consequences. For example, given that we can arbitrarily relate any 
stimuli, and given that verbal stimuli can take on the functions of other stimuli in a 
relational frame, we are likely to have many aversive psychological experiences that 
cannot be avoided simply by avoiding specific situations. Instead, we develop 
strategies to try to avoid private experiences such as memories and emotions, a 
process referred to as experiential avoidance (EA). Relational framing allows verbal 
events to dominate behaviour, so that we can respond to the thought ‘I am unlovable’ 
as if it is reality, perhaps by feeling sad or ashamed, and by avoiding intimacy. This 
process of taking verbal events to be reality is known as cognitive fusion (CF). A 
model of human functioning and suffering (Hayes & Strosahl, 2004), has been 
developed to account for the way in which EA, CF, and related processes impact 
psychological functioning.  
The model suggests that it is psychological inflexibility (excessive verbal 
control over behaviour and the inability directly to contact environmental 
contingencies, reducing the ability to take action in a valued life-direction) that 
contributes to the development and maintenance of psychopathology. The processes 
addressed in the model are described dimensionally, accounting for what Hayes et al., 
(2012, p. 61) have referred to as the “continuous nature of human behaviour”. As a 
dimensional model, it is in keeping with the dimensional approach increasingly being 
                                                 
1 The psychological inflexibility model is often referred to as the ‘ACT model’ or the ‘hexaflex model’ 
in the ACT literature (e.g. Hayes et al., 2006). Accordingly, in this thesis these terms will be used 
interchangeably, acknowledging the possibility that the processes addressed in the model may have 
relevance beyond ACT. CHAPTER II  
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taken to modelling personality functioning, the clinical issue relevant to this thesis 
(see Chapter I). 
The ACT model can be expressed in terms of both psychological inflexibility 
and flexibility, the latter being hypothesised to be associated with psychological 
wellbeing (see Figures 2.1 and 2.2). The model outlines six inter-related 
psychological processes that contribute to psychological flexibility/inflexibility. Each 
of the six processes have been named and defined separately (e.g. Hayes, et al., 
2006,) with the implication being that although they are related, each process could 
also be measured and manipulated individually. 
 
 
Figure 2.1 ACT Model of Psychological Inflexibility 
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Figure 2.2 ACT Model of Psychological Flexibility 
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report measures (Cronbach & Meehl, 1955). In this thesis, the terms process and 
construct will both be used, depending on the context. 
  A number of studies in this thesis will contribute to the empirical examination 
of the psychological inflexibility model, both through the validation of a new self-
report measure of CF, (see Chapter IV), through attempts to use this measure to 
examine the relationship between CF and other processes from the model, and to test 
the relationship between CF and poor personality functioning (see Chapters V and 
VI). In the meantime, in the service of clarity and a detailed understanding of the 
central ACT model, the six processes will each be described separately. Given that 
CF is the focus of this thesis, it will be addressed in greater detail than the other 
processes.  
 
Inflexible Attention ---- Flexible Attention to the Present Moment  
  The ability to be ‘present’ with environmental and psychological experiences 
as they occur, moment by moment, is seen as beneficial in the ACT model. Being in 
the present moment makes it more likely that the individual will be psychologically 
available to be impacted by environmental contingencies, rather than merely being 
dominated by verbal events, and thus being in the present moment can undermine CF. 
At the less psychologically helpful pole of this dimension is inflexible attention, 
where the individual’s attention is dominated by private experience such as 
cognitions, often relating to past experiences (memories) or possible future 
experiences (worries). 
  Examining the emotional impact of attention wandering from the present 
moment, Killingsworth and Gilbert (2010) conducted a large-scale study (N = 2250) 
using an iPhone application. They gathered data at random intervals from 
participants, noting what activity the participant was engaged in, where their attention 
was, and their current level of happiness. The results showed that mind-wandering 
(not being in the present moment) occurred approximately 50% of the time, was 
ubiquitous across activities, and was a better predictor of happiness (or lack of it) 
than activity. In fact mind-wandering tended to be associated with unhappiness, with 
time-lag analysis indicating that mind-wandering tended to precede unhappiness 
rather than the other way round. 
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Experiential Avoidance ----- Acceptance of/ Being Open to Experience 
  EA has been defined as “the phenomenon that occurs when a person is 
unwilling to remain in contact with particular private experiences (e.g., bodily 
sensations, emotions, thoughts, memories, behavioural predispositions) and takes 
steps to alter the form or frequency of these events and the contexts that occasion 
them” (Hayes, Wilson, Strosahl, Gifford, & Follette, 1996). Attempts to avoid private 
experiences are not always problematic; there are circumstances where temporary 
suppression of a private experience can be adaptive or at least not harmful; for 
example, using distraction to cope with a time-limited, one-off procedure at the 
dentist is unlikely to lead to lasting psychological difficulties. It is the over-reliance 
on and rigid application of EA that leads to and maintains psychological problems 
(Hayes, et al., 2012), in part at least as a result of the ‘rebound effect’ that is well 
documented in the thought and emotion suppression literature (e.g. Abramowitz, 
Tobin, & Street, 2001). In the ACT model, acceptance of or openness to experience is 
seen as an alternative to EA, where acceptance is defined as "actively contacting 
psychological experiences—directly, fully, and without needless defence” (Hayes, et 
al., 1996, p. 1163).  
By far the largest body of empirical research connected to the inflexibility 
model is the large number of studies supposedly examining EA. This process has 
been shown to be associated with an array of psychological diagnoses, and to predict 
outcomes in ACT intervention studies (see Hayes, et al., 2006, for a summary of this 
research). The overwhelming majority of these studies have used the Acceptance and 
Action Questionnaire (AAQ; Hayes et al., 2004), to measure EA, but in fact the AAQ 
appears to measure a broader construct than EA (see Chapter VI, Section 6.1.3 for 
more details). The many published studies showing the relationships between EA and 
other variables are therefore relevant to EA, but not merely EA. In this thesis, 
whenever the AAQ is referred to (as opposed to the AAQII), it will be understood 
that the authors of the research under discussion intended to measure EA (not 
inflexibility), despite the measure containing some non-EA focussed items. 
Testing the hypothesis that acceptance of private experiences is advantageous 
in terms of psychological functioning, there are a small number of component studies 
that have examined the impact of brief acceptance interventions, with positive results 
being reported. For example, Levitt, Brown, Orsillo, & Barlow (2004), compared an 
ACT-style acceptance intervention with thought suppression and distraction CHAPTER II  
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conditions, with a sample of individuals with panic disorder. They found that the 
acceptance group were more willing to participate in a CO2 challenge task, and 
reported feeling less anxious than the other groups, despite no physiological 
differences being found between the three groups. 
Cognitive Fusion ----- Cognitive Defusion 
  CF has been defined by Strosahl, et al., (2004, p. 32) as “excessive attachment 
to the literal content of human thought that makes healthy psychological flexibility 
difficult or impossible”. It has also been defined as occurring “when an individual’s 
verbal processes (i.e., thoughts) markedly regulate overt behaviour in ineffective 
ways due to an inability or failure to notice the process of thinking, or context, over 
the products of thinking, or content” (Ciarrochi, Bilich, & Godsell, 2010, p. 53). For 
example, an individual might experience thoughts about a possible future event, such 
as the death of a loved one, as if those thoughts are descriptions of reality, or even as 
if those thoughts are actual current reality. This means that it is possible for an 
individual to be sitting next to a very much alive loved one whilst at the same time 
experiencing emotional and even physiological aspects of grief over their imagined 
future death. Aspects of fusion, as it is outlined in the ACT literature, include the 
dominance of thoughts in the field of awareness, and over emotion and action, the 
inability to view thoughts from different perspectives, psychological entanglement 
with thoughts, and taking the content of thoughts to be literal reality. 
The risk to psychological wellbeing from CF is that when fused, the 
individual’s behaviour is influenced more by inflexible and insensitive verbal rules, 
with attention being dominated by the content of thoughts, and less by direct contact 
with environmental contingencies. This means, for example, that an individual’s 
behaviour may be influenced unhelpfully by a rule or other thoughts (e.g. ‘I can’t go 
out with the other students after class because I get too anxious’; ‘they think I’m 
boring’). People with their attention caught up in these kinds of thoughts are less 
‘available’ to register and be impacted by direct environmental contingencies, such as 
classmates smiling at them or momentary feelings of warmth when someone talks to 
them in class. The result may be increased avoidance of social situations and 
ultimately even the development of a self-maintaining social anxiety problem. 
In the ACT literature, due to the impact of relational framing, CF along with 
EA, is seen as a particularly powerful determinant of psychological inflexibility, and 
hence these processes “prolong suffering” (Ciarrochi, et al., 2010, p. 53), and play a CHAPTER II  
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central role in the development and maintenance of psychopathology Hayes & 
Strosahl, 2004). Furthermore, CF is viewed (Hayes, et al., 2006), as leading to and 
supporting EA. As an example, individuals who are fused with thoughts such as ‘I am 
unlovable’ may experience these thoughts to be reality, with their attention dominated 
by such thoughts, which understandably would be aversive. This might lead to EA to 
try and reduce the aversive impact of the thoughts. Individuals who have similar 
thoughts but who are able to see them as ‘just thoughts’ and who can view 
themselves from other perspectives too, are less likely to experience such aversive 
reactions and are therefore less likely to resort to EA.  
This latter capacity is referred to as cognitive defusion, and is at the more 
psychologically healthy pole of this dimension. There are dozens of cognitive 
defusion techniques used within ACT (see Hayes and Strosahl, 2004, for examples), 
which have been designed to reduce fusion. There have been a number of 
experimental studies designed to test brief defusion interventions, usually in relation 
to aversive stimuli such as negative self-statements. For example, Masuda and 
colleagues have conducted a series of studies investigating the impact of rapid 
repetition of self-referential negative words (Masuda, Hayes, Sackett, & Twohig, 
2004; Masuda, Hayes, Twohig, Drossel, Lillis, & Washio, 2009; Masuda, Twohig, 
Stormoa, Feinstein, Chou, & Wendell, 2010). De Young, Lavender, Washington, 
Looby, and Anderson (2010) also tested this form of defusion intervention. Watson, 
Burley and Purdon (2010) tested the same defusion practice in relation to 
contamination-focused obsessional thoughts. In contrast, Healy, Barnes-Holmes, 
Barnes-Holmes, Keogh, Luciano, and Wilson, (2008) tested the impact of adding the 
phrase “I am having the thought that” as a prefix to negative and positive self-
statements. Each of these studies has shown the significant impact of a defusion 
practice on at least one dependent variable such as emotional discomfort, willingness 
to read and think about personal statements, and the believability of the target words 
or statements. 
  However, all of these studies have employed measures of believability of 
words and thoughts with the assumption that this is the equivalent of measuring CF, 
despite believability being a narrow operationalisation of CF (see Chapter IV for a 
discussion of this issue). Furthermore, none of the measures of believability used 
were established as being psychometrically sound. For example (and typical of this 
group of studies), Healy et al. (2008) asked participants to rate on a scale from 0 to CHAPTER II  
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100 the extent to which they found each statement believable. Caution therefore 
should be exercised when drawing conclusions about the impact of defusion practices 
from this research.  
  There have been few correlational or mediational studies examining CF in 
relation to other variables. As outlined in Section 2.3.2.2, the development of the 
AAQ facilitated a great deal of this type of research in relation to EA/psychological 
inflexibility. As there has been no well-designed, broadly applicable measure of CF 
available until very recently, there is currently no equivalent large body of CF-
focused research (see Chapter IV for a detailed examination of CF measurement). In 
one exception, (Zettle, Rains & Hayes, 2011), believability of thoughts (used as a 
proxy for CF) was found to have mediated the impact of an ACT intervention for 
depression. In another outcome trial (ACT for psychosis), believability of 
hallucinations was found to mediate the relationship between hallucination frequency 
and associated distress (Gaudiano & Herbert, 2006).  
  To summarise, there is a small amount of CF-relevant research, in the form of 
correlational and mediational studies, as well as laboratory-based component studies 
testing the impact of defusion techniques. In general, this research has yielded results 
supportive of the ACT model, but the lack of a good measure of CF has hindered 
examination of this important process. 
Attachment to Conceptualised Self ----- Contact with Self-As-Perspective 
  In the ACT model, particular attention is paid to three experiences of self 
(Stewart, Villatte, & McHugh, 2012); the conceptualised self, which is the verbally 
constructed view of self, self as a process of moment-by-moment awareness, and self-
as-perspective (also referred to as self-as-context.) Fusion with the conceptualised 
self is seen as leading to EA and contributing to psychological inflexibility. For 
example, taking a thought about oneself such as ‘I’m the kind of person who always 
gives up on things’ to be literal, is likely to impact on the ability to take effective 
action in life.  
Hayes, et al., (2006, p. 9) describe this perspective on self as “the context for 
verbal knowing” rather than “the content of that knowing”, and when we experience 
ourselves as self-as-context, we experience ourselves as being not merely the content 
of our thoughts and feelings, but as the conscious container for them. This experience 
of self can be particularly helpful for individuals who are fused with negative self-CHAPTER II  
   
44 
referential thoughts, in that they can have moments of experiencing themselves as not 
merely the content of such thoughts. 
  The impact on psychological health of this process as it is operationalised in 
the ACT model has not been empirically tested in isolation from other aspects of 
ACT, although exercises and metaphors designed to support experience of self-as-
perspective are generally included in efficacious ACT treatment protocols. 
Additionally, mindfulness practice is seen as a context in which this sense of self is 
supported and experienced, and there is a large body of literature attesting to the 
psychological and physical health benefits of regular mindfulness practice (see 
Grossman, Niemann, Schmidt, & Walach, 2004, and Piet & Hougaard, 2011, for two 
meta-analyses of the clinical impact of mindfulness). 
Lack of Connection with Personal Values ------ Connection with Personal Values 
  All cognitive and behavioural psychotherapies place some emphasis on 
setting behavioural goals, but ACT is unusual in its emphasis on the individual 
connecting with their personal values as a means of ensuring that actions taken are in 
the service of what is personally important to them, and to motivate engagement in 
specific behaviours, even over long periods of time. Values have been defined as 
“freely chosen, verbally constructed consequences of on-going, dynamic, evolving 
patterns of activity, which establish predominant reinforcers for that activity that are 
intrinsic in engagement in the valued behavioural pattern itself” (Wilson & Dufrene, 
2008, p. 64). Less technically, they are “our heart’s deepest desires: how we want to 
be, what we want to stand for, and how we want to relate to the world around us”, 
and “leading principles that can guide us and motivated us as we move through life” 
(Harris, 2007, p. 167).  
  Whilst values are an important aspect of the ACT model, and there are many 
exercises in ACT protocols specifically designed to help individuals connect with 
their personal values, relatively little research has been conducted that specifically 
examines the role of valuing. As with several of the ACT model processes, this is at 
least in part due to issues of measurement. One exception is McCracken and Yang 
(2006), who developed a measure of values and valued action specifically for patients 
dealing with chronic physical pain. They found that engagement with values made a 
unique contribution to the prediction of patient functioning (both physical and 
psychosocial), independent of the predictive power of pain acceptance. Using a 
different approach, in a study that investigated valuing by testing a stand-alone values CHAPTER II  
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intervention, Creswell, Welch, Taylor, Sherman, Gruenewald, & Mann (2005) found 
that in a laboratory-based experiment with a student sample, affirmation of personal 
values acted as a protective factor in terms of hormonal and psychological responses 
to a stressful task.  
  These two studies suggest that it is possible to examine valuing and its impact 
on psychological functioning, and furthermore, that as the model predicts, connection 
or lack of with personal values may well impact functioning, but a great deal more 
research is needed in this area.  
Lack of or Ineffective Action ----- Committed Action 
  ACT is a behavioural psychotherapy, and as such the ability to engage in 
values-based activity, and to make values-consistent behavioural changes, is an 
essential aspect of the therapy. The risk according to the hexflex model, when CF and 
EA are predominant, and when there is a lack of connection with values, is that 
behaviour will be inflexible and ineffective. This may take the form of avoidance and 
lack of persistence, or alternatively, excessive and impulsive actions (Hayes, et al., 
2012). In the hexaflex model, what is thought to contribute to psychological 
flexibility and thus to psychological wellbeing is “the development of larger and 
larger patterns of effective action linked to chosen values” (Hayes, et al., 2006, p. 9). 
This development of a broader behavioural repertoire is seen as allowing greater 
possibilities for positive reinforcement from environmental contingencies. 
  There is a great deal of research attesting to the negative impact of 
behavioural avoidance in relation to many psychological difficulties, including 
anxiety disorders and depression (see Barlow, 2002, and Ottenbreit & Dobson, 2004, 
respectively, for summaries of this literature). Similarly, impulsive and excessive 
behaviours such as self-harm and substance misuse, have also been linked with poor 
psychological functioning (e.g. Kingston, Clarke, & Remington, 2010). Interventions 
that encourage effective and flexible action such as behavioural activation treatments 
for depression, and exposure-based treatments for anxiety disorders have proved to be 
effective (e.g. Dimidjian et al., 2006; Ost, Thulin, & Ramnero, 2004). Although none 
of this research is specific to ACT, behavioural interventions in the context of ACT 
protocols closely resemble those developed by the wider behavioural and cognitive 
behavioural research community, albeit with the emphasis on behaviour being in the 
service of personal values.  
 CHAPTER II  
   
46 
2.2.1.2.1 Summary 
  Some efforts have been made to empirically examine the six core processes of 
the ACT model, in particular in relation to psychopathology, with reported findings 
generally supporting the model. However, there are significant gaps in the literature, 
particularly when considering the relationships amongst the processes, and in fact 
Hayes et al, in their 2006 review paper stated that at that stage, correlational study-
based investigations of the model had not generally involved examining the role of 
the processes individually. To date there are virtually no published studies testing the 
ACT model in relation to complex psychological difficulties such as PD. 
 
2.2.1.3 ACT: Therapeutic Features 
  Hayes et al., (2012) suggest that the value of a good clinical model is that it 
should directly indicate what would constitute effective clinical interventions. In the 
case of ACT, the model indicates six processes that contribute to psychological 
inflexibility and are thus implicated in psychopathology. The therapy was therefore 
developed specifically to address these processes. For a detailed description of ACT, 
see Hayes and Strosahl, 2004, and Hayes et al. For an outline of an ACT protocol 
specifically for PD, see Chapters VII and VIII. Below is a brief summary of the key 
features of the therapy. 
As can be understood from the hexaflex model, the primary aim of ACT is to 
increase psychological flexibility, rather than to reduce symptomology, although the 
latter is often a consequence of ACT interventions, as demonstrated in many ACT 
outcome trials. The intention is that regardless of specific diagnosis or 
symptomology, excessive verbal control over behaviour will be disrupted and the 
capacity to make direct contact with environmental contingencies will increase, along 
with the ability to take action in valued life directions. Although some didactic 
teaching can occur in ACT, much greater emphasis is placed on setting up contexts, 
both within and between sessions, where the patient can become directly aware of 
their experiences of, for example, the impact of CF and EA. Such experiential 
exercises are often based on metaphors and paradoxes, which Hayes et al., (2004, p. 
6) refer to as “non-linear forms of language”. Essentially, the aim of such CHAPTER II  
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interventions is to bring awareness to the processes of language and cognition, rather 
than to provide the patient with a new set of beliefs. 
It is common for overviews of ACT to describe the course of therapy in linear 
terms (e.g. Hayes & Smith, 2005; Ruiz, 2010), as if there is just one effective order in 
which to address the six core processes, and it can make theoretical and clinical sense 
to address some aspects of the hexaflex before others. One example of this is that 
supporting the cultivation of willingness and ability to experience uncomfortable 
thoughts and emotions is likely to be helpful before inviting an individual to take new 
behavioural steps in a valued direction. However, this therapeutic work rarely 
happens in a simple, linear fashion. One way to think about the hexaflex model is that 
the four processes on the left of the model, present moment awareness, acceptance, 
cognitive defusion, and self-as-perspective, are mindfulness-related processes, with 
the two processes on the right of the model, values and committed action, being 
concerned with behavioural change. An ACT therapist who is paying attention to the 
moment-by-moment experiences of the patient will be likely to move back and forth, 
addressing the processes on either side of the hexaflex as required. For example, 
when the patient begins to get fused and avoidant when focusing on values or 
committed action, a shift is made to address the mindfulness processes, in order to 
help the individual hold the thoughts and feelings that have arisen, in defused, 
accepting awareness. This approach mirrors that of another 3
rd wave therapy, DBT, 
where the therapist moves flexibly back and forth between acceptance and change 
therapeutic strategies. 
ACT handbooks have also tended to include long lists of specific experiential 
exercises and metaphors, to be used to address particular processes such as CF and 
EA (e.g. Hayes & Strosahl, 2004). As a result of this, and the linear description of 
ACT, it could be assumed that the therapy consists of a set of prescribed techniques 
that should be applied in a relatively inflexible order and manner. In fact, because 
ACT was developed to address the hexaflex processes, any experiential exercises, 
metaphors, and interpersonal exchanges between therapist and patient that facilitate 
awareness and direct experience of the impact of those processes, can be incorporated 
in the therapy, within the limits of what is safe and acceptable to the patient. Thus, 
some ACT therapists use a great deal of pre-planned experiential exercises, whilst 
others rarely use these methods, instead using more informal, conversational CHAPTER II  
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interventions, informed by a moment-by-moment formulation in terms of the 
hexaflex processes.  
  This issue of rigid adherence to a therapeutic plan versus flexible 
responding in the moment is of importance when considering how to best test a 
therapy in a research outcome trial. There is a tension between the need to describe 
the intervention as clearly as possible and to reduce variation in participant 
experience on the one hand, and on the other, to represent the therapy realistically, 
including the capacity of the therapist to respond flexibly, which might be considered 
as contributing to the effectiveness of intervention. A validated ACT adherence and 
competence measure (Forman, Herbert, Moitra, Yeomans, & Geller, 2007), reflects 
this tension in that it assesses the extent to which therapists address specific processes 
and issues within therapy, but does not require therapists to address them using 
particular interventions. This tension in relation to ACT is touched on again in this 
thesis, in the chapters dealing with ACT treatment development trials. 
With these caveats in mind, a typical order of addressing key processes and 
issues in ACT is as follows: 
 
•  Creative hopelessness – inviting the individual to reflect on how effective or 
otherwise their (typically avoidant) coping strategies have been to date 
•  Underlining the likelihood that automatic compulsive avoidance of private 
experiences such as emotions, whilst understandable, is likely to be 
ineffective, particularly in the long-term 
•  The possibility of acceptance as an alternative to avoidance 
•  Relationship to thoughts – cognitive fusion and defusion 
•  Relationship to self – conceptualised self and self-as-context 
•  Values 
•  Committed action 
 
2.2.1.4 Evidence Supporting ACT: Outcome and Process Findings 
  Ruiz (2010) identified more than 30 RCTs where an ACT-based intervention 
had out-performed a control condition. These outcome studies included protocols 
addressing Axis-I disorders such as depression (Zettle & Hayes, 1986), psychosis CHAPTER II  
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(Bach & Hayes, 2002), and social phobia (Block, 2002), as well as other conditions 
such as work stress (Bond & Bunce, 2000) and difficulties associated with chronic 
pain (McCracken et al., 2005). As with any therapeutic approach in its infancy 
however, there have been criticisms levelled at the quality of this evidence. Ost 
(2008) conducted a systematic review and meta-analysis of the ACT RCTs available 
at the time where ACT had been compared to CBT, concluding (based on the quality 
of the trials and the efficacy of the interventions), that at that point ACT could not be 
considered an empirically supported intervention. His methodology was criticised and 
his findings were reanalysed (Gaudiano, 2009), with Gaudiano refuting Ost’s 
conclusions. Powers, Zum, Vorde, Sive, Vording, and Emmelkamp (2009) also 
carried out a meta-analysis, concluding that ACT outperformed waiting list control 
conditions, but not other established interventions. Again, these findings were 
reanalysed (Levin & Hayes, 2009), who, based on their corrections to the data and 
methods used by Powers et al., concluded that ACT did significantly outperform 
established interventions. 
Some efforts have been made not only to test the efficacy of ACT 
interventions, but also to ascertain whether therapeutic gains occur through theory-
consistent means. The findings of these kinds of studies have tended to support the 
ACT clinical model. For example, Zettle et al., (2011), in their reanalysis of data from 
an ACT and CBT for depression RCT (Zettle & Rains, 1989), found that post-
treatment CF level mediated reduction in depression at follow-up, in the ACT 
condition only.   
Despite the promising outcome and process data summarised above, Ost was 
justified in some of his criticisms of the ACT evidence base. Published outcome trials 
have varied considerably in size and quality, with some early trials in particular being 
relatively poorly designed. In fact, a similar situation with regards to research quality 
can be found in the early, published trials of other mental health interventions such as 
DBT and MBSR, perhaps suggesting that this is a common feature of psychosocial 
treatment development in the 1980s and 1990s. Recent improvements in study quality 
may be a function of improvements in funding for ACT trials, and may also be linked 
to the general shift towards better quality outcome trials in mental health research 
over the last decade or so, linked with the introduction of guidelines for conducting 
and reporting such studies (e.g. Boutron et al., 2008). One of the difficulties with this 
particular body of evidence is that because ACT was designed to be a transdiagnostic, CHAPTER II  
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broadly applicable approach, it is being tested in many settings in relation to many 
difficulties, both psychological and physical. This means that studies are currently 
somewhat ‘thinly spread’.   
 
2.2.1.4.1 ACT, Complex Mental Health Problems, including PD 
  There are a handful of studies suggesting that ACT might have potential with 
more complex or difficult-to-treat presentations including poly-substance abuse 
(Hayes et al., 2004), and psychotic depression (Gaudiano et al, 2007). Unlike DBT 
and MBCT, which were each developed for use with just one clinical group, ACT is a 
trans-diagnostic approach. Therefore, it might be of particular relevance to a group of 
patients who tend to have co-morbid and heterogeneous presentations, such as PD 
patients. To date only three small-scale outcome trials have tested an intervention that 
includes aspects of ACT, with people with PD diagnoses.  
Holmes and colleagues (Holmes, Georgescu, & Liles, 2006; Hurley & 
Holmes, 2010) are testing a group-based psychotherapeutic intervention for BPD. 
The intervention, contextually-based DBT, is essentially full-programme DBT with 
all skills and teaching that refer to changing the content of private experiences 
modified in line with ACT principles. Although a trial of this intervention has not, to 
date, been published, the researchers have presented some interim outcome data at a 
conference (Hurley & Holmes). Data from 33 participants who completed the 
intervention indicated group improvements in depression, anxiety, and psychological 
flexibility. A predicted improvement in quality of life was not found, with the 
researchers speculating that it “is not until Stage 3 [DBT] that one is actively engaged 
in the process of improving quality of life.” No data on changes in self-harm or other 
BPD-relevant variables was presented. 
  The study was small-scaled and uncontrolled, both appropriate research 
design features for a preliminary treatment development trial. However, given these 
limitations, the lack of data on self-harm and suicide attempts when these are specific 
and important targets of the treatment, and the fact that the study has not been 
published in a peer-reviewed journal thus far, the promising outcomes have to be 
viewed with caution. In addition, the contribution of ACT to this intervention has 
been clearly delineated (Holmes et al., 2006), and it is evident that the intervention is 
predominately DBT in nature. It is consequently difficult to argue that this is really a 
test of ACT in relation to PD.  CHAPTER II  
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Gratz and Gunderson (2006) presented preliminary data on the impact of a 14-
week, outpatient, group intervention for women with BPD diagnoses who were self-
harming. The intervention was described as an acceptance-based emotion regulation 
group, emphasising “the control of behavior when emotions are present, rather than 
the control of emotions themselves”, (p. 26). The intervention combined elements of 
DBT, ACT, emotion-focused therapy and behaviour therapy. Participants were 
randomly assigned to this group plus outpatient TAU (N = 12), or outpatient TAU 
only (N = 10). There were significant between-group differences in favour of the 
target intervention on most of the study outcome variables including deliberate self-
harm, BPD symptomology, depression, anxiety, and EA, and significant pre to post 
changes in most outcome variables for the intervention condition but not the control 
condition. 
  Although these results are promising, particularly for such a time-limited 
intervention, they are based on a small number of participants, making generalisation 
from the results difficult. The sample size was also not large enough to allow for 
formal investigation of variables that might be mediating the therapeutic gains, 
although emotion dysregulation and EA did significantly reduce, pre- to post-group. 
Another limitation of the study was that because the intervention combined at least 
four treatment approaches, it is impossible to determine which are the active 
components. While it is appropriate to use small samples in early stage treatment 
development trials, particularly with high-risk patient groups, this study has not yet 
been followed up by further, larger-scale published trials. 
   Finally, one study has tested ACT as a stand-alone treatment with a sample 
that included PD patients. Clarke, Kingston, James, Bolderston, and Remington (in 
prep), carried out a small-scale RCT comparing ACT (N = 26) with a CBT-style 
TAU intervention (N = 19), with a heterogeneous sample of patients with treatment 
resistant mental health problems. Approximately 50% of the sample had a PD 
diagnosis in addition to Axis I diagnoses. Self-harming behaviour within the previous 
six months was an exclusion criterion for the study. 
Immediately post-intervention, patients in both conditions showed significant 
improvements in Axis I and Axis II symptomology, and quality of life, with no 
between-group differences. However, these improvements tended to be better 
maintained at 6-month follow-up by those who had received ACT, with many in the 
CBT-TAU condition relapsing. Attrition rates were also significantly higher for the CHAPTER II  
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CBT-TAU condition. Despite these promising findings, the authors noted that the 
participants with PD symptomology tended to be the most difficult to treat. The 
majority of PD participants met the diagnostic criteria for just one PD, and at follow-
up, 2/3rds of those in the ACT condition no longer met diagnostic criteria for a PD. 
  As with the other ACT for PD trials, this study was based on a small sample 
and was statistically underpowered. Nevertheless, the results show that people with 
complex, chronic mental health problems, including those with PD diagnoses, can 
benefit from a time-limited, group-based, ACT intervention.  
Although not a test of ACT with PD, Berking et al. (2009) found that EA 
adversely impacted reduction of depression during DBT treatment of BPD, with those 
participants showing high levels of EA being left with high levels of depression post-
therapy. This finding suggests that ACT, a therapy that specifically targets EA might 
indeed be an appropriate candidate for a post-DBT intervention for PD patients.  
In summary, there is a small body of empirical evidence suggesting that ACT-
based interventions can be beneficial for people with PD diagnoses. However, no 
study to date has tested ACT with a heterogeneous group of PD patients (with poor 
personality functioning across diagnoses), despite co-morbidity in PD diagnoses 
being common. 
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CHAPTER III 
Methodological Considerations 
 
This PhD is concerned with complex psychological problems (PDs), treatment 
development in relation to these problems, and the particular psychological processes, 
such as CF, which are thought to underpin these problems and therefore might be 
expected to be addressed by effective interventions. There is guidance available 
regarding the process of development and empirical testing of such interventions, 
guidance that acknowledges the particular methodological challenges presented by 
this work. For example, the UK Medical Research Council published a framework 
(Campbell et al., 2000; Medical Research Council [MRC]) guiding methodological 
decisions through the structure of a four-phase research model, with an additional 
theoretical, pre-research phase (see Figure 3.1). The authors suggest that the model 
can be applied to research utilising a range of designs and methodologies, and as such 
provides a useful adjunct to the large body of clinical research guidance that focuses 
purely on RCTs (see Nezu & Nezu, 2008, as a recent example).   
  Alternatively, Rounsaville, Carroll, and Onken (2010) outline a three-stage 
model that provides a more detailed breakdown of the scientific decisions and 
activities in the early stages of behavioural treatment development. The stages of this 
model are mapped onto the Campbell et al. (2000) phases model in Figure 3.1. This 
chapter will be structured around the Campbell et al. phases, with reference made to 
Rounsaville et al. where appropriate. 
 
3.1 Preclinical or Theoretical Phase 
This pre-research phase involves critically reviewing relevant theories and 
existing empirical evidence, in order to begin the process of developing an 
intervention that is thought likely to have a positive impact on the target health 
problem(s). This stage will not be addresses in detail here, as the previous two 
chapters of this thesis represent a thorough articulation of this phase. 
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Figure 3.1  
Phases in the Design and Evaluation of Complex Interventions (Campbell et al., 
2000) Incorporating Stages in the Development of Behavioural Therapies 
(Rounsaville at al., 2001) 
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3.2 Phase I: Modelling 
The modelling phase is designed to develop a scientific understanding of the 
nature and impact of processes relevant to the target problem and the intervention 
under development, as well as to examine the impact of sub-components of complex 
interventions (Campbell et al., 2000). It is also at this pre-intervention stage, (Stage Ia 
in the Rounsaville et al., 2001 model), where appropriate measures to be piloted in 
the exploratory phase are selected, with new measures being developed as required. 
Several of the studies in this PhD are designed to serve these various functions, and 
thus the methodological and statistical issues commonly encountered in modelling 
research will be examined in detail. 
 
3.2.1 Measurement 
Selection and/or development of well-designed and methodologically 
appropriate measures at this pre-clinical phase is extremely important to ensure good 
quality data and therefore the accuracy of the conclusions drawn (Fernandez-
Ballesteros & Botella, 2008). Table 3.1 summarises commonly used types of 
measures in psychological research. These measures’ defining characteristics and 
their suitability for particular uses, will be outlined below, with particular focus on 
the types of measures used in this PhD. The methodology for the development of 
new, self-report questionnaires will also be outlined in detail, as this relates to one of 
the current studies (see Chapter IV).  
 
3.2.1.1 Self-Report Measures 
  Fernandez-Ballesteros and Botella (2008, p. 95) define self-report measures 
(SRMs) as those that utilise “verbal information about any event reported by a given 
subject about him- or herself”. SRMs are used in the majority of clinical outcome 
research, and are the only data collection method in approximately 25% of clinical 
outcome studies (Lambert, 1994). This is despite the widely reported principle that 
the most likely path to accurate assessment in research, including clinical research, is 
through the use of multiple assessment methods (Campbell & Fiske, 1959; Eid & 
Deiner, 2006). The reasons for reliance on SRMs will be discussed in Section 3.2.1.2. CHAPTER III  
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SRMs can be used to collect a wide range of subjective information from 
research participants, including information about external events (that could be 
observable by others), as well as internal emotional, cognitive, and physiological 
events. 
 
Table 3.1 
 Measurement Methodologies and Data Output 
Category of measure                Type of measure                   Output data 
Self-report                                            Psychometric                         Quantitative 
                                                             measures such as  
                                                             questionnaires 
                                                    
                                                             Structured interview               Quantitative  
 
                                                             Semi-structured interview      Qualitative or  
                                                                                                             quantitative  
 
                                                             Focus groups                          Qualitative  
 
                                                             Diaries/journals                      Qualitative  
 
                                                            Self-observation/                     Qualitative or  
                                                             self-monitoring                       quantitative  
                                                             
 
                                                            ‘Think-aloud                            Qualitative  
                                                             protocols’ 
 
Observation                                         Behavioural observation        Quantitative or      
                                                                                                            qualitative  
 
                                                            Physiological observation      Quantitative  
 
                                                            Psychological ability tests      Quantitative         
                                                   
                                                            Implicit tests                           Quantitative  
 
 
 
3.2.1.2 Psychometric Measures 
  Psychometric measures such as questionnaires are the most commonly used 
measures in clinical research (Fernandez-Ballesteros & Botella, 2008). They are often 
used to operationalise psychological constructs such as depression or quality of life, 
and tend to consist of a number of questions or statements, known as items, that CHAPTER III  
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address particular symptoms or aspects of the target construct. They can also be used 
to gather data on opinions and experiences. They are used as outcome measures in 
clinical research, as process measures, to examine possible mechanisms of change, 
and as screening measures, in the initial stages of clinical studies.  
  Self-report psychometric measures are typically self-administered in the 
absence of the researcher, as this is a relatively economical method of gathering data, 
(Edwards, 2010). Other advantages to gathering data in this way include the 
likelihood of reduced social desirability and interviewer influence effects.  
  However, these advantages may be offset by disadvantages such as more 
participants failing to complete self-administered psychometrics and thus rendering 
the data unusable or of questionable quality. Other disadvantages of self-report 
psychometric measures are features of their design. They tend to consist of closed 
questions with a small, pre-determined range of possible responses. Clearly, the 
advantage of this is the standardised nature of the data yielded. However, respondents 
cannot respond accurately if the measure does not include a response option that 
matches their experience. Naturally, any measure, including self-report psychometric 
measures can vary in quality, with poorly designed and tested measures yielding 
misleading or unusable data. For this reason, there is a lengthy and complex process 
recommended for the development of new psychometric measures, as outlined below. 
(e.g., Clark & Watson, 2003).  
 
3.2.1.2.1 Item Development 
  Nunally and Bernstein (1994) indicate that the first step in developing a 
psychometric measure of a construct is to use relevant theory to delineate the range of 
the content of that construct, which then guides the content of the items. Clark and 
Watson (2003) suggest that the initial item pool should be broader than theoretical 
understanding of the construct, and include items that ultimately will be excluded for 
being only tangentially related to the construct. 
  The specific wording of items and the format of the overall questionnaire are 
important issues that will impact the performance of the measure. A detailed 
examination of these issues is beyond the scope of this thesis, but comprehensive 
guidance is available (e.g., Kline, 1986; Clark & Watson, 2003; Edwards, 2010). 
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3.2.1.2.2 Psychometric Evaluation 
  Once a prototype version of a measure has been constructed, it is administered 
to a suitable sample, and a complex process commences with the aim of examining 
the performance of the items, the factor structure of measure, and its reliability and 
validity. Throughout this iterative process, items are excluded from the measure if 
they are shown to be adversely affecting the psychometric properties of the measure, 
or are redundant.  
  The distribution of responses for each item is examined for skew and kurtosis. 
Items are also dropped if they do not correlate adequately with enough other items or 
have high enough item-total correlations to warrant further analysis (Field, 2005; 
Wicksell et al., 2008). At this stage it is also usual to carry out a Kaiser-Meyer-Olkin 
test of sampling adequacy (KMO; Kaiser, 1970; Kaiser 1974), and Bartlett’s 
Sphericity test to ascertain if the pattern of correlations amongst the items is 
sufficiently compact and that the items are sufficiently related, to warrant further 
analysis. 
 
3.2.1.2.3 Factorial Structure 
  Factor analysis is used to examine the relationships between observed 
variables (responses to items), and the latent constructs (referred to as factors) that it 
is hoped the measure actually measures (Byrne, 2010). Exploratory factor analysis 
(EFA) is used when this relationship is uncertain, as is the case early in the process of 
psychometric measure development. Another form of factor analysis, confirmatory 
factor analysis (CFA) will be discussed in Chapter IV. 
 
3.2.1.2.4 EFA 
  As outlined above, EFA is used to explore the underlying factor structure of a 
measure. It is also used as a basis for further item elimination. EFA examines whether 
the relationships between a set of items, that is, common variance, is based in their 
relationships with underlying factors. There are several available approaches for 
‘extracting’ these factors from the data; the two most commonly used, according to 
Russell (2002), are principal components analysis (PCA) and principal axis factoring 
(PAF). Based on a review of the evidence, Russell recommends PAF, as it may more 
accurately reflect population factor loadings than PCA. Furthermore, it is usually the CHAPTER III  
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case that CFA is used in the later stages of scale development, but as PCA is not 
based on the common factor model (Thurstone, 1947), as both PAF and CFA are, it 
can be problematic attempting to replicate in CFA, facture structures identified using 
PCA (Brown, 2006). 
  Commonly, the decision about how many factors should be retained is guided 
by the Kaiser criterion, which suggests that all factors extracted that have eigenvalues 
greater or equal to 1 should be retained. However, this tends to lead to over-retention 
of factors. Instead, the scree test (Cattell, 1966) is used, which involves plotting a 
graph of eigenvalues against number of extracted factors. The cut off point for the 
number of factors retained is indicated by a clear change in the slope on the graph. 
  For ease of interpretation the extracted factors are then rotated. There are 
various forms of rotation available. Russell (2002) recommends using an oblique 
(Promax) rotation, which allows for correlation between factors, though in fact the 
Promax rotation initially involves a Varimax (orthogonal) rotation. This is then 
followed by a relaxation of the requirement that the factors are uncorrelated. 
Therefore, the rotation would also indicate if the factors were in fact uncorrelated 
(Fabrigar et al., 1999).  
 
3.2.1.2.5 Reliability 
  Field (2005, p.743) defines reliability as “the ability of a measure to produce 
consistent results when the same entities are measured under the same conditions”. 
The most common measure of scale reliability is Cronbach’s alpha (α), which is a 
measure of the internal consistency of the scale. For example, someone who is 
depressed should get a high score on a psychometric measure of depression. The 
measure is said to have good internal consistency if that person also scores highly on 
any randomly selected items from the scale. Caution is needed when interpreting 
Cronbach’s α, as it varies in relation to the number of items in the scale (Cortina, 
1993). 
  The other commonly examined form of scale reliability is test-retest 
reliability, which indicates how stable the measure is over time. The magnitude of the 
relationship between mean respondents’ scores from two time points is usually 
expressed in terms of Pearson’s correlation coefficient (r), with a larger value of r 
indicating greater reliability.  CHAPTER III  
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3.2.1.2.6 Validity 
  A measure can be demonstrated to be reliable without it being clear that it is 
measuring the construct it was designed to measure (the validity of the measure). 
Indeed, reliability is necessary but not sufficient for validity in psychometric 
measures. Therefore such measures should be evaluated against standards of various 
forms of validity. Some aspects of validity should be addressed at the item generation 
stage of questionnaire construction. Face validity, for example, is an indication that 
the content of items look like they represent the construct underlying the measure, 
whereas content validity, is the extent to which the domain of content of the construct 
is sampled through the items. There are no objective ways of measuring or testing 
face or content validity, but following published guidance on item development and 
consulting the relevant literature and experts in the field with regards to item content, 
may increase these forms of validity. 
  Other forms of validity, such as predictive, criterion, concurrent, convergent, 
construct, and discriminant validity, are examined once the measure has been 
constructed, and can all be objectively measured and tested using statistical means. 
Nunally and Bernstein (1994) argue that predictive, criterion and concurrent validity 
are all based on the same logic and procedures and that it therefore does not make 
sense to treat them as separate entities. Essentially, these forms of validity measure 
the ability of the scale under development to predict a criterion external to the 
measure, either using a current criterion or by predicting score or performance on a 
criterion at some point in the future.  
  Construct validity (also known as factorial validity), is a measure of the 
relationship between the manifest variables (scale items) and the underlying construct 
or factors. There are a number of ways of examining construct validity. Convergent 
validity, for example, is established by testing the strength of relationships (using 
Pearson’s correlation coefficient), between scores on the scale under development, 
and scores on measures of related constructs. For example, it would be predicted that 
scores on a measure of CF would significantly correlate with scores on a measure of 
mindfulness, as these two constructs are related, according to ACT theory, though 
sufficiently differentiated so as not to lead to a total correlation (1.0) between scores 
on two such measures. On the other hand, discriminant validity involves 
demonstrating that there is no significant relationship between scores on measures of 
constructs that should not, according to theory, be related. It is clear that ideally, CHAPTER III  
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correlations in tests of convergent validity will be high, and those in tests of 
discriminant validity will be low, though there is no consensus about what constitutes 
high and low enough (Trochim, 2006). At the very least, discriminant correlations 
should always be lower than convergent correlations. 
  Another common approach to examining construct validity is the use of CFA. 
A model of the relationships between the observed variables (items) and latent 
variables (the target construct) is developed, based both on theoretical predictions and 
research findings, including perhaps the outcome of EFA. CFA, in the form of SEM 
is used to test how well the model fits the data (see Section 3.2.2.3 for an outline of 
SEM).  
 
3.2.1.2.7 Psychometric Measures in Clinical Research 
  There are some specific issues to be taken into account when developing 
measures for use in clinical settings. It is important to administer the measure to the 
relevant clinical populations during the development process, as item performance, 
overall measure performance, and factor structure can all vary from sample to sample 
(Marks, 2004). The measure will need to be stable over time but at the same time, 
sensitive to change, if being used in an intervention study. Finally, the measure 
should be able to discriminate between different clinical populations.  
  In summary, SRMs are the most commonly used measures in clinical 
research, and have several advantages including ease and cost of administration, as 
well as the standardised nature of the data they yield, allowing comparison with the 
findings of other research. However, they can be costly and time-consuming to 
develop, and the limited response option they offer could lead respondents to ignore 
item or respond inaccurately (Wilkinson, Joffe, & Yardley, 2004). Other self-report 
approaches such as interviews might address some of these concerns, and could be 
considered as alternatives to questionnaires. 
  
3.2.1.3 Interviews 
  Interviews vary between being completely structured and consisting of closed 
questions, through being loosely (semi) structured and based on open questions that 
are adapted and extended depending on the material that is arising in the particular 
interview, to, at the other extreme, interviews that are virtually unstructured. The 
latter are more common in clinical treatment settings than in clinical research CHAPTER III  
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(Widiger, 2008). It has been argued that structured interviews are essentially 
“questionnaires that are administered verbally” (Fylan, 2005, p. 65), but with the 
advantage of the possibility of a rapport being formed between interviewer and 
interviewee that might aide eliciting of more complete data (Wilkinson et al., 2004). 
Usually, structured interviews are designed to yield quantitative data, for example 
structured clinical interviews designed to lead to a categorical clinical diagnosis, such 
as the Diagnostic Interview Schedule (DIS; Robins, Helzer, Croughan, & Ratcliff, 
1981).  
  Completely structured interview schedules are fairly uncommon, it being 
more typical for a clinical diagnostic interview to have a fair amount of structure, in 
terms of the order and wording of questions, but also allow the interviewer some 
flexibility to ask follow-up and clarifying questions. One example of this type of 
semi-structured interview offering an advantage over questionnaires is in the field of 
PD diagnosis. There are questionnaires available, such as the Millon Multiaxial 
Clinical Inventory III (MMCI-III; Millon, 1994) that are designed to indicate whether 
an individual has a particular PD diagnosis. However, these types of questionnaires 
make it difficult to distinguish between occasional experience of symptoms, and 
long-term difficulties (Perry, 1993) and can lead to ‘false positive’ diagnoses.  
  In an attempt to address this issue, other PD diagnostic systems consist of a 
screening questionnaire, followed by an interview. The interviews use a structured 
format and proscribed wording of questions, but with some flexibility, to elicit more 
detailed information on which to base the final diagnosis. The Structured Clinical 
Interview for DSM-IV Axis II (SCID-II; Spitzer et al., 1996) is an example of this 
type of diagnostic tool. These kinds of diagnostic interviews are used both as 
screening tools in clinical research and as outcome measures. 
  Other kinds of semi-structured interviews are used in clinically focused 
research. They are often much less structured than diagnostic interviews, and are 
designed to elicit qualitative data relating to the interviewee’s subjective experiences 
(Boyatzis, 1998). The data they elicit cannot be used to test hypotheses, but one use 
of such interviews is to form hypotheses that can be tested with further research. This 
thesis does not involve the use of qualitative analysis methodologies to analyse data 
from such interviews, and therefore the relevant methodological and design issues 
will not be reviewed (see Marks & Yardley, 2004 or Forrester, 2010 for an overview).  
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3.2.1.4 Other Self-report Measures 
  As was outlined in Table 3.2, there are several other self-report measure 
methodologies used in psychological research. These include the use of focus groups, 
to elicit qualitative data from a group of individuals who have an experience in 
common (Wilkinson, 2005) and the use of diaries and journals to elicit similar 
qualitative material on an individual basis (Ferguson, 2005). There are also much less 
commonly used self-report methodologies such as self-observation and thinking-
aloud protocols (see Fernandez-Ballesteros & Botella, 2008). However, they are not 
relevant to this thesis, and therefore will not be reviewed. 
 
3.2.1.5 Observation 
  The other main category of measurement methodologies covers those that 
involve observation of the research participant, rather than their self-report of 
subjective experience. Due to space constraints, just one observation methodology 
will be reviewed here; behavioural observation. 
 
3.2.1.5.1 Behavioural Observation 
Behavioural observation can be carried out in a structured and relatively 
objective way, resulting in quantitative data, such as the frequency of a target 
behaviour. It can also be used in participant observation studies, where the influence 
of the researcher’s own perspective and experience is acknowledged (Ballinger, 
Yardley, & Payne, 2004). Behavioural observation can be carried out in the context 
of a number of different research designs, including naturalistic designs, for example 
where naturally occurring interactions between nurses and patients are video recorded 
or directly observed (e.g. Manias, Botti, & Bucknall, 2002).  
Behavioural observation can also be carried out in more contrived situations, 
where the participant is observed whilst carrying out a standardised activity. In a 
clinical assessment setting, the aim of this kind of observation is to “derive valid 
inferences about how the patient will behave in a current or future natural 
environment” (Haynes, 2003, p. 236). This type of behavioural observation is also 
frequently used in psychological experiments, for example gathering participant gaze-
direction and reaction-time data in a computer-based attentional bias task (e.g. Mogg, 
Bradley, Field, & De Houwer, 2003). This type of experimental design, often used in 
the modelling phase of clinical research to examine the role of psychological CHAPTER III  
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processes under controlled conditions, typically uses both observation and self-report 
data gathering methodologies. An account of the experimental designs and statistical 
tests used in this type of research can be found in Section 3.2.2.  
  As with all measurement methodologies, appropriateness and sensitivity to 
target behaviours, as well as reliability and validity are important issues. Haynes 
(2003) notes that in the case of clinical assessment, because analogue behavioural 
observation instruments are usually idiographic, they can have high content validity, 
are likely to be sensitive to measure the behaviour in question, and acceptable to the 
individual patient. However, too little attention tends to be paid to other types of 
validity, and reliability, and of course it is difficult to compare data yielded by 
different idiographic measures. 
  Standardised, particularly computer-based observational methodologies have 
the advantage of collecting data in an objective and accurate manner, and in such a 
way that it can be compared across participants. However, as is the case with any 
situation when collecting data in a controlled and contrived manner, the extent to 
which the data can be seen to represent real life must be considered. Overall, 
observational data collection can have advantages over self-report methodologies, in 
that the data is not influenced by the opinions or memory of the participant. However, 
observation may be time-consuming compared to self-report measurement, as can be 
the development of such measures. 
 
3.2.1.6 Conclusions 
This section has reviewed the main measurement methodologies relevant to 
this thesis. Given that there are so many ways of gathering data, suitability to purpose 
and quality of the specific measures under consideration should be used to make 
measurement decisions. In practice, it is desirable to use a number of different 
measurement methodologies to examine a process or evaluate an intervention, in 
order to increase confidence in the validity of the process or the intervention 
(Widiger, 2008; Campbell & Fiske, 1953).  
3.2.2 Model Building and Testing 
  In this modelling phase, research studies are often designed to understand the 
relationships between two or more variables, for example, to establish that a CHAPTER III  
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theoretically consistent relationship exists between a psychological process, such as 
psychological flexibility, and a psychological problem such as depression. Hayes et 
al., (2006) review this type of data in support of the ACT model of psychopathology. 
At the most basic level, this involves establishing the existence of a correlational 
relationship between the variables, although it is common for researchers to seek a 
somewhat more detailed understanding of the relationship, by testing whether one 
variable predicts or is a risk factor for another, (Nock, Janis, & Wedig, 2008).This is 
commonly tested using regression analysis, where (in simple linear regression), a 
value of the outcome variable is predicted from a predictor variable, by applying a 
model to the data that offers the most accurate predictions. This basic approach is 
extended, in multiple regression, to examine the relative impact of several predictor 
variables on the outcome variable. 
 
3.2.2.1 Cross-Sectional Designs 
  Both correlational and regression-based studies tend to be associated with 
cross-sectional research designs, involving gathering data on the variables of interest 
on one occasion only, with all data being collected at the same time. Advantages to 
this kind of research design include the relative ease, speed and low cost of 
conducting this type of study. Such studies can be used to generate hypotheses about 
the relationship between variables, which can be tested more rigorously in subsequent 
research. The most important limitation of this design is that it is impossible to infer 
causality in any relationships identified between variables, as such designs do not 
involve randomisation or collecting data at multiple time points.  
 
3.2.2.2 Mediation and Moderation Analyses 
One specific use of regression analysis is to test the role of possible mediator 
and moderator variables. Kazdin (2007; p. 3) defines a mediator as “an intervening 
variable that may account (statistically) for the relationship between the independent 
and dependent variable”, and a moderator as “a characteristic that influences the 
direction or magnitude of the relationship between and independent and dependent 
variable”. Studies that examine the role of possible mediators or moderators are 
commonly used in one of two ways. They can be used at the pre-intervention phase to 
build models of the relationship between relevant variables. For example, Rosenthal, 
Polusny, and Follette (2006) examined the relationship between perceived criticism CHAPTER III  
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in family of origin (the independent variable; IV) and psychological distress in 
adulthood (the dependant variable; DV). They concluded that EA fully mediated this 
relationship. 
   Mediation analysis can also be used to increase understanding of mechanisms 
of change in intervention studies. For example, Gaudiano and Herbert (2005) 
conducted an RCT comparing TAU with TAU plus ACT, for inpatients with 
hallucinations or delusions. Mediational analysis indicated that believability of 
hallucinations fully mediated the relationship between frequency of hallucinations 
and distress. Examination of potential moderators of outcome in RCTs can help 
identify which patients might benefit most from the intervention being tested, and 
under what circumstances (Kraemer, Wilson, Fairburn, and Agras, 2002). 
Mediation Baron and Kenny (1986) describe the following method, known as the 
causal steps approach, (see Figure 3.2) for testing whether the relationship between 
an initial variable, X, and an outcome variable, Y, is mediated by an intervening 
variable, M. The mediational model is specified based on theoretical predictions of 
the relationships between the variables, and any previous, relevant research findings. 
The paths between the various variables (a, b, c, c’) are then estimated using multiple 
regression. Other methods of estimating paths in mediation analyses, such as 
Structural Equation Modelling, will be reviewed later. 
  The Baron and Kenny method involves four steps: 
Step 1. Show that X significantly predicts Y by estimating and testing path c, using 
regression analysis (path c in Figure 3.2: 1.). 
Step 2. Show that X significantly predicts the mediating variable, M, by estimating 
and testing path a (Figure 3.2: 2.), by effectively treating M as an outcome variable. 
Step 3. Show that the mediator, M significantly predicts Y, by estimating and testing 
path b (Figure 3.2: 2.). It is not enough to demonstrate a correlation between M and 
Y, as they might be correlated as a result of both being caused by X. Therefore, X 
must be controlled when testing the impact of M on Y. 
Step 4. Complete mediation by M of the relationship between X and Y is seen to have 
been established if path c’ (Figure 3.2: 2.), drops to zero. That is, if X no longer 
affects Y when both are entered into a multiple regression model and M is controlled. 
If the impact of X on Y reduces when M is entered in the model, but is different from 
zero, M is seen to be partially mediating the relationship between X and Y. CHAPTER III  
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There have been criticisms of the Baron and Kenny causal steps approach 
(Bollen & Stine, 1990; MacKinnon, Lockwood, Hoffman, West, & Sheets, 2002; 
MacKinnon & Fairchild, 2009). MacKinnon et al. (2002) have demonstrated that this 
approach lacks statistical power to detect mediated effects. 
 
Figure 3.2 Mediational Model Based on Baron and Kenny (1986) 
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Bollen and Stein (1990) have argued that the approach is only suitable for variable 
data that is normally distributed, despite the fact that this is often not the case for 
mediated effects. The causal steps approach also requires a significant relationship 
between the predictor (X) and outcome (Y) variables, despite several authors arguing 
that it is possible for mediation to exist without this relationship being significant 
(Preacher & Hayes, 2004; MacKinnon & Fairchild, 2009). These criticisms imply 
that the Baron and Kenny approach is a particularly conservative method, and that 
there might be situations where mediation effects are occurring but remain 
undetected. For these reasons, newer approaches to mediation have been developed 
(see Section 3.2.2.3). 
  To test the statistical significance of the mediated effect of M, this effect is 
divided by its standard error, with the result being compared to the critical value, for 
example p = .05. This is the basis of the Sobel test (Sobel, 1982), a commonly used, 
though conservative (MacKinnon, Warsi, & Dwyer, 1995) test of significance in 
mediational analyses. However, given the likelihood of nonparametric distributions 
outlined above, and also that the Sobel test works best with large samples, CHAPTER III  
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bootstrapping methodology is increasingly utilised as an alternative means of testing 
the indirect effect (Preacher & Hayes, 2004). Bootstrapping is a computer-intensive 
resampling procedure, which is not dependant on the normal distribution of data. In 
bootstrapping, the sample under analysis is assumed to represent the population. 
Many (commonly 1000 or more) sub-samples the same size as the original sample are 
drawn from the original data, with replacement, and used to derive the sampling 
distribution of the indirect effect. The multiple estimates of the mediation effect are 
sorted from high to low, and this distribution is used to derive required confidence 
levels. 
  There are concerns about the interpretation of mediational analyses, 
particularly in relation to intervention trials (Kraemer et al, 2002; Kazdin, 2007; Nock 
et al., 2008). Nock et al. (2008, p. 212) summarise the main concern thus: “just as 
correlation does not equal causation, mediation does not equal mechanism”. By this 
they mean that although a mediator variable is often referred to as a mechanism of 
change, there is considerable difference between the two. As stated before, a mediator 
is “an intervening variable that may account (statistically) for the relationship 
between the independent and dependent variable”, (Kazdin, p. 2007; p. 3), whereas, a 
mechanism is “the basis for this effect, i.e., the processes or events that are 
responsible for the change; the reason why change occurred or how change came 
about” (Kazdin, 2007). Demonstrating a statistically significant mediation effect is an 
important first step in identifying a mechanism of change, but it is not sufficient. 
Kazdin (2007) outlines seven criteria for establishing a mechanism: 
1. Strong association between the relevant variables. 
2. Specificity of the impact of the mediating variable on the causal relationship (for 
example between a psychosocial intervention and anxiety), rather than many 
variables mediating the relationship.  
3. Consistency, in terms of the mediated effect being demonstrated in several studies, 
with different samples. 
4. Experimental manipulation, allowing for greater confidence in the assumption of 
causality between the initial and the outcome variable. 
5. Establishing a timeline, such that initial and mediator variables precede outcomes. 
6.Demonstrating the existence of a gradient, such that higher levels (stronger dose or 
greater activation) of the mediator are associated with greater response in the 
outcome variable. CHAPTER III  
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7. Plausibility and coherence of the explanation of the mediation effect, based on 
relevant theory, and other empirical evidence. 
  These are recent developments in methodological thinking about mechanisms 
of change, and it is understandable that the majority of psychotherapy research 
studies (including ACT research), testing mediation, do not yet adhere to these 
guidelines. 
 
Moderation Where there is a linear, causal relationship between an initial variable X 
and an outcome variable Y (see Figure 3.3), a third variable, M, can be seen as a 
moderator of that relationship if it alters the strength of the relationship. For example, 
a psychosocial intervention (X) may increase quality of life (Y) in patients with 
chronic pain, but this increase in quality of life might be greater for women than men. 
Thus, gender (M) moderates the effect of the intervention on quality of life.  
 
Figure 3.3 Moderation model based on Baron and Kenny, 1986) 
 
                                                           M 
 
                                                            
                         X                    Y 
 
 
  Several key conditions have been identified for moderation effects to be 
detected and accurately interpreted (Judd & Kenny, 2010), including the need for M 
to be measured prior to X being measured, particularly if M is a variable that can 
change. This is less of an issue when M is a variable, such as race or blood type, 
which does not change. Another important issue is the need to have a robust 
justification for the direction of the causal (X -> Y) relationship that has been 
specified, particularly if the initial variable, X, is not manipulated. Multiple 
regression is used to detect moderator effects by testing the impact of the interaction 
between X and M on Y.  
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3.2.2.3 Structural Equation Modelling 
  As indicated in Section 3.2.2.2, mediational analysis can be carried out using 
a number of different methods. In recent years, structural equation modelling (SEM) 
has increasingly been used as an alternative to the multiple regression-based method 
outlined above. SEM is a general statistical methodology that takes a confirmatory 
(rather than an exploratory or descriptive) approach to the analysis of a structural 
model (Byrne, 2010). It has several advantages over more traditional multivariate 
methodologies, including the capacity to model and test complex, multiple, 
multivariate relationships simultaneously, as well as the capacity in SEM to assess 
and take into account measurement errors.  
  SEM is used to model and test the relationships between both directly 
observable manifest variables, and latent variables, that is, variables that cannot be 
observed or measured directly. In SEM, latent variables associated with IVs are 
known in as exogenous variables (influenced by factors outside of the specified 
model), whilst those associated with DVs are referred to as endogenous variables, and 
are therefore influenced by the exogenous variables, although not necessarily directly. 
The hypothesised relationships between variables are specified as a model, and 
visually represented in a path diagram. SEM is used to examine both measurement 
models, which outline the relationships between manifest and latent variables, and 
structural models, which examine the relationships just between latent variables.  
  Kline (2005) outlines six general, iterative steps in SEM: 
1. Specify the model. The hypothesised relationship between the various variables is 
made explicit, usually in the form of a path diagram.  
2. Identify the model, by ensuring that it is theoretically possible to calculate all 
parameter estimates for the hypothesised model. 
3. Select appropriate measures of the variables. 
4. Estimate the model. This includes calculating the parameter estimates for the 
model, testing goodness-of-fit of the model, and consider alternative models that 
could also account for the data. 
5. Re-specify the model, if necessary, and go through the analysis steps again. 
6. Report the model and analysis thoroughly in any published papers. 
  SEM is a powerful and flexible analytic tool, used for a range of purposes in 
addition to its application to mediational analysis, including CFA (see Chapter IV).  CHAPTER III  
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  Despite the strengths of SEM, as with all methodologies, it has limitations. 
For example, it requires relatively large sample sizes, with many published studies 
being based on inadequately sized samples (Westland, 2010). It is also common in 
published studies for authors to neglect to consider and examine the fit of alternative 
models. It is also possible, of course, that important variables have been omitted from 
the model altogether, perhaps due to inadequate attention being paid to theoretical 
understanding of the subject matter. 
 
 
3.2.2.4 Experimental Designs 
  The major limitation with any study based on a cross-sectional design is that it 
is impossible to infer causality from the results. In fact, assuming causality in a 
relationship between two variables even in a prospective or longitudinal study where 
data relating to the IV is collected prior to collection of data relating to the DV is still 
problematic, as it is possible that a third, untested variable might cause both the IV 
and the DV. The solution, in its simplest form, is to compare two situations, one 
where the hypothesised cause (IV) is present, the other where it is absent, with all 
other factors that might affect the outcome being controlled (Field & Hole, 2003). In 
practice, this is achieved through randomly assigning participants to two conditions 
and systematically manipulating the IV (Field & Davey, 2005).  
  This experimental research design is the basis of the RCT, seen as the ‘gold 
standard’ for evaluating the efficacy of psychosocial treatments (Nezu & Nezu, 
2008). RCTs, including strengths and weaknesses of the design, will be reviewed in 
Section 3.3.2. However, the experimental design is also the basis of one type of 
model building and testing research; hence its inclusion in this section. Building 
models purely based on correlational data is common, due to the relative ease of data 
collection and the naturalistic set-up of such studies, usually lending the research a 
degree of ecological validity (Field & Davey, 2005). Also, there can be ethical issues 
involved in research where variables are manipulated in such a way that participants 
experience detrimental effects, at least temporarily. The difficultly as outlined above, 
is that such models cannot be said to be truly causal models. 
  Campbell et al. (2000) also recommend the testing of sub-components of such 
interventions under controlled, experimental conditions in the modelling phase. As an 
example, cognitive defusion techniques form part of most ACT treatment protocols, CHAPTER III  
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although relatively little is known empirically about the process of fusion, let alone 
the efficacy of defusion techniques. A small number of authors (e.g. Masuda et al., 
2010) have conducted controlled, experimental studies designed to test the impact of 
stand-alone defusion interventions. 
 
3.2.2.5 Statistical Considerations in Experimental Designs 
The randomisation of participants to two or more controlled conditions, as 
occurs in experimental research designs, implies that the data from the groups of 
participants will be compared. The simplest form of group comparison is in the case 
where there are just two groups, with one IV and one DV. It is usual to analyse the 
data from such designs using a t-test, which generally involves calculating the 
difference between the observed difference between the group means and the 
difference between population means (if the null hypothesis was true). This figure is 
then divided by an estimate of the standard error of the difference between the group 
means (Field, 2005). There are a number of different forms of t-test, depending on 
whether the same or different participants are assigned to each condition. 
  In reality, it is rare that clinical experimental research is this simple, and it is 
more common for some form of analysis of variance (ANOVA) to be used, to 
compare data from several groups, perhaps at more than one time point, or with 
several variables to be considered simultaneously. In theory, a series of t-test could be 
carried out to analyse data from this type of experiment, but the use of multiple 
analyses in this way would increase the risk of type I error, that is rejecting a true null 
hypothesis (Wilcox, 2008). 
  ANOVA is the collective term for a broad and flexible class of statistical 
models designed to partition the variance (variability in a dataset), and thus to assess 
the contribution of each variable to the variance. ANOVA can be used in relatively 
simple situations, for example to examine whether several means are equal or not, in 
relation to the same variable (known as a factor), in the case of a one-way ANOVA. 
However, they are often used in more complex situations where several levels are 
examined in more than one factor. There are several ANOVA variants, including 
analysis of covariance (ANCOVA), in which it is possible to partial out the variance 
associated with a covariate variable, and multivariate analysis of variance 
(MANOVA), used when there are more than one dependant variables.  CHAPTER III  
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  As with all statistical tests, ANOVA is based on a set of assumptions, the 
main ones being independence of observations, homogeneity of variance of errors, 
and normal distribution of scores. In clinical research settings, the assumption of 
independence of observations in particular, is often invalid, as outcome measures tend 
to be administered to the same participant on several occasions. In such situations, 
repeated measures ANOVA models are used to determine whether changes in variable 
score are a function of time.  
  ANOVA tests can indicate that there are group differences in a dataset, but 
not specifically where those differences lie (Field, 2005). For this reason, both 
planned contrasts and post hoc tests are used following ANOVA, to determine more 
precisely the location of these differences. However, conducting post hoc tests 
(essentially multiple t-tests), raises the risk of Type I errors, and so Bonferroni 
correction is employed, in which the acceptable Type I error rate (α) is reduced in 
proportion to the number of post hoc tests.  
 
3.3 Phase II: Exploratory Trial 
  According to Campbell et al. (2000), this is the phase in the development of a 
complex clinical intervention where a protocol is developed for comparing (using a 
pilot RCT) the target intervention with a suitable alternative. Realistically, conducting 
even a small-scale RCT places a considerable burden on researchers, due to the many 
treatment and research matters that have to be addressed prior to running an RCT, 
including the development of a treatment manual, therapist training materials and 
methods, and methods of evaluating treatment quality and adherence (Rounsaville et 
al., 2001), as well as the need to meet NHS ethical and research and development 
requirements. Rounsaville et al. therefore sub-divide Stage I of their model with 
Stage Ia being where much of this preparatory work is done, alongside the prototype 
treatment being piloted (in an uncontrolled setting), with a small number of patients. 
Stage Ib is essentially a pilot RCT, embarked upon once a final version of the new 
treatment has largely been settled. Rounsaville et al. (2001) argue that the kinds of 
activities carried out at Stages Ia and b are vital to the success of the overall treatment 
development process. The complexities of treatment development will be outlined in 
detail in Chapter VII. Suffice it to say, this can be a lengthy phase of the overall 
research process (Rounsaville et al., 2001). CHAPTER III  
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  As an example, Goldstein, Axelson, Birmaher, and Brent (2007) demonstrated 
the appropriateness of an open trial in the early stages of treatment development in 
high-risk circumstances. They adapted DBT for use with adolescents with bipolar 
disorder (BD), and despite evidence indicating the effectiveness of DBT for adults 
with other disorders, due to risks associated with BD, and the young, vulnerable 
patient group, the authors chose a non-randomised, pre-post design. Such designs 
allow clinicians to adapt the intervention in response to patient response, whilst still 
providing structure and scientific rigour. Pilot, open trials also tend to involve small 
numbers of patients, minimising risk if aspects of the new intervention appear to have 
an adverse impact. 
  The major limitation of this kind of research design is that without randomly 
assigning participants to more than one condition, it is impossible to be completely 
confident that any therapeutic change is actually due to the target intervention. 
 
3.3.1 Statistical Considerations in Small-Scale, Open Trials 
  It is common to analyse data from uncontrolled, pre-post studies, in terms of 
group differences from pre-intervention to post-intervention, using t-tests or repeated 
measures ANOVAs (see Section 3.2.2.5). However, due to the small number of 
participants, it may be more appropriate to use non-parametric statistical tests (tests 
that do not rely on parametric assumptions such as the data being normally 
distributed). These tests tend to be more robust than parametric tests and have 
superior power relative to sample size. Commonly, the wilcoxon signed-rank test is 
used in place of a dependent t-test, in pre-post studies where scores on an outcome 
measure are collected at two time points from the same participants. Friedman’s 
ANOVA is used as a substitute for a repeated-measures ANOVA. 
  Another approach to the issue of analysing data from small numbers of 
participants is to test for reliable and clinically significant change, pre to post 
intervention, for individual participants (Jacobson & Truax, 1991). For each outcome 
measure, a reliable change index is determined by subtracting the individual’s pre 
score from their post score and dividing the result by the standard error of difference 
between the two scores (Christensen & Mendoza, 1986). If this index is greater than 
1.96, this is taken (at the p < .05 level) to indicate that reliable change has occurred.  CHAPTER III  
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  Jacobson and Truax (p. 633) suggest that the least arbitrary way of defining 
clinically significant improvement is that “the level of functioning subsequent to 
therapy places the client closer to the mean of the functional population than it does 
to the mean of the dysfunctional population.” This approach involves calculating a 
cut-off point midway between appropriate clinical sample and normative sample 
means, and observing whether an individual participant’s score on an outcome 
measure crosses the cut-off point following the intervention. 
 
3.3.2 RCTs 
  RCTs are currently viewed (e.g. Chambless & Hollon, 1998) as the yardstick 
by which to evaluate psychosocial intervention trials. The predominant strength of 
this design is that randomised allocation of participants under controlled conditions 
protects against threat to the internal validity of the research (Clark-Carter & Marks, 
2004), that is, the confidence with which causal inferences can be made from the 
research results. Factors that might, without random allocation to conditions and 
manipulation of the IV, make it difficult to accurately interpret the results of a clinical 
trial include pre-intervention systematic differences in participant characteristics such 
as age, and differences in history, including illness and treatment history (Nezu & 
Nezu, 2008). There are other potential threats to the internal validity of intervention 
trials, such as differential attrition rates between conditions. 
Additional benefits of using an RCT design at the exploratory phase of 
treatment development are that the actual trial methodologies, such as the 
randomisation process, that will be used later in the research programme are trialled, 
and accurate power calculations can be made (see Section 3.3.3). 
  As with all research designs, there are potential weaknesses and limitations of 
RCTs. Whilst protecting against some major threats to internal validity, RCTs raise 
the risk of threat to external validity, that is the extent to which the conclusions drawn 
from the study can be generalised to other settings, with other patients, and where the 
intervention is carried out by other clinicians (Nezu & Nezu, 2008). It has been 
argued (Seligman, 1995) that comparing interventions under highly controlled 
research conditions, and deciding which intervention is the most effective and 
appropriate to offer in the ‘real world’, are different questions. The issue of CHAPTER III  
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translating results from often highly controlled efficacy research to ‘real world’ 
clinical settings, is one that understandably concerns both researchers and clinicians 
alike (Persons & Silberschatz, 2002), and will be addressed in more detail in Section 
3.5.  
  Regardless of the validity of these criticisms of RCTs, and others, such as the 
ethical issues raised by randomising patients to conditions that are thought to be less 
effective than others, or requiring patients to wait, perhaps months, before 
commencing treatment, RCTs remain central to the process of developing and testing 
psychosocial interventions (Campbell et al., 2000; Rounsaville et al., 2001). RCTs are 
by far the most common design of published clinical outcome trials, with detailed 
guidance being available to improve the quality of reporting RCTs, in the form of the 
Consolidated Standards of Reporting Trials statement (CONSORT; Altman, 1996; 
Altman et al., 2001; Boutron, Moher, Altman, Schulz, & Ravaud, 2008). 
 
3.3.3 Statistical Considerations in RCTs 
  The types of statistical tests typically used in RCT-based efficacy trials have 
already been reviewed in Section 3.2.2.5. However, particular issues regarding 
statistical power, sample size, effect size and participant attrition are often raised in 
relation to RCTs and so will be addressed here (although these issues can apply to 
other types of research designs). The power of a statistical test is an indication of the 
probability that an effect will be detected (when there is actually an effect to detect). 
Failing to detect such effects is referred to a type II error. So, power = 1 - β, where β 
is the probability of a type II error. The power of a test is greater if the hypothesis 
being tested is directional, or if the study has a within-participants design rather than 
a between-groups design, and power increases with increased control in a study, 
increased sample size, and increased effect size (Clark-Carter & Marks, 2004). Of 
these factors, sample size is often the one most readily influenced by researchers. 
Cohen (1962; 1988) recommends that as a minimum, power of .8 is attained, which 
still leaves a 1 - .8 = .2 chance (20%), that a type II error will occur.  
  It is important (particularly in clinical outcome research) to be able to 
determine not only if a relationship between variables, or the difference between 
groups is statistically significant, but also if the effect that has been detected is CHAPTER III  
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meaningful. This is done by calculating the size of the effect (in a specific sample), in 
a standardised way. Cohen (1962; 1988) has outlined a range of methods for 
calculating effect sizes for different statistical tests, as well as indicating what 
constitutes small, medium, and large effects. It is common practice to report effect 
sizes for non-significant results in underpowered studies (e.g. Goldstein et al., 2007). 
  One of the realities of psychological research, including tests of psychosocial 
interventions, is that there will be a loss of participants (referred to as attrition), while 
the study is running. Patients drop out of psychotherapy, often early on in treatment 
(Kazdin, 2003), even without the additional demands and disincentives of being a 
participant in a research study. Attrition can undermine the whole design of the study, 
for example when significant numbers of participants assigned to a waiting list 
control condition drop out. Such attrition can also make it more difficult to interpret 
research findings. For example, it can prove difficult to determine whether 
participants dropped out of a control condition because they were disappointed not to 
have been randomised to the target intervention, or because the control intervention 
involved features that were actually unpalatable to some patients.  
   This kind of differential attrition between conditions is particularly 
problematic when analysing data from RCTs. It raises the risk of violating the 
assumptions on which ANOVAs are based. Furthermore, if such participants are 
excluded from the analysis of the data (a strategy known as per protocol analysis), 
this risks the loss of the advantages of randomisation, and thus is a serious threat to 
internal validity (Hollis & Campbell, 1999). Intention to treat analysis (ITT), is a 
recommended alternative strategy (Hollis & Campbell, 1999; Ruiz-Canela, Martinez-
Gonzalez, & de Irala-Estevez, 2000), where data from all participants, including those 
who dropped out or did not adhere in some other way to the research protocol are 
included in analyses.  
  Missing data is one of the problematic effects of attrition, and several 
strategies for estimating missing data values are available, though it has been argued 
(Hollis & Campbell, 1999, p. 673), that “clinical trials usually do not collect 
sufficient data to allow good estimation, and the only commonly feasible options are 
using the last observed response (carry forward) or assuming that all missing 
responses were constant”. This strategy, often referred to as last observation carried 
forward (LOCF), involves using the last collected data from a participant at all 
subsequent data-collection points, and is based on the assumption that this will yield a CHAPTER III  
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conservative estimate of the impact of the intervention. Of course, if the intervention 
would have in fact resulted in a negative impact on the participant (one possible 
reason why an individual might decide to drop out early in from a clinical trial), then 
LOCF might result in the intervention being viewed as more benign than it actually 
is.   
 
3.4 Phase III: Definitive RCT 
  Suitably powered RCTs are extremely expensive and time-consuming to 
conduct, and it is usual for research funding bodies to require considerable evidence 
of the kinds of development work outlined above before providing funding for a 
large-scale RCT (Lancaster, Dodds, & Williamson, 2004). However, pilot RCTs tend 
to be underpowered, and almost certainly do not involve large enough numbers of 
participants to allow for investigations of potential mechanisms of change based on 
mediation analysis or SEM. It is therefore important for a definitive RCT to be 
conducted, in which a well-defined and piloted intervention is tested against an 
appropriate control condition, under conditions that would allow the detection of any 
effects that are present, and therefore would also allow confidence in the conclusion 
that the intervention is not effective in relation to some outcome measures, if no 
significant group differences are detected. Definitive RCTs are used to demonstrate 
the efficacy of an intervention, meaning that there is empirical evidence that the 
intervention ‘works’ under controlled conditions (Gilbert & Irons, 2005). It does not 
necessarily follow that the intervention, when offered to patients in routine clinical 
settings and under less controlled conditions, will still be effective, an issue that will 
be addressed in Section 3.5.  
    
3.5 Phase IV: Long-Term Implementation 
  According to the Division 12 Task Force (Chambless & Hollon, 1998), for a 
psychosocial intervention to be considered well established, it must be supported by 
evidence of efficacy from at least two RCTs, conducted by independent research 
groups. Without independent replication, even an intervention with exceptional 
outcome data from a well-designed RCT will still only be considered promising, CHAPTER III  
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based on these guidelines. Therefore, Campbell et al. (2000) see replication as a vital 
component of the final stage of treatment development. 
  During this phase, where a promising intervention is hopefully tested by 
several groups of investigators, it is desirable for the quality of the control condition 
to improve. Typically, in early RCTs testing new interventions, the control condition 
is often treatment-as-usual (TAU) or a waiting list control (Chambless & Hollon, 
1998), with the quality of TAU varying considerably. Although TAU and no 
treatment control conditions are seen as acceptable by the Division 12 Task Force, 
moving onto test a new psychosocial intervention against established treatments 
raises confidence in the target intervention. Certainly, quality of control conditions is 
one of the main criteria on which criticisms of the evidence base for new and 
developing interventions are based. For example, Øst (2008) concluded that neither 
DBT nor ACT could be considered empirically supported therapies (EST), based on 
the Division 12 Task Force criteria, citing poor control conditions, amongst other 
criticisms.  
  In Section 3.3.2, a criticism of RCT design was outlined, based on the view 
that such trials have little in common with ‘real world’ clinical settings and practice. 
Indeed, it has been argued (Pearson & Silberschatz, 2003) that in order to reduce 
variability within groups in RCTs, many patients with multiple or complex diagnoses 
are excluded (perhaps up to 70%, according to Westen, Novotny, & Thompson-
Brenner, 2004), resulting in RCT participants having little in common with actual 
patients. 
  There are two main approaches to dealing with this concern regarding the 
external validity of RCTs. The first is to argue that supportive evidence from RCTs is 
necessary but not sufficient to establish that an intervention will be effective under 
routine clinical conditions, and that the definitive RCT phase in treatment 
development should be followed by a final phase where the generalisability of the 
intervention to less controlled settings, with different practitioners, is tested. 
Unfortunately, this frequently does not happen (Clarke, 2003), with less controlled, 
field effectiveness trials relatively uncommon in the published literature.  
  Another approach, (Seligman, 1995; Pearson & Silberschatz, 2003) is to argue 
that alternative study designs, such as the consumer report (Seligman, 1995) and field 
effectiveness studies should be used instead of RCTs to answer questions about the 
usefulness of interventions in ‘real world’ conditions. Of course, excluding RCTs CHAPTER III  
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from the programme of research designed to develop a new intervention would 
almost inevitably result in a reduction in internal validity. This issue illustrates a 
broader tension in clinical research design; every decision regarding study design and 
methodology will in all likelihood result in both an intended advantage and some 
unwished-for cost or disadvantage. In this way, all clinical research is a process of 
creative compromise, with the researcher making methodological decisions based on 
the best information available at the time, the phase or stage in the research 
programme, and the specific aims of the study in question.  
 
3.6 The Present Thesis 
  Chapter I reviews the current literature and research evidence in relation to the 
scientific understanding of PDs and their treatment. From this review, it is clear that 
there is less empirical research concerned with PDs than with other common mental 
health diagnoses. More specifically, despite a growing evidence base for psychosocial 
interventions for BPD, there are significant gaps in the literature regarding the 
treatment of other PD diagnoses, and for people with BPD who are behaviourally 
stable following DBT, but who continue to experience psychologically difficulties. 
  Chapter II critically reviews the development of behavioural and cognitive 
behavioural psychotherapies, including third wave therapies such as ACT. There are a 
small number of empirical studies that suggest that ACT might be of benefit to people 
with PD diagnoses, though there is currently no published test of ACT as an 
intervention for a group with mixed PD diagnoses, nor as a post-DBT intervention. 
Chapter II also reviews the important role hypothesised for CF in the development of 
psychopathology across diagnoses, but notes the paucity of empirical research testing 
this aspect of the ACT model, with no research examining the relationship between 
CF and PD. The lack of a well-designed, broadly applicable measure of CF limits the 
ease with which the results of such studies can be compared, and indeed limits CF-
focused research in general. Given that so little is known about the relationship 
between ACT and PDs, the studies that comprise this thesis fall into the modelling 
and exploratory phases, as described by Campbell et al. (2000) and Rounsaville et al. 
(2001). 
  Chapter III, the current chapter, critically reviews methodological and 
statistical issues relevant to the types of research included in this thesis. CHAPTER III  
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  Study 1 outlines the clinical validation of a new self-report measure of CF, 
based on a mixed mental health sample including PD. Study 2, an ACT theory 
development and testing study, utilises this measure in a cross-sectional design with a 
community sample, to test CF as a possible mediator in the relationship between 
predictors of PD and actual personality functioning. Study 3, focusing on theory 
testing, is an analogue study designed to yield a measure of behavioural avoidance 
and to shed light on the relationship between CF and behavioural avoidance in a 
student sample (more extreme forms of behavioural avoidance being common and 
problematic in PD patients).  
  Studies 4 and 5 extend this programme of research into the exploratory, 
clinical phase, by testing an ACT intervention with DBT graduates with mixed PD 
diagnoses and Axis I difficulties. Given that this is a novel use of ACT with a 
relatively high-risk population, a cautious approach to these clinical trials was taken. 
Study 4 tests an ACT group-based protocol in an open, pre-post trial with a small 
sample, with data being collected pre-intervention, post intervention, and at 6-months 
post-intervention. Based on the data and experiences from this initial group, the 
intervention protocol was modified, and Study 5 tests the modified, 24-week group 
protocol with a small sample, again in an uncontrolled trial. Taken as a whole, this 
thesis outlines an integrated research programme designed to develop scientific 
understanding of a key ACT process (CF), and of PD from an ACT perspective, and 
to use this understanding to begin to develop a theoretically coherent, ACT-based 
intervention for people with poor personality functioning. 
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CHAPTER IV 
Study 1. The Clinical Validation of a Self-Report Measure of CF 
 
4.1 Introduction 
CF plays a central role in the ACT theory of psychopathology. However, to date, no 
adequate measure of fusion has been published, hindering empirical investigation of 
the construct. The primary aim of this study was to continue the validation process of 
a new, self-report measure of CF, with a clinical sample, in order to make available a 
good quality measure for use in both clinical and research settings. 
 
4.1.1 CF 
  CF (defined in Chapter II, Section 2.2.1.2) concerns the way in which we 
relate to our cognitions. Fusion with thoughts involves taking them to be reality, 
being unable to see them from different perspectives, being psychologically 
‘entangled’ with thoughts, and thoughts dominating awareness, emotion and action. 
CF is hypothesised to significantly contribute to psychological inflexibility, and thus 
to be an important determinant of psychopathology. CF is similar to processes such as 
decentering, thought-action-fusion, and metacognitive awareness, but there are 
important differences. Decentering involves the acceptance of thoughts and emotions, 
as well as self-compassion, in addition to the capacity to ‘step back’ from thoughts 
and emotions (Fresco et al., 2007), the latter being the aspect of decentering most 
related to CF. Thought-action-fusion (Shafran, Thordarson, & Rachman, 1996) 
specifically refers to beliefs sometimes associated with obsessional-compulsive 
disorder that thinking that something harmful will happen actually increases the 
likelihood of it happening. The construct is thus much more specific than cognitive 
fusion, and does not (unlike cognitive fusion) refer to a broad awareness of the 
process of thinking. Metacognition is seen as the awareness of the process of thinking 
(Teasdale et al, 2002), and beliefs about thinking (Cartwright-Hatton &Wells, 1997), 
with the one published measure of metacognition being a measure of beliefs about 
worry and intrusive thoughts. CHAPTER IV 
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  Theoretically, CF is viewed as a context-determined process. However, for the 
purposes of questionnaire-based measurement, it is treated as a trait-like construct, 
where individual differences can be determined. The inconsistency of this strategy 
with the behavioural theory on which ACT is based, has been discussed by the 
authors of the AAQI (Hayes et al., 2004), in relation to EA, who underline the 
pragmatic utility of the approach. 
4.1.2 Measurement of CF 
  Despite the hypothesised importance of CF to psychological health (and to 
ACT theory), there has been relatively little investigation of the process (Blackledge, 
2007), compared, for example, with the research literature investigating EA. Even the 
most basic information relating to fusion, such as norms for different populations, is 
not available. It could be argued that the paucity of fusion-focused research is in large 
part due to measurement issues. 
  There is no single, commonly used self-report measure of CF, in the way that 
the AAQI (Hayes et al., 2004) and AAQII (Bond, et al., 2011) are commonly used as 
measures of EA and psychological flexibility. Instead, several authors have 
developed measures of CF for use with specific populations, with the items of those 
measures referring to specific cognitions that an individual from that population 
might experience. An example is the Stigmatizing Attitudes-Believability Scale 
(SAB; Hayes et al., 2004), which was designed to measure fusion with stigmatising 
attitudes of counsellors who work with substance misuse patients. This type of 
measure can be adapted for use with another, similar population. For example, Taylor 
(2010, unpublished manuscript) used the same basic structure for a self-report 
measure of fusion with stigmatising attitudes of mental health professionals working 
with patients with PD diagnoses. However, because these questionnaires use specific 
cognitions or attitudes as items (e.g., “Personality disordered clients are demanding, 
you can never do enough”), they cannot be used to measure CF in a range of 
populations and situations.  
  There are also examples (Healy et al., 2008; Masuda et al., 2010) of 
researchers using a single item (for example, “Rate the extent to which you found the 
previous statement believable”), as a measure of CF. However, it has been argued CHAPTER IV 
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that single item measures are less reliable than those with multiple items (Nunally, 
1970). 
  Measures such as the SAB can be effective in terms of doing the job they 
were designed to do; to measure the believability of certain thoughts for a particular 
group of people, but they were not designed to be general measures of CF and cannot 
function as such. They are not flexible enough in their design to be used with a range 
of populations or cognitions, and therefore they are severely limited in how much 
they can contribute to an understanding of CF. 
  There is another, equally important limitation of this type of measure. They 
were designed to measure the believability of thoughts or attitudes, which is taken to 
be equivalent to fusion. Indeed, all current published measures of CF are actually 
measures of believability, despite CF being defined and operationalised in a much 
broader way in the ACT literature (e.g., Hayes et al., 1999; Hayes and Strosahl, 
2004). In these key ACT texts, believability of thoughts is seen as just one aspect of 
fusion. For a measure of CF to have content validity in terms of addressing the 
process as it is described in the literature, it would also need to address the other 
aspects of fusion, such as the inability to view thoughts from different perspectives, 
outlined in Section 4.1.1. There is no published measure of CF that addresses the 
process more fully and accurately in this way. 
  Furthermore, it is not unusual for these believability measures to remain 
psychometrically untested, leaving a question mark about the reliability and validity 
of such measures. 
 
4.1.3 Cognitive Fusion Questionnaire 
  Prior to the current study, a self-report measure, the Cognitive Fusion 
Questionnaire (CFQ; Appendix B) was developed and validated with several non-
clinical samples (Gillanders et al., submitted)
2. We, (Gillanders, Bolderston and 
Bond) designed the CFQ to be a measure of the broad construct of CF, rather than 
merely measuring believability. It was also designed to address fusion with 
                                                 
2 The initial development of the CFQ occurred prior to this PhD. Due to space limitations, the methods 
employed in its development will not be outlined in detail here, but are described in detail in 
Gillanders et al. 
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cognitions in general, rather than specific thoughts, so that it can be used as a general 
measure of CF across a wide range of populations.  
  The CFQ consists of 13 items; nine fusion and four defusion. We generated an 
initial pool of 44 items, which was rated by members of the ACT Special Interest 
Group of the British Association of Behavioural and Cognitive Psychotherapists on 
how well each item represented the construct. Ratings were based on a 4-point scale 
(‘not at all representative’, ‘a little representative’, ‘moderately representative’, and 
‘highly representative’). Only those items with a modal rating of moderately or 
highly representative were included in the original prototype of the questionnaire. 
The final 13-item version was arrived at through an iterative process of item 
performance analysis and EFA. Items were designed to operationalise key aspects of 
CF and defusion, including getting entangled with thoughts (e.g. ‘I tend to get very 
entangled with my thoughts’), the dominance of thoughts over emotions and action 
(e.g., ‘I get so caught up in my thoughts that I am unable to do the things that I most 
want to do’), believability of thoughts (e.g., ‘Even when I am having upsetting 
thoughts, I can see that those thoughts may not literally be true’), and the capacity to 
experience thoughts from different perspectives (e.g., ‘I find it easy to view my 
thoughts from a different perspective’).  
The CFQ is based on a 7-point Likert-type scale, with respondents being 
asked to rate how true each item is for them, ranging from ‘never true’ to ‘always 
true’. Items address both fusion and defusion, for example ‘I overanalyse to the point 
where it’s unhelpful’ and ‘I find it easy to view my thoughts from a different 
perspective’. The measure is scored so that higher scores indicate greater fusion (the 
defusion items are reverse-scored). The CFQ has a Flesch-Kincaid reading index of 
5.4, suggesting that the average 10-year-old child could make sense of the wording of 
the items (Kincaid, Fishburne, Rogers & Chissom, 1975). 
EFA with non-clinical samples yielded two factors, with the fusion items 
associated with one factor, and the defusion items with the other. As was noted in 
Chapter II, Section 2.2.1.2, in the ACT literature CF and defusion are understood to 
be opposite ends of the same construct (Blackledge, 2007). It was therefore important 
to ascertain whether these two factors were both substantive, implying that they 
represented fusion and defusion as different, though related constructs, or if the two 
factors were a result of a method effect, in this case due to systematic differences in 
item wording between the fusion and defusion sets of items (Brown, 2006). CFA CHAPTER IV 
   
87 
indicated that a one-factor solution with method effect specified (stipulating 
covariance amongst the error terms for the defusion items) provided the best fit to the 
data, supporting the hypothesised view of fusion and defusion being opposing 
elements of the same construct. This finding indicated that the CFQ should be scored 
as a total scale, and not as separate fusion and defusion subscales, although it is 
possible that the questionnaire could perform differently, and yield an alternative 
factor structure, with a clinical sample.  
The CFQ appears to be a highly reliable measure with non-clinical samples. 
Internal consistency of the questionnaire, as measured by Cronbach’s α, is excellent, 
ranging from .81 to .89, with a mean α of .85. Test-retest reliability, assessed using 
Pearson’s correlation coefficient, is also very good (r = .79), over a period of one 
month. Normative and validity data are available for the CFQ from several non-
clinical samples, with the current number of respondents totalling more than 1000. 
With regards to norms, mean total score across non-clinical samples is 42.89 (SD = 
11.73), with total score ranging from 13 to 85 (the scale has a possible range of 13 to 
91).  
As can be seen in Table 4.1, the CFQ relates as would be predicted to 
measures of relevant variables. For example, it correlates positively with measures of 
psychopathology and correlates negatively with a measure of mindfulness (Five 
Facets Mindfulness Questionnaire; FFMQ; Baer et al., 2008), thus providing 
evidence for convergent and divergent validity. The relationship between the CFQ 
and the Balanced Inventory of Desirable Responding Impression Management Scale 
(BIDR; Paulhus, 1991), a measure of social desirability in responding, has also been 
examined in a community sample (n = 47). The correlation was non-significant, 
suggesting that score on the CFQ is not significantly influenced by socially desirable 
responding. 
One matter of note is that there is a particularly large correlation between the 
CFQ and the AAQII (Bond et al., 2011). In fact the AAQII, designed to measure 
psychological inflexibility, has been administered to four non-clinical samples with 
the CFQ, resulting in correlations of .58, .69, .83, and .85. Field (2005) suggests that 
a correlation as high as .8, and perhaps even above .9 between two variables would be 
needed to indicate the possibility of multicollinearity. 
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Table 4.1 
Correlations Between the CFQ and Measures of Relevant Variables (Pearson’s 
Correlation Coefficient) 
                 
        Measure   
 
     
  CORE  HADS 
anxiety 
HADS 
depression 
WHOQOL  DLSS  AAQII    FFMQ 
 
 
CFQ 
 
N 
 
.59** 
 
113 
 
.54* 
 
144 
 
  .39* 
 
144 
 
-.47** 
 
113 
 
-.43** 
  
167 
  
 
 .69** 
 
167 
 
 
 
 -.61* 
 
44 
 
Note. ** correlation significant at p < .001 level (2-tailed) * correlation significant at p < .01 (2-tailed). 
CORE = Clinical Outcomes in Routine Evaluation (global distress); HADS = Hospital Anxiety and 
Depression Scale; WHOQOL = World Health Organisation Quality of Life brief measure; DLSS - 
Deiner’s Life Satisfaction Scale; AAQII = Acceptance and Action Questionnaire Version II; FFMQ = 
Five Facets Mindfulness Questionnaire   
   
In this case, this would raise the possibility that the two questionnaires are 
measuring the same construct. The ACT model would suggest that CF and 
psychological flexibility are strongly related, but nonetheless, they are described 
separately (see Chapter II for a detailed examination of this issue). Additional data is 
needed not only to further test the performance of the CFQ in relation to the AAQII, 
but to provide insight into the nature of the relationship between these aspects of the 
ACT model. 
In summary, based on the data currently available, the CFQ appears to be a 
reliable and valid brief, self-report measure of CF, with a factor structure consistent 
with the ACT theoretical view of the construct. However, to date, it has not been 
administered to a clinical sample. There are therefore no clinical norms available, and 
it has not been tested in terms of reliability and validity with a clinical sample. 
Furthermore, the factor structure has not been examined with a clinical sample, and 
thus the final structure of the questionnaire, in terms of whether it is psychometrically 
meaningful or not to score separate fusion and defusion subscales, remains unsettled.   
    
4.1.4 Present Study 
  The purpose of the present study was to extend the development work 
outlined above by gathering a range of psychometric data in relation to the CFQ, with 
a mental health clinical sample. This is an important step in the development of the CHAPTER IV 
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measure, because it was designed to be utilised in both non-clinical and clinical 
research settings. If it were to perform well psychometrically with clinical samples, 
the CFQ could be used for a variety of purposes, including testing the hypothesised 
role of CF in the development and maintenance of psychological disorders, and 
assessing the impact of defusion and more general ACT clinical interventions. 
The study research questions were as follows: 
With a mental health clinical sample: 
1. What is the factor structure of the CFQ? 
2. What is the internal reliability of the CFQ? 
3. What is the test-retest reliability of the CFQ? 
4. Does the CFQ demonstrate concurrent validity? 
5. Does the CFQ demonstrate convergent and divergent validity in relation to a range 
of clinically relevant self-report measures? 
6. What are the mental health norms for the CFQ (including its relationship with 
demographic variables)? 
 
4.2 Method 
 
4.2.1 Participants 
  An opportunity, outpatient mental health sample (n = 183) was recruited from 
a number of sources within Dorset Healthcare University NHS Foundation Trust 
(DHUFT), and two Scottish NHS Trusts
3. These sources included community mental 
health teams and primary care mental health services, as well as specialist PD, eating 
disorder and community recovery services. All participants had been assessed by a 
qualified mental health professional as having a current mental health problem such 
as mood disorders, anxiety disorders, eating disorders, and PDs.  
The sample was 73.2% female (n = 134), with a mean age of 39.5 (SD = 
12.80; range = 18 - 68). In terms of ethnic origin, 86.9% (n = 159) identified 
themselves as white, 1.1% as Asian, .5% of mixed ethnic origin, and 10.9% did not 
                                                 
3 The Scottish data were collected by Dr. David Gillanders (approved by the University of Edinburgh 
and Scottish NHS research ethics committees), and shared in anonymised form. CHAPTER IV 
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provide this information. In terms of current mental health treatment status, 78.1% (n 
= 143) reported currently receiving psychological treatment such as counselling. 
  A sample size of 84 was determined to be adequate to ensure acceptably 
narrow confidence intervals for the construct validity aspect of the study. A sample 
size of at least 130 was viewed as acceptable for the analysis of the factor structure 
(Nunally, 1978; Russell, 2002). 
  Participant inclusion and exclusion criteria for the study were as follows: 
Inclusion criteria 
(i) 16 years old and above 
(ii) Currently using the above NHS mental health services on an outpatient basis. 
 
 
Exclusion criteria 
(i) Patient is not well enough to make an informed decision about participation in the 
study, or any possibility that participation may have an adverse affect on the patient’s 
psychological wellbeing. 
(ii) Under the age of 16. 
(iii) Current psychotic symptomology that might impair capacity to give informed 
consent, or to complete the questionnaires accurately. 
(iv) Learning disability 
(v) Other organic disorder that might impair capacity to give informed consent, or to 
complete the questionnaires accurately. 
(vi) Currently participating in other research. 
  Data from an international, community sample recruited via the internet for 
another study in this thesis (see Chapter V) were used to examine the concurrent 
validity of the CFQ. This sample (n = 160) was 73.75% female (n = 118), with a 
mean age of 30.00 (SD = 11.54) and age range of 16 to 70. Country of origin was 
reported as the US by 53.13% (n = 85), and the UK by 28.75% (n = 46) of the 
sample. The majority (83.75%, n = 134) reported being of white ethnic origin. In 
answer to the following question: ‘Have you ever sought treatment for a 
psychological problem (for example depression, anxiety, relationship difficulties, 
substance misuse, eating disorder)?’, 92 (57.50%) responded positively, forming a 
self-declared clinical sub-sample. 
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4.2.2 Materials 
4.2.2.1. Cognitive Fusion Questionnaire (CFQ; Gillanders et al., submitted) For 
details of the measure and its development, see Section 4.1.3.  
4.2.2.2. Brief Demographics Questionnaire. Participants were asked to indicate their 
age, gender, ethnic origin, and whether they were currently receiving psychological 
treatment (see Appendix C). 
4.2.2.3 Construct Validation Questionnaires. The following common and well-
validated measures were used to examine the construct (convergent and divergent) 
validity of the CFQ. 
  The Symptom Checklist-90-R (SCL-90-R; Derogatis, 1994). The SCL-90-R is 
a widely used 90-item self-report measure, designed to evaluate a broad range of 
psychopathology symptoms. Respondents indicate on a 5-point scale (0 = not at all to 
4 = extremely) how much they were distressed by each symptom over the past 7 days. 
Example of symptoms included are ‘feeling fearful’ and ‘other people being aware of 
your private thoughts’. 
The SCL90-R measures nine symptom dimensions (Somatisation, Obsessive-
Compulsive, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic 
Anxiety, Paranoid Ideation, and Psychoticism). Three global indices (Global Severity 
Index (GSI), Positive Symptom Distress Index, and Positive Symptom Total) can be 
calculated from the raw data. The GSI, indicating overall psychological distress, is 
the SCL-90-R index most widely reported in the literature, and is the one used in the 
current study. 
  The mean GSI is .31 (SD = .31) for a non-psychiatric sample, with a mean of 
1.26 (SD = .68) for a psychiatric outpatient sample. The measure has good 
psychometric properties including internal reliability for the nine scales ranging from 
α = .77 to 90, and test retest reliability ranging from r = .80 to .90 for a 1-week 
period.    
  The Personality Diagnostic Questionnaire (PDQ; Hyler et al., 1988). The 
PDQ is a screening tool for PDs, consisting of 99 true/false questions based on DSM-
IV diagnostic criteria. Examples of items include ‘I get special messages from things 
happening around me’ and ‘Spending time with family and friends just doesn’t 
interest me’. The questionnaire can be used either as a stand-alone screening tool (as 
it is in this study), to give an indication of personality functioning (a score of 50 or CHAPTER IV 
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more positive responses indicating the likelihood of pathological personality 
functioning), or positive responses to the questionnaire items can be followed up by 
structured interview questions to yield PD diagnoses. For this type of screening 
questionnaire, the PDQ shows good internal consistency (mean α = .71 across several 
samples), and test-retest reliability (mean r = .67).  
  The PDQ contains six items designed to highlight possible poor quality data 
in the form of under-reporting and other suspect responses. An example of these 
items is ‘Sometimes I get upset’ (an under-reporting response if answered 
negatively). 
  The Acceptance and Action Questionnaire Second Version (AAQII; Bond et 
al., 2011). The AAQII is a self-report measure of psychological inflexibility, the 
central ACT-relevant psychological process. It has items addressing the individual’s 
relationship to thoughts and emotions, and the impact of thoughts and emotions on 
the individual’s ability to live life as they would like. Items include ‘Worries get in 
the way of my success’ and ‘I’m afraid of my feelings’. Respondents are asked to rate 
how true each item statement is for them, on a seven-point scale ranging from Never 
true to Always true.  
This 7-item questionnaire has good internal consistency (mean Cronbach’s α 
= .84 across several samples) and test-retest reliability (r = .81 for a 3-month 
interval). Mean total score for a community sample is 18.53 (SD = 7.52), and for the 
only clinical sample reported (substance misusers in the US), mean total score is 
28.34 (SD = 9.92). 
  The Beck Depression Inventory, 2
nd edition (BDI-II; Beck, Brown, and Steer, 
1996). This is a 21-item self-report questionnaire measuring the range of cognitive, 
biological, emotional and behavioural symptoms of depression as listed in DSM-IV. 
Each of the items consists of a symptom, followed by a list of four statements 
increasing in intensity on a scale of 0 to 3. For example the symptom ‘sadness’ is 
followed by the following four statements; ‘I do not feel sad’ (0), ‘I feel sad much of 
the time (1), ‘I am sad all of the time’ (2), and ‘I am so sad or unhappy that I can’t 
stand it’ (3). Respondents are asked to indicate which statement best describes how 
they have been feeling over the past two weeks.   
A score of 0 – 13 is no or minimal depression, 14 – 19 indicates mild 
depression, 20 – 28 indicates moderate depression, and above 28 (to the maximum CHAPTER IV 
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score of 63) indicates severe depressive symptomology. Good internal reliability (α = 
.92 for an outpatient sample) and test retest reliability (r = .93) are reported. 
  The Kentucky Inventory of Mindfulness Skills (KIMS; Baer, Smith, & Allen, 
2004). The KIMS is 39-item self-report measure of mindfulness, based on the way in 
which mindfulness is conceptualised in DBT (Linehan, 1993). It gives an overall 
mindfulness score, as well scores for four components of mindfulness (mindful 
observing, mindful describing, acting in awareness, and accepting without 
judgement). The KIMS has good psychometric properties, including internal 
reliability (α ranging from .83 to .91) and test-retest reliability (r ranging from .65 to 
.83 over a 2-week period).  
  The Automatic Thoughts Questionnaire (ATQ; Hollon & Kendall, 1980). The 
ATQ is a process measure widely used in CBT research. Respondents are asked to 
rate on a scale of 1 (Not at all) to 5 (All the time) how frequently over the last week 
they have experienced each of 30 negative automatic thoughts. Items include ‘why 
can’t I ever succeed?’ and ‘I hate myself’. People with a diagnosis of depression tend 
to score above 90 on the ATQ, with non-depressed people scoring below 60 
(Derubeis et al., 1990). The measure has good psychometric properties, including 
excellent internal reliability (Cronbach’s α = .97). 
  The Severity Indices of Personality Problems (SIPP; Verheul et al., 2008). 
The SIPP is a self-report measure of adaptive and maladaptive personality 
functioning. It consists of 118 items that fall into five domains; self-control, identity 
integration, relational capacities, responsibility, and social concordance, with 
respondents being asking to indicate the extent to which they agree or disagree with 
each statement as a description of themselves over the previous three months. 
Examples of items include ‘I know exactly who I am and what I am worth’ (an 
identity integration item), and ‘I can work with people on a joint project in spite of 
personal differences’, a social concordance item. The SIPP has very good 
psychometric properties, with Cronbach’s α for the five domains ranging from .88 to 
.94, with a mean of .91. Test-retest reliability for the five domains, (over a period of 
two to three weeks), ranges from r = .87 to r = .93. 
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4.2.3 Procedure 
  NHS ethical approval (Reference number: 09/H0502/78; Appendix D), 
DHUFT research and development approval, University of Southampton Psychology 
ethical and research governance approval were all obtained for this study. 
Clinicians from a range of mental health teams were given the study 
information sheet (Appendix E). Recruiting via clinicians, though potentially 
introducing bias into the sample was seen as clinically and ethically preferable to 
contacting mental health patients without consulting their key clinician. Potential 
participants were informed about the study either directly by their key clinician, or by 
the researcher. In all cases, if mental health service users expressed interest in 
participating in the study, they were given or sent the participant information sheet 
(see Appendix E). If they then decided to participate, written consent was required 
(see Appendix E). The participant information sheet emphasised that participation 
was on a voluntary basis and specifically that access to clinical services would not be 
affected by the decision to participate or not.  
  The study consisted of two phases. The initial phase, designed to gather data 
for validation purposes, involved participants completing the whole questionnaire 
pack. Based on previous studies, it was estimated that the questionnaire packs would 
take no longer than 40 – 45 minutes to complete. Participants recruited during the 
later phase of the study, were asked to complete just the CFQ and the brief 
demographic questionnaire, taking approximately 10 minutes. These additional data 
were used to carry out CFA.  
  Participants completed the questionnaires in the privacy of their home. 
Consenting participants were offered help to complete the questionnaires, if required, 
from the IPTS research assistant. No participants asked for this help. 
  All questionnaires were labelled with a unique identification number for each 
participant. Questionnaires contained no participant identifying information. Each 
participant received a debrief sheet (Appendix E), containing supervisor and student 
contact details. Participants were encouraged to make contact in the unlikely event 
that they experienced any distress or problem as a result of participating in the study.  
  A subset of participants who indicated that they were not currently receiving 
psychological treatment were sent the CFQ only, three weeks after they completed it 
for the first time, in order to determine test-retest reliability.  CHAPTER IV 
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4.2.4 Analysis Plan 
  Stage One of the analysis focused on examining the CFQ individual items 
particularly in terms of skew and kurtosis, as well as examining the data for outliers. 
Stage Two utilised SEM to carry out CFA in order to examine the factor structure of 
the measure. The fit of factor models to the data was evaluated using the following fit 
indices: χ
2/df ratio, comparative fit index (CFI) root mean square error of 
approximation (RMSEA), and Akaike’s information criterion (AIC). 
  Although commonly reported (usually in the form of the χ
2/ df ratio,) χ
2 is 
highly sensitive to sample size and is considered to be unnecessarily conservative 
(Brown, 2006). As a result, several alternative fit indices have been developed It is 
common practice to report one of the comparative fit indices available, such as the 
CFI, and a fit index that takes parsimony into consideration, such as the RMSEA. The 
CFI and the RMSEA (both used in this study) are the indices generally recommended 
(Bentler, 1990; Brown, 2006; Byrne, 2010). The AIC is used to compare two or more 
models when a χ
2  difference test cannot be used, due to models not being nested. To 
indicate good model fit, the χ
2/ df ratio should be 2.0 or less (Bollen, 1989), the CFI 
should have a value close to .95 (Hu & Bentler, 1999), and an RMSEA value of .05 
or less indicates good fit. For the AIC, a smaller value represents a better model fit. 
  Stage Three assessed the internal reliability, test-retest reliability, construct 
and concurrent validity of the CFQ, as well as producing clinical norms. Internal 
reliability was tested using Cronbach’s α, test-retest reliability and construct validity 
using Pearson’s correlation coefficients, and concurrent validity using independent t-
tests. PASW Statistics 18 software was used for all data analysis except CFA, which 
was conducted using AMOS 17 software. 
 
4.3 Results  
4.3.1 Data Screening 
  Prior to analysis the data were examined in a number of ways. Raw data from 
the CFQ were examined to see if any individual items had several missing responses, 
indicating that perhaps participants had difficulties understanding or answering that 
particular item. This was not found to be the case. In fact there were just 7 missing 
responses on the CFQ for the whole of the dataset, spread over 6 items.  CHAPTER IV 
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  Missing data was then examined more broadly. It was found that six (7.7%) of 
the participants who had been administered the full set of study questionnaires (n = 
78) had more than 10% data missing from one measure, and therefore the data for 
that individual for that measure was excluded from subsequent analyses. All other 
instances of missing data were dealt with by replacing with the sample mean, as is 
usual practice (Tabachnick and Fidell, 2001). No participants who had been 
administered just the CFQ had more than 10% missing data. A total of 10 (12.8%) 
participants had their PDQ data excluded from analysis based on their responses to 
the PDQ items designed to indicate under-reporting and other suspect responses. 
4.3.2 Stage One: Item Characteristics, Distribution and Outliers 
Participants responded using the full range of possible responses (1 - 7) for all 
CFQ items. The mean score and standard deviation for each item are shown in Table 
4.2. Frequency distributions for each item of the CFQ were tested for skewness and 
kurtosis (Table 4.3). West, Finch and Curran (1995), recommended by Byrne (2010), 
suggest that skew and kurtosis values above 7 indicate problematic, non-normal 
distributions. Using these guidelines, none of the CFQ items were found to have 
problematic distributions. Box plots and Mahalanobis distance values were used to 
identify univariate and multivariate outliers (Byrne, 2010), leading to the exclusion of 
the data from six participants, resulting in a final sample size of 177. 
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Table 4.2 
Descriptive Data for CFQ Items  
     
 
Items 
 
Mean 
 
SD 
 
1 My thoughts cause me distress or emotional pain 
 
4.85 
 
1.32 
2 I get so caught up in my thoughts that I am unable to do the 
things that I most want to do 
4.54  1.45 
3 Even when I am having distressing thoughts, I know that 
they may become less important in the future 
4.16  1.40 
4 I over-analyse situations to the point where it’s unhelpful 
for me 
5.05  1.57 
5 I struggle with my thoughts  5.03  1.46 
6 Even when I’m having upsetting thoughts, I can see that 
those thoughts may not literally be true 
3.97  1.43 
7 I get upset with myself for having certain thoughts   4.72  1.52 
8 I need to control the thoughts that come into my head  4.85  1.64 
9 I find it easy to view my thoughts from a different 
perspective 
3.34  1.51 
10 I tend to get very entangled in my thoughts  4.97  1.50 
11 I tend to react very strongly to my thoughts  4.79  1.47 
12 It’s possible for me to have negative thoughts about myself 
and still know that I am an OK person 
3.89  1.68 
13 It’s such a struggle to let go of upsetting thoughts even 
when I know that letting go would be helpful 
 
5.07  1.52 
 
Table 4.3 
Skew and Kurtosis Data for CFQ Items (n = 177) 
         
Item 
no. 
Skew  Skew 
critical 
ratio 
Kurtosis  Kurtosis 
critical 
ratio 
 
1 
 
  -.26 
 
  -1.39 
 
-.06 
 
 -.16 
2    -.15  -.83  -.09   -.24 
3    -.22  1.20  -.03  -.09 
4    -.68    -3.70  -.03   -.09 
5    -.43    -2.33  -.07   -.19 
6     -.08   -.41  -.24  -.66 
7    -.48    -2.59  -.07   -.20 
8    -.47    -2.55  -.30   -.81 
9    -.35   -1.90  -.19  -.52 
10     -.68    -3.71  .16   .43 
11    -.29     -1.56  -.41    -1.12 
12     -.07       -.40  -.63   -1.72 
13    -.58    -3.14  -.25   -.68 
 CHAPTER IV 
   
98 
4.3.3 Stage Two: CFA 
  Based on the results of EFA and CFA with several non-clinical samples, it 
was predicted that a single factor model with method effect specification would best 
fit the data. As can be seen in Figure 4.1, the error terms for the four defusion items 
were covaried, to indicate that the reason why these four items appear to form a 
separate subscale is due to them all being influenced by a method effect (in this case, 
systematic item wording differences between fusion and defusion items), rather than 
them relating to a substantive second factor. Good CFA practice suggests testing a 
number of theoretically feasible factor solutions (Brown, 2006). Therefore, four 
models were tested using SEM. Model 1 was a single-factor solution, Model 2, a two 
unrelated-factors solution, and Model 3, a two-factor solution with related factors. 
Model 4 was the single-factor model with method effect specification. 
From Table 4.4 it can be seen that Models 3 and 4 both fit the data well, with 
χ
2/ df ratios below 2.0, CFI above .95, and RMSEA close to .05. The fit indices for 
Models 1 and 2 suggest that these two models do not fit the data as closely. A χ
2 
difference test cannot be used to assess whether Model 3 or 4 fits the data best, as 
they are not nested models. However, Model 4, the hypothesised model, provides the 
best fit on all indices, including the AIC, which is specifically used to compare 
models. Given, additionally, that this model is more parsimonious and is also theory-
consistent, it is the model that should be retained. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CHAPTER IV 
   
99 
Figure 4.1 
Model Specification of Predicted Factor Structure with Standardised Regression 
Weights 
 
 
Note. All paths significant at p < .01. Large circle represents latent variable, squares represent  
manifest indicators, err denotes error terms. Double-ended arrows indicate covariance between  
error terms. 
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Table 4.4 
Fit Indices for CFA Comparing Four Factor Models for the CFQ 
               
      Fit index 
 
       
Model  χ
2  df  χ
2 /df  CFI    RMSEA 
 
AIC 
 
1. One factor 
 
201.63 
 
65 
 
  3.12 
 
 .84 
 
 
 
 .11 
 
 
279.63 
 
2. Two unrelated 
factors 
 
114.50  65    1.762   .94     .10 
 
192.50 
3. Two related 
factors
1 
 
 99.15  64     1.55   .96     .06  179.15 
4. One factor, method 
effect specified 
 
 86.88  59     1.47   .97     .05 
 
176.88 
Note. χ
2 = minimum fit function chi-squared; df = degrees of freedom; CFI = comparative fit index; 
RMSEA = root mean square error of approximation; AIC = Akaike’s Information Criterion;
 1 Pearson’s 
correlation between the two related factors = -.34, p < .001 
 
   
4.3.4 Stage Three: Reliability 
  Internal consistency, as measured by Cronbach’s α coefficient was examined 
for the CFQ total scale, the fusion subscale and the defusion subscale. The results can 
be seen in Table 4.5, with equivalent statistics from community samples, for 
comparison. The total scale and fusion subscale was shown to have excellent internal 
consistency, while the defusion subscale was shown to have acceptable internal 
consistency, particularly when the fact that it consists of just four items is taken into 
account. All α values were above the commonly used benchmark of .70 (Tabachnick 
& Fidell, 2001).   
Test-retest reliability was assessed by examining the relationship between 
CFQ total scores from questionnaires completed three weeks apart by a subsample of 
participants (N = 19). A significant correlation was found between the two scores, 
using Pearson’s correlation coefficient (r = .84, p < .001).  
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Table 4.5 
Cronbach’s α Coefficient for the CFQ, for Clinical and Non-Clinical Samples* 
         
    Cronbach’s α 
 
   
CFQ scale  Clinical 
sample 
n = 177 
Non-clinical 
samples Range 
n = 1072 
  Non-clinical 
samples 
 Mean  
n = 1072 
 
CFQ total scale 
 
 
.86 
 
 .81 - .89 
 
  
 
.86 
CFQ fusion subscale 
 
.89   .88 - .93     .91 
 
CFQ defusion 
subscale 
 
.72   .54 - .78     .72 
Note. *Non-clinical values quoted from Gillanders et al., (submitted) 
4.3.5 Sample Characteristics 
  Table 4.6 shows clinical normative data for the CFQ, presented alongside 
equivalent data from community samples. As would be expected, this clinical sample 
had a higher mean total fusion score than the non-clinical sample. Analysis of CFQ 
score by gender using independent t-tests indicated yielded no significant gender 
differences on the total score (t(175) = 1.29, p = .20), the fusion subscale, (t(175) = 
.73, p = .47), or the defusion subscale, (t(175) = -1.80, p = .07), although the latter 
was close to being significant, with men, on average, scoring as more defused than 
women. The relationship between CFQ score and age was assessed using Pearson’s 
correlation coefficient. No significant relationships were found, for the CFQ total 
scale (r = -.09, p = .23), fusion (r = -.08, p = .27), or defusion (r = .06, p = .45) 
subscales. This is in keeping with data from community samples. 
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Table 4.6 
Normative data for the CFQ, for clinical and non-clinical samples* 
           
CFQ scale  Clinical 
sample 
mean score 
(SD) 
n = 177 
 
Clinical 
sample 
range  
n = 177 
 
Non-clinical 
samples 
mean score 
(SD) 
n = 1072 
  Non-clinical 
samples 
 range  
n = 1072 
 
CFQ total scale 
 
 
60.77(11.37) 
 
31 - 86 
 
 
 42.89(11.73) 
 
  
 
13 - 85 
CFQ fusion 
subscale 
 
44.46(9.45)  20 - 63   30.49(10.03)     9 - 63 
 
CFQ defusion  
        subscale 
 
15.20(4.30)  4 - 27   12.40(4.22)     3 - 28 
Note. *Non-clinical values quoted from Gillanders et al., (submitted) 
 
4.3.6 Concurrent, Convergent, and Divergent Validity 
  It was expected that the CFQ could discriminate between clinical and non-
clinical samples, with the latter displaying lower scores (concurrent validity). This 
was tested using an internet sample from another study that forms part of this thesis 
(see chapter VI), as that study yielded a self-declared clinical sample (n = 92) and a 
self-declared non-clinical sample (n = 68)
4, both of which had also completed the 
same measure of psychopathology, the SIPP (Verheul et al., 2008). This allowed the 
possibility not only to assess whether the CFQ could distinguish between the self-
declared clinical and non-clinical samples, but also to verify the clinical status of 
these samples by testing for a difference between them in terms of SIPP score.  
  As predicted, the mean total CFQ score of the clinical sample (51.49, SD = 
14.56) was higher than that of the non-clinical sample (41.57, SD = 13.70). Similarly, 
the mean average SIPP score of the clinical sample (4.89, SD = .81) was lower than 
that of the non-clinical sample (5.28, SD = .70), indicating poorer personality 
functioning. There was a significant difference in mean CFQ total scale score 
between the self-declared clinical and non-clinical samples (t(158) = 4.37, p < .001) 
                                                 
4 Participants were asked the following question: ‘Have you ever sought treatment for a psychological 
problem (for example depression, anxiety, relationship difficulties, substance misuse, eating 
disorder)?’  
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and between the two samples in terms of SIPP score (t(157) = -3.16, p = .002). This 
provides preliminary evidence that the CFQ can distinguish between clinical and non-
clinical samples that have been verified in terms of score on a well-validated and 
reliable indicator of psychopathology. 
  Further evidence of concurrent validity would come from CFQ scores 
correlating with measures of psychopathology and distress, as CF is viewed in the 
ACT model as contributing to these types of difficulty (Hayes et al., 1999). 
Relationships between the CFQ and such measures were assessed using Pearson’s 
correlation coefficient (Table 4.7). Results were consistent with the hypothesis that 
score on the CFQ would be positively correlated with measures of psychological 
difficulties such as depression and personality problems. This was the case both for 
the CFQ total scale, and for the two possible subscales, which both related to 
measures of psychopathology in expected directions.  
 
Table 4.7 
Correlations Between the CFQ and Measures of Psychopathology (Pearson’s 
Correlation Coefficient) 
         
    Measure 
 
   
CFQ scale  BDI 
 
SCL-90   PDQ   
 
CFQ total scale 
 
 
 
.71** 
n = 77 
 
 
.66** 
n = 76 
 
 
 .48** 
n = 62 
 
 
  
CFQ fusion 
subscale 
 
 
.66** 
n = 77 
 
.62** 
n = 76 
 .47** 
n = 62 
 
  
CFQ defusion 
subscale 
 
-.56** 
n = 77 
 
-.52** 
n = 76 
 -.32* 
n = 62 
 
  
Note. ** correlation significant at p < .001 level (2-tailed) * correlation significant at p < .01 
BDI = Beck Depression Inventory; SCL-90 = Symptom Checklist-90-R Global Severity Índex; PDQ = 
Personality Diagnostic Questionnaire  
 
  It was also expected that score on the CFQ would correlate positively with 
measures of related variables, such as the AAQII, a measure of psychological 
inflexibility (convergent validity), but would have an inverse relationship with the 
KIMS (divergent validity). From Table 4.8 it can be seen that this is indeed the case, CHAPTER IV 
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again with all forms of the CFQ demonstrating significant correlations with these 
variables, in the expected directions. The CFQ total scale and fusion subscale both 
correlate particularly strongly with the AAQII, an issue that has already been raised 
in relation to the validation of the CFQ with non-clinical samples (Section 4.1.3). 
Although the r values for the clinical sample fall just below those suggested by Field 
(2005) as possibly indicating multicollinearity, these results and their possible 
implications regarding the relationship between the CFQ and the AAQII will be 
addressed in detail in the discussion (Section 4.4.2). 
   Examination of the correlations between the two potential CFQ subscales and 
all of the variables in Tables 4.7 and 4.8 shows that the subscales appear to be 
performing very similarly, although inversely. This provides support for the 
interpretation that rather than relating to two substantively different factors, the fusion 
and defusion items are in fact just oppositely worded and scored indicators of a single 
factor. 
 
 
Table 4.8 
Correlations Between the CFQ and Measures of Relevant Variables (Pearson’s 
Correlation Coefficient) 
         
    Measure 
 
   
CFQ scale  AAQII 
 
KIMS   ATQ   
 
CFQ total scale 
 
 
 
.78** 
n = 77 
 
 
-.67** 
n = 78 
 
 
 .64** 
n = 78 
 
 
  
CFQ fusion 
subscale 
 
 
.74** 
n = 77 
 
-.61** 
n = 78 
 .58** 
n = 78 
 
  
CFQ defusion 
subscale 
 
-.57** 
n = 77 
 
.54** 
n = 78 
 -.54** 
n = 78 
 
  
Note. ** correlation significant at p < .001 level (2-tailed) * correlation significant at p < .01 
AAQII = Acceptance and Action Questionnaire, Version II; KIMS = Kentucky Inventory of 
Mindfulness Skills; ATQ = Automatic Thoughts Questionnaire 
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4.4 Discussion 
 
  CF plays a central role in ACT theory, according to which it makes an 
important contribution to establishing psychological difficulties. Despite this 
hypothesised role, there has been little empirical research conducted to examine the 
nature of CF or its impact on mental health, to a large extent due to the lack of a well-
validated, broadly applicable measure. A new measure, the CFQ, has been developed 
to address these issues, and early data with non-clinical samples has been 
encouraging (Gillanders, et al., submitted). The aim of this study was to build on this 
prior CFQ development research by beginning the process of examining the 
psychometric properties and performance of the measure with a clinical sample. The 
results of this study, based on an NHS mental heath outpatient sample, provided 
promising evidence regarding the performance of items, factor structure, reliability, 
and validity of the measure. The study findings, and their implications including 
recommendations for further research, will be discussed below, in the order that the 
research questions were originally stated in Section 4.1.4. 
 
4.4.1 Study Findings 
4.4.1.1 Factor Structure 
  A fundamental issue to be addressed in this study was the factor structure of 
the CFQ. With non-clinical samples, a one-factor model with the specification of a 
method effect provided the best fit to the data, suggesting that (in accordance with 
ACT theory), CF as measured by the CFQ is unidimensional. However, 
questionnaires can yield different factor structures with different types of samples, so 
it was important to test the factor structure with mental health participants. Two 
models fit the clinical data well; a two-related-factors model and a one-factor with 
method effect model. However, the latter provided the best fit to the data, and 
coupled with the findings regarding performance of the fusion and defusion subscales 
in relation to other variables, these findings confirmed the single-factor structure 
observed with non-clinical samples. 
  This finding is important for a number of reasons. Crucially, it enables the 
format of the measure to be finalised. It would not make sense to score the fusion and CHAPTER IV 
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defusion items as separate subscales, given that they do not appear to represent two 
substantive factors. As a result, the CFQ will be scored as a total scale only. It could 
be argued that if the 13 items are indicators of just one factor, given that the defusion 
items appear to add little to the scale psychometrically-speaking, they could be 
excluded from the final version of the measure. However, these items address 
important content of the construct, such as believability of thoughts, which is not 
addressed by fusion items. Therefore, in the interests of content validity, all 13 items 
have been retained. 
  Replicating the factor structure indicates also that the measure is performing 
consistently across very different samples, including the current, purposely mixed-
diagnosis sample. Furthermore, the fact that a single factor structure best fits the data 
has important implications, in that this is the first attempt to produce a measure of the 
broad construct of CF, as an alternative to the existing measures that use believability 
of thoughts as a limited proxy for the construct. The fact that these 13 relatively 
heterogeneous items load onto just one factor provides initial empirical support for 
the way in which fusion is conceptualised in ACT theory and interventions.  
 
4.4.1.2 Reliability 
  The CFQ demonstrated very good internal reliability and test-retest reliability 
with this clinical sample. On both counts it was found to be as reliable with this 
clinical sample as it is with community samples. 
 
4.4.1.3 Construct Validity 
  The CFQ performed well in relation to several forms of construct validity. It 
was able to distinguish between clinical and non-clinical samples (concurrent 
validity). It also related in predicted ways to measures of several relevant variables, 
demonstrating convergent and divergent validity. This included the CFQ strongly 
relating to well-validated measures of psychological distress and disorders, such as 
the SCL-90-R (Derogatis, 1994) and the BDI-II (Beck et al., 1996). Although this is 
cross-sectional, correlational data, from which causality cannot be inferred, these 
results are consistent with ACT theory regarding the association between CF and 
psychopathology. Further research, in the form of RCTs and mediation studies, are 
required to examine a potential causal role for fusion. CHAPTER IV 
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  It was noted earlier (Sections 4.1.3 and 4.3.6) that with both non-clinical and 
clinical samples, the CFQ and the AAQII are highly correlated. This is important 
because it relates to the way in which CF and psychological flexibility are 
conceptualised and relate to each other, issues about which there is a lack of clarity in 
the ACT literature. Some authors describe fusion and flexibility as if they are related 
but differentiated (e.g. Blackledge, 2007), with the implication that it should be 
possible to measure and investigate them independently. Other authors, for example, 
Wilson & Dufrene (2008) suggest that there is essentially just one process at work 
(psychological flexibility), and that terms such as CF and EA represent the different 
ways in which psychological flexibility can impact human experience. Therefore, 
attempting to develop a stand-alone measure of CF, and then examining how it relates 
to the AAQII (designed to measure psychological flexibility), could provide 
important data to help guide clarification and refinement of this aspect of the model.  
  With non-clinical samples the correlation between the two measures has 
ranged from .58, which would seem to support the ‘related but separate’ view, to .85, 
which could be seen as an indication that the two measures are in fact measuring the 
same construct. The correlation between the two measures with the clinical sample 
was .78; just below the level at which multicollinearity might be suspected (Field, 
2005). Unfortunately therefore, this finding does not particularly help clarify the 
situation regarding ACT processes and how they relate. It could also be argued, that 
even if a view was taken that both measures are basically measuring the same 
construct, this does not necessarily imply therefore that there is no difference between 
CF and psychological flexibility. An alternative explanation could be that one or both 
of the measures does not accurately reflect the construct it was designed to measure. 
Specifically, given the questions about the validity of the AAQ and AAQII (see 
Section 2.2.1.2), it is possible that the high correlation between the CFQ and the 
AAQII results from problems with the latter measure, and therefore should not be 
interpreted as indicating that fusion and inflexibility of essentially the same construct. 
However, if it was assumed that the CFQ and the AAQII are accurately 
measuring the same construct, then the CFQ might more precisely be described as a 
measure of psychological flexibility in relation to cognition. Further research is 
required to explore these various issues, including an examination of how the two 
measures each relate to a range of relevant variables, as well as how they both 
perform in various research and clinical settings. Additionally, the items from both CHAPTER IV 
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measures could be entered into EFA together, to see if they load onto different 
factors.
5 
 
4.4.1.4 Normative Issues 
  This study allowed clinical norms to be ascertained for the CFQ for the first 
time. As expected, mean CFQ score for this mental health sample was higher than the 
mean score derived from non-clinical data. No relationship was found between score 
on the CFQ and age, or between CFQ score and gender. Both of these findings fit 
with those from research with non-clinical samples. 
 
4.4.2 Methodological Limitations   
  The main methodological limitations of this study relate to the sample, in 
terms of size, composition, and recruitment. As noted in section 4.2.1, a sample size 
of 84 was determined to be adequate to ensure acceptably narrow confidence 
intervals for the construct validity aspect of the study. In fact 78 participants were 
recruited to this part of the study, resulting in it being marginally underpowered. This 
was a particular issue in relation to the PDQ, which requires some completed 
questionnaires to be excluded from analysis due to responses on screening items. 
However, the precise size of correlational relationships is not usually predicted in this 
type of study, with the direction and significance of the relationship usually seen as 
most important. Given the significance levels and sizes of correlations between 
variables found in this study, it seems unlikely that the conclusions drawn from the 
findings would change substantially, even if some small changes in r values resulted 
from an increased sample size.   
  Sample composition was an additional issue for this study. Although a 
strength of the study was that participants were recruited from a broad range of 
mental health services, increasing the generalisability of the findings, there were other 
sample composition-related limitations. Men were underrepresented, as were people 
with non-white ethnicity. The sample also includes few participants above the age of 
65. Caution is therefore required when generalising from the results, and future 
                                                 
5 Since the current research was completed, data from a study investigating distress in prison staff has 
shown that the CFQ accounts for variance in distress above and beyond that accounted for by the 
AAQII (Gillanders et al., submitted), thus providing support for the hypothesis that the CFQ and 
AAQII measure related but distinct constructs.  CHAPTER IV 
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research will be necessary to evaluate the performance of the CFQ with other, more 
varied clinical samples. 
    Finally with regards to sample-related methodological limitations, the study 
recruitment strategy may have introduced bias in the sample, because clinicians were 
free to decide not to discuss the study with patients who they deemed unsuitable. This 
raises the possibility for example, that potential participants with more severe 
difficulties, more acute difficulties, and particular diagnoses, may have been excluded 
through the recruitment process. However, a suitable balance has to be reached 
between requirements of scientific rigour and clinical and ethical issues, and 
particularly for the first testing of a new questionnaire with a clinical sample, this 
level of caution was appropriate.    
4.4.3. Future Research 
  In addition to the continued validation research indicated in earlier sections of 
the discussion, rather than using further heterogeneous samples, future research could 
take a different approach to establishing the applicability of the CFQ to people with a 
range of diagnoses. Repeated demonstration of the utility of the CFQ with samples of 
people with more specific diagnoses such as depression and psychosis, would 
robustly establish the general applicability of the measure. Such an approach, 
requiring as it would the recruitment of several clinical samples, was beyond the 
scope of this PhD. The CFQ will also need to be tested in terms of sensitivity to 
therapeutic change. There is some initial data indicating that scores on an earlier 
prototype of the CFQ changed significantly following an ACT-based intervention for 
PTSD (Bastien, Hermann, & Moore, 2010), but this should be verified with this final 
version of the measure. To this end, the CFQ has been included as a process measure 
in the pilot treatment development studies that forms part of this PhD (Chapters VII 
and VIII). 
The unique flexibility that the design of the CFQ affords, opens the door for a 
range of important new research developments. The CFQ could be used to provide 
data about the nature of CF and its impact on psychological health and ill health, 
including how different populations, with different experiences, compare with 
regards to levels of fusion. The measure could also play a role in testing important 
aspects of the ACT model, including shedding light on the nature of psychological CHAPTER IV 
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flexibility, the central ACT process. Finally, it could be used to measure the impact of 
standalone cognitive defusion techniques, as well as broader ACT treatment 
protocols, with the possibility, for the first time, of comparing these findings across 
different samples and diagnoses. 
 
4.4.4 Summary 
  In summary, the CFQ is a brief self-report questionnaire that provides a novel 
approach to measuring CF, an important ACT-relevant construct. Data from this 
study show that it performs well with a mental health sample, with very good 
reliability and validity, whilst having greater content validity than alternative 
measures. As with all new psychometric measures, an on-going process of validation 
is required to continue to increase confidence in the measure. 
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CHAPTER V 
 
Study 2. Modelling the Role of CF in Relation to Personality Functioning 
 
5.1 Introduction 
 
The ACT model indicates that CF plays an important role in the development of 
psychopathology. Given that it is a transdiagnostic model, the implication in relation 
to PD is that CF is associated with poor personality functioning in general, rather than 
a specific PD diagnosis. With the development of the CFQ (as outlined in the 
previous chapter), it is now possible to model and test these relationships. The current 
study was designed to test specifically whether CF mediates the relationships 
between two risk factors of poor personality functioning – negative affectivity (NA) 
and childhood trauma (CT), and actual personality functioning in adulthood. 
 
5.1.1 Risk Factors for Poor Personality Functioning 
  Both genetic and environmental risk factors for PD have been investigated 
empirically. Kendler et al. (2008) identified three genetic risk factors for PD, the most 
substantial of which was labelled “negative emotionality”. This had significant 
loadings on six PD diagnoses, across all three clusters, and was characterised as 
reflecting “a broad vulnerability to PD pathology” (p. 1438). In essence, this factor 
appears to represent a general vulnerability to poor personality functioning in adult 
life, regardless of specific PD diagnosis. Other researchers have reported similar 
findings (e.g. Livesley et al., 1998). 
Environmental risk factors for PD have also been identified. For example, 
Johnson et al. (1999) found that traumatic experiences in childhood, such as abuse 
and neglect, significantly increased the risk of PD in adulthood, a finding that they 
have replicated and explored in detail (Johnson, Cohen, Chen, Kasen, & Brook, 
2006). Again, these kinds of traumatic experiences are implicated across PD 
diagnoses, suggesting that they increase vulnerability to poor personality functioning 
in general. CHAPTER V 
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5.1.1.2 NA and PD 
  One way in which negative emotionality (the broad genetic risk factor) has 
been operationalised is as NA – the temperamental predisposition to experience 
negative affect (Larsen & Diener, 1987; Bryant, Yarnold, & Grimm, 1996).  Several 
studies have investigated NA as a risk factor for PD-related behaviours. Gratz (2006) 
found that NA was a risk factor for deliberate self-harm (DSH) (associated with some 
PD diagnoses), for female students, while Gratz and Roemer (2008) also reported that 
one aspect of NA, negative affect intensity, was related to DSH. Kingston et al., 
(2010) found that negative affect intensity was significantly related to engagement in 
maladaptive behaviours often associated with PD, including DSH and substance 
misuse. 
  Lynch, Robins, Morse, and Krause (2001) reported that with a sample of 
psychiatric outpatients (50% with PD diagnoses), negative affect intensity was 
significantly correlated with hopelessness and depression (both associated with PD). 
Lynch, Cheavens, Morse, and Rosenthal (2004) found that with a sample of 
depressed older adults, NA, suicidal ideation and hopelessness were correlated.  
  Although these studies involve DVs that are correlates of PD, rather than 
actual poor personality functioning, taken as a whole, their results suggest that NA is 
likely to be a risk factor for poor personality functioning. 
 
5.1.1.3 CT and PD 
  CT, in the form of abuse and neglect, has consistently been shown, through 
both cross-sectional and prospective studies, to be associated with or to predict many 
psychological disorders (Marx & Sloan, 2002; Widom, DuMont, & Czaja, 2007). 
This includes a range of PD diagnoses, in both men and women (e.g. Herman, Perry, 
& van der Kolk, 1989; Raczek, 1992; Krinsley et al., 1992).  
 
5.1.2 The Role of CF 
  Despite the evidence suggesting that both NA and CT are associated with a 
significant increase in the risk of poor personality functioning in adulthood, not 
everyone who experiences these risk factors will go on to develop such difficulties. It 
is therefore important to identify variables that mediate these relationships. Given that CHAPTER V 
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adult patients cannot alter their genetic endowment or childhood experiences, it may 
be of considerable value to identify intermediary processes that could be addressed 
through psychosocial interventions. 
  According to the ACT model, the way that individuals relate to their private 
experiences including memories of CT and negative emotions – in particular the 
extent to which they are dominated by these experiences (CF) – will be implicated in 
psychological suffering (Hayes & Strosahl, 2004). Clinical observation supports the 
idea that CF might be a mediating variable in relation to PD. Patients with PDs 
appear to struggle with cultivating a defused relationship with private experiences. 
Being dominated by their private experiences in this way appears to play a role in 
maintaining poor functioning, for example by increasing the urge to avoid situations 
in which fused-with aversive thoughts might be experienced. Clinical practice 
suggests that as long as PD patients remain fused in this way, it is difficult for them to 
engage with exposure-based interventions designed to reduce avoidance. 
Observations of this kind are consistent with the hypothesis that CF leads to EA 
(Greco et al., 2008). 
  There is currently no published research testing CF as a mediating variable in 
the relationship between established risk factors and poor personality functioning, but 
a small number of studies have investigated related issues, such as the role of fusion 
as a mediator of other forms of psychological difficulties, and the mediating effects of 
variables linked with CF. In terms of the role of CF in relation to psychological 
problems, it has been shown to mediate the impact of ACT on depression (Zettle et 
al., 2011), and it also appears to be associated with reduction in hospitalisation rates 
for people with psychosis (Bach & Hayes, 2004).   
  Several studies have tested EA, as measured by the AAQ (Hayes et al., 2004), 
as a mediator in relation to the kinds of risk factors discussed above, and in relation to 
IVs that are correlates of PD. These studies are relevant because of the hypothesised 
link between CF and EA and the high correlation between the CFQ and the AAQII 
demonstrated in Chapter IV. For example, Kingston et al. (2010) found that EA 
mediated the relationships between two risk factors (CT and negative affect intensity) 
and PD-relevant maladaptive behaviours such as DSH. Similarly, Reddy, Pickett, and 
Orcutt (2005) reported that EA mediated the relationship between childhood 
psychological abuse and mental health symptoms in college students. Marx and Sloan 
(2002) found that in a college sample, EA mediated the relationship between CSA CHAPTER V 
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and psychological distress. The same process has been found to mediate dropout from 
an inpatient DBT treatment program for BPD (Rusch et al., 2008), and predict 
depression levels in BPD patients receiving DBT (Berking et al., 2009).  
  Given the link between EA and fusion, in addition to the clinical observations 
previously outlined, it seems logical to hypothesise that CF will act as a mediator in 
relation to personality functioning. A measure designed to address CF in a clear, 
precise manner should be used to test this, to avoid the kind of confusion that exists 
in relation to the measurement of EA and psychological flexibility at this time (see 
Chapter II, Section 2.2.1.3 for details). 
 
5.1.3 Study Synopsis, Methodological and Design Considerations 
  The purpose of the present study was to test CF as a mediating variable in the 
relationships between NA and personality functioning, and CT and personality 
functioning. This was done by first conducting a mediational analysis (following 
Baron & Kenny, 1986) with each risk factor relationship separately. It was predicated 
that CF would fully mediate both relationships. Following this, mediational models 
involving both risk factors were tested using SEM.  
The design of this study was influenced by the methods available for 
measuring the variables of interest and the design of relevant published research. 
There are easily administered, validated self-report measures available for all the 
study variables. Although there are alternative methods of measuring CT and 
personality problems (e.g. semi-structured interviews), they are time-consuming, 
expensive, and do not allow participants to anonymously provide sensitive 
information. In addition, interview-based assessments of personality problems (e.g., 
the SCID-II) yield a set of diagnoses rather than a personality functioning continuous 
variable. For these reasons, the study is based on self-report measures (see Section 
5.2.3).  
  Testing models of the study variables in the manner outlined above, using a 
cross-sectional design, offers an important first step in assessing the relationships 
between these variables, and is in keeping with much of the relevant published 
research. If these models prove useful, other designs that involve randomisation and 
collecting data prospectively would be helpful to assess causality. CHAPTER V 
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In order to provide a setting in which participants could share personal 
information privately, as well as to facilitate the recruitment of a large, international 
sample, the study was based on the internet, being accessed via several public-access 
research websites. 
 
5.2 Method 
5.2.1 Design 
  This study was based on a cross-sectional design, using self-report measures 
of the variables of interest. The mediational variable tested was CF. The IVs in the 
study were CT and NA; the DV was personality functioning in adulthood. 
 
5.2.2 Participants 
  An opportunity sample (n = 234) was recruited via public-access 
research websites (see Appendix F). The only exclusion criteria were that participants 
had to be at least 18 years old and be able to understand English. As can be seen in 
Table 5.1, the majority of participants were female (76.5%) approximately half were 
living in the USA, and a third in the UK. The mean age was 29 (ranging from 18 to 
70).  
A minimum sample size of 200 is often given as a rule-of-thumb to yield 
reliable results from SEM but this figure has been criticised as “conservative” and 
“simplistic” (Iacobucci, 2010). Anderson and Gerbing (1984) regard a sample size of 
150 as sufficient, particularly when effects are large, the variables included in the 
model are reliable, and the models being tested are relatively simple. Although the 
latter two points do apply in the current study, the size of the effects are unknown, 
and so a sample size in excess of 200 was viewed as ideal, with 150-200 being seen 
as acceptable.  
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Table 5.1 
Demographic Information 
   
 
Demographic 
 
 
Internet community sample 
(n = 234) 
 
 
Mean age (SD) 
Age range 
 
28.84 (11.33) 
18 - 70 
Gender (% female) 
Country of residence: 
                       USA 
                       UK 
                       Europe (other) 
                       Asia 
                       Other 
Ethnic origin: 
                       White 
                       Asian 
                       Black 
                       Mixed 
                       Other ethnic group 
Treatment for a mental health 
problem (% yes) 
76.50% 
 
52.56% 
30.34% 
4.70% 
3.85% 
8.55% 
 
88.89% 
4.27% 
2.56% 
1.28% 
2.99% 
 
50.86% 
   
 
 
5.2.3 Materials 
5.2.3.1 Cognitive Fusion Questionnaire, (CFQ; Gillanders et al., submitted) For 
details see Chapter IV, Section 4.2.2. 
 
5.2.3.2 Childhood Trauma Questionnaire (CTQ; Bernstein, Fink, Handelsman, & 
Foote, 1994). The CTQ is a 28-item, self-report measure that retrospectively assesses 
a range of traumatic childhood experiences in five categories: sexual abuse, physical CHAPTER V 
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abuse, emotional abuse, physical neglect and emotional neglect. The measure yields a 
total score or five subscales. Respondents indicate on a five-point scale (from never 
true to very often true), the accuracy of each of the items. Items include “When I was 
growing up people in my family said hurtful or insulting things to me” (an emotional 
abuse item), and “When I was growing up I had to wear dirty clothes” (a physical 
neglect item). The CTQ has very good psychometric properties, including a 
Cronbach’s α figure of .91 for the measure as a whole (Scher, Stein, Asmundson, 
McCreary, & Forde, 2001), and test-retest reliability ranging from .79 to .86 over an 
average of four months (Bernstein et al.). 
 
5.2.3.3 Affect Intensity Measure - Negative Affectivity subscale (AIM-NA; Larsen & 
Diener, 1987; Bryant, Yarnold, & Grimm, 1996). The 40-items of the AIM have been 
used as a whole scale and as various different subscales. Following Gratz (2006), a 
12-item NA variable was created by combining the six negative intensity items (for 
example “When I do feel anxiety it is normally very strong”), and the six negative 
reactivity items (for example “When I talk in front of a group for the first time my 
voice gets shaky and my heart races”). This variable was selected because it most 
resembles the negative emotionality general genetic risk factor for PD identified by 
Kendler et al. (2008). The AIM has good psychometric properties, with Cronbach’s α 
ranging from .87 to .90. Internal reliability figures for the negative intensity and 
reactivity subscales range from .66 to .72, the lower figures in all likelihood being a 
result of the small number of items in each subscale. Gratz (2006) did not report a 
Cronbach’s α figure for the NA variable, but it is likely to be higher than the figures 
for the intensity and reactivity subscales. 
 
5.2.3.4 Severity Indices of Personality Problems (SIPP; Verheul et al., 2008). The 
SIPP is a self-report measure of personality functioning. It consists of 118 items in 
five domains; self-control, identity integration, relational capacities, responsibility, 
and social concordance. Respondents indicate the extent to which they agree or 
disagree with each statement in relation to the previous 3 months. Items include ‘I 
know exactly who I am and what I am worth’ (an identity integration item), and ‘I 
can work with people on a joint project in spite of personal differences’ (a social 
concordance item). The SIPP has very good psychometric properties, with 
Cronbach’s α for the five domains ranging from .74 to .79, with a mean of .77. Test-CHAPTER V 
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retest reliability for the five domains, (over a period of two to three weeks), ranges 
from r = .87 to r = .93. 
  For the present study, an overall personality functioning variable was created 
by averaging scores across the five SIPP domains. The authors of the SIPP have not 
published data using the measure in this way, reporting that they have not explored 
the possibility of a single factor or higher order factor solution for the SIPP, with a 
community sample (Andrea, personal communication, 2011). Andrea notes, however, 
that the five domains appear to “hang together” much better in community samples 
than they do with PD samples, and speculates that the SIPP might well perform 
differently (and yield a different factor solution) with a non-PD sample.  
  Ideally, the factor structure of the SIPP with a community sample would be 
examined using EFA and CFA. Given the large number of items in the measure, this 
was not possible with the current sample, but the internal consistency of the overall 
SIPP variable and the inter-correlations between the five domains were assessed. This 
provided some preliminary evidence relevant to scoring the SIPP as a single variable. 
 
5.2.3.5. Brief Demographics Questionnaire. Participants were asked to indicate their 
age, gender, country of residence, ethnic origin, and whether they had ever sought 
treatment for a mental health problem (see Appendix G). 
 
5.2.4 Procedure 
  University of Southampton Psychology ethical approval and research 
governance approval were obtained. This online study provided potential participants 
with information about the nature of the study (on a webpage), prior to their giving 
consent to participate by clicking a button at the end of the information page (see 
Appendix I). Specifically, detailed warning was given that some questions were of a 
sensitive nature. Participants were advised to complete the study privately. It was 
emphasised that participants could end the study at any point, and then proceed to the 
final information page, which included not only the contact details of the researcher 
(an experienced clinical psychologist), but also contact details for UK and 
international support agencies. 
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5.2.5 Analysis Plan 
  Stage One of the analysis was designed to yield skew, kurtosis and internal 
consistency data for each of the study variables, as well as normative data. Stage Two 
involved Baron and Kenny’s (1986) four-step mediational analysis (see Section 
3.2.2.2) to assess CF as a mediating variable in the relationship between CT and adult 
personality functioning, and in a separate analysis, between NA and personality 
functioning. The bootstrapping procedure recommended by Preacher and Hayes 
(2004) was used to assess the significance of the indirect effect in the two mediation 
models (see Section 3.2.2.2 for more details). 
  Stage Three utilised SEM to test more complex mediation models involving 
both predictor variables. The fit of the various models to the data was evaluated using 
the following fit indices: χ
2/df ratio, comparative fit index (CFI), root mean square 
error of approximation (RMSEA), and Akaike’s Information Criterion (AIC). An 
explanation for the use of these indices is given in Chapter IV (Section 4.2.4).   
  PASW/SPSS Statistics 19 software was used for all data analysis except SEM, 
which was conducted using AMOS 18 software. 
 
 
5.3 Results 
   
5.3.1 Stage One: Data Screening and Preliminary Analyses 
  Prior to conducting any statistical analyses, the data were examined in a 
number of ways. Of the 234 participants, 26 (11.11% of the sample) were found to 
have more than 10% of data missing from a questionnaire, but across participants no 
particular questionnaire was avoided. The data for these participants were excluded 
from subsequent analyses. The CFQ was the only questionnaire for which there were 
no examples of more than 10% of the data missing. All other missing data (less than 
10% per questionnaire) was replaced by the sample mean (Tabachnick & Fidell, 
2001).  
  A further four sets of data were excluded from the analysis as each of these 
participants had given the same response to all items on a measure, indicating that 
they were not completing the measures accurately. Mahalanobis distance values CHAPTER V 
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identified two possible outliers, but examination of the data indicated that they 
appeared to be outliers because their scores on the CTQ were high (indicating 
substantial CT), whereas the distribution of sample responses in general was 
somewhat skewed towards low levels of trauma. Given that the data for these two 
participants were not contributing to this skew, and because it was considered 
important to include individuals who reported CT, their data were included in the 
analyses. This resulted in a final sample size of 204. 
 
Table 5.2 
Skew and kurtosis data for all study variables 
 
Variable  skew  c.r.  kurtosis  c.r. 
 
 
CFQ 
SIPP 
Neg AIM 
CTQ 
 
.32 
-.26 
.08 
1.48 
 
1.89 
-1.50 
.49 
8.66 
 
-.42 
-.88 
-.72 
1.99 
 
-1.23 
-2.56 
-2.08 
5.86 
Note. CFQ = Cognitive Fusion Questionnaire; SIPP  = Severity Index of Personality Problems; Neg 
AIM = negative affectivity subscale of the Affect Intensity Measure; CTQ = Childhood Trauma 
Questionnaire; c.r. = critical ratio. 
 
 
  Table 5.2 shows skew and kurtosis data. There is no general agreement as to 
what constitutes problematic levels of skew and kurtosis (Byrne, 2010). Using the 
guidance given by West et al. (1995) that a figure of 7 or less is acceptable, it can be 
seen that none of the study variable distributions differ from normality sufficiently to 
be of concern. 
  Table 5.3 contains means and standard deviations for all variables. 
Interestingly, mean score on the CFQ (48.47) falls between mean CFQ scores for 
community samples (41.53) and a clinical sample (60.76) (Gillanders et al., 
submitted). This fits with the fact that approximately half the current sample 
identified themselves as having sought help for a mental health problem at some 
point. Table 5.3 also shows Cronbach’s α scores. The CFQ, SIPP and CTQ had 
excellent internal consistency, and the negative affectivity subscale of the AIM had 
good internal consistency.  
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Table 5.3 
Means, Standard Deviation, and Internal Reliability Values for All Study Variables 
 
                                                          Community Internet sample (n = 204) 
 
Variable 
 
Mean (SD) 
 
Cronbach’s α 
 
CFQ 
SIPP 
Neg AIM 
CTQ 
 
  48.47 (15.13) 
5.01 (.77) 
45.44 (9.79) 
  43.00 (17.43) 
 
.90 
.97 
.82 
.94 
Note. CFQ = Cognitive Fusion Questionnaire; SIPP  = Severity Index of Personality Problems; Neg 
AIM = negative affectivity subscale of the Affect Intensity Measure; CTQ = Childhood Trauma 
Questionnaire. 
 
Table 5.4 shows the inter-domain correlations for the five SIPP domains. 
These range from .42 to .81, with a median of .60. These figures are considerably 
higher than those reported by Verheul et al. (2008), with a PD sample, and provide 
support that the subscales of the SIPP are sufficiently highly related that an overall 
personality functioning variable can be created from them. 
 
5.3.1.1 Bivariate correlations 
  Bivariate correlations between all study variables are reported in Table 5.5. 
All the variables correlated significantly with each other after the required p value 
was adjusted for multiple comparisons (p = .05/4 = .0125). It should be noted that 
because the SIPP is scored so that a higher score represents more adaptive personality 
functioning, whereas all the other measures are scored so that higher score indicates 
poorer functioning or a greater level of problem, the SIPP has inverse relationships 
with all other study variables.   
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Table 5.4 
Inter-Correlations Between SIPP Subscales 
 
                                                                     SIPP domains 
 
  Self cont  Social 
Conc 
Identity 
Int 
Relation  Responsib 
 
Self cont 
 
- 
 
.70* 
 
.81* 
 
.58* 
 
.67* 
Social Conc    -  .61*  .57*  .52* 
Identity Int      -  .76*  .59* 
Relation        -  .42* 
Responsib          - 
Note. Self cont = Self control; Social Conc = Social Concordance; Indentity int = Identity integration; 
Relation = Relational Capacities; Responsib = Responsibility. All are subscales of the Severity Index 
of Personality Problems. 
*≤ .005 (adjusted for multiple comparisons). 
 
 
Table 5.5 
Bivariate Correlations Between Study Variables 
 
  CFQ  SIPP  NegAIM  CTQ 
 
CFQ 
 
- 
 
-.77*** 
 
.51*** 
 
.35*** 
SIPP    -  -.39***  -.33*** 
NegAIM      -  .18** 
CTQ        - 
Note. CFQ = Cognitive Fusion Questionnaire; SIPP  = Severity Index of Personality Problems; Neg 
AIM = negative affectivity subscale of the Affect Intensity Measure; CTQ = Childhood Trauma 
Questionnaire. 
** = significant at p. < .01; *** = significant at p. < .001. 
 
 
5.3.2 Stage Two: Mediational Analyses 
  CF was tested as a mediating variable in the relationships between NA and 
personality functioning, and separately, between CT and personality functioning. 
These analyses followed Baron and Kenny’s (1986) causal step approach (see Section CHAPTER V 
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3.2.2.2). The mediation models are displayed graphically in Figure 5.1. Focussing 
firstly on NA as a predictor, the four mediation steps were satisfied as follows: 
1. NA significantly predicted personality functioning: t(202) = -6.06, p < .001, β =      
 -.39, R
2 = .15. 
2. NA significantly predicted CF: t(202) = 8.35, p < .0001, β = .51, R
2 = .26. 
3. CF significantly predicted personality functioning: t(202) = -17.19, p < .001, β =     
 -.77, R
2 = .59. 
4. When both NA and CF (the mediator) were included in the model, NA no longer 
significantly predicted personality functioning (t(201) = -.04, p = .97, β = -.002), 
whilst CF still significantly predicted it (t(201) = 14.77, p < .001, β = -.77). R
2 for the 
model was .59, with NA accounting for no variance in the DV other than indirectly 
via CF.   
Focussing on CT as a predictor, the four steps were satisfied as follows: 
1. CT significantly predicted personality functioning: t(202) = -4.94, p < .001, β =       
-.33, R
2 = .11. 
2. CT significantly predicted CF: t(202) = 5.25, p < .0001, β = -3.28, R
2 = .12. 
3. CF significantly predicted personality functioning: t(202) = -17.19, p < .001, β =      
-.77, R
2 = .59. 
4. When both CT and CF (the mediator) were included in the model, CT no longer 
significantly predicted personality functioning (t(201) = -1.46, p = .15, β = -.07), 
whilst CF still significantly predicted it (t(201) = 15.67, p < .001, β = -.75). R
2 for the 
model was .60, with CT accounting for no variance in the DV other than indirectly 
via CF.   
 
In each case, the significance of the indirect effect (via CF) was tested using 
the Preacher and Hayes (2004) bootstrapping method (see Table 5.6). Confidence 
intervals that do not include zero indicate a significant indirect effect, which was the 
case with both mediated relationships. Overall, these findings suggest that CF may 
play an important role in the relationships between risk factors and problematic 
personality functioning. However, models of PD development such as Linehan’s 
(1993) biosocial model of BPD suggest that these kinds of risk factors are likely to be 
related, so the final stage of analysis involved using SEM to test more complex 
mediational models involving both NA and CT. 
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Figure 5.1 
Mediation Models Involving Each Risk Factor: 
1. NA 
 
 
                                    CFQ 
                .507**                           -.771**                      
                                  
 NegAIM                                                  SIPP 
                         -.392** / -.002ns 
 
Note. Neg AIM = negative affectivity subscale of the Affect Intensity Measure; CFQ = Cognitive 
Fusion Questionnaire; SIPP  = Severity Index of Personality Problems 
ns = non-significant standardised regression coefficient; ** standardised regression coefficient 
significant p < .001 
 
 
2. CT 
 
 
                                   CFQ 
                .346**                           -.771**                      
                                  
        CTQ                                                 SIPP 
                         -.328** / -.069ns 
 
Note. CTQ = Childhood Trauma Questionnaire; CFQ = Cognitive Fusion Questionnaire; SIPP  = 
Severity Index of Personality Problems 
ns = non-significant standardised regression coefficient; ** standardised regression coefficient 
significant p < .001 
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Table 5.6 
Tests of CF as a Mediator of Significant Associations between Independent and 
Dependant Variables                                                                                    
   
 Indirect Effects                 BCa 95% CI  
Variables  Point 
Estimate 
  SE    Lower        Upper 
 
CFQ mediating the 
impact of Neg AIM 
 
 
-.0305 
 
 
.0042 
 
 
-.0395           -.0225 
 
CFQ mediating the 
impact of CTQ 
 
 
 
-.0114 
 
 
.0023 
 
 
-.0160           -.0070 
 
Note. BCa Cl = bias corrected and accelerated confidence intervals, derived from 2,000 bootstrap 
samples of the data.  Neg AIM = negative affectivity subscale of the Affect Intensity Measure; CTQ = 
Childhood Trauma Questionnaire; CFQ = Cognitive Fusion Questionnaire. 
 
 
5.3.3 Stage Three. SEM Mediational Models 
  The final analysis stage involved testing the fit of a hypothesised full 
mediation model (Figure 5.2, Model B), to the data, and comparing the fit of this 
model with other, theoretically justifiable models. The four models tested (see Figure 
5.2) were: 
Model A – fully mediated model with the two risk factors (NA and CT) unrelated; 
fusion mediating the relationships between risk factors and personality functioning 
Model B – fully mediated model, as in Model A, but with the risk factors covarying 
Model C – fully mediated model with the risk factors covarying, with personality 
functioning acting as the mediator in the relationships between risk factors and fusion 
Model D – partially mediated model with the two risk factors covarying, with a direct 
path between CT and personality functioning, as well as the indirect path via fusion. 
The direct path from NA to personality functioning was not included because the 
indirect effect of fusion on this path was so substantial that adding the direct path 
would be highly unlikely to improve the model fit. 
  It can be seen from Figure 5.2. that all the regression coefficients in all four 
models were significant and signed in expected directions, except for the direct path CHAPTER V 
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between CT and personality functioning, which was  non-significant (Model D). This 
lack of significance suggests that the path is redundant and can be removed. 
Nonetheless, the fit of all four models was examined. In a well-fitting model, χ
2 /df 
should be less than 2, the CFI value should be above .95, and the RMSEA value 
should be less than .05. The AIC is a fit index that takes parsimony into 
consideration, with a lower value indicating a better fit.  
   
Table 5.7. 
Fit Indices for Four Mediation Models 
 
  Model                                                  Fit index 
             
             
  χ
2  df       χ
2 /df   CFI     RMSEA 
 
  AIC 
 
A 
 
 8.83 
 
3 
 
  2.94 
 
  .98 
 
      .10 
 
 
53.06 
B   2.13  2     1.07   1.0            .02                       
 
52.68 
C 
 
        30.63  2  15.31   .89            .27  81.17 
D 
 
  0  1     0   1.0         0  56.86 
Note. χ
2 = minimum fit function chi-squared; df = degrees of freedom; CFI = comparative fit index; 
RMSEA = root mean square error of approximation; AIC = Akaike’s Information Criterion 
 
  Table 5.7 shows that the that Models A and C did not fit the data well in terms 
of the various fit indices: these were therefore rejected in favour of the other two 
models. Models B and D, the full and partial mediation models both fitted the data 
very well. However, it has already been noted that the direct path from the CTQ to 
the SIPP was non-significant. A χ
2-difference test was performed between models B 
and D as follows:   
Model B χ
2 = 2.13(2) - Model D: χ
2 = .001(1) = χ
2 -difference = 2.129(1).  
The critical value for χ
2 with 1 degree of freedom is 5.99 (p < .05), and as 2.129 is 
less than this critical value, it was concluded that adding the direct path from CT to 
personality functioning did not improve the fit of the model to the data. The AIC 
values also indicated that Model B, the fully mediated model, represented the best 
fitting, most parsimonious model. In this model, CF predicted 59% of the variance in 
personality functioning. CHAPTER V 
   
127 
Figure 5.2 
SEM Path Diagrams: Model A 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. CFQ = Cognitive Fusion Questionnaire; SIPP  = Severity Index of Personality Problems; Neg 
AIM = negative affectivity subscale of the Affect Intensity Measure; CTQ = Childhood Trauma 
Questionnaire; e1 and e2 denote error terms. 
** represents standardised regression weights significant at p. < .001. 
 
 
SEM Path Diagrams: Model B 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. CFQ = Cognitive Fusion Questionnaire; SIPP  = Severity Index of Personality Problems; Neg 
AIM = negative affectivity subscale of the Affect Intensity Measure; CTQ = Childhood Trauma 
Questionnaire; e1 and e2 denote error terms. 
** represents standardised regression weights significant at p. < .001. * represents covariance  
significant at p. < .05. 
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SEM Path Diagrams: Model C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. CFQ = Cognitive Fusion Questionnaire; SIPP  = Severity Index of Personality Problems; Neg 
AIM = negative affectivity subscale of the Affect Intensity Measure; CTQ = Childhood Trauma 
Questionnaire; e1 and e2 denote error terms. 
** represents standardised regression weights significant at p. < .001. * represents covariance 
significant at p. < .05. 
 
 
SEM Path Diagrams: Model D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. CFQ = Cognitive Fusion Questionnaire; SIPP  = Severity Index of Personality Problems; Neg 
AIM = negative affectivity subscale of the Affect Intensity Measure; CTQ = Childhood Trauma 
Questionnaire; e1 and e2 denote error terms. 
** represents standardised regression weights significant at p. < .001. ns. represents non-significant 
standardised regression weight. * represents covariance significant at p. < .05. 
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5.4 Discussion 
 
5.4.1 Study Findings 
  Previous research has identified both NA and CT as risk factors for poor 
personality functioning in adult life. It is, however, important to establish the 
processes through which these risk factors impact personality functioning, to develop 
theoretical understanding and to guide the development of more effective 
psychosocial interventions (the modelling phase of treatment development, outlined 
by Campbell et al., 2000).  
  The ACT model of psychopathology suggests that CF is implicated in the 
development of psychological difficulties across diagnoses. However, the role of 
fusion with personality functioning has not been examined empirically to date. This 
study therefore aimed to test CF as a mediating variable in the relationships between 
the two risk factors and personality functioning. It was predicated that CF would fully 
mediate both relationships. 
   
5.4.1.1. Mediational Analyses 
  As predicted, CF was shown to fully mediate the relationships between the 
two risk factors and personality functioning. Causality cannot be inferred from these 
results owing to the cross-sectional design of the study. However, the results are 
consistent with the account that (in relation to NA), it is individuals’ fused 
relationship with their private experiences—rather than propensity to experience 
negative emotions intensely and reactively per se—that leads to them developing 
personality problems in adult life. Similarly, these results are consistent with the view 
that for people who have experienced CT, their relationship to their thoughts and 
memories influence whether they go on to develop problematic personality 
functioning.  
  It has been hypothesised that genetic and environmental risk factors for 
personality problems do not influence personality functioning in isolation, but rather 
that such risk factors transact with each other, at least in relation to BPD (Linehan, 
1993). When both NA and CT were included in an SEM mediation model together, it 
was found that that they were indeed significantly related. The model that stipulated CHAPTER V 
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that they were independent of each other fitted the data poorly in comparison to the 
model where they co-varied. This finding is supportive of a general interactive risk 
model in relation to poor personality functioning across diagnoses.  
  When both risk factors were included in SEM models, it was found that a 
model where CF fully mediated the relationships between the risk factors and 
personality functioning was the best fitting and most parsimonious, consistent with 
the results from the single-risk factor mediation analyses. This model fitted the data 
very well, accounting for 59% of the variance in the DV. 
 
5.4.1.2. Performance of the CFQ 
The results of this study provide further support for the reliability, validity, 
and utility of the CFQ. With this community-based sample, approximately 50% of 
whom had sought help for a psychological problem, the CFQ demonstrated excellent 
internal reliability. It also related in a theoretically consistent manner to the other 
study variables. It was also the only study questionnaire without a single instance of a 
participant leaving more than 10% of the items incomplete, suggesting that 
participants found it straightforward to complete. Overall, the CFQ showed itself to 
be an excellent measure for the purpose of this study. 
 
5.4.1.3. Performance of the SIPP Composite Variable 
In order to test relatively simple models, a composite variable was created 
from the SIPP subscales. The measure had not been used in this way before. Verheul 
et al. (2008) selected a five-factor SIPP model on the basis of CFA, but did not report 
having tested a single factor or higher order factor model. Unfortunately, the current 
sample was not large enough to conduct factor analysis, but it was possible to 
conduct three forms of analyses relevant to this issue. Cronbach’s alpha was 
calculated for the composite version of the measure, and it was found to be very high 
(.97), indicating excellent internal consistency. Cronbach’s alpha is influenced by the 
number of items in a measure, and as the SIPP has 118 items, this figure could have 
been thus inflated, but other published personality problem measures with similar 
numbers of items have much lower Cronbach’s alpha values. For example, the mean 
alpha across several samples for the PDQ (Hyler et al., 1988), which contains 99 
items, is .71. Clearly a large number of items is not sufficient to produce a high alpha 
value. The apparently excellent internal consistency of the SIPP variable indicates CHAPTER V 
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that the items are highly intercorrelated, and could be consistent with them measuring 
the same construct.  
  The intercorrelations between the five SIPP subscales were also calculated. 
They ranged from .42 to .81, with a median of .60. These figures are substantially 
higher than those reported by Verheul et al. from their clinical sample (.27 to .60, 
with a median of .40). This high subscale intercorrelation suggests that, for this 
sample at least, they are sufficiently related for it to be acceptable to combine them to 
produce an overall indicator of personality functioning. Certainly, there are published 
measures with comparable subscale intercorrelations where the measure is scored 
both in terms of its individual subscales and as a single measure. One example is the 
Psychological Inflexibility in Pain Scale (PIPS; Wicksell, Renofalt, Olsson, Bond, & 
Melin, 2008), the authors of which reported a two-factor structure with a correlation 
of .46 between the two resultant subscales. The measure is scored either as a single 
measure or as two subscales.  
  Finally on this matter, the SIPP composite variable related in theoretically 
consistent ways with the other study variables. That said, the high correlation 
between this variable and the CFQ raises questions about the relationship between 
ACT-relevant processes such as fusion, and personality. Hayes et al. (2006) argue 
that psychological inflexibility (to which fusion contributes) is highly predictive of—
and represents a general vulnerability for—psychopathology across diagnostic 
categories. From this perspective, it is not surprising that score on the CFQ should be 
seen to so strongly predict score on the SIPP in the mediation model yielded by this 
study. However, another possible explanation for this finding is that psychological 
inflexibility is actually personality by another name. Further research (such as testing 
the predictive utility of the CFQ and the AAQII above and beyond measures of 
personality) is required to clarify this issue. However, the fact that there was very 
poor model fit when the SIPP was tested as a mediator in relation to the CFQ as a DV 
(Model C), might suggest that the processes being measured by these two 
questionnaires are not equivalent. 
Overall, these findings support scoring the SIPP as a global measure of 
personality functioning, and suggest that the resultant measure is both reliable and 
valid. CHAPTER V 
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5.4.2 Methodological Limitations 
  A number of limitations as well as strengths should be taken into account 
when considering the results of this study. In terms of strengths, the sample was large 
enough to ensure confidence in the results of the analyses. It included participants 
with a wide range of ages, unlike many published studies based on young, student 
samples, and the sample was international. On the other hand, there was bias in 
favour of female participants, and the sample was predominantly Caucasian. 
Although the use of internet-based research websites ensured a large and 
geographically varied sample, this methodological choice also resulted in a self-
selecting, opportunity sample, and provided no means of verifying demographic and 
other data independent of the information given by participants themselves. Caution 
should therefore be exercised when generalising from these results. 
  The cross-sectional design of the study limits the conclusions that can be 
drawn from the findings. Despite both IVs having been identified as risk factors for 
poor personality functioning in other research including longitudinal studies, 
causality cannot be inferred from the current study, and these mediational models 
should be tested in studies that measure the relevant variables across time. Obviously, 
for ethical reasons, these particular IVs cannot be manipulated, although ‘natural 
experiments’ such as the work of Rutter and colleagues examining the development 
of adopted children from the UK and Romania (Rutter, 2004) can go some way to 
address these kinds of methodological limitations. There are uncontrolled, 
prospective studies that follow children into adulthood and track the impact of CT 
(for example) on personality development (e.g. Johnson et al., 1999) but they are 
extremely expensive and by their nature, take many years to complete. It is unrealistic 
to consider these as viable methodological options specifically for testing potential 
mediating variables.  
  However, as a body of evidence develops regarding risk factors for poor 
personality functioning (to which this study has contributed), it is possible that 
interest will grow in relevant mediating processes, and as a result, measures of 
potential mediating variables may in future be included in large-scale, longitudinal 
studies. Another, more realistic way to examine the mediating role of CF (and other 
possible mediators and moderators) in relationship to personality functioning would CHAPTER V 
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be to include them as process variables in RCTs, to test whether they mediate 
personality functioning outcomes. This will be discussed further in Section 5.4.3. 
  Although the findings of this study represent an important addition to the 
scientific understanding of personality functioning, other temperamental predictors in 
addition to NA—such as impulsive aggression and inhibition—have been identified 
(Kendler et al., 2008). It is a limitation of this study that only NA was included in the 
models tested, and further research should build on this study by testing more 
complex models.  
  Finally, in terms of methodological issues, the dependence on self-report 
measures in this study, although in keeping with much of the relevant published 
research, is a limitation. It is possible to gather data about CT in particular, through 
other means such as examining childhood health and social care records, and through 
the use of interview. However, each of these methods is associated with other 
potential problems, such as the lack of participant anonymity perhaps resulting in 
poorer recruitment, and possible biases in the personal disclosure and official 
reporting of childhood trauma.  
5.4.3 Implications and Future Research 
  The results of this study are important for a number of reasons. They provide 
the first empirical evidence that CF is related to poor personality functioning. The 
findings are consistent with clinical observation, and also provide support for the 
ACT model of psychopathology, which, although conceptualised as transdiagnostic, 
has never been investigated in relation to personality functioning across diagnoses. 
Given that risk factors have been identified that appear to negatively impact 
personality functioning across many PD diagnostic categories, it makes sense to 
investigate intermediary processes that are also thought to act transdiagnostically. Of 
course, the picture is more complicated than this, as studies investigating risk factors 
for personality difficulties have also identified factors that appear to predict specific 
personality problem presentations. CF, despite accounting for a substantial proportion 
of the variance in personality functioning in the models tested in this study, will not 
be the only mediating variable of relevance in this complex situation. For example, it 
may be that whilst fusion mediates the action of general predictors, other processes 
may mediate the impact of more specific risk factors. Future research should include CHAPTER V 
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a systematic examination of an array of theoretically meaningful potential mediators 
and moderators, an issue that is returned to below in relation to DBT and EA. 
  Fusion has not previously been tested as a mediating variable in relation to 
personality problems, and in fact due to measurement issues (see Chapter IV for more 
details), it has rarely been examined as a mediating variable in relation to any 
psychological difficulties. This study has therefore made a significant scientific 
contribution both in terms of examining an aspect of the ACT model empirically, as 
well as increasing knowledge about influences on the development of personality 
difficulties. However, these findings are based on a sample that includes people 
across the spectrum of personality functioning, and it would be useful to test these 
mediation models with a clinical sample of people with personality difficulties.  
  These results have important clinical as well as theoretical implications. Given 
that adults with personality problems can neither change their histories nor their 
genetic make-up, it is vital to identify intermediary processes that impact the 
development and maintenance of such problems, which can potentially be addressed 
therapeutically. CF plays an important part in the ACT model, and defusion exercises 
are included in all ACT treatment protocols, so it might be assumed that ACT would 
be helpful in treating poor personality functioning. However, ACT remains virtually 
untested in relation to personality difficulties (see Chapter II for a review of the few 
relevant trials), and PDs tend to be substantially more difficult to treat than Axis I 
disorders (Bender et al., 2001). Whilst the findings of the current study indicate the 
relevance of CF to personality functioning, it does not necessarily follow that ACT 
will prove to be a safe and effective treatment for people with poor personality 
functioning. Careful treatment development work is needed to explore this 
possibility. 
  DBT is already well established as a psychosocial intervention for BPD. It is 
possible that defusion is one of the mechanisms of change in DBT with this patient 
group, and this possibility should be tested empirically. In their 2006 theoretical 
paper outlining possible mechanisms of change in DBT for BPD, Lynch, Chapman, 
Rosenthal, Kuo, and Linehan consider mindfulness and the reduction of literal belief 
in rules amongst the likely mechanisms of change, both of which could be understood 
in terms of fusion/defusion. Additionally, DBT treatment strategies such as 
irreverence could also be viewed as supporting defusion. Lynch et al. in fact suggest 
several possible mechanisms of change, thus pointing to the need to test multiple CHAPTER V 
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potential mediators and the relationships between these mediators, both in relation to 
risk factors and treatment outcomes. 
  It has been argued (Greco et al., 2008) that CF leads to EA, although there is 
in fact a lack of clarity about how the various ACT-relevant variables relate to each 
other (see Chapter II, Section 2.2.1.2). It would therefore be theoretically important to 
test both CF and EA as mediators. As discussed in Chapter IV, the AAQ (Hayes et 
al., 2004), which has commonly been used to measure EA, includes items that 
address psychological flexibility rather than just those relating to EA, and includes 
fusion-related items. Consequently, the AAQ may not be the best tool for examining 
the relationship between CF and EA and their respective roles in relation to 
personality functioning. A more precise and/or non-questionnaire based measure of 
EA should be developed before these processes are tested together as mediating 
variables, in order to yield data that will help refine the ACT model. Given that 
avoidant behaviours are so commonly observed amongst people with poor personality 
functioning, a measure of the behavioural aspects of EA might be particularly useful. 
  Finally, and somewhat at a tangent to the focus of the current study, the study 
findings provide initial support for the use of a composite SIPP variable that gives a 
measure of overall personality functioning. Future research in the form of EFA and 
CFA with sufficiently large community and personality difficulty samples is needed 
to continue the examination of the factor structure and psychometric performance of 
this variable. 
 
5.4.4 Summary 
  The results of this study provide the first empirical evidence that CF may play 
a significant mediating role in the relationships between risk factors for personality 
problems and actual personality functioning in adulthood. This has important 
theoretical implications, in terms of increasing understanding of personality 
difficulties, as well as providing support for the ACT model of psychopathology. 
These findings are also important clinically, in that they suggest that if fusion can be 
effectively addressed through psychotherapeutic interventions, this might have a 
positive impact on outcome in the treatment of personality problems.  
  A number of directions for future research suggest themselves from the 
findings of the present study. In terms of theory, it is important to understand more 
about fusion and how it relates to other processes and behaviours, particularly those CHAPTER V 
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relevant to ACT. Given the limitations of the self-report measures of ACT-relevant 
processes currently, a fruitful first step might be to test fusion in relation to a 
behavioural measure relevant to personality problems. Clinically, and in relation to 
poor personality functioning, the next logical step, based on the models of treatment 
development outlined in Chapter III, is a small scale, uncontrolled treatment 
development trial of ACT for poor personality functioning.  
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CHAPTER VI 
Study 3: An Investigation of the Behavioural Correlates of CF 
 
6.1 Introduction 
Research focusing on the behavioural consequences of CF has been relatively limited 
to date, to a large extent owing to the lack of an appropriate measure of the construct. 
Study 1 and Study 2 of this thesis reported on the validation of a new self-report 
measure of CF and used it to demonstrate how CF mediated aspects of poor 
personality functioning. An additional benefit of the development of the CFQ is that 
it is now possible to investigate empirically the consequences of CF in a variety of 
novel ways. The current study assessed the behavioural consequences of fusion, 
specifically in relation to EA, because these two variables together play a crucial role 
in the ACT model of psychopathology (Hayes et al., 1999). Behaviours that serve to 
avoid distressing thoughts and emotions, such as DSH and binge eating, are 
commonly observed with people with PD diagnoses, and appear to have a detrimental 
effect on psychosocial functioning. Indeed, Kingston et al. (2010) found that report of 
such behaviours was strongly related to known risk factors for PD. Therefore, 
developing methodologies that enhance the investigation of CF and EA is likely to 
yield clinically relevant as well as theoretically important findings.  
 
6.1.1 Laboratory-Based Investigation of CF 
  Recent guidance on the evaluation of psychosocial interventions has 
emphasised that, in addition to establishing the efficacy of interventions, it is 
necessary to test the theories and models on which such interventions are based 
(David & Montgomery, 2011; Lohr, 2011). Levin et al., 2012, have argued that 
laboratory-based research can make an important contribution to this process, because 
it provides an opportunity to isolate and manipulate variables in a more precise and 
controlled manner than would be possible when testing complex psychotherapy 
treatment protocols in clinical settings.  CHAPTER VI 
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  As discussed in Chapter IV, the lack of a psychometrically sound, widely 
applicable measure of CF has hindered empirical examination of the construct, 
including in the laboratory. The few relevant, laboratory-based publications are 
component studies, each experimentally testing a standalone, brief defusion 
intervention, usually in relation to aversive stimuli such as negative self-statements 
(see Chapter II, Section 2.2.1.2 for a review). There are no published studies 
specifically designed to investigate fusion (rather than defusion interventions).  
Theoretically, it is possible to fuse with positive or neutral stimuli 
(Blackledge, 2007), but the few published experimental investigations of CF have all 
focused primarily on defusion in relation to negative or aversive material, not only 
because there is an assumption that fusion with negative material is more problematic 
than fusion with positive or neutral material (e.g. Healy, et al., 2008), but also 
because there appears to be an untested—and usually unarticulated—assumption that 
we fuse more readily with negative private experiences than with positive. To date, 
no studies designed to test this assumption have been published. More surprisingly 
still, given the central role of these processes in the ACT model, few studies—
laboratory-based or otherwise—have investigated the relationship between CF and 
EA. 
 
6.1.2 CF and EA  
  Although examining the impact of components of complex psychotherapies is 
a central aspect of model testing (Campbell et al., 2000; Levin et al., 2012), 
evaluating whether that model’s variables relate to each other in predicted ways is 
also important. Few published studies have done this in relation to CF and variables 
relevant to EA. As outlined in Chapter II, Section 2.2.1.2, EA is a process central to 
the ACT model that has been defined as “the phenomenon that occurs when a person 
is unwilling to remain in contact with particular private experiences (e.g., bodily 
sensations, emotions, thoughts, memories, behavioural predispositions) and takes 
steps to alter the form or frequency of these events and the contexts that occasion 
them” (Hayes et al., 1996). ACT theory suggests that CF should be strongly related to 
EA, with some authors arguing that CF leads to EA, in that there would be no need to 
attempt to avoid a private experience such as a judgemental thought about oneself, CHAPTER VI 
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unless one was fused with it (Greco, et al., 2008; Pistorello et al., 2000). Efforts to 
avoid private experiences and the situations that might trigger them are commonly 
observed in psychotherapeutic work with people with PD diagnoses, and clinical 
observation indeed suggests that fusion with uncomfortable private experiences leads 
to EA. 
  In their test of a brief defusion exercise with a student sample, Healy, et al, 
(2008) found that defusion was associated with greater participant willingness to read 
and think about negative self-statements. This finding could be seen as supporting the 
ACT model, given that willingness is viewed in ACT as the opposite of EA, in the 
same way that fusion and defusion are viewed as being inversely related. However, 
willingness was indexed using a self-report rating scale from 0 to 100, rather than a 
psychometrically tested instrument or a behavioural measure of willingness, so 
caution should be used when drawing conclusions from this finding. Watson et al. 
(2010), in their investigation of defusion in relation to obsessional compulsive 
symptomology, found that a brief defusion practice had no impact on EA, as 
measured by the AAQ (Hayes et al., 2004). As will be discussed in Section 6.1.3, the 
use of the AAQ as a measure of EA is problematic. Thus, although it is possible that 
the lack of impact of this defusion exercise on AAQ score indicates that fusion and 
EA are not related as outlined in the ACT model, it is equally possible that the 
measures used in the study do not adequately address the constructs in question. 
Additionally, it could also be that CF and EA are related, but that the defusion 
exercise used in this study did not impact CF sufficiently to affect those relationships.  
Finally, Wicksell et al. (2008) labelled the two subscales of their measure of 
psychological inflexibility in physical pain, ‘cognitive fusion’ and ‘avoidance of 
pain’, and found that they were moderately, positively correlated. However, given 
that this measure is designed for use with a physical pain sample and its items refer 
only to pain, it cannot be assumed that the same relationship between the two 
variables would be found in the general population or mental health samples, in 
relation to private experiences other than pain.    
  In summary, the published literature examining the relationship between CF 
and EA is limited, both in terms of the number and quality of studies, although both 
ACT theory and some limited relevant data suggest that CF and EA are positively 
related. Research designed to examine the relationship between the two constructs 
without employing clinical-type interventions, as well as research utilising better CHAPTER VI 
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quality, more appropriate measures, would aid testing of this aspect of the ACT 
model. Given the role that these processes are hypothesised to play in 
psychopathology, increasing understanding of the relationship between CF and EA is 
important for both clinical and theoretical reasons. Self-report measurement of CF 
has significantly improved with the development of the CFQ, but the existing 
measure of EA remains problematic.  
6.1.3 Measuring EA 
  The AAQ (Hayes, et al., 2004) has been used as a measure of EA extensively 
in the ACT literature. However, as Hayes and colleagues (2006, p. 10) point out, 
although the AAQ was originally described as a measure of EA, it in fact “ measures 
the degree to which an individual fuses with thoughts, avoids feelings, and is unable 
to act in the presence of difficult private events”. It therefore measures a much 
broader construct than EA, and the revised version of the measure, the AAQII, (Bond 
et al., 2011), is now described as a measure of psychological inflexibility. This 
revision of the measure and the construct it is designed to measure is particularly 
problematic, given that the AAQ/AAQII is the main ACT process measure. There are 
other measures, such as the Emotion Control Questionnaire (Roger & Najarian, 1989) 
and the State Emotion-Regulation Questionnaire (Kashdan & Steger, 2006) that 
include items that address EA, but again, both are measures of broader constructs.  
Given that no precise self-report measure of EA for use with the general 
population or mental health samples is currently available, the use of an alternative 
form of measurement is indicated. One possibility is a measure of behavioural 
avoidance. This would be particularly helpful in terms of clinical relevance, because 
such avoidance is frequently observed with PD patients. In terms of the definition of 
EA quoted in Section 6.1.2, such a measure would be assessing the action taken to 
alter the form or frequency of private experiences and the contexts that occasion 
them.  
  In clinical settings, a simple and effective measure, the behavioural approach 
test (BAT), is commonly used to assess behavioural approach/avoidance responses to 
aversive stimuli in relation to anxiety disorders (Anthony & Swinson, 2000). This 
task measures how near to the stimulus the patient is willing to approach, or how long 
they are willing to stay in contact with the stimulus. A particular strength of the BAT CHAPTER VI 
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is that it directly measures approach/avoidance, and therefore the results are 
straightforward to interpret. 
In non-clinical research settings, several computer-based measures of 
behavioural approach/avoidance responses have been developed (see Krieglmeyer & 
Deutsch, 2010 for a review). These measures are easy to administer in a controlled 
manner using a computer, but they tend to measure approach/avoidance behaviours in 
a less direct manner than the BAT. For example, the manikin task employs an image 
of a manikin on a computer monitor that the individual can move towards or away 
from the stimulus, rather than, for example, the participant actually moving away 
from the stimulus or being able to avoid it by clearing the screen. Other tasks make 
use of the affective Simon effect (Simon & Rudell, 1967; de Houwer, Crombez, 
Baeyens, & Hermans, 2001), where the participant is instructed to respond to a non-
affective cue such as the grammatical category of word stimuli (for example noun or 
verb), but a supposedly irrelevant, affective cue, (positive or negative word meaning), 
impacts the participant’s performance on the task. These tasks yield reaction time 
data, from which the extent of approach or avoidance behaviour is inferred.  
Using yet another computer-based task design, Cochrane, Barnes-Holmes, 
Barnes-Holmes, Stewart, and Luciano (2007) found that participants who scored 
highly on the AAQ (Hayes et al., 2004)—which was intended as a measure of EA by 
the authors—took longer than low-scoring participants to react in a task that required 
them to choose whether to view aversive or neutral images. High AAQ scoring 
participants also—based on the author’s interpretation of event-related potential 
(ERP) data—possibly might have been engaging in more verbal activity (which the 
authors interpreted as verbally-based avoidance strategies) than those with low AAQ 
scores. Although these findings are generally supportive of the ACT model, they are 
based on the interpretation of reaction time data, in a study in which the AAQ plays a 
central role, and with a very small sample size (six participants per group in the ERP 
experiment). This approach can therefore only be seen as raising interesting 
possibilities for further research rather than as resulting in a valid and reliable 
behavioural measure of avoidance.   
  For the purposes of this study, I developed a measure of the behavioural 
aspect of EA that drew on the strengths of both the BAT and the computer-based 
tasks discussed above. The measure and its administration are described in detail in 
Sections 6.2.2.1 and 6.2.3. In brief, a simple, computer-based task allowed CHAPTER VI 
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participants to directly avoid prolonged contact with stimuli—in this case, negatively 
and positively valenced self-referential adjectives—by removing them from the 
monitor. The length of time each participant left the stimuli on the monitor was used 
as the measure of behavioural avoidance. Although the majority of defusion-focused 
studies have used only negatively valenced word stimuli, it was decided to 
additionally include positively valenced stimuli in order more flexibly to examine 
assumptions in the ACT literature about CF.  
6.1.4 Study Design, Aims, and Hypotheses 
  The purpose of the present study was to develop a measure of the behavioural 
aspect of EA and to use it in conjunction with the CFQ to examine the relationship 
between CF (the IV) and EA (the DV). Based on ACT theory, it was expected that 
CF would positively correlate with EA (view time for stimuli), at least in relation to 
negative stimuli. However, if participants fully understood the purpose of the study, 
this knowledge could impact their behaviour, rendering the measure invalid. It was 
therefore necessary to represent the experiment as a test of memory, in order to 
disguise its true purpose (see Section 6.2.3 for the details of this aspect of the task). 
Thus, participants, having been told that there would be a memory test later, were 
presented with the stimuli, one at a time, which they viewed for as long as they 
wished. A stimulus recognition memory test duly followed and recognition data were 
collected and analysed on an exploratory basis rather than to test specific hypotheses, 
because any relationship between CF and recognition might be confounded by 
stimulus view time. 
  Although the processes and behaviours of interest in this study are observed in 
psychotherapy with people with PD diagnoses, it was decided to recruit a non-
clinical, student sample in the first instance. This decision was made for both ethical 
reasons (not wishing to trial a methodology that features negative, self-referential 
stimuli with vulnerable participants), and practical reasons (the difficulty of recruiting 
a clinical sample).  
The hypotheses were as follows: 
1. CF, as measured by the CFQ, will be negatively correlated with view time for 
negative words. CHAPTER VI 
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2. CF, as measured by the CFQ, will be positively correlated with view time for 
positive words. 
6.2 Method 
6.2.1 Participants 
  An opportunity sample of fluent English speaking volunteer undergraduate 
and postgraduate psychology students at the University of Southampton (n = 40) was 
recruited (see Table 6.1 for demographic information). Undergraduate participants 
earned course credits for their participation.  
  It was difficult to calculate the required sample size for the study, because 
there were no published experiments using the same measure of behavioural 
avoidance. A required sample size of 28 was estimated, assuming statistical power of 
.8, a large effect size (r = .5), and using α = .05. Allowing for the likelihood of some 
invalid or incomplete datasets, and/or for the possibility of a smaller effect size, it 
was decided to recruit between 35 and 40 participants. 
6.2.2 Materials 
6.2.2.1 Behavioural Task 
  The experiment was created using Presentation software. All word stimuli 
were presented in black type using Monaco font on a plain white background, in the 
centre of a computer monitor (Intel® Pentium® 4 CPU 2.80GHz, with a 15 inch 
VGA CRT monitor with standard keyboard attached, which was used to register 
participant responses). A fixation cross was displayed in the centre of the screen 
between word presentations.  
The adjective stimuli for the presentation and recall phases of the task were 
taken from a list of 139 positively and negatively valenced human trait adjectives 
devised by Cili (2012), selected from a list of 555 such adjectives, originally rated in 
terms of likeability (Anderson, 1968).  Cili had 20 students rate the valence of each 
word on a scale from -3 (very negative) to +3 (very positive), and used the mean 
rating for each word as its valence index. A subset of 48 (24 positive and 24 negative) 
of the most highly valenced words from Cili’s list was selected, for the present study 
(see Appendix H). 
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Table 6.1 
Demographic Information 
   
 
Demographic 
 
 
Student sample 
(N = 40) 
 
Mean age (SD) 
Age range 
 
20.18 (3.74) 
18 - 40 
Gender (% female) 
Country of origin: 
                       UK 
                       Europe (other) 
                       Asia 
                       Other 
Ethnic origin: 
                       White 
                       Asian 
                       Black 
                       Mixed 
                       Other ethnic group 
90% 
 
85.00% 
2.50% 
5.00% 
7.50% 
 
85.00% 
7.50% 
2.50% 
2.50% 
2.50% 
   
 
Examples of positively valenced words selected included ‘honest’, 
‘intelligent’ and ‘optimistic’. Examples of negatively valenced words include 
‘hostile’, ‘selfish’ and ‘deceitful’. The mean valence indices for the two sets of words 
(positive: 2.19; negative: 2.11) did not differ significantly, t(46) = 1.20, p = .24. Six 
emotionally neutral words (such as ‘cabinet’ and ‘elephant’), which did not appear in 
the list developed by Cili, were used for practice trials prior to the main stimuli 
presentation phase of the task.  
   
6.2.2.2 Cognitive Fusion Questionnaire, (CFQ; Gillanders et al., submitted). See 
Chapter IV, Section 4.2.2. 
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6.2.2.3. Brief demographics questionnaire. Participants were asked to indicate their 
age, gender, country of origin, and ethnic origin. (Appendix I). 
6.2.3 Procedure 
  University of Southampton Psychology ethical approval was obtained for this 
study prior to recruitment via the psychology student credits webpage.  
  The task consisted of three phases; an instruction/practice phase, a word 
presentation phase, and a word recognition phase. 
Instruction and Practice Phase 
The computer used for the task was situated on a desk in a quiet, well-lit 
cubicle. Participants read a study information sheet and signed a consent form (see 
Appendix J). They then completed the CFQ and the demographic questionnaire, on 
the computer. The researcher then asked participants to read a set of instructions on 
the monitor screen, as follows. 
This is an experiment investigating predictors of performance on a memory of 
words task. 
Words will be presented on the screen, one at a time, one after the other. 
Your task is to read each word, and when you are ready, strike the RETURN 
key to see the next word. There will be a recognition memory task involving 
these words at the end of the experiment. 
In between words, there will be a cross in the middle of the screen. Please 
focus on the cross while you are waiting for the next word to appear, rather 
than letting your attention wander. 
Please ask if you have any questions. 
When you are ready, press the SPACE BAR to begin some practice trials. 
 
  The instructions were followed by six practice trials, with the researcher still 
in the room. The practice trials used neutral words (‘rainfall’, ‘elephant’, ‘window’, 
‘cardigan’, ‘refrigerator’, and ‘cabinet’). Non-personal words were used so that 
participants were able to experience the format of the study without being given prior 
warning about the nature of the main task stimuli. As the participant cleared each 
word from the screen, it was replaced by a fixation cross in the centre of the screen, CHAPTER VI 
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with an inter-trial interval of 2000 ms. Following the practice trials the researcher left 
the room and the participant read the following instructions on the screen: 
“The main part of the experiment will be in the same form as the practice trials. When 
you are ready, please strike the Space Bar to start the actual experimental trials.”  
Word Presentation Phase    
  The 16 positively and 16 negatively valenced words of the main trials were 
presented in a pseudo-random order (no sequence of more than three words of the 
same valence). After viewing a word for as long as required, participants used the 
keyboard return key to remove it from the screen. The duration for which each word 
was on the screen was recorded. After 32 trials, a further set of instructions appeared 
on the screen, as follows: 
“A series of words will now be presented on the screen, one at a time, one after the 
other. 
“You should use the keys marked ‘SEEN’ and ‘NOT SEEN’ to indicate whether you 
saw the word on the screen presented earlier in the experiment or not.” 
Word Recognition Phase 
Eight positively and eight negatively valenced words were selected from the 
32 presented in the main part of the task, excluding the words that had been presented 
in the first and last eight word presentation trials, to avoid primacy and recency 
effects. These words were interspersed with 16 previously unseen words (half 
positively and half negatively valenced), from the original list of 48 adjectives. These 
32 words were presented in a pseudo-random order, one at a time. A response of 
‘seen’ or ‘not seen’ to a word cleared the screen. There was an inter-trial interval of 
2000ms, with a fixation cross in the centre of the screen. Once the participant had 
completed the memory trials, a final message appeared on the monitor screen as 
follows:  
“You have now finished the experiment. Please let the researcher know. 
“THANK YOU FOR PARTICIPATING” 
  Before leaving, participants were verbally debriefed and given a study debrief 
form (Appendix J). 
 
6.2.4 Analysis Plan 
  In Stage One of the analysis, the raw data were inspected, outliers removed, 
and normative data (including skew and kurtosis indices) were obtained for each of CHAPTER VI 
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the study variables. Stage Two used t-tests to compare mean view times for positively 
and negatively valenced words. Stage Three utilised Pearson’s r correlation tests to 
examine the relationships between CF (score on the CFQ) and word view time (EA). 
PASW Statistics 19 software was used for all data analysis. 
 
6.3 Results 
6.3.1 Stage One. Data Screening and Preliminary Analyses 
  Before conducting any statistical tests, the CFQ and behavioural task data 
were screened for missing responses. There was no data loss from either the CFQ or 
the behavioural task variables.  
  View time and memory data were then prepared for analysis. As is common 
practice in related research fields such as attentional bias research, view times more 
than 2 standard deviations outside of each participant’s mean were excluded, as were 
reaction times that were below a cut-off point; in this case, 500ms (e.g. Lees, Mogg 
& Bradley, 2012; Vassilopoulos, 2005). On these grounds, six participants were 
excluded from the study because more than 25% of their view time data was below 
500ms, suggesting that they were not effectively engaged with the task. This left a 
final N of 34. 
Memory data were collected in the form of hits (H) (correctly indicating that a 
word had been seen in the main word presentation trials), and false alarms (F) 
(indicating a word had been seen before when in fact it had not previously been 
presented) as these are the two types of response that are used to calculate recognition 
memory sensitivity, based on signal detection theory (SDT; Green & Swets, 1966). 
As is usual practice (Stanislaw & Todorov, 1999), rates of 1 and 0 were adjusted to 
allow for the calculation of memory sensitivity values. Rates of 0 were replaced with 
0.5/n, and rates of 1 were replaced with (n - 0.5)/n, where n is the number of seen 
previously or not seen previously trials. An index of recognition memory sensitivity 
(discriminability index; d’) was calculated for each participant by entering their F and 
H scores in an on-line calculator (Neath, 2012), which used the formula d’ = z(H) – 
z(F), where z(F) is the z score for false alarms and z(H) is the z score for hits 
(Macmillan, 1993). CHAPTER VI 
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  Consistent with the criteria used elsewhere in this thesis (see Chapter IV 
Section 4.3.2), a cut-off point of above or below +/- 7 was used to determine 
unacceptable levels of skew or kurtosis. Table 6.2 shows that none of the study 
variables showed problematic distributions. Table 6.3 shows the means and standard 
deviations for all study variables. The mean score on the CFQ (41.24) is almost 
identical to that found with other student and non-clinical samples. 
 
Table 6.2 
Skew and Kurtosis Data for All Study Variables 
 
Variable  skew  c.r.  kurtosis  c.r. 
 
 
CFQ 
Pos VT 
Neg VT 
d’ Pos 
d’ Neg 
 
.20 
1.48 
1.63 
-.75 
-.99 
 
.47 
3.53 
3.88 
-1.78 
-2.35 
 
-.06 
1.36 
2.00 
.67 
1.32 
 
-.07 
1.61 
2.49 
.79 
1.58 
Note. CFQ = Cognitive Fusion Questionnaire; Pos VT = view time for positive words in ms; Neg VT = 
view time for negative words in ms; d’ Pos = d’ for positive words; d’ Neg = d’ for negative words; 
c.r. = critical ratio  
 
Table 6.3 
Means and Standard Deviations for All Study Variables 
 
                                                                  Community Internet sample (n = 34) 
 
Variable 
 
Mean 
 
SD 
 
CFQ 
Pos VT 
Neg VT 
Pos d’ 
Neg d’ 
 
41.24   
2084.18 
2100.04 
2.22   
2.18 
 
9.43 
1441.77 
1285.77 
.61 
.61 
Note. CFQ = Cognitive Fusion Questionnaire; Pos VT = view time for positive words in ms; Neg VT = 
view time for negative words in ms; Pos d’ = d’ for positive words; Neg d’ = d’ for negative words; 
SD = standard deviation 
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6.3.2 Stage Two. Comparisons between view time for positively and negatively 
valenced words. 
  A paired sample t test indicated that there was no significant difference in 
view time between positively and negatively valenced words (Table 6.4). 
 
Table 6.4 
Paired Sample t Tests Comparing Positive and Negative View Time 
 
                                          Word valency 
                                             
 
 
Positive 
Mean (SD) 
 
Negative 
Mean (SD) 
 
t  df  p 
 
VT 
 
2084.18 
(1441.77) 
 
2100.04 
(1285.77) 
 
-.30 
 
33 
 
.76 
Note. VT = view time in ms 
 
6.3.3 Stage Three. Relationship Between CFQ Score and Stimulus View Time. 
  Table 6.5 shows the bivariate correlation between CF and view time. The 
relationships between CF and view time for both positive and negative words were 
statistically significant, with higher score on the CFQ being associated with longer 
view times for both types of words. A Hotelling-Williams test using Fisher’s 
transformation of r values to Z scores was used to assess whether there was a 
significant difference between the correlation between CF and view time for negative 
words and the correlation between fusion and view time for positive words. The 
results indicate that the difference was not significant, z = -1.44, p = .15. 
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Table 6.5 
Bivariate Correlations between CFQ Score and View Time 
  
                             Pos VT                   Neg VT                                                          
 
   r   p  r  p 
 
CFQ 
 
.42 
 
.014 
 
.46 
 
.001 
Note. CFQ = Cognitive Fusion Questionnaire; Pos VT = view time  
for positive words; Neg VT = view time for negative words 
 
 
6.3.4 Memory Data Analysis 
Given that the memory data from the experiment were collected, the 
relationship between CFQ score and recognition memory (d’) was tested, in relation 
to positively and negatively valenced words. Bivariate correlations showed a non-
significant trend for CF to correlate with recognition memory for negative words (r = 
.28, p = .11), but there appeared to be no relationship between CF and memory for 
positive words (r = .13, p = .46). However, stimulus view time is likely to have 
confounded these results, and the study was not sufficiently powered to statistically 
partial out its effect. 
 
6.4 Discussion  
6.4.1 Study Findings 
  This experiment was designed to pilot a new measure of behavioural 
avoidance and to use this measure and the CFQ to examine the relationship between 
CF, and behavioural avoidance in relation to self-referential adjectives. It was 
predicted that fusion would be associated with avoidance of negatively valenced 
stimuli, indicated by shorter view times for those words. In fact the opposite was 
found; there was a highly significant correlation between CFQ score and view time 
for negative words, with higher fusion being associated with longer view times. Both 
ACT theory and previous relevant research (e.g. Healy et al., 2008) suggest that CF 
and EA are positively correlated, so it is unlikely that the results of this study indicate CHAPTER VI 
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that CF and the behavioural aspect of EA are negatively correlated. It seems more 
likely that the computer task functioned as a behavioural measure of CF. That is, 
when participants were given control over how long they viewed each word, view 
time did not function as a measure of avoidance or willingness to be in contact with 
the stimuli, but rather it indicated entanglement with negative stimuli and thus 
difficulty in disengaging from them. 
  It was more difficult to predict what relationship if any there would be 
between CF and avoidance/willingness in relation to positively valenced words, 
because most ACT theoretical writing focuses on fusion with aversive private 
experiences. The only relevant published study that has included positively valenced 
stimuli (Healy et al., (2008), was designed to test the impact of a defusion exercise, 
which had little effect on relationship to those positive stimuli. Furthermore, due to a 
design flaw in their measurement of thought believability (used as a proxy for CF) in 
the defusion condition of their study, conclusions cannot be drawn from their thought 
believability data, including conclusions about relative believability of positive and 
negative thoughts.  
In the present experiment it was predicted that CF would be positively 
correlated with willingness to view positively valenced words, as indicated by view 
times, and indeed a significant relationship of this kind was found between score on 
the CFQ and positive word view time. However, as discussed above, it seems likely 
that the task was actually functioning as a behavioural measure of CF rather than 
avoidance/willingness. Therefore, the findings could possibly be interpreted as 
indicating that people with a higher propensity to fuse do so with both positively and 
negatively valenced self-referential words (though further testing of this conclusion is 
needed). If this is the case, it is not that these findings indicate that fusion is related to 
willingness to view positive stimuli, but that people who score higher on a measure of 
CF appear to get more ‘entangled with’ and ‘caught up in’ (to use the wording of 
CFQ items), verbal stimuli, regardless of the valency of those stimuli.   
Interestingly, Cochrane et al. (2007) found that in the ERP aspect of their 
study, participants scoring highly on the AAQ were possibly engaging in more verbal 
activity than those with low scores, and this activity did not appear to differ in 
relation to aversive or neutral stimuli. The authors interpreted this verbal activity as 
cognitive avoidance strategies, but the ERP data offers no possibility of establishing 
if this was the case, or if this verbal activity could in fact be characterised as CF.   CHAPTER VI 
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The relationship between score on the CFQ and view time for negative words 
was not significantly different to the relationship between CFQ score and view time 
for positive words, based on the Hotelling-Williams correlation difference test. 
However, the study was underpowered for this test. If a well-powered study did 
demonstrate a significant difference in these relationships, with the relationship 
between CFQ score and view time for negative words being stronger (the very small 
difference in correlation size in this study might suggest this possibility), this could 
indicate that negative self-referential words form the basis of a superior behavioural 
measure of CF, compared to positive words, perhaps because we more readily fuse 
with negative stimuli, as assumed in the ACT literature. An alternative explanation 
for such a difference might be that there is some bias towards fusion with negative 
stimuli in the CFQ items. 
The results of this experiment indicated that there was no significant 
difference in view time for positively and negatively valenced words. This is in 
keeping with findings in the attentional bias literature, where attentional bias for 
threat is not usually found with non-clinical samples (Bar-Haim et al., 2007).  
Although this experiment yielded some interesting results, the computer task 
did not appear to be functioning as conceived; that is, as a measure of behavioural 
avoidance. However, a behavioural measure of CF is a useful addition to ACT 
research resources, complementing, as it does, the CFQ. The ability to examine a 
construct via more than one methodology can only increase confidence in that 
construct (Campbell, & Fiske, 1959), notwithstanding the fact that the development 
of this measure was not the original aim of the study. 
 
6.4.1.1 CF, EA, and the ACT Model 
  The findings of this study are also important because they raise a significant 
issue regarding the ACT model, in that they can be interpreted (based on the model) 
to suggest that the computer task measured CF rather than EA, as originally predicted 
(also in line with the ACT model). Having both processes in the model, one (CF) that 
implies attentional entanglement with stimuli and therefore difficulty disengaging 
from them, and the other (EA) implying the need to disengage from stimuli, means 
that, as was the case here, the model can account for stimulus-related behaviour, 
regardless of whether the data indicates approach or withdrawal in relation to that 
stimulus.  CHAPTER VI 
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It makes theoretical sense to suggest that CF leads to EA (Greco et al., 2008; 
Pistorello et al., 2000), implying that CF happens prior to efforts to avoid a stimulus 
and its psychological impact. If it could be demonstrated that these processes occur at 
different time points following presentation of a stimulus, this would sharpen the 
predictive power of the model, in that it could be predicted that at time X CF would 
occur, whereas at (later) time Y, EA would be expected. This would represent an 
improvement on the current situation where the model predicts both/either processes.  
  These processes have not been examined in this way to date within the ACT 
literature, but a similar issue has been explored empirically in a related field. In the 
attentional bias literature, the vigilance-avoidance model (Mogg & Bradley, 1998), 
which states that for anxious people vigilance for threatening stimuli is followed by 
avoidance of those stimuli, has been tested indirectly by examining sequential points 
in time on the ‘attentional timeline’ (e.g. Mogg & Bradley, 2006). By presenting 
stimuli for shorter and longer lengths of time, and finding that attention is turned 
towards threat stimuli with shorter presentation times, and turned away from those 
stimuli at longer times, the researchers infer that avoidance follows vigilance in the 
seconds following presentation of an aversive stimulus. Mogg and Bradley (1998, p. 
837) suggest that anxious individuals may “initially direct their attention to threat, but 
then try and avoid detailed processing of it in an attempt to minimise their 
discomfort”. The avoidance aspect of this description fits well with definitions of EA 
such as that of Hayes et al., (1996), quoted in Section 6.1.2. More recently, several 
studies (e.g. Fox, Russo, Bowles, & Dutton, 2001; Koster, Crombez, Vershuere, & 
De Houwer, 2004) have yielded findings suggesting that for anxious people it is 
difficult to disengage from negatively valenced stimuli once they are paying attention 
to them, and it is this that results in longer reaction times in dot-probe tasks rather 
than vigilance for threat, as claimed by Mogg and Bradley. From this latter 
standpoint, the vigilance-avoidance model begins to resemble a CF-EA model, as 
difficulty to disengage closely resembles being entangled with and dominated by 
stimuli, phrases that are commonly used to describe CF. For possible ways of taking 
this line of research forward, see Section 6.4.2. 
Although the findings of the present study are limited, what this study has 
achieved is to pilot the kinds of behavioural paradigms that could be used to test these 
issues further, under controlled, laboratory-based conditions. These observations also 
point to a useful distinction between treating CF as a trait (as is the case with the CHAPTER VI 
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CFQ), and attempting to directly tap into fusing behaviour, moment by moment. 
Participants who reported via the CFQ that they tended to fuse with thoughts (CF as a 
trait), in fact exhibited fusion-like behaviour in this study, but might be predicted to 
exhibit avoidance-like behaviour at different points in time. 
Finally, in terms of study findings, there was a non-significant trend for a 
correlation between CF and recognition memory for negative words, but it is likely 
that view time had an impact on this relationship. Due to the sample size, the study 
was statistically underpowered to partial out the potentially confounding effect of 
view time. In order to more accurately assess the relationship between CF and 
recognition memory, a larger sample would need to be recruited for the current 
experiment, to achieve enough statistical power to be able to control for the impact of 
view time. Given that the task was shown not to be functioning as originally 
predicted, it was decided not to continue recruiting. An alternative means of 
accurately testing the CF-memory relationship would be to experimentally control 
view time, which as outlined in Section 6.4.2, is likely to be a design feature of any 
future developments of this experiment.  
6.4.2 Methodological Limitations 
  There were a number of limitations, both to the overall design of the study, 
and specifically to the design and functioning of the behavioural paradigm. Firstly, 
there are limitations related to the sample. The experiment was underpowered (due to 
sample size), to carry out some secondary statistical tests. It was based on a 
predominantly female, student sample, with an under-representation of people from 
ethnic minorities. These limitations should be borne in mind when generalising from 
the findings.  
  With regards to the functioning of the behavioural task, it is commonly the 
case that when developing a new behavioural paradigm, a phase of testing, modifying 
and retesting is necessary before the task under development functions as required. 
This study represents the beginning of such a process, and as such it was expected 
that further ‘fine-tuning’ of the task design would be required. In the event, as 
outlined in Section 6.4.1, substantial modifications appear to be warranted. The 
methodologies used in the attentional bias literature may suggest ways to test the 
predicted differential impact of CF and EA on behaviour, by developing dot-probe or CHAPTER VI 
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other tasks that examine behaviour at several time points following stimulus 
presentation. The limitation of the dot-probe methodology however is that as the 
name implies, it measures response time to a neutral dot probe, and infers attentional 
biases from this data. A strength of the task used in the current experiment was that it 
yielded a more direct measure of avoidance/approach behaviour. However, it was 
designed to allow participants to view stimuli for as long as they wished, and 
therefore view time could not be experimentally manipulated. The task would need to 
be significantly modified to render it capable of measuring behavioural responses at 
different time points. 
In the current experiment, the mean stimulus view time was approximately 
2000ms, and at that point on the attentional timeline (using attentional bias literature 
terminology), higher score on the CFQ was positively associated with view time for 
negative stimuli, suggesting psychological entanglement with those stimuli. One 
possibility would be to conduct a second set of stimulus presentation trials for each 
participant, with the stimulus presentation time (determined by the experimenter) 
varying around a fixed time substantially greater than 2000ms, that is, further along 
the time line. Obviously view time could not be used as a behavioural measure, but 
the number of attempts to remove stimuli from the screen by hitting a key might be 
expected to function as a measure of behavioural avoidance at this longer view time.  
Given that participants would not actually be able to influence how long the 
stimuli were presented for, efforts would need to be made to convince them that they 
did have control over stimulus view time so that they would attempt to remove 
stimuli from the screen. Having the presentation time vary would be one way of 
making the design of the experiment less obvious. Another would be to have practice 
sessions in which they did have control over presentation time, immediately prior to 
the experimental trials.  
It would be hypothesised that at this later point on the time line, score on the 
CFQ would correlate with attempts to remove negative stimuli from the screen, the 
latter functioning as a measure of the behavioural aspect of EA. In fact, using this 
modified version of the behavioural task, latency to first key strike (to remove the 
stimulus from the screen) and number of key strikes could both be measured, with the 
prediction that latency to first key strike would function as a measure of CF, and 
number of subsequent key strikes as a measure of EA. If an orderly change in 
behaviour in relation to change in stimulus duration could be demonstrated, this CHAPTER VI 
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would help address the problem of the ACT model being able to account for both 
entanglement with and avoidance of aversive stimuli, outlined in Section 6.4.1. The 
CFQ, which has been shown to be a valid measure of CF, would be essential to test 
these predictions. 
If CF was shown to occur before EA, this says nothing about the former 
causing the latter. All that could be concluded from this type of study design is that 
the findings were consistent with the hypothesis that CF leads to EA. An 
experimental manipulation of CF would be required to demonstrate causality. 
 
6.4.3 Implications and Future Research 
  The results of this experiment represent a unique contribution to ACT 
research, in that they demonstrate the initial work to develop novel behavioural 
measures of key ACT variables. The development of easy to administer, validated 
behavioural measures of CF and EA would significantly broaden the range of 
methodological possibilities for ACT research. To a large extent ACT-focused 
research is currently dependent on self-report measures and, in the case of EA, a less 
than ideal self-report measure. To be able to measure behaviours in relation to CF and 
EA, rather than rely on verbal self-reflections, would be wholly in keeping with the 
theoretical and philosophical underpinnings of ACT, and it has long been understood 
(Campbell & Fiske, 1953) that to have confidence in the validity of a construct and 
measures of that construct, methodological heterogeneity in measurement design is 
important. To have available good quality self-report and behavioural measures of 
core ACT variables would be an important development, and one to which this study 
makes a contribution. 
   The findings from this experiment provide preliminary empirical evidence 
relating to a common assumption in the ACT literature and in ACT therapy (that we 
can fuse with both positive and negative material, but more readily with the latter). 
The study findings also highlight important issues for the theory on which ACT is 
based, and as such contributes an essential step in the scientific testing of ACT as a 
psychotherapy (David & Montgomery, 2011; Lohr, 2011). Although preliminary in 
nature, the findings of this study raise interesting questions in that they could be 
explained in a number of ways.  CHAPTER VI 
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  In addition to the modifications to address design and performance limitations 
suggested in Section 6.4.2, future research could involve other possible enhancements 
and developments being made to the behavioural task and to the experiment as a 
whole. In terms of the task, introducing neutral stimuli in addition to positively and 
negatively valenced stimuli would allow testing hypotheses to do with the 
relationship to emotionally charged stimuli compared to neutral stimuli. Different 
forms of stimuli such as images of scenes and faces should be tested in similar 
experiments, to see if the results found in the current study apply only to linguistic 
stimuli, or are more broadly applicable.  
  Given that CF and EA are observed in psychotherapeutic settings with people 
with mental health diagnoses, and that these processes appear (based on clinical 
observation) to contribute to the maintenance of those mental health difficulties, it 
will be important to carry out these kinds of studies with relevant clinical populations, 
to enhance understanding of the impact of CF and EA. In particular, fusion with and 
attempts to avoid negative thoughts and memories are commonly observed with 
people with PD diagnoses. More specifically, people with these kinds of mental 
health problems report particular difficulties in relation to fusion with negative or 
judgemental self-referential words, thoughts and memories, and this fusion appears to 
understandably give rise to a range of efforts to avoid such private experiences. Some 
of the avoidance strategies used by people with PDs, such as self-harm and substance 
misuse, significantly increase risk to their safety. Other EA strategies, such as 
avoiding leaving one’s home, or avoiding social contact, although not risky in the 
same way, are clearly debilitating and highly detrimental to wellbeing and quality of 
life.  
  Refining the behavioural task developed in the current study and then 
administering it with PD patients would help to clarify the role of these particular 
variables with this patient group. The findings of such studies might influence ACT 
therapeutic interventions. Such findings would also provide empirical evidence 
relating to another aspect of ACT theory; namely that these processes are universal in 
nature, and that people with a range of psychological difficulties as well as those 
without any psychiatric diagnosis, are likely to be impacted by these processes in 
similar ways, albeit to differing degrees. Care would need to be taken when using 
these kinds of behavioural measures with a PD sample, given that negative self-
referential stimuli are used, but some defusion coaching could be included at the end CHAPTER VI 
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of the behavioural task to guard against any potential negative impact. It might be 
predicted that larger effects would be detected in these kinds of tasks when 
administered to people with PD diagnoses (compared to this non-clinical, student 
sample, because of their apparent greater propensity to fuse and avoid. 
  Finally, as noted in Section 6.4.1, there are similarities between attentional 
bias models that have been developed in relation to anxiety disorders, and the 
hypothesised relationship between CF and EA, as it is understood within the ACT 
literature. It may be fruitful to both areas of research to empirically examine these 
possible similarities. One strategy for this, described in detail in Section 6.4.2, might 
involve a modified version of the behavioural task, where stimulus avoidance 
behaviour would be monitored when stimuli were presented for varying presentation 
times. This would serve to link the examination of fusion with an existing and well-
developed body of research. Another possible way of understanding cognitive fusion 
and the length of time spent attending to verbal stimuli might be in terms of stimulus 
elaboration. Again, there is a body of literature addressing this phenomenon, which 
again could guide the development of future laboratory-based empirical examination 
of fusion. Developing links in this way between ACT research and other well-
established theoretical and methodological approaches would guard against ACT 
theory being developed in isolation, and thus would reduce the risk of ‘reinventing 
the wheel’.  
6.4.4. Summary 
  This experiment demonstrated a unique application of the CFQ in the initial 
development of new behavioural measures of key ACT processes. The study resulted 
in the development of a behavioural measure of CF. Considerable further 
development and piloting work would be needed to modify the behavioural task 
involved to function as both a measure of CF and EA. The results of this experiment 
suggest a clear strategy for this future research.  
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Chapter VII 
 
Study 4: Uncontrolled pilot development trial of an ACT-based group 
intervention for post-DBT patients with poor personality functioning
6 
 
7.1 Introduction 
As reviewed in Chapter I, DBT is currently the psychosocial treatment of choice for 
PD, although some DBT graduates continue to experience difficulties post-treatment 
(see Section 7.1.1). Most psychotherapy treatments for PD (including DBT) have 
been developed for one particular PD diagnosis, although many patients present with 
several PDs (McGlashan et al., 2000), suggesting general poor personality 
functioning across diagnostic categories. Taking into consideration the current 
strengths and limitations of DBT in relation to patients with poor personality 
functioning and histories of self-harm, a logical next step might be to develop a post-
DBT intervention that would be theoretically compatible with DBT, that would be 
expected to address poor personality functioning across PD diagnoses, and that would 
be designed to impact engagement in life as well as symptomology. 
Chapter V demonstrated that CF, a key ACT process, is implicated in poor 
personality functioning. Other research has confirmed the relevance of EA (another 
central ACT process), to PDs (see Section 7.1.2). These processes are hypothesised to 
be universal and to underpin many, apparently disparate, psychological difficulties. 
ACT was developed to impact positively on these processes and should therefore 
have a beneficial effect across mental health diagnoses. Furthermore, there would 
seem a strong possibility that ACT might be beneficial for people specifically with 
poor personality functioning across PD diagnostic categories. Supportive of this 
hypothesis is the fact that ACT emphasises engagement in a personally valued life
7, 
an issue with which many DBT graduates appear to struggle (see section 7.1.1). 
This study was therefore designed to pilot a form of ACT for patients with 
general poor personality functioning, who have graduated from DBT and are no 
longer self-harming, but who are still experiencing difficulties.  
                                                 
6 See Chapter I, Section 1.1.1 for a discussion of usage of the term poor personality functioning 
7 The term personally valued life and other similar phrases are used in the ACT literature to indicate a 
life that is meaningful and engaging to the individual. See Section 2.2.1.2 for a definition and a 
description of values as understood in ACT.     CHAPTER VII 
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7.1.1 DBT and PD 
As discussed in Chapter I, DBT is an effective intervention for the reduction 
of parasuicidal behaviours for people with BPD, and results in reductions in Axis I 
symptomology for the same patient group. There are also some indications that DBT 
can be beneficial for people with treatment-resistant depression with co-morbid 
cluster A and C PDs, with a modified form of DBT currently being tested with this 
patient group (Lynch et al., 2011-2016). Despite these important benefits of DBT, 
both empirical findings (e.g. McMain et al., 2009) and the author’s clinical 
experience, indicate that many DBT graduates, although no longer self-harming, 
continue to lead restricted lives, showing little engagement in personally meaningful 
activities and relationships, and with continued Axis I and Axis II symptomology.  
Linehan (1993) initially suggested that what is currently referred to as DBT 
for BPD is in fact the first of several stages of therapy required for this patient group. 
She indicated that many graduates of Stage I DBT would be experiencing “quiet 
desperation” (Dimeff & Linehan, 2001, p. 2), and would need further therapeutic 
work to build a life sufficiently personally valued to be “a life worth living” 
(Linehan, 1993, p. 172). She proposed further stages (once high-risk behaviours had 
been reduced) to address PTSD symptomology, avoidance of emotional experiences, 
Axis I disorders, and issues of every-day living, such as relationships and occupation. 
To date, these follow-on stages of DBT have not been empirically tested and 
published, but Linehan’s outline of them has provided some guidance as to what a 
post-DBT intervention might usefully target.  
 
7.1.2 ACT Processes and Personality Functioning  
  The findings from Chapter V suggest that CF is associated with poor 
personality functioning in general (as opposed to being relevant to one specific PD 
diagnosis). Other research has indicted that EA is also highly relevant to PD. For 
example, Kingston et al. (2010) found that EA mediated the relationship between 
known risk factors for problem behaviours such as self-harming and substance 
misuse, and engaging in those behaviours. These kinds of behaviours are strongly 
associated with several PD diagnoses. In another mediation study, Gratz, Tull and 
Gunderson (2008) found that EA mediated the relationship between anxiety CHAPTER VII 
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sensitivity and BPD. Also in relation to BPD, Rosenthal, Cheavens, Lejuez, and 
Lynch (2005) showed that thought suppression (an aspect of EA) mediated the 
relationship between negative affectivity and BPD symptomology. As part of a DBT 
outcome trial, Berking, Neacsiu, Comtois, and Linehan (2009) found that EA 
hampered the reduction of depressive symptomology in patients with BPD diagnoses 
being treated with DBT.  
Outcome studies that address mindfulness, another process relevant to ACT, 
have demonstrated benefits to participants with complex psychological difficulties 
such as recurrent depression (e.g. Kuyken et al., 2008), and multi-substance misuse in 
an incarcerated sample (Bowen et al., 2006). Both problems are highly comorbid with 
PD. 
  To summarise, although there are few published studies that directly test the 
relationship between ACT model processes and personality functioning, the evidence 
available suggests that these processes are relevant to such diagnoses, and as a result, 
a small number of clinical studies have been conducted, testing the impact of ACT 
for PD. 
 
7.1.3 ACT-Based Interventions for PD 
  As reviewed in Chapter II, Section 2.2.1.4.1, three small-scale outcome trials 
have tested an ACT-based intervention for PD (Gratz & Gunderson, 2006; Hurley & 
Holmes, 2010; Clarke et al., in prep). Two trials focussed on BPD; both yielded 
promising findings in relation to Axis I symptomology (Gratz & Gunderson, and 
Hurley & Holmes). The former also reported significant improvements in BPD 
symptoms. Clarke et al. reported that their ACT group intervention for a “treatment-
resistant” sample, half of whom met the diagnostic criteria for at least one PD 
diagnosis, outperformed TAU on a range of Axis I, Axis II, and quality of life 
measures. 
 However, no study to date has tested ACT with a heterogeneous group of PD 
patients, with poor personality functioning across PD diagnoses. Although the Gratz 
and Gunderson (2006) study suggests that ACT might have a positive impact on self-
harm, the empirical support for DBT reducing parasuicidal behaviours if far more CHAPTER VII 
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substantial, and therefore DBT should initially be offered to people with poor 
personality functioning who are self-harming and/or experiencing suicidal urges. 
However, once they have achieved stability in terms of parasuicidal 
behaviours, an ACT-based intervention might represent a logical next therapeutic step 
for this patient group. Such an intervention would be offered with the aims of 
facilitating engagement in a valued life and improvement in psychological 
functioning, whilst maintaining safety. The aim of this study therefore was to carry 
out initial development of an ACT-based intervention for people with poor 
personality functioning, and to test the pilot form of the treatment with a small, 
heterogeneous, post-DBT PD sample, examining the feasibility, acceptability and 
impact of the intervention. 
   It was hypothesised that there would be significant changes, pre- to post-
treatment, on measures of engagement in life, psychopathology, and processes 
hypothesised to mediate such changes.  
 
7.1.4 Methodological Considerations 
  There have been no previous trials of ACT for post-DBT patients with poor 
personality functioning, so decisions about the study design and the intervention were 
guided by clinical understanding of this complex and potentially risky patient group, 
along with data from previous, similar studies. Published guidance suggests that an 
initial treatment development trial, particularly with a high-risk patient group, should 
be small-scale (Campbell et al., 2000), and perhaps in the form of an uncontrolled, 
pre-post trial (Rounsaville et al., 2001). This is a tried and tested DBT treatment 
development strategy for patients with complex mental health difficulties (e.g. Telch, 
Agras, & Linehan, 2000; Goldstein, Axelson, Birmaher, & Brent, 2007), and has also 
been successfully used as a first step in the development of an ACT treatment 
protocol for treatment resistant mental health problems (Clarke et al., 2012). The 
present study was therefore designed as an open, pre-post trial. 
Treatment development trials are used not only to pilot a psychosocial 
intervention, but also to evaluate the sensitivity and applicability of outcome and 
process measures for the patient group. In total, 10 measures were included to 
evaluate their performance (See Section 7.2.3). ACT targets psychological CHAPTER VII 
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inflexibility, in the service of increasing valued action and engagement in life. 
Measures relevant to these aims, such as the Valued Living Questionnaire  (VLQ; 
Wilson, Sandoz, Kitchens, & Roberts, 2010), and the Flourishing Scale (FS; Diener 
et al. 2009), were therefore used as primary outcomes. It was also considered 
important to include measures of inflexibility and related processes. 
ACT is not designed primarily to reduce symptomology, although psychiatric 
symptoms often do reduce following ACT interventions. Measures of Axis I and II 
symptomology, such as the SCL-90-R (Derogatis, 1994), and the SCID-II (First et al., 
1997) are commonly used in PD psychotherapy trials, and were therefore included as 
secondary outcome measures. The use of these common psychometric measures 
supports the replication of studies and comparison with findings from different 
studies. Given that most previous relevant studies have addressed a specific PD 
diagnosis, these trials have not included a measure of personality functioning across 
diagnostic categories. Taking into consideration the heterogeneous nature of the 
patient group selected, the SIPP (Verheul et al., 2008) was included as an outcome 
measure. 
It is expected practice in clinical trials to measure clinician adherence to the 
study treatment protocol (Rounsaville et al., 2001). However, by definition, in early-
stage treatment development trials, the protocol has not been finalised and is open to 
modification. For this reason, clinician protocol adherence was not assessed. 
  The previously published ACT studies referred to in section 7.1.3 suggest that 
an intervention that in some way combines ACT and DBT might be effective for this 
patient group, and all the relevant trials reviewed in Section 7.1.3 were based on 
group interventions. In fact, given that the clinicians for the present study had already 
designed and successfully tested an ACT-based group intervention for people with 
complex problems including PD (Clarke et al., in prep), it was decided to base the 
ACT intervention for the current study on the existing protocol, but to make some 
substantial changes including the addition of some elements of DBT, to take into 
consideration the specific patient group (see Appendix K for details of the protocol 
development). 
  Finally, although Gratz and Gunderson indicated that an ACT/DBT 
intervention might effectively impact self-harm, it was decided to take a conservative 
approach to the development of this intervention for this particularly complex patient 
group, by excluding people who had engaged in parasuicidal behaviour, as defined by CHAPTER VII 
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Kreitman (1977)
8, within the previous six months. All participants however, had 
extensive histories of self-harm. 
 
7.2 Method 
7.2.1 Design 
This study was based on an uncontrolled, pre-post design. The IV was a 20-
session ACT-based group intervention, with DVs including measures of engagement 
in life, valued action, personality functioning, depression, global symptom severity, 
and self-harm frequency. Process variables were measures of CF, psychological 
inflexibility, and self-compassion. All measures were administered pre-intervention, 
post-intervention, and at 6-month follow-up, except the SCID-II measure of PD 
diagnosis, which was administered pre-intervention and at follow-up. 
 
7.2.2 Participants 
NHS research ethics committee approval (ref: 10/H0502/5; Appendix L), 
University of Southampton Psychology ethical approval and research governance 
approval were obtained prior to participant recruitment. Participants were recruited in 
February and March 2010 via DBT therapists based at the Intensive Psychological 
Therapies Service, a specialist, tertiary, PD treatment service within Dorset 
HealthCare University NHS Foundation Trust (for details of the recruitment 
procedure, see Section 7.2.4.1). Inclusion and exclusion criteria for the study were as 
follows: 
 
 
 
 
 
                                                 
8 1. Nonfatal, intentional self-injurious behaviours resulting in actual tissue damage, illness, or risk of death; or 2. 
any ingestion of drugs or other substances not prescribed or in excess of prescription with clear intent to cause 
bodily harm or death”.  
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Inclusion Criteria: 
 1. 18 years old and above. 
2. PD diagnosis at intake. 
3. Minimum of 12 months DBT prior to this study. 
4. No parasuicidal behaviour during the 6 months prior to the study (see 
footnote in Section 7.1.4 for definition). 
5. Continued significant psychological difficulties. 
6. Under the care of a community mental health team (CMHT). 
Exclusion Criteria: 
1. Under the age of 18. 
2. Currently, or in the 6 months prior to this study, engaged in parasuicidal 
behaviour (see footnote in Section 7.1.4 for definition). 
3. Currently meets DSM-IV diagnostic criteria for a psychotic disorder. 
4. Currently meets DSM-IV diagnostic criteria for eating disorder, with a 
body mass index currently below 17.5. 
5. Currently meets DSM-IV diagnostic criteria for substance dependence. 
6. Learning disability. 
7. Other organic disorder that might impair capacity to give informed consent, 
or to participate. 
   
Clarke et al. (2012) detected effects in an ACT treatment development trial for 
transdiagnostic mental health problems with a sample size of 10. It was therefore 
decided to aim for the same sample size in the current study. Figure 7.1 shows the 
flow of participants through the trial stages. Initially, 10 potential participants were 
approached about the study, of whom six started the intervention. Table 7.1 shows 
group demographic information, and baseline data regarding engagement in self-
harm, DBT, and current mental health status. All participants were female, with 
extensive histories of deliberate self-harm, averaging 36 years. The period free of 
self-harm prior to the ACT group averaged 10 months.
9  
All participants had completed DBT prior to attending the ACT group. The 
duration of DBT varied considerably between participants (16 to 34 months), as did 
                                                 
9 Based	 ﾠon	 ﾠconversations	 ﾠthat	 ﾠoccurred	 ﾠseveral	 ﾠweeks	 ﾠinto	 ﾠthe	 ﾠintervention,	 ﾠthe	 ﾠtherapists	 ﾠthought	 ﾠit	 ﾠlikely	 ﾠ
that	 ﾠparticipant	 ﾠ4	 ﾠhad	 ﾠself-ﾭ‐harmed	 ﾠwithin	 ﾠthe	 ﾠ6	 ﾠmonths	 ﾠprior	 ﾠto	 ﾠthe	 ﾠgroup,	 ﾠbut	 ﾠhad	 ﾠnot	 ﾠdeclared	 ﾠthis	 ﾠin	 ﾠ
order	 ﾠto	 ﾠbe	 ﾠincluded	 ﾠin	 ﾠthe	 ﾠintervention.	 ﾠThe	 ﾠparticipant	 ﾠwas	 ﾠunwilling	 ﾠto	 ﾠclarify	 ﾠthis	 ﾠmatter.	 ﾠIt	 ﾠwas	 ﾠdecided	 ﾠ
to	 ﾠallow	 ﾠher	 ﾠto	 ﾠcontinue	 ﾠin	 ﾠthe	 ﾠstudy. CHAPTER VII 
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the interval since the end of weekly DBT sessions, prior to the start of the ACT group 
(1 to 77 months). All participants scored in the clinical range for either depression or 
global symptom severity, or both. 
 
 
Figure 7.1 Flowchart of Participant Recruitment, Assessment, and Treatment 
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Attended recruitment 
assessment interview 
(n = 7) 
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(n = 4) 
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Table 7.1 
Demographics and Baseline Statistics 
   
 
Demographic/Baseline statistic 
 
 
N = 6 
 
Mean age (range) 
 
46.83 (36 – 57) 
Gender (% female) 
% taking psychotropic medication 
Mean months of DBT (range)
1 
Mean months since end DBT (range)
2 
Mean years self-harm (range)
3 
Mean months since self-harm (range)
4 
% in clinical range for depression
5 
% in clinical range on SCL-90R GSI
6 
100% 
100% 
22.40 (16 – 34) 
21.6 (1 – 77) 
35.67 (25 – 48) 
10.33 (6 – 14) 
83.33 
100 
   
Note. 
1Number of months of DBT intervention. 
2Number of months since the end of regular DBT 
sessions, by the start of ACT group. 
3Number of years history of any form of deliberate self-harm, 
from first reported instance of self-harm, to most recent. 
4Number of consecutive self-harm free 
months prior to the start of the ACT group. 
5% scoring at least 14 on the Beck Depression Inventory-II. 
6% scoring at least .70 on the Symptom Check List – 90 Revised, Global Severity Index. 
 
 
Table 7.2 shows baseline PD diagnosis data for each participant, indicating 
the very high level of personality psychopathology in the group. All except 
participant 6 had PD diagnoses from two different PD clusters, with two participants 
having PD diagnoses from all three clusters.  
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Table 7.2 
PD Baseline Statistics 
   
 
Participants (N = 6) 
 
 
PD diagnoses 
 
1 
 
2 
3 
4 
 
5 
 
6 
 
Mean PD diagnoses (range)
1 
Group PD diagnoses: 
(number of participants with 
diagnosis)
2 
 
BPD, Paranoid, Dependent, Depressive, Passive-
aggressive 
BPD, Paranoid, Passive-aggressive 
BPD, Paranoid, Depressive, Passive-aggressive 
BPD, Paranoid, Schizotypal, Depressive, 
Passive-aggressive 
BPD, Paranoid, Dependent, Avoidant, 
Depressive, Passive-aggressive 
Dependent, Avoidant, Depressive 
 
4.3 (3 - 6) 
     BPD (5), Paranoid (5), Depressive (5), Passive-  
     Aggressive (5), Dependent (3), Avoidant (2),  
     Schizotypal (1) 
   
Note. 
1Lifetime prevalence of specific PD diagnoses based on the Structured Clinical Interview for 
DSM-IV Axis II Disorders (SCID-II). 
2PD diagnoses in the sample, arranged in order of frequency.  
 
7.2.3 Materials 
7.2.3.1 Primary Outcome Measures 
All measures were administered pre-intervention, post-intervention, and at 6-
month follow-up, except for the SCID-II PD diagnostic interview, which was 
administered pre-intervention and at 6-month follow-up only. The SCID-II was 
administered differently in order to focus the SCID-II assessment on the 12 months 
prior to each of the assessment dates, that is the year prior to the ACT group starting, 
and the year prior to the 6-month follow-up date (the latter 12-month period covered 
the time that the group was running and 6 months post-treatment). CHAPTER VII 
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Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II; First, et 
al., 1997). The SCID-II is a semi-structured interview designed to diagnose PDs in 
line with DSM-IV criteria. It consists of a 140-item screening questionnaire, followed 
by the interview, which is used to examine in more detail positively scored items 
from the screening questionnaire. Example of items include “Do you find it hard to 
disagree with people even when you think they are wrong?” (dependent PD), and “Do 
you have trouble finishing jobs because you spend so much time trying to get things 
exactly right?” (obsessional-compulsive PD). Items on the screening questionnaire 
are responded to yes or no. Items in the interview can be rated by the interviewer as 1 
– symptom not present, 2 – threshold, or 3 – symptom present. Each PD diagnosis is 
based on the number of 3 ratings for that PD, with the number required for diagnosis 
varying from PD to PD. The SCID-II has been shown to have adequate internal 
consistency (α ranging from .61 to .97 across diagnoses, with a mean α of .82 
(Maffei, et al., 1997). 
  The SCID-II was designed to measure the lifetime prevalence of PDs, as PDs 
have traditionally been seen as disorders from which it was not possible to recover. In 
line with previous research (Clarke et al., in prep), the SCID-II has been adapted so 
that it yields lifetime prevalence diagnoses, as originally intended, but also previous 
12 months prevalence data, in order to examine change in PD diagnoses over time. 
Severity Indices of Personality Problems (SIPP; Verheul et al., 2008). For 
details of the SIPP, see Chapter IV, Section 4.2.2. 
Valued Living Questionnaire (VLQ; Wilson et al., 2010). The VLQ is the 
most commonly used values-focused measure in ACT research. It was designed to 
assess the importance of different life domains to the respondent, as well as how 
consistently they have acted with respect to each domain in the week prior to 
completing the questionnaire. The 10 life domains addressed are family relations, 
marriage/couples/intimate relations, parenting, friendships/social relations, 
employment, education/training, recreation, spirituality, citizenship/community life, 
and physical well-being, with importance and consistency being rated from 1 to 10 
for each domain. Internal consistency for the importance scale is α = .77, and α = .75 
for the action scale. However, the original VLQ scoring procedure is often modified 
by researchers and clinicians. For this study, the adaptation developed by Taylor 
(2010) was used, which focuses on the three life domains rated as personally most 
important by the respondent. CHAPTER VII 
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Flourishing Scale (FS; Diener, et al. 2009). The FS is an 8-item measure of 
important aspects of human functioning and engagement in life, including meaningful 
relationships and a sense of purpose. Items include “ I lead a purposeful and 
meaningful life”, and “I am engaged and interested in my daily activities”. Each item 
is rated on a 7-point scale, ranging from “strongly agree” to “strongly disagree”. 
There is little published research using the FS to date, but some psychometric data is 
available. The non-clinical mean score is 44.97 (SD = 6.56). It has good internal 
consistency (α = .87), and adequate test-retest reliability (r = .84), over a 3-month 
period.  
 
7.2.3.2 Secondary Outcome and Process Measures 
Symptom Checklist-90-R (SCL-90-R; Derogatis, 1994). For details of the 
SCL-90-R see Chapter IV, Section 4.2.2. 
Beck Depression Inventory, 2
nd edition (BDI-II; Beck, Brown, & Steer, 1996). 
For details of the BDI-II, see Chapter IV, Section 4.2.2. 
Deliberate Self-Harm Inventory (DSHI; Gratz, 2001). The DSHI is a 17-item 
questionnaire designed to measure the frequency, severity, and duration of several 
self-harming behaviours. Each item addresses a different form of self-harming 
behaviour, such as cutting and biting. To measure change in self-harming behaviour 
over time, Gratz recommends creating a continuous variable based on the number of 
incidents of self-harm (of any kind), over a specific time period. Based on this 
variable, Gratz reported a frequency of 1.05 self-harm events per participant over a 
3.5-month time period, in a student sample (N = 150). Based on the same variable, 
the DSHI has acceptable internal consistency (α = .82) and test-retest reliability (r = 
.68 over a 3-week period).  
Cognitive Fusion Questionnaire, (CFQ; Gillanders et al., under review) For 
details of the CFQ, see Chapter IV, Section 4.2.2. 
Acceptance and Action Questionnaire Second Version (AAQ-II; Bond, et al., 
2011). For details of the AAQII, see Chapter IV, Section 4.2.2. 
   Self-compassion Scale (SCS; Neff, 2003) The SCS is a 26-item measure 
consisting of six sub-scales measuring self-kindness, self-judgment, common 
humanity, isolation, mindfulness, and over-identification. It can also be scored to 
yield an overall self-compassion score. It is headed “how I typically act towards 
myself in difficult times”, with each item being rated on a 5-point scale, ranging from CHAPTER VII 
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“almost never” to “almost always”. Examples of items include “I try to be loving 
towards myself when I’m feeling emotional pain” (self-kindness item), and “When I 
think about my inadequacies, it tends to make me feel more separate and cut off from 
the rest of the world” (isolation item). The non-clinical mean for the overall score is 
18.96 (SD = 3.64). A mean overall score in an outpatient depressed sample has been 
reported (Kuyken, et al. (2010) as 14.74 (SD = 5.54). It has excellent internal validity 
(α = .92) and test-retest reliability (r = .93 over a 3-week period). 
 
7.2.4 Procedure 
7.2.4.1 Recruitment 
  DBT therapists at the IPTS were asked to identify potential participants from 
their caseloads. They discussed recruitment with their current DBT patients and 
nominated interested candidates who met the criteria. They also nominated suitable 
DBT graduates. Nominated candidates received a patient information sheet (see 
Appendix M) and an invitation to an individual assessment with a therapist (SC or 
HB).  
  These assessments were used to establish whether potential participants met 
the inclusion criteria or any exclusion criteria, as well as whether the assessor and 
patient both thought that the intervention would be relevant to the individuals’ needs. 
Potential participants meeting the various criteria were offered a place in the group 
and written consent was obtained prior to inclusion in the study (see Appendix M). 
The participant’s care network, including GP and CMHT professionals, were sent 
information about the study (see Appendix M), as well as confirmation that the 
patient had consented to participate. CMHTs were asked to confirm that they would 
keep the individual registered to their care for the duration of the study, to ensure a 
familiar source of support if needed. 
 
7.2.4.2 Pre-Intervention Assessment 
  Immediately prior to the start of the group, participants were sent the pre-
group pack of questionnaires to complete, and were invited to attend a pre-group 
assessment meeting. At the meeting, the SCID-II PD diagnostic interview was carried CHAPTER VII 
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out by a suitable qualified and experienced mental health professional from the IPTS 
team, who was independent to the research team.  
 
7.2.4.4 Intervention 
  The ACT group consisted of 20 weekly, 2.5-hour sessions, and one further 
2.5-hour session at 6-month follow up. The general structure of the sessions was as 
follows: 
•  Brief mindfulness practice and review of this practice 
•  Review of diary cards (containing information about risk issues and skills use 
over the previous week), for each participant 
•  Review of homework set in the previous session, followed by any teaching 
points or individual therapeutic interventions arising from this review 
•  Short break 
•  Weekly topic (teaching and experiential exercises) 
•  Mindful review of the session 
•  Set homework for the following week 
 
  The group was facilitated by two ACT and DBT trained clinical 
psychologists, Sue Clarke (the CI for the study), who is a UK DBT trainer, and Helen 
Bolderston (PhD student). They provided each other with peer supervision, as well as 
receiving a small amount of phone supervision from Dr Kelly Wilson, one of the 
developers of ACT. The group was run by two therapists rather than one, due to the 
complex and challenging nature of the patient group. This strategy had been effective 
in the Clarke et al. trial, and is consistent with DBT skills groups. The stated aims of 
the group were to: 
(i) Maintain behavioural stability (in terms of parasuicidal behaviour) 
(ii) Begin to develop a life that is more valued and less restricted. 
  A description of ACT can be found in Chapter II. An outline of the specific 
topics addressed in each session of this protocol can be seen in Table 7.3. A more 
detailed description of the treatment phases can be found in Appendix N.  The 
therapists applied the protocol flexibly, making minor modifications depending on 
their in-the-moment experiences of individual participants and group dynamics. 
Similarly, although the 20 sessions were designed to guide participants through a CHAPTER VII 
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series of treatment phases in a linear fashion, sensitivity to the needs of the group 
occasionally indicated that topics should be held over until the next session, or 
revisited more than once throughout the life of the group. Over the course of the 
intervention as a whole however, all planned topics were addressed. 
 
7.2.4.5 Role of DBT in the Intervention 
Although the intervention was predominantly ACT-based, some DBT-
focussed content and structure was included to help maintain behavioural stability 
and to facilitate the transition from DBT. The basic sessional structure (see Section 
7.2.4.4) resembled a DBT skills-group. Participants completed a DBT diary card each 
week, which the therapists reviewed with them to monitor risk and DBT skills use. 
Participants were consistently coached to use DBT skills in challenging situations. 
ACT was thus introduced as a compatible addition to DBT rather than a replacement, 
enabling patients to move towards engagement in a valued life, whilst remaining safe. 
 
7.2.4.6 Modification of ACT 
ACT has a reputation for being a psychologically evocative therapy, in that by 
encouraging patients to be psychologically present with their private experiences, it 
almost inevitably results in patients at times experiencing uncomfortable emotions, 
memories, and so on. Patients in the ACT condition of Clarke et al. (in prep.), for 
example, reported this aspect of ACT to be both challenging and rewarding. 
However, people with poor personality functioning tend to be particularly unskilled 
in terms of emotion regulation and processing, and therefore can become very 
anxious at even the thought of experiencing emotions. Linehan referred to people 
with BPD as “emotionally phobic” (Linehan, 1993), for example. When developing 
the treatment protocol, it was thought that the classic ACT message that control and 
avoidance of private experiences is problematic and acceptance is the most effective 
way forward (Hayes & Strosahl, 2004), could be particularly disturbing for this 
patient group. The anxiety generated might result in patients becoming less 
psychologically flexible and therefore less willing to engage in valued behavioural 
change. Such fear of experiencing emotions and other private experiences might also 
increase the risk of self-harm, which all group participants had used historically to 
cope with difficult emotions, memories and so on.  CHAPTER VII 
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For these reasons, this key ACT message was offered in a specific form; that 
over-reliance on avoidance and control strategies was likely to cause long-term 
difficulties such as lack of engagement in valued living, but that such strategies might 
be effective in the short-term as survival strategies. The overall aim in relation to this 
fundamental ACT principle was for patients to develop the ability to discriminate 
between situations where temporary avoidance of private experiences might be the 
most effective strategy, and situations where acceptance of such experiences might be 
most effective, and then being able to act accordingly. This message was designed to 
be compatible with DBT, where patients are encouraged to use both acceptance and 
change strategies, with distraction, for example, (a clear avoidance strategy), being 
viewed as an effective distress tolerance skill. At the same time, the message was 
seen as being entirely compatible with the ACT principle of workability, and 
certainly more in line with ACT principles than a simplistic, rigidly held rule to the 
effect of ‘you should never avoid or control your private experiences, regardless of 
the context in which they are arising.’ 
Some ACT experiential exercises were also excluded or modified to make 
them more suitable for this patient group. For example, the values clarification 
exercise ‘Attending your own funeral’, which is included in several ACT textbooks 
and many effective ACT protocols (Hayes & Strosahl, 2004; Hayes & Smith, 2005), 
was not included, as it was thought that its focus on the imagined recent death of the 
participant, would be emotionally dysregulating for this patient group. This (and 
other ACT exercises) were changed not as an avoidance of material that might trigger 
thoughts of death or suicide (such topics of course came up from time to time in a 
group for post-DBT PD patients in any case), but so that group participants could 
engage in the experiential exercises and hopefully benefit from them, rather than 
merely becoming dysregulated. 
It is not just ACT experiential exercises that can be emotionally stirring. The 
behaviour of ACT therapists can also contribute to patients experiencing intense 
emotions. The therapist being psychologically present to their own thoughts, 
emotions and other private experiences during therapy, at times using self-disclosure 
about those experiences, communicating care and compassion for the patient, being 
willing to show vulnerability, being willing to notice and stay with pain and 
discomfort; these valued aspects of ACT therapist behaviour can all serve to intensify 
the emotional and therapeutic experience (supporting processes such as willingness CHAPTER VII 
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and defusion), and are seen as important contributors to therapeutic change (Wilson 
& Dufrene, 2008). However, for people with long histories of interpersonal and 
intimacy problems, people who are also emotionally phobic and easily dysregulated, 
experiencing the therapist in this way could easily feel threatening and emotionally 
overwhelming.  
The therapists in this trial therefore modified their behaviour, in that they used 
less self-disclosure in relation to private experiences, and disclosed less of their 
observations or curiosity about patients’ in-the-moment psychological experiences. 
The therapists also conducted fewer individual pieces of therapeutic work in the 
group (a regular feature of the original 16-week protocol), and those pieces of 
individual work that did happen were shorter and less exposing for the patient.  
 
7.2.4.7 Role of Mindfulness in the Intervention 
  Each group session began with a brief mindfulness exercise followed by a 
review of participants’ experiences of that exercise. The reason for including these 
exercises were: 
1. To help participants become more psychologically present at the start of the 
session.  
2. To support participants to hold any distress in mindful awareness. 
2. To communicate the need for regular mindfulness practice to the group. 
3. To keep a familiar feature from DBT. 
  Mindfulness practices were gradually changed over the course of the 
intervention to allow participants to build their capacities under relatively 
undemanding conditions. Thus exercises (a) increased in duration (from 2 – 10 
minutes), and (b) moved from a focus on objects or experiences outside of the body 
(e.g., pebbles) to a focus on internal experiences (e.g., thoughts, emotions, bodily 
sensations) as group members’ skills developed. These transitions were designed to 
overcome common difficulties in achieving defused, mindful awareness of internal, 
personal experiences (compared to external, less personal experiences). Significantly, 
many people with poor personality functioning have experienced body-related trauma 
and may initially be disturbed by a focus on physical sensations. All participants were 
given a compact disc containing recordings of the key group mindfulness and 
defusion practices. These were recorded by HB, an experienced mindfulness teacher. 
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Table 7.3 
Weekly Session Topics 
 
 
Treatment phase 1: Transition from DBT to ACT 
 
Session 1: A foundation to build on 
Topics covered: Introductions; ground rules; orientation to the intervention 
structure and style; ACT and DBT – similarities and differences; the 
importance of DBT as a stable base from which to begin engaging more 
flexibly in life. 
Experiential exercise: Pairs-based discussion of ‘One thing that I changed 
through DBT that I am pleased about’ and ‘One positive step I would like to 
take in my life during this group’. 
 
Session 2: A brief introduction to values 
Topics covered: What values are and are not; compass metaphor; values and 
goals; values and vulnerability; connecting with your values can be 
uncomfortable; Why it might be effective in life to connect with values. 
Experiential exercise: What matter enough to me that I’m putting myself 
through 20 weeks of therapy, with all the struggles that is likely to entail? 
 
 
Treatment phase 2: Creative hopelessness 
 
Session 3: Why language leads to suffering 
Topics covered: How difficult it is for humans to be happy; simple, RFT-
based explanation of the role of language and cognition in human suffering; 
language as a gift and a burden; introduction to EA and the potential 
difficulties it can lead to. 
Experiential exercise: Thinking/writing about the kinds of actions they take 
to supress, control, avoid uncomfortable private experiences, followed by 
sharing in the group. 
 
Session 4: The pull of avoidance 
Topics covered: EA, the pain of presence and the pain of absence; different 
rules inside and outside the body for control and avoidance; short-term use 
of avoidance and control strategies for crisis survival vs. costs of 
persistent/long-term use; why we do what doesn’t work. 
Experiential exercise: ‘Yellow-jeep’ thought suppression exercise. 
 
Session 5: Why willingness? 
Topics covered: What willingness is and is not; willingness as an alternative 
to control and avoidance; Chinese handcuffs metaphor; research evidence 
on the role of EA and willingness. 
Experiential exercise: Being willingly out of breath; ‘Why and how might 
willingness be relevant to me personally?’ written exercise. 
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Treatment phase 3: Cognitive defusion 
 
Session 6: The trouble with thoughts 
Topics covered: Noticing the process of thinking; CF/defusion. 
Experiential exercise: Brief guided mindfulness of thoughts exercise; 
‘Watching the mind-train’ defusion exercise. 
 
Session 7: Having a thought vs. buying into a thought      
Topics covered: CF and defusion; the conditioned nature of thoughts; the 
goal of defusion. 
Experiential exercise: Defusion exercise – ‘Milk, milk, milk’; Complete the 
following sentences – ‘Mary had a little . . .’; Brief cognitive defusion 
exercise: ‘I am having the thought that . . .’; Cognitive defusion exercise – 
‘Leaves on a stream’. 
 
Session 8: Review session 
Topics covered: No new topic introduced. Participants encouraged to 
suggest topics they would find it helpful to revisit. 
Experiential exercise: None planned – organised in the moment in response 
to participants’ needs. 
 
 
Treatment phase 4: Developing a different relationship to history, private 
experiences and self 
 
Session 9: Willingness revisited 
Topics covered: Why willingness matters – the possibility of a different 
relationship with your private experiences and history; willingness and 
traumatic history; willingness as a path to emotional freedom 
Experiential exercise: The unwelcome guest at the party metaphor 
 
Session 10: Mindfulness  
Topics covered: Reviewing what mindfulness is; why mindfulness is 
important; why mindfulness is so challenging; the aims of mindfulness; tips 
on how to practice. 
Experiential exercise: 3-minute breathing space 
 
Session 11: If I’m not my thoughts, then who am I? Self-as-context 
Topics covered: Simple RFT explanation of how our sense of self develops 
in childhood, and what happens when we grow up in less than optimal 
conditions for this; metaphor of a photographer lighting a scene in different 
ways so that different aspects are visible and invisible, to explore taking 
different perspectives on ourselves – some features can become 
‘highlighted’ and we lose sight of others; getting overly attached to one 
view of the self vs. holding our self-stories lightly; self-as-content; self as a 
process of on-going awareness; the observing self 
Experiential exercise: Exploration of the chess metaphor with a chessboard 
and pieces; mountain meditation – metaphor of the self as a solid, 
unchanging mountain in the presence of emotional storms and weather CHAPTER VII 
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Treatment phase 5: Values and committed action 
 
Session 12: Reintroducing values 
Topics covered: Sweet moments; why pay attention to sweet moments?; 
blue beads in a jar metaphor; why choose valued living? – research evidence 
and personal reasons (giving dignity to struggle and pain, building a more 
satisfying life etc).   
Experiential exercise: Pairs exercise describing a recent sweet moment  
 
Session 13: Choosing to value 
Topics covered: Values as chosen life-directions – ‘passengers on the bus’ 
metaphor; values questions: ‘if you could choose, what would you choose?’, 
‘how do you want to be in your life?’, ‘what do you want to stand for?’ 
Experiential exercise: 80
th birthday values exercise; clarifying values 
worksheet. 
 
 
Session 14 What I do and how I feel 
Topics covered: The link between activity and mood; low mood and low 
activity; different functions of activity – satisfaction, pleasure, self-
nurturing, depleting, avoiding/numbing. 
Experiential exercise: Written exercise noting the function of activities 
yesterday – discussion in pairs – ‘what have I learned from this exercise 
about how I spend my time and the function of these activities (or lack of 
them)?’ 
 
Session 15 Increasing values-consistent activity 
Topics covered: Valued actions – choice and flexible responding vs. rigid 
rules; values as a process rather than an outcome; barriers to taking valued 
action. 
Experiential exercise: 10 steps to ‘trying on a value’ – choosing a value to 
work with, planning to take a small step in that valued direction, dealing 
with barriers etc. 
 
Session 16: Increasing values-consistent activity 2: Starting to do things 
you’ve been avoiding  
Topics covered: The metaphor of ‘a jump is a jump’ – taking valued action 
is not about the size of the jump, it’s about jumping into life, regardless of 
the size of the jumps; why we don’t jump into life – what holds us back; 
metaphor of the willingness dial; metaphor of the tin-can monster. 
Experiential exercise: Planning small steps in a valued direction – 
something you value but have been avoiding. 
 
Session 17: Review session: The ACT story so far 
Topics covered: No new topic introduced. A review of the journey of the 
group so far; participants encouraged to suggest topics that they would find 
it helpful to revisit. 
Experiential exercise: None planned – organised in the moment in response 
to participants’ needs. CHAPTER VII 
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Treatment phase 6: Looking beyond the group 
 
Session 18 DBT and ACT; Acceptance and change 
Topics covered: Acceptance and change in both DBT and ACT; ‘in any 
moment, how do I make a choice between acceptance and change?’ – 
current psychological and physical resources, long-term costs vs. short-term 
benefits; what does my experience (rather than my mind) tell me; chronic or 
discreet circumstances. 
Experiential exercise: Building the habit of taking valued action: 10 steps to 
‘trying on a value’. 
 
Session 19 The choice to live a more vital life 
Topics covered: Metaphor of the crucial fork in the road – the old path, 
where avoidance is in charge of your life, and a new path where valued 
living plays a role. 
Experiential exercise: Building the habit of taking valued action: 10 steps to 
‘trying on a value’. 
 
 
Session 20 The choice to live a more vital life continued 
Topics covered: The group ending; reflection on the group experience; 
future plans 
Experiential exercise: Writing exercise focused on – what I most value in 
life; what I’ve been doing to cope with difficult thoughts etc. in relation to 
this, the cost to me and others of me rigidly relying on these coping 
strategies, what it would mean to be able to respond to life more flexibly, to 
make choices based on my values and goals, what would a small step in that 
direction look like and what would it mean to me? 
 
 
 
   
7.2.4.8 Post-Intervention Assessment 
  Immediately post-intervention, patients completed a questionnaire pack. They 
were also invited to attend an informal meeting with a research assistant working for 
the IPTS, to gather feedback about their experience of the group, as well as any 
suggestions for changes they would want made to the protocol for future groups. 
 
7.2.4.9 Follow-Up Assessment 
  A final group session occurred 6 months after the final weekly session. This 
was used to support participants to re-orient to the aims and methods of the 
intervention, and to guide them to use ACT and DBT approaches as appropriate, to CHAPTER VII 
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address any difficulties they were experiencing. A final set of questionnaires was also 
administered at the 6-month follow-up, as was a final SCID-II interview. 
7.2.5 Analysis Plan 
  Stage One involved dealing with missing data and calculating baseline values 
for all variables. Group session attendance was also examined to shed light on the 
feasibility of the intervention. Stage Two consisted of non-parametric group analyses 
to test for mean differences across the three data collection times, for the primary 
outcome measures. A non-parametric test was used (Friedman’s ANOVA for 
repeated measures) because of the small number of participants involved. The use of 
this statistical test, which does not require normally distributed data, meant that the 
distribution of the variables did not need to be examined. Effect sizes were not 
calculated due to the small sample size. 
Stage Three involved assessing individual participant changes by calculating a 
reliable change index (RCI; see Section 3.3.1 for an outline of this method). Stage 
Four involved dealing with data from variables where RCIs could not be calculated 
due to lack of the necessary psychometric information. Informal, verbal feedback 
from participants at the end of the intervention was also considered at this stage. 
 
7.3 Results 
 
7.3.1 Stage One. Preliminary Analysis and Participant Characteristics  
  The amount of data missing from the completed psychometric measures was 
negligible (less than 1%) so missing items were replaced with the sample mean, as 
recommended by Tabachnick and Fidell (2001). 
  Patients attended 14 out of 20 treatment sessions, on average. This figure rose 
to 17 for the five treatment completers. One patient dropped out of therapy after week 
7. She completed the post-group, but not follow-up, psychometrics. 
Participant 4, in addition to the lack of clarity about her self-harming 
behaviour prior to the ACT group (see Section 7.2.2), showed an inconsistency in her 
baseline psychometric data. Her SCID PD assessment (conducted face-to-face) 
indicated a complex presentation of 5 PD diagnoses, an assessment that matched the CHAPTER VII 
   
181 
clinical observations of the group therapists. However, at baseline this participant 
scored just 11 on the BDI-II, a figure indicating no or minimal depression, despite 
reporting self-harm urges, suicidal ideation, and high levels of misery at times during 
group sessions, including in early sessions. On other outcome measures at baseline 
(the SCL90-R GSI for example), she scored in the clinical range, as would be 
expected from her face-to-face presentation. Her data has been included in the various 
analyses outlined below, but the reliability of her self-report data in particular remains 
uncertain. 
Table 7.4 shows group mean scores for all study measures at the three data 
collection time points. Two sets of data were missing from the 6-month follow-up 
means, due to one participant having dropped out of the study, and another being 
physically ill and unable to provide data.   
 
7.3.2 Stage Two. Group statistical analyses  
Friedman’s ANOVAs were conducted on all primary outcome variables 
except the SCID-II. As there were only two data collection points for the SCID-II, a 
Wilcoxon signed-rank test was used. All participants completing the intervention 
were included in the analyses (n = 5), with the post-intervention data from participant 
2 being carried forward to the follow-up data point, (following recommendations by 
Hollis and Campbell, 1999), as she completed the intervention sessions but was not 
able to provide follow-up psychometric data.  
As can be seen from Table 7.5, there were no significant group changes in 
primary outcome measures across the three data collection points. A Wilcoxon 
signed-rank test indicated that there was also no significant difference between 
numbers of PD diagnoses based on the SCID-II interview, from pre to 6-month 
follow-up, (z = -.54, p = .59) 
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Table 7.4 
Means and Standard Deviations for All Study Measures 
   
                                            Mean (SD) 
 
Measures  Pre-group 
N = 6 
Post-group 
N = 6 
6-month follow-up 
N = 4 
 
Primary 
FS 
VLQ CI 
VLQ CA 
SCID-II  
SIPP Self-con 
SIPP Respon 
SIPP Ident  
SIPP Relat 
SIPP Social 
 
 
30.67 (9.22) 
6.83 (1.22) 
4.47 (2.05) 
2.83 (2.23) 
35.00 (7.85) 
37.50 (5.43) 
24.67 (3.83) 
27.67 (10.52) 
39.33 (5.96) 
 
 
35.00 (14.19) 
6.83 (1.09) 
5.89 (1.63) 
- 
34.67 (9.14) 
37.67 (6.02) 
28.67 (5.01) 
29.67 (11.69) 
39.83 (6.79) 
 
 
34.33 (12.10) 
7.58 (1.26) 
6.24 (1.46) 
3.25(1.71) 
29.50 (7.05) 
36.50 (5.80) 
23.25 (.96) 
32.50 (8.96) 
35.00 (8.12) 
 
Secondary/ 
process 
BDI-II 
SCL-90R GSI 
DSHI 
CFQ 
AAQII 
SCS  
 
 
 
 
26.83 (10.32) 
1.50 (.62) 
0 .00 (0.00) 
57.17 (18.54) 
35.67 (7.66) 
15.71 (3.76) 
 
 
 
 
28.33 (10.73) 
1.86 (.97) 
1.40 (2.61) 
51.33 (15.02) 
32.17 (9.37) 
15.67 (4.21) 
 
 
 
 
34.75 (3.95) 
2.27 (.78) 
2.80 (4.38) 
56.25 (6.80) 
38.50 (5.97) 
13.24 (3.40) 
 
Note. FS = Flourishing Scale; VLQ CI = Valued Living Questionnaire Current Importance; VLQ CA = 
Valued Living Questionnaire Current Action; SCID-II = Structured Clinical Interview for DSM-IV 
Axis II Disorders; SIPP Self-con = self control domain; SIPP Social = social concordance domain; 
SIPP Ident = identity integration domain; SIPP Relat = relational functioning domain; SIPP Respon = 
responsibility domain; BDI-II = Beck Depression Inventory; SCL-90 GSI – Symptom Checklist-90 
Global Severity Index; DSHI = Deliberate Self-Harm Inventory; CFQ = Cognitive Fusion 
Questionnaire; AAQII – Acceptance and Action Questionnaire 2
nd Version; SCS = Self Compassion 
Scale. CHAPTER VII 
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Table 7.5 
Friedman ANOVAs for Repeated Measures at Pre, Post, and Follow-Up 
   
                                             n = 5 
 
Measures  chi-sq  df  p 
 
 
FS 
VLQ CI 
VLQ CA 
SIPP Self-con 
SIPP Respon 
SIPP Ident  
SIPP Relat 
SIPP Social 
 
.55 
1.73 
2.00 
.74 
1.53 
3.11 
.11 
4.78 
 
2 
2 
2 
2 
2 
2 
2 
2 
 
.76 
.42 
.37 
.69 
.47 
.21 
.95 
.09 
       
 Note. FS = Flourishing Scale; VLQ CI = Valued Living Questionnaire Current Importance; VLQ CA 
= Valued Living Questionnaire Current Action; SIPP Self-con = self control domain; SIPP Social = 
social concordance domain; SIPP Ident – identity integration domain; SIPP Relat = relational 
functioning domain; SIPP Respon = responsibility domain. 
 
7.3.3 Stage Three. Reliable and Clinically Significant Individual Changes 
  RCIs were calculated for the following measures: BDI, SCL-90 GSI, SIPP, 
FS, CFQ, SCS, and the AAQ-II, from pre to post intervention, and from pre to 
follow-up. RCIs were not calculated for the SCID-II, DSHI, or VLQ, as the required 
psychometric data was not available for the form of these measures used in the study. 
The results are displayed in Table 7.6, with those of the primary outcome measures 
being displayed graphically in Figure 7.2.  
An RCI of 1.96 or above indicated a statistically reliable change at the p = .05 
level. The clinical change categories were determined (following Jacobson and 
Truax, 1991) by calculating the mid-point between the clinical mean and the non-
clinical mean for each measure, and examining whether each participant’s scores had 
crossed that cut-off point either post-intervention or at follow-up. A reliable change 
that crossed the cut-off point from the clinical to non-clinical side was labelled CHAPTER VII 
   
184 
“recovered”. A reliable change in a positive direction but not crossing the cut-off 
point was labelled “improved”. A reliable change in the direction of poorer 
functioning was viewed as deterioration. Non-significant changes were labelled 
“same”. 
  As can be seen from Table 7.7, the pattern of results is mixed, with some 
participants improving or recovering on some measures, some deteriorating, and 
some not showing reliable change. Participant 1 had mixed results immediately post-
intervention, including some improvements (the SIPP identity integration subscale 
and the FS), but appeared to have deteriorated during the follow-up period. 
Participant 2 showed reliable, positive changes on several measures immediately post 
intervention, including on the BDI-II, some SIPP subscales, but was not available to 
provide psychometric data at follow-up. Participant 4 appears to have deteriorated on 
several outcome measures at the post-intervention point, including the BDI-II and the 
SCL-90-R, changes that for the most part were maintained at follow-up. Participant 5 
showed little change immediately post-intervention, but had improved on several 
measures by the follow-up data collection point, including three of the five SIPP 
subscales. Participant 6 showed significant improvement on two primary outcome 
measures post-intervention, this improvement being maintained at follow-up for the 
BDI-II only. There were very few changes in score for any of the questionnaires used 
to address potentially relevant processes (the CFQ, AAQII, and the SCS). 
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Table 7.6 
Reliable and Clinically Significant Individual Changes 
 
 
                          
                                          Post 
                                         (n = 5) 
 
     
Follow-up 
(n = 4) 
    
 
 
 
 
Measures  Recovered  Improved  Same  Deteriorated  Recovered  Improved  Same  Deteriorated 
 
FS  
    SIPP S-con  
SIPP Social  
SIPP Ident  
SIPP Relat 
SIPP Respon 
BDI-II 
SCL-90 GSI 
CFQ 
AAQII 
SCS 
 
1 
1 
0 
1 
0 
1 
1 
0 
0 
0 
1 
 
0 
0 
0 
1 
0 
0 
1 
0 
0 
0 
0 
 
4 
2 
5 
3 
5 
3 
2 
4 
5 
5 
3 
 
0 
2 
0 
0 
0 
1 
1 
1 
0 
0 
1 
 
0 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
 
0 
0 
0 
0 
2 
0 
1 
0 
1 
0 
0 
 
4 
0 
4 
4 
2 
4 
1 
2 
3 
4 
3 
 
0 
2 
0 
0 
0 
0 
2 
2 
0 
0 
1 
                 
Note. FS = Flourishing Scale; SIPP S-con = self control domain; SIPP Social = social concordance domain; SIPP Ident – identity integration domain; SIPP Relat = 
relational functioning domain; SIPP Respon = responsibility domain; BDI-II = Beck Depression Inventory; SCL-90 GSI – Symptom Checklist-90 Global Severity 
Index; CFQ = Cognitive Fusion Questionnaire; AAQII – Acceptance and Action Questionnaire 2
nd Version; SCS = Self Compassion Scale. 
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Figure 7.2 
RCI Data for Primary Outcome Measures 
 
Legend 
           Line of no change                Reliable change limits                  Clinical significance change limits 
 
 
Flourishing Scale 
                          Pre-Post                                                    Pre-Follow-Up 
                                          
                                         
SIPP Self-Control Subscale 
                         Pre-Post                                                     Pre-Follow-Up 
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SIPP Social Concordance Subscale 
                         Pre-Post                                                       Pre-Follow-Up 
          
 
SIPP Identity Integration Subscale 
                         Pre-Post                                                       Pre-Follow-Up 
          
 
SIPP Relational Functioning Subscale 
                         Pre-Post                                                       Pre-Follow-Up 
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SIPP Responsibility Subscale 
                         Pre-Post                                                       Pre-Follow-Up 
          
 
 
7.3.4 Stage Four. Data Not Analysed Using the RCI Methodology 
The VLQ, SCID-II and the DSHI could not be analysed using the RCI 
methodology, owing to the lack of required psychometric data for these measures. 
Figure 7.3 shows group mean changes in current importance of life domains (valuing) 
and valued action taken, across the three data collection points. The extent to which 
the group reported valuing the various VLQ life domains remained constant during 
the intervention, but rose during the follow-up period. Action taken in relation to 
valued life domains increased during the intervention, and in the follow-up period.  
Changes in number of PD diagnoses as determined by the SCID-II are 
displayed in Table 7.7. As with the RCI data presented in 7.3.3, there was a mixed 
picture of results, with Participant 1 deteriorating, and Participants 5 and 6 
improving. Interestingly, Participant 4, who appeared to deteriorate significantly on 
several other outcome measures, (though with some doubt about the reliability of 
some of her self-report data), showed no change in PD diagnoses as determined by 
this face-to-face interview. 
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Figure 7.3 
Group Mean Current Importance (Valuing) of Life Domains, and Valued Action 
Legend 
            Valued action                     Current Importance (valuing)   
                    
 
Table 7.7 
Changes in PD Diagnoses Based on 12-Month SCID-II Prevalence 
     
 
Participant 
 
 
Pre 
 
6-month follow-up 
  
 
1 
2 
3 
4 
5 
6 
Mean no. PDs 
 
2 
0 
2 
5 
6 
2 
2.83 
 
4 
- 
- 
5 
3 
1 
3.25 
 
 
 
  Changes in participant self-harming behaviour are outlined in Table 7.8. No 
participants made suicide attempts either during the intervention or the follow-up 
period. Participants 2, 5, and 6 engaged in no self-harming behaviour either during CHAPTER VII 
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the group or the 6-month follow-up. Participant 4, who is likely to have self-harmed 
during the 6-months prior to the intervention commencing, also reported having 
occasionally self-harmed during the life of the group and during the follow-up period. 
Participant 1 had one minor episode of self-harm whilst the group was on-going, and 
several more episodes during the follow-up period. None of the participants required 
medical attention as a result of these self-harm incidents, and using the criteria drawn 
up for an on-going RCT involving participants with PD diagnoses (Lynch, 2011 - 
2016), all incidents of self-harm in the current trial would be categorised as either 
adverse events or adverse reactions, the two least serious categories of incidents. 
 
Table 7.8 
Participant Self-Harming Behaviour 
     
 
Participant 
 
During therapy 
 
During follow-up 
  
 
1 
2 
4 
5 
6 
 
1 x scratch 
0 
3 x scratch; 3 x bite 
0 
0 
 
10 x scratch 
0* 
4 x scratch 
0 
0 
 
Note. *Although no psychometric data on self-harm were available for Participant 2 
during the follow-up period, her electronic health records were accessed to assess 
whether any self-harm occurred. 
    
A research assistant carried out informal, face-to-face interviews with each 
participant, at the end of the intervention, to give them the opportunity to provide 
feedback about their experience of the group, and any suggestions of changes to be 
made to the protocol. Feedback was passed on to the therapists in anonymous form. 
These arrangements were designed to make it easier for participants to give less 
positive feedback, if necessary. The feedback was not formally analysed, but the most 
common themes were: CHAPTER VII 
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•  The intervention was helpful, with mindfulness practice and specific ACT 
exercises such as cognitive defusion and values-focused behavioural 
activation, being singled out as particularly useful. 
•  Although being in a group with other people was anxiety provoking, it was 
also helpful to get to know other people dealing with similar issues. 
•  The therapists and their style of working were helpful and supportive. 
•  There was too much material covered in too few sessions; the intervention 
was not long enough - not enough time to start making life changes. 
•  The first few weeks of the group were emotionally challenging (the sessions 
covering creative hopelessness), which at times was helpful but at other times 
felt dysregulating and unhelpful. 
•  There should have been more explanation of the relationship between DBT 
and ACT skills, early in the group. 
•  The 6-month follow-up period felt like a long time to try and maintain 
recently initiated life changes, without any therapeutic input. 
Four of the five treatment completers said that they would definitely recommend 
the group to a friend with similar issues. The fifth participant said that she would not 
recommend the group unless changes were made in line with her feedback.  
 
7.4 Discussion 
 
7.4.1 Study Findings 
  A small number of previous studies have suggested that ACT might be an 
effective intervention for PD, but prior to this study it had not been tested with a 
heterogeneous, post-DBT PD sample. This study was designed to begin the process 
of developing an ACT-based group intervention for people with poor personality 
functioning across PD diagnoses, who had graduated from DBT but were still 
reporting difficulties in terms of symptomology and engagement in a valued life. The 
feasibility, acceptability and impact of the intervention were assessed post therapy, 
and at 6-month follow-up. Given that this is the first trial of this newly developed 
protocol with a highly complex and potentially risky patient group, the impact of the CHAPTER VII 
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intervention on the group as a whole and on individual participants will be discussed 
in some detail. 
 
7.4.1.1 Impact on Valued Action and Engagement in Life 
Given that ACT is primarily designed to bring about greater engagement in a 
personally meaningful life regardless of symptomology, findings from measures such 
as the VLQ and the FS are particularly important. There was a non-significant group 
mean increase in values-related action during the intervention, with this trend 
continuing during the follow-up period. Similarly, there was a non-significant 
increase in group mean engagement in life (FS); RCI calculations showed that for 
two participants these FS improvements reached statistical significance. Several 
participants verbally reported increases in valued actions such as seeking and starting 
voluntary employment. The researchers were concerned that these important 
behavioural changes were not being captured by the measures included in the study, 
an issue that will be discussed in Section 7.4.2. 
Although these changes are modest, it appears possible that the protocol had 
some impact on these primary outcome measures. Given the very small sample size, 
however, more research is needed before firm conclusions can be drawn. There are no 
published PD treatment trials that have included these measures, so it is not possible 
to compare findings. 
 
7.4.1.2 Impact on Parasuicidal Behaviour and Psychiatric Symptomology 
Parasuicidal Behaviour. The original aims of the intervention were to help 
participants engage in a valued life while maintaining behavioural stability in terms 
of parasuicidal behaviour. Based on the small amount of relevant previous research, 
improvements in mental health symptomology were also predicted. In terms of 
behavioural stability, no participants made suicide attempts during the group or the 
follow-up period, and no one was hospitalised for psychiatric reasons during these 
two time periods, but two of the five completers engaged in episodic, relatively minor 
self-harm. 
Due to the small sample size and lack of a randomised controlled study 
design, it is difficult to interpret these findings. Certainly, some self-harm is reported 
in the follow-up periods of DBT for BPD trials (e.g. van den Bosch et al., 2005), and 
it may be that for people with very extensive self-harm histories such as the current CHAPTER VII 
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participants, this is to be expected. Alternatively, it could be argued that all 
participants reported a 6-month self-harm free period prior to the intervention 
(although there is doubt about this claim for one participant), and therefore these 
incidents of self-harm during the study are a negative reflection on the intervention. It 
may be relevant that both participants who self-harmed during the study reported the 
minimum number of months self-harm free prior to the intervention (6 months), with 
participants who reported longer periods without self-harm prior to the study, fairing 
better. Clearly, further investigation of this important issue is required. 
Psychiatric Symptomology Although ACT was not developed with the 
specific aim of reducing psychiatric symptomology, such reductions do often occur 
following ACT interventions, including those for PD. In the current study, impact on 
both Axis I and Axis II symptomology was inconsistent. Half of the original six 
participants appear to have significantly benefitted from the protocol, as evidenced by 
reductions in Axis I and/or Axis II symptomology. For two of these participants, 
some of these improvements were evident at the follow-up point. Participant 2 was 
unable to provide psychometric data at follow-up, but one of the therapists met with 
her several months later, when she reported feeling positive and more active in her 
life than she had done prior to participating in the group.  
Two participants who completed the intervention reported deteriorations in 
psychiatric symptoms during or following the group. Participant 1 showed little 
change in psychiatric symptomology immediately post-intervention, but deteriorated 
during the follow-up period. At the follow-up group session she described significant, 
aversive life events that had occurred during the follow-up period, and her view was 
that she would have deteriorated more severely if she had not experienced the ACT 
group. There is no way of determining if this was the case, and it is possible that her 
deterioration was linked to the intervention rather than post-group life experiences. 
It is even more difficult to be certain about the experience of participant 4, 
who showed significant deterioration across measures of Axis I psychopathology, and 
a measure of personality functioning (the SIPP), but no change in her number of PD 
diagnoses at follow-up. It seems likely that she under-reported her level of depression 
and self-harming behaviour prior to the group starting. The therapists’ experience of 
participant 4 was that she presented in challenging ways throughout the group 
sessions, including episodes of dissociation, and hostility towards the therapists. It is 
possible, of course, that these observations represent personal reactions of the CHAPTER VII 
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therapists rather than being accurate representations of the patient. Although she 
verbally described some increases in valued action, both therapists felt that on 
balance that participant 4 had not benefitted from the intervention. 
Possible Moderators It is important to try to identify possible moderating 
factors that might help distinguish between participants who benefitted and those who 
did not, so that those who are unlikely to benefit would not be offered the 
intervention in the future. With the small sample size it is not possible to test potential 
moderators statistically, but some possible hypotheses do suggest themselves. As was 
outlined above, the two participants who deteriorated both had a shorter period of 
time self-harm free prior to the ACT group than those who benefitted. Additionally, 
one of them had just a few weeks following DBT before she began the ACT group, 
whereas the other had several years gap between DBT and ACT, and was the only 
participant who had self-harmed since completing DBT, suggesting that she was no 
longer using her DBT skills effectively. All the patients who reported benefits had 
had 6 to 12 months since finishing weekly DBT sessions, a period of time that 
perhaps can be interpreted as sufficient to allow a habit of effective skills use to be 
established independent of DBT input, but not long enough for skills use to have 
become neglected.  
Although both participants who deteriorated had an above average number of 
PD diagnoses (five each), this on its own did not appear to make it more likely that an 
individual would not benefit from the intervention, because participant 5, who had six 
PD diagnoses, appears to have benefitted. It could be the case that patients with 
different PD diagnoses require different psychotherapeutic interventions, and that the 
protocol tested in the study was appropriate for some diagnoses but not others. This 
could fit with the fact that different forms of DBT are being developed for different 
groups of PD presentations (Lynch & Cheavens, 2008). However, looking at specific 
PD diagnoses, the only one that was present for either participant 1 or 4 but not the 
other participants is schizotypal PD (participant 4). All the other PD diagnoses for 
both of these participants were also associated with participants who benefitted from 
the group. It is possible that the intervention was unhelpful specifically with regards 
to schizotypal PD, although drawing this conclusion based on the experience of just 
one participant would be premature.  
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7.4.1.3 Feasibility and Participant Satisfaction 
  In terms of feasibility, the intervention performed well. Five of the original six 
participants completed the group (83%), an attrition rate comparable to other pilot 
ACT interventions for PD (e.g. Clarke et al., in prep, reported 13% attrition from 
their ACT condition). Session attendance was good, with a mean attendance of 78% 
of the group sessions, rising to 87% for participants who completed therapy.  
Although patient satisfaction was not formally assessed, in post-intervention 
interviews four of the five completers said that they would recommend the group to a 
friend with similar issues, with the fifth participant indicating that she would 
recommend it if some specific changes were made, such as extending the length of 
the group. All completing participants reported having found some aspects of the 
intervention helpful. This feedback, although informal, suggests that the majority of 
the participants were satisfied with the intervention. 
  The participant who dropped out indicated that she had found the 
creative hopelessness phase of the intervention emotionally challenging. The 
therapists encouraged group members to reflect on the possible short-term benefits of 
avoidance as a strategy, particularly in high-risk, emotionally dysregulating 
situations, versus the potential costs of over-reliance on avoidance, in terms of lack of 
engagement in a satisfying life. However, more than one participant took this to mean 
that avoidant strategies were no longer an option open to them, and that they ‘should’ 
be able to accept any and all personal experiences. This extreme and inaccurate 
construing had not been observed in previous ACT groups run by the therapists, but 
appeared to be common in this patient group. 
 
7.4.1.4 Other Study Findings 
  There were few significant changes in any of the process measures included in 
the study, despite there being theoretical and/or prior empirical justification for their 
inclusion. Of the two ACT-relevant process measures, the AAQII showed no 
significant changes at all, with just one participant reporting a significant 
improvement on the CFQ. Half the sample reported a change on the SCS either pre to 
post-group or pre-group to follow-up.  
  There are various possible explanations for the relative lack of change in 
process measure scores. One explanation is that despite prior empirical findings to the 
contrary, these processes (e.g. CF) are not implicated in the therapeutic change CHAPTER VII 
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resulting from this kind of intervention. Another possibility is that some or all of 
these processes do play important roles, but the intervention was not effective enough 
to elicit measurable change. A third possibility is that the measures are either 
unsuitable for this patient group, or are not sensitive enough to detect any changes 
that did occur. Certainly, the RCI methodology is very sensitive to a measure’s test-
retest reliability, where the difference between excellent and very good reliability can 
make the difference between significant and non-significant results.   
  The majority of outcome trials for psychosocial treatments for PD have 
focused on one PD diagnosis (usually BPD), with other co-morbid PDs rarely being 
reported. This perpetuates the impression that the norm is for PDs to occur 
independently of each other. Contrary to this impression, the participants in this study 
all had lifetime prevalence diagnoses of several PDs, with the majority having 
diagnoses from more than one PD cluster. These findings provide support for the 
view that there is likely to be core personality pathology that is not diagnostic 
category-specific, and fits with the move in DSM-V to a more dimensional approach 
to PD diagnosis.  
  In keeping with the findings from published DBT intervention trials for BPD 
(e.g. McMain et al., 2009), the participants in this study all reported significant, on-
going psychiatric symptomology at baseline, despite having had a minimum of 12 
months full-programme DBT, and having engaged sufficiently well with DBT that 
they had managed to successfully address their self-harming behaviours. This is not 
to suggest that these prior experiences of DBT had had no impact on 
psychopathology, but rather that DBT targeting parasuicidal behaviours had not been 
as effective at eliminating psychiatric symptomology. This issue will be discussed 
more fully in Chapter IX, Section 9.1.2. It is also possible that without DBT input, 
patients were deteriorating, a possibility that could be explored by collecting data 
over several months prior to an ACT intervention. 
  At baseline, participants scored highly on measures of two ACT-relevant 
processes; psychological flexibility and CF. These findings are consistent with 
previous study findings that link these processes with poor personality functioning, 
including those from Chapter V of this thesis. It is interesting that such high levels of 
inflexibility and CF were found in a sample of DBT graduates, an intervention that 
emphasises mindfulness practice and other acceptance-focused skills, and might have 
been expected to positively impact these processes. However, it was observed by the CHAPTER VII 
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study therapists that the group participants consistently favoured avoidance-focused 
DBT skills, and that the majority appeared to be using mindfulness practice as an 
avoidance strategy, by focusing their attention on a picture, for example, in order to 
try to ‘block out’ upsetting thoughts or feelings.  
7.4.2 Methodological Limitations 
  This study was designed as an initial treatment development trial, and as such 
was limited in several ways. It was deliberately small in scale, an appropriate design 
decision when trialling a new treatment with a potentially high-risk patient group. 
However, the original plan was to run two consecutive groups to recruit at least 10 
participants. Following the first group it was decided to modify the treatment protocol 
to the extent that the data from further groups could not be combined with the current 
data. This resulted in the current study having a smaller than planned sample size, 
rendering it difficult to detect group effects, and the need for caution when 
generalising from the findings.  
As there was no control group or randomisation of participants, it is possible 
that changes observed in the participants could be the result of factors independent of 
the intervention, such as life events, or factors not specific to the intervention, such as 
therapeutic alliance. The study findings would therefore require replication in a 
larger, controlled trial for firm conclusions to be drawn. 
A further limitation was the reliance on self-report measures to assess change 
(with the exception of the SCID-II). Although this is no different to the majority of 
psychotherapy outcome trials, self-report measures are vulnerable to demand bias and 
inaccuracy of responding, as well as participant fatigue or boredom when completing 
a large battery of tests. In this study, steps were taken to address these possible 
concerns. Participants were identified by an ID number on questionnaires rather than 
name, and completed the questionnaires at home, in an attempt to minimise potential 
demand bias. To reduce the possibility of fatigue or boredom, they were also told that 
they could take up to 5 days to complete each set of psychometrics. 
The study measures were also limited in the sense that group members 
verbally reported making positive behavioural changes such as starting voluntary 
work, which were not necessarily reflected in scores on the study questionnaires. The 
VLQ, which is designed to measure change in valued activity has content that is CHAPTER VII 
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somewhat general and abstract in nature, and does not allow the recording of 
information about specific activities. Although positive shifts in VLQ action scores 
were seen for the group, it is possible that a measure measuring the frequency of 
specific behaviours might more accurately reflect the behavioural changes seen in the 
group. 
A further methodological limitation in relation to measures is that the two 
VLQ variables (valuing/current importance and valued action) were both treated as 
outcome measures in this study. It might be more in keeping with ACT theory to use 
the valuing variable as a process measure, whilst retaining action in relation to values 
as an outcome measure.  
Finally, in relation to measurement issues, it is possible that the lack of 
changes in score on the process measures could be a result of their not being suitable 
for use with this specific patient group. However, this seems unlikely, particularly in 
the case of the CFQ, which was shown in Chapter V to correlate highly with 
personality functioning. Similarly, although the AAQII has not been used in 
published studies involving PD samples, the earlier version of the same measure, with 
which the AAQII correlates very highly, has repeatedly been seen to perform well in 
studies involving PD samples. 
 
7.4.3 Protocol Limitations 
There were several possible limitations to the intervention protocol. Based on 
feedback from participants and the experience of the therapists, it seems likely that 
the protocol had too few sessions, and covered too much material in those sessions. It 
also seems likely that addressing creative hopelessness, and specifically the issue of 
acceptance versus avoidance, in the way it was addressed, could be improved. It is 
possible, with changes made to some aspects of the intervention that more 
consistently positive outcomes might be attained. 
Of course it is also possible that even with such modifications, this kind of 
protocol will prove to have only limited benefits for this patient group. This might be 
due to a fundamental design aspect of the protocol, for example, that it is based on a 
group intervention. This particular example seems unlikely, however, as the majority 
of outcome trials for people with PD diagnoses are based on group interventions. CHAPTER VII 
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Alternatively, it might be the case that this intervention, designed as it is to address 
general processes such as CF, has a positive impact on some shared aspects of poor 
personality functioning, but that different PD diagnoses require specifically tailored 
interventions to have a greater impact. However, if this were the case, the fact that all 
of the participants in the study had several different PD diagnoses would suggest that 
they would each require a number of different psychosocial interventions, in addition 
to the 12 months or more DBT they have already received. It might therefore be 
reasonable to test an improved, general intervention in the first instance. 
 
7.4.3 Implications and Future Research 
  The results from this initial treatment development trial suggest that an ACT-
based group intervention for a post-DBT, heterogeneous PD sample is feasible, 
acceptable to patients, and may have some positive impact on engagement in valued 
life activities and symptomology. However, the findings were mixed, with some 
participant apparently not benefitting. It would be usual practice to follow a small 
scale, open trial of this nature, with a larger, controlled trial, to test the protocol under 
more illuminating conditions (Rounsaville et al., 2001). However, it seems likely that 
the protocol could be improved. For this reason, a second small, open trial evaluating 
a modified version of the protocol is the most logical next step. Changes might 
include: 
1.  Adding more sessions to the protocol. 
2.  Removing or simplifying some content. 
3.  Changing the way creative hopelessness, acceptance and avoidance are 
addressed. 
4.  Adding some top-up sessions during the follow-up period. 
5.  Bridging the gap between DBT and ACT more effectively. 
6.  Using a checklist of life activities to try to capture the behavioural changes 
identified in group sessions. 
7.  Gathering independent information about patient self-harming behaviour 
prior to the intervention commencing. 
8.  Adding a baseline period prior to the start of the group, to examine patient 
stability, post-DBT. CHAPTER VII 
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7.4.4 Summary 
  This initial treatment development trial of an ACT-based group intervention 
for post-DBT PD patients elicited mixed results, with several modifications to the 
protocol suggesting themselves as possible ways to improve the impact of the 
intervention. Therefore, Chapter VIII outlines a second, similar trial, examining the 
impact of the modified protocol. 
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CHAPTER VIII 
   
Study 5: A Second Uncontrolled Pilot Development Trial of an ACT-based 
Group Intervention for Post-DBT Patients with Poor Personality Functioning 
 
8.1 Introduction 
Chapter VII outlined the rationale for a post-DBT ACT intervention for patients with 
PD diagnoses with continuing psychological difficulties and limited engagement in a 
valued life. The results of an uncontrolled pilot trial of this intervention were mixed, 
with little change for some participants on study measures. This chapter therefore 
reports a second uncontrolled trial of a modified version of the protocol, for post-
DBT patients with poor personality functioning across PD diagnostic categories. It 
was hypothesised that there would be positive changes, pre to post-treatment, on 
study measures of engagement in life, activity, and Axis I and II symptomology. 
  
8.2 Method 
8.2.1 Design 
  The study was based on an uncontrolled, pre-post design. The IV was a 24-
week ACT-based group intervention (plus psychiatric treatment as usual); the DVs 
being the same measures as those in the first trial. Two groups were run, sequentially. 
An additional data collection point was added 3-months prior to the intervention 
starting, as a means of determining how stable participants’ scores on study variables 
were, post-DBT.  This was seen as important, given that participants’ scores on 
measures of psychopathology in the previous study indicated high levels of 
psychiatric difficulties, pre-ACT, despite all participants being DBT graduates. This 
raised the possibility of participant deterioration since finishing DBT.  
8.2.2 Participants 
All ethics approval, inclusion and exclusion criteria, and recruitment 
arrangements were identical to those in the previous study. Participants were 
recruited between August 2010 and July 2011. Given concerns about the accuracy of CHAPTER VIII 
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self-report information about recent parasuicidal behaviour in the previous study, in 
the current study, these data were verified using the NHS electronic clinical notes 
system. 
Figure 8.1 shows the flow of participants through the trial stages. Of the 15 
people referred into the study, 10 commenced therapy (five in each of two groups). 
One dropped out of the second group after the first session. 
 
Figure 8.1 Flow Chart of Participant Recruitment, Assessment, and Treatment 
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) 
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Table 8.1 contains demographic information and baseline data regarding self-
harm, DBT history, and current mental health status. All participants were female, 
and had completed DBT prior to attending the ACT group, with the duration of DBT 
ranging from 16 to 26 months. The interval following the end of weekly DBT 
sessions and joining the ACT group varied considerably (1 to 108 months). All 
participants had histories of self-harm, averaging 22.50 years (ranging from 3 to 43). 
The period free of self-harm prior to the intervention ranged from 6 to 18 months. All 
participants scored in the clinical range for both depression and global symptom 
severity. 
   
Table 8.1 
Demographics and Baseline Statistics 
   
 
Demographic/Baseline statistic 
 
N = 10 
 
Mean age (range) 
 
43.10 (29 – 56) 
Gender (% female) 
% taking psychotropic medication 
Mean no. months of DBT (range)
1 
Mean no. months since end DBT (range)
2 
Mean number years self-harm (range)
3 
Mean no. months since self-harm
4 
% in clinical range for depression
5 
% in clinical range on SCL-90R GSI
6 
100% 
100% 
19.30 (16 – 26) 
21.70 (1 – 108) 
22.50 (3 – 43) 
12.80 (6 – 18) 
100 
100 
Note. 1: Number of months of DBT intervention. 2: Number of months since the end of regular DBT 
sessions, by the start of ACT group. 3: Number of years history of any form of deliberate self-harm, 
from first reported instance of self-harm, to most recent. 4: Number of consecutive self-harm free 
months prior to the start of the ACT group. 5: % scoring at least 14 on the Beck Depression Inventory-
II. 6: % scoring at least .70 on the Symptom Check List – 90 Revised, Global Severity Index. 
 
Table 8.2 shows baseline PD diagnosis information for participants, indicating 
a very high level of personality psychopathology.  All except participant 4 had PD 
diagnoses from two different PD clusters, with four participants having PD diagnoses 
from all three clusters. CHAPTER VIII 
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Table 8.2 
PD Baseline Statistics 
   
 
Participants (N = 10) 
 
 
N = 10 
 
1 
2 
3 
 
4 
5 
 
6 
7 
8 
9 
 
 
10 
 
 
Mean PD diagnoses (range)
1 
Group PD diagnoses: 
most common to least 
common (number of 
participants with diagnosis) 
 
BPD, Obsessive-compulsive 
BPD, Dependant, Avoidant, Depressive 
BPD, Depressive, Obsessive-compulsive, Paranoid, 
Passive-aggressive 
BPD 
BPD, Dependant, Avoidant, Schizotypal, Anti-
Social 
BPD, Dependant, Depressive 
Dependant, Avoidant, Depressive, Paranoid 
BPD, Paranoid, Dependant, Avoidant, Depressive, 
Obsessive-compulsive, Passive-aggressive 
Avoidant, Depressive, Obsessive-compulsive, 
Schizoid 
BPD, Paranoid, Dependant, Avoidant, Depressive, 
Obsessive-compulsive 
 
4.1 (1 - 7) 
BPD (8), Depressive (7), Avoidant (6), Dependant 
(6), Obsessive-compulsive (5), Paranoid (4), 
Passive-aggressive (2), Schizoid (1), Schizotypal 
(1), Antisocial (1)  
   
Note. 
1Lifetime prevalence of PD diagnoses based on the SCID-II.  
8.2.3 Materials 
8.2.3.1 Measures 
All measures used were the same as those in the first treatment development 
trial (see Chapter VII, Section 7.2.3), with the exception of the Life Activity Schedule CHAPTER VIII 
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(LAS) and the Client Satisfaction Questionnaire-8 (CSQ-8; Larsen, Attkisson, 
Hargreaves, & Nguyen, 1979). Because several participants in the previous study 
mentioned positive behavioural changes in group sessions, the LAS was included in 
the current study in an attempt to measure such changes. The CSQ-8 was included to 
measure participant satisfaction (see below for details of these measures).  
All except the SCID-II, LAS and the CSQ were administered at four time 
points; 3 months prior to the start of the intervention, pre-intervention, post-
intervention, and at 6-month follow-up.  The SCID-II was administered pre-
intervention and at 6-month follow-up, as per the previous study. The LAS was 
completed as part of the routine group administration procedure by participants prior 
to the start of each group session. The CSQ-8 was completed only once, shortly after 
the intervention ended. 
Life Activities Schedule (LAS) See Appendix O. This idiographic measure of life 
activity frequency and type was developed specifically for this trial. It is an anglicised 
version of the Life Activities Checklist included in Lejuez, Hopko, and Hopko, 
(2001), a behavioural activation treatment for depression trial. The original checklist 
did not include a scale, so a 4-point scale was added, ranging from Once in the last 
week to More than once a day in the last week. The schedule covers 131 positive or 
enjoyable activities, (examples include “Visiting friends or having friends visit”, 
“Listening to music”, and “Doing charity work”), and has space for participants to 
add a further six activities. The measure yielded two variables; mean weekly activity 
level across all activities, and mean number of types of activity per week. No 
psychometric data are available for this measure.     
Client Satisfaction Questionnaire-8 (CSQ-8) This is an 8-item self-report measure of 
client satisfaction with health services. Items include “Have the services you received 
helped you to deal more effectively with your problems?” and “How would you rate 
the quality of the service you received?” Responses are on a 4-point scale, the 
labelling of which varies between items. The measure yields a total score ranging 
from 8 to 32, with higher score indicating greater satisfaction. It has very good to 
excellent internal consistency (Cronbach’s α ranging from .86 to .93). 
  ACT is primarily designed to increase valued action and engagement in life, 
rather than to reduce symptomology. For this reason, the VLQ, FS, and LAS were 
used as primary outcome measures, along with two measures of personality 
functioning (SCID-II and SIPP).  CHAPTER VIII 
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8.2.4 Procedure 
  Recruitment and assessment followed the same procedures as the first trial 
(see Chapter VII, Section 7.2.4). 
 
8.2.4.1 Intervention 
  The following changes were made to the original ACT protocol (which was 
outlined in Section 7.2.4.4). 
Number of sessions The number of weekly sessions was increased from 20 to 24 
because participants from the first trial reported they would have benefitted from 
more time to make valued life changes. In addition, 1-month and a 3-month follow-
up sessions were added, again following participant feedback. 
Content of sessions Some changes were made to the content of the ACT group 
protocol. More detailed coverage of the links between DBT and ACT was included at 
the beginning of the group, to aid participants’ transition from one approach to the 
other. A small amount of content, both didactic and experiential, was removed from 
several sessions, to allow more time to address the remaining material. No topics 
were completely removed from the protocol. Additionally, the content addressing 
RFT and experiences of self was simplified.  
  Some participants from the previous trial reported finding the creative 
hopelessness aspect of the intervention—a feature of the early stages of many ACT 
mental health protocols—anxiety provoking. This was because their primary coping 
strategy (avoidance) was being singled out as potentially unhelpful, prior to any 
additional skills or coping strategies having been taught. Although the “control and 
avoidance is the problem” message inherent in many ACT protocols had already been 
modified to be less disturbing to this patient group (see Chapter VII, Section 7.2.4.6 
for details), further changes were made. Specifically, the order of the early sessions 
was altered so that a new ACT skill (as it was referred to in the group)—cognitive 
defusion—was introduced and practiced, prior to any exploration of the potential 
costs of avoidance. In this way, the willingness and ability to allow private 
experiences such as thoughts and emotions to be present, was introduced as 
something that all participants were already familiar with (through repeated defusion 
practices).  CHAPTER VIII 
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 Finally, as indicated above, because the group members were familiar with 
the idea of learning and utilising new skills (from DBT), the main capacities 
associated with the six ACT processes were conceptualised in this way in the 
modified protocol. They were added to the DBT skills on the diary card completed by 
participants on a daily basis, and as each new ACT skill was taught, group members 
were encouraged to practice and use them alongside their DBT skills. The ACT skills 
were described on the diary card as follows: 
•  Cognitive defusion 
•  Clarifying values 
•  Practicing willingness 
•  Taking valued action 
•  Connecting with YOU (not your mind) who can notice and choose 
•  Noticing sweet moments 
 
8.2.5 Analysis Plan 
  The same analysis plan as the first trial was used, based on non-parametric 
group statistics and individual RCI calculations, but with a small number of 
modifications. Firstly, possible group differences between 3-month pre- and 
immediately pre-group scores on all measures were investigated in Stage Two, to 
assess the stability of scores, post-DBT and prior to ACT. Secondly, effect sizes 
were calculated. Finally, two additional measures (the LAS and the CSQ-8) were 
included. 
 
8.3 Results 
8.3.1 Stage 1. Preliminary Analysis and Participant Characteristics 
  There was less than 1% data missing from the psychometric measures, so 
missing items were replaced by the sample mean (Tabachnick & Fidell, 2001). One 
participant dropped out after the first session. She completed 3-month pre- and  
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Table 8.3 
Means and Standard Deviations for All Study Measures 
   
                       Mean (SD) 
  
 
                                                  
 
Measures 
3-month pre 
N = 10 
Pre-group 
N = 10 
Post-group 
N = 9 
Follow-up 
N = 7* 
 
FS 
Activity 
Activity types  
VLQ CI  
VLQ CA  
SCID-II 
          SIPP S-con 
SIPP Social  
SIPP Ident  
SIPP Relat 
SIPP Respon 
 
33.44 (11.30) 
- 
- 
6.05 (2.63) 
4.94 (2.40) 
- 
4.45 (.72) 
5.48 (1.05) 
3.17 (.76) 
3.62 (.98) 
4.25 (.85) 
 
31.11 (10.86) 
.39 (.31) 
22.11 (10.35) 
5.33 (1.29) 
4.47 (1.65) 
2.33 
4.27 (.82) 
5.19 (.95) 
3.08 (.63) 
3.43 (.79) 
4.13 (.84) 
 
35.44 (8.50) 
.39 (.32) 
27.33 (17.29) 
6.71 (2.32) 
4.62 (1.80) 
- 
4.55 (.83) 
5.49 (1.02) 
3.14 (.59) 
3.61 (.91) 
4.21 (.96) 
 
35.14 (9.87) 
.39 (.22) 
26.78 (11.13) 
7.90 (1.63) 
7.36 (1.08) 
2.22 
4.42 (.99) 
5.42 (1.38) 
3.12 (.66) 
3.48 (.74) 
4.14 (.79) 
DSHI 
BDI-II 
SCL-90-R GSI 
CFQ 
AAQII 
SCS 
CSQ 
0 (0) 
33.11 (13.68) 
1.75 (.73) 
59.67 (8.94) 
33.00 (4.50) 
14.54 (2.84) 
- 
0 (0) 
35.78 (11.37) 
1.77 (.77) 
60.89 (11.60) 
32.00 (5.27) 
14.22 (2.95) 
- 
1.22 (2.22) 
33.33 (8.17) 
1.94 (.73) 
62.56 (11.17) 
34.56 (6.35) 
14.69 (3.66) 
28.67 (2.74) 
1.14 (1.95) 
27.57 (12.39) 
1.68 (.91) 
56.14 (11.45) 
32.71 (3.82) 
14.86 (4.39) 
- 
Note. FS = Flourishing Scale; Activity = LAS mean number of activities; Activity types = LAS mean 
number of types of activity; VLQ CI = Valued Living Questionnaire Current Importance; VLQ CA = 
Valued Living Questionnaire Current Action; SCID-II = Structured Clinical Interview for DSM-IV 
Axis II Disorders; SIPP S-con = self control domain; SIPP Social = social concordance domain; SIPP 
Ident – identity integration domain; SIPP Relat = relational functioning domain; SIPP Respon = 
responsibility domain; BDI-II = Beck Depression Inventory; SCL-90 GSI – Symptom Checklist-90 
Global Severity Index; DSHI = Deliberate Self-Harm Inventory; CFQ = Cognitive Fusion 
Questionnaire; AAQII – Acceptance and Action Questionnaire 2
nd Version; SCS = Self Compassion 
Scale. 
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pre-group measures only. Patients attended 18 of the 24 sessions, on average. This 
figure rose to a mean of 19 for the treatment completers. Table 8.3 shows group 
means scores on all study variables at the four data collection time points. Two sets of 
data were missing at follow-up, due to one participant having just given birth, and 
another being unavailable due to her partner being seriously ill. Pre-intervention, this 
sample showed poorer functioning on all SIPP personality domains compared with 
the PD sample norms provided by the authors of the measure (Andrea, personal 
communication). In terms of Axis I pathology (BDI-II and SCL-90_R GSI), this 
sample was comparable to the high-risk BPD samples in DBT and CBT for BPD 
trials (e.g. Davidson et al., 2006; McMain et al., 2009). 
 
8.3.2 Stage Two. Group Statistical Analyses and Effect Sizes  
8.3.2.1 Group Statistical Analyses 
Friedman’s ANOVAs were conducted at pre- post, and follow-up, on all 
primary outcome variables except the SCID-II. All participants completing the 
intervention were included in the analyses (n = 9), with the post-intervention data 
from participants 6 and 7 being carried forward to the follow-up data point, 
(following recommendations by Hollis and Campbell, 1999), because they completed 
the intervention sessions but were not able to provide follow-up psychometric data.  
Table 8.4 shows there was a significant increase in valued action across the 
three data points included in the analysis, which remained significant following 
Bonferroni correction for multiple comparisons (p = .05/10 = .005). None of the other 
changes were significant. 
A Wilcoxon signed-rank test yielded no significant difference between the 
two data collection points for the SCID-II, indicating no significant difference 
between numbers of PD diagnoses from pre-intervention to 6-month follow-up, (z = -
.28, p = .78). 
Based on the Friedman Test results, post-hoc Wilcoxon signed-rank tests were 
carried out on the VLQ current action data. Pre- to post-intervention, there was no 
significant change (z = 0, p = 1.0). Post-intervention to 6-month follow-up there was 
a significant increase in valued action (z = -2.37, p = .02). 
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Table 8.4 
Friedman ANOVAs for Repeated Measures at Pre, Post, and Follow-Up 
   
                                            n = 9 
 
Measures  chi-sq  df  p 
 
FS 
VLQ CI 
VLQ CA 
SIPP S-con 
SIPP Respon 
SIPP Ident  
SIPP Relat 
SIPP Social 
Activity 
Activity type 
 
1.75 
2.36 
11.53 
2.57 
2.87 
.29 
2.57 
.29 
.06 
2.97 
 
2 
2 
2 
2 
2 
2 
2 
2 
2 
2 
 
.42 
.31 
.003** 
.28 
.87 
.87 
.28 
.87 
.97 
.23 
       
 Note. **Significant at the .05/10 = .005 level; FS = Flourishing Scale; VLQ CI = current importance 
(valuing); VLQ CA = current action; SIPP S-con = self control domain; SIPP Social = social 
concordance domain; SIPP Ident – identity integration domain; SIPP Relat = relational functioning 
domain; SIPP Respon = responsibility domain; Activity = LAS mean number of activities; Activity 
types = LAS mean number of types of activity. 
    
   
8.3.2.2 Effect Sizes 
  It is common practice to calculate effect sizes for changes in group means, 
where non-significant results could result from the study being statistically 
underpowered. (e.g. Goldstein et al., 2007.) Based on Cohen’s (1988) guidelines 
regarding effect sizes, it can be seen in Table 8.5 that the changes in several of the 
study variables are of medium or large size. From pre to post-intervention, there were 
medium or large effect sizes in the direction of better functioning, for flourishing in 
life, activity type, valuing, self-control, and social concordance. 
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Table 8.5 
Effect Sizes 
     
Measures  3-month-Pre 
 
ES 
Pre-Post  
 
ES 
Pre-F-UP 
 
ES 
 
 
 
FS 
Activity 
Activity type  
VLQ CI  
VLQ CA  
SCID-II 
      SIPP S-con  
SIPP Social  
SIPP Ident  
SIPP Relat 
SIPP Respon 
 
.29* 
-
1 
-
2 
.45* 
.62* 
- 
.49* 
1.10* 
.21* 
.39* 
.45* 
 
1.08 
0.00 
.67 
.91 
.14 
- 
.88 
.65 
.17 
.32 
.28 
 
.52 
0.00 
.71 
2.82 
2.51 
.22 
.32 
.42 
.11 
.08 
.03 
 
 
DSHI 
BDI-II 
SCL-90 GSI 
CFQ 
AAQII 
SCS 
0 
.40* 
.05* 
.12* 
.42 
.14* 
1.26* 
.36 
.31* 
.50* 
.83* 
.29 
 
1.58* 
.84 
.22 
.51 
.44* 
.36 
 
Note. *Effect in the direction of poorer functioning; 
1and
2: activity data was not collected prior to the 
intervention. 
FS = Flourishing Scale; Activity = LAS mean number of activities; Activity types = LAS mean 
number of types of activity; VLQ CI = Valued Living Questionnaire Current Importance; VLQ CA = 
Valued Living Questionnaire Current Action; SCID-II = Structured Clinical Interview for DSM-IV 
Axis II Disorders; SIPP S-con = self control domain; SIPP Social = social concordance domain; SIPP 
Ident – identity integration domain; SIPP Relat = relational functioning domain; SIPP Respon = 
responsibility domain; BDI-II = Beck Depression Inventory; SCL-90 GSI – Symptom Checklist-90 
Global Severity Index; DSHI = Deliberate Self-Harm Inventory; CFQ = Cognitive Fusion 
Questionnaire; AAQII = Acceptance and Action Questionnaire 2
nd Version; SCS = Self Compassion 
Scale. 
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There were similar sized positive effects for post-follow-up changes in 
valuing, valued action, depression, general psychiatric symptomology, fusion and 
psychological flexibility. From pre-intervention to follow-up there were medium or 
large positive effects in flourishing, activity type, valuing, valued action, depression 
and defusion. Deliberate self-harm showed a large effect in the direction of more 
incidents of self-harm, as there were no occurrences of self-harm at the pre-group 
time point. Both fusion and psychological flexibility were associated with medium to 
large effects in the direction of poorer functioning, pre-post group, with this direction 
being reversed for both variables post-group to follow-up, resulting in a positive, 
medium-sized effect for changes in fusion, pre-follow-up, and a negative medium-
sized effect for changes in flexibility, pre-follow-up. 
 
8.3.2.3 3-Month Pre-Intervention Data 
  There were no significant differences between mean ranked scores 3 months 
prior to the intervention and immediately pre-intervention on any of the study 
measures, as tested using Wilcoxon signed-rank tests. However, for the majority of 
the study variables, effect size calculations indicated group mean changes in the 
direction of poorer functioning in the 3 months prior to the start of the ACT 
intervention (Table 8.5), suggesting a general deterioration in functioning. These 
changes ranged from negligible in size (SCL-90-R), to very large (social 
concordance). The only exceptions were the AAQII, which yielded a medium-sized 
effect in the direction of better functioning, and the DSHI (the latter due to self-harm 
in the months prior to the intervention being an exclusion criterion). 
 
8.3.3 Stage Three. Individual Participant RCIs 
  Individual participant RCIs were calculated for the following measures: SIPP, 
FS, BDI-II, SCL-90 GSI, CFQ, AAQ-II, and the SCS, from pre- to post-intervention, 
and from pre-intervention to follow-up (see section 7.3.3 for details of this approach). 
RCIs were not calculated for the LAS, SCID-II, DSHI, or VLQ, as the psychometric 
data needed to carry out these calculations were not available for the form of these 
measures used in the study. The results are displayed in Table 8.6, with those of the 
primary outcome measures also displayed graphically in Figure 8.2. CHAPTER VIII 
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The majority of participants showed no statistically reliable changes between 
pre-group and post-group or follow-up, on the majority of measures. However, it can 
be seen in Figure 8.2 that for the FS, the majority of participants are above the line of 
no change on the pre to post graph, indicating changes in score in the direction of 
better functioning, which were not large enough to be considered reliable. A similar 
pattern can be seen on the pre-post group graphs for the SIPP self-control, identity 
integration, and social concordance subscales. This pattern fits with the medium to 
large effect sizes reported for these variables other than identity integration, in 
Section 8.3.2.2. The other SIPP graphs indicate a less consistent pattern, with 
participants variously moving in the direction of better functioning, showing little or 
no change, and in a minority of cases, moving in the direction of poorer functioning.   
Participant 10 showed consistent, reliable and clinically significant change 
across many of the study measures at both the post and follow-up time points. 
Participants 6 and 8 showing reliable and clinically significant changes on more than 
one outcome measure, post-group. Participant 5 showed deterioration across more 
than one measure, both post-group and at follow-up. 
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Table 8.6 
Reliable and Clinically Significant Individual Changes 
 
 
                          
                                          Post 
                                         (n = 9) 
 
     
Follow-up 
(n = 7) 
    
 
 
 
 
Measures  Recovered  Improved  Same  Deteriorated  Recovered  Improved  Same  Deteriorated 
 
FS  
    SIPP S-con  
SIPP Social  
SIPP Ident  
SIPP Relat 
SIPP Respon 
BDI-II 
SCL-90 GSI 
CFQ 
AAQII 
SCS 
 
0 
0 
1 
0 
0 
1 
0 
0 
0 
0 
1 
 
2 
2 
0 
2 
1 
0 
3 
0 
0 
0 
0 
 
7 
7 
8 
6 
8 
8 
5 
8 
9 
8 
8 
 
0 
2 
0 
1 
0 
0 
1 
1 
0 
1 
0 
 
0 
1 
1 
0 
0 
0 
2 
0 
0 
0 
0 
 
0 
0 
0 
1 
1 
0 
0 
1 
1 
0 
0 
 
7 
5 
6 
6 
6 
7 
4 
5 
6 
6 
7 
 
0 
1 
0 
0 
0 
0 
1 
1 
0 
1 
0 
                 
Note. FS = Flourishing Scale; SIPP S-con = self control domain; SIPP Social = social concordance domain; SIPP Ident – identity integration domain; SIPP Relat = 
relational functioning domain; SIPP Respon = responsibility domain; BDI-II = Beck Depression Inventory; SCL-90 GSI – Symptom Checklist-90 Global Severity 
Index; CFQ = Cognitive Fusion Questionnaire; AAQII – Acceptance and Action Questionnaire 2
nd Version; SCS = Self Compassion Scale. 
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Figure 8.2 
Graphs of Reliable and Clinically Significant Change for Each Participant 
 
Legend 
         Line of no change    ----- Limits of reliable change    .…. Clinical cut-off 
   
Flourishing Scale 
                          Pre-Post                                                    Pre-Follow-Up 
      
 
 
SIPP Self Control Subscale 
                          Pre-Post                                                    Pre-Follow-Up 
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SIPP Relational Functioning Subscale 
                          Pre-Post                                                    Pre-Follow-Up 
      
 
 
SIPP Identity Integration Subscale 
Pre-Post                                         Pre-Follow-Up 
      
 
 
SIPP Responsibility Subscale 
                          Pre-Post                                                    Pre-Follow-Up 
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SIPP  Social Concordance Subscale 
                          Pre-Post                                                    Pre-Follow-Up 
      
 
 
 
8.3.4 Stage Four. Data Not Analysed Using the RCI Methodology 
The LAS, VLQ, SCID-II and DSHI data could not be analysed using the RCI 
methodology, and are presented in tabular and graph form below. Figure 8.3 shows 
that amount of activity, as measured by the LAS, did not change pre to post-group, or 
pre-group to follow-up. However, the different types of activities group members 
engaged in did increase from pre to post-group, with much of that increase being 
maintained at 6-month follow-up, suggesting a broadening of participants’ 
behavioural repertoires. The amount of activity specifically associated with personal 
values (measured by the VLQ), did increase for participants – marginally from pre to 
post-group and substantially from post-group to follow-up. This latter increase in 
valued action followed an increase in valuing (current importance of valued life 
domains) during the intervention; an increase that continued during the follow-up 
period.  
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Figure 8.3 
Group Means for LAS, VLQ, SCID-II, and DSHI, with Standard Error Bars 
 
        LAS amount of activity*                          LAS types of activity 
         
*Each activity was rated on a 0 – 4 scale as follows: 
0 = Not at all in the last week; 1 = Once in the last week; 2  = More than once in the last week; 3 
=Every day in the last week; 4 = More than once a day in the last week. The amount of activity 
variable was based on the mean of this rating across all activities on the measure. 
 
               VLQ Valuing                                         VLQ Action 
      
              
                          DSHI                                             SCID-II 
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Changes in number of PD diagnoses as determined by the SCID-II are 
displayed in Table 8.7. Three of the seven participants for whom there were follow-
up SCID-II data available, showed improvements, two deteriorated, and two showed 
no change. For some participants (e.g. 9 and 5), their change in number of PDs was 
consistent with changes on other measures. However, a notable exception to this was 
Participant 4, who showed a mixed set of results on the other study variables, but 
significant deterioration in terms of PD diagnoses, an issue that will be addressed in 
the discussion section. 
 
Table 8.7 
Changes in PD Diagnoses Based on 12-Month SCID-II Prevalence 
     
 
Participant 
 
Pre-therapy 
 
 
6-month follow-up 
 
1 
2 
3 
4 
5 
6 
7 
8 
10 
Mean no. PDs 
 
1 
3 
3 
1 
1 
3 
1 
3 
5 
2.3 
 
0 
2 
3 
4 
2 
- 
- 
3 
2 
2.2* 
Note. *Mean based on data from participants 6 and 7 being carried forward from pre-intervention 
 
Changes in participant self-harming behaviour are outlined in Table 8.8. No 
participant made a suicide attempt either during the intervention or the follow-up 
period. The majority of participants engaged in no self-harming behaviour either 
during the group or the 6-month follow-up period. Participants 4, 5, and 7 all reported 
a small number of self-harm incidents during the life of the group, with Participants 4 
and 5 also reporting some self-harm during the follow-up period. None of the CHAPTER VIII 
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participants required medical attention as a result of these self-harm incidents, and 
using the criteria drawn up for an on-going RCT involving participants with PD 
diagnoses (Lynch et al., 2011 – 2016), all incidents in the current trial would be 
categorised as either adverse events or adverse reactions, the two least serious 
categories of incidents. 
   
Table 8.8 
Participant Self-Harming Behaviour 
     
 
Participant 
 
 
During therapy 
 
During 6-month follow-up 
  
 
1 
2 
3 
4 
5 
6 
7 
8 
10 
 
0 
0 
0 
1 x cut 
3 x cut, 3 x head bang 
0 
4 x punched wall 
0 
 
0 
0 
0 
2 x cut, 1 x skin pick, 1 x head bang 
1 x cut, 3 x head bang 
0 
0 
0 
0 
Note. Where no follow-up psychometric data on self-harm were available, electronic health records 
were accessed for this period to assess whether any self-harm occurred. 
 
8.3.4.1 Participant satisfaction 
  Participant satisfaction was assessed using the CSQ-8, administered within 
two weeks of the end of the intervention. The mean total score was 28.7, out of a 
possible 32, indicating very high levels of satisfaction with the intervention, in terms 
of quality of the service and the extent to which it met participants’ needs. This result 
compared favourably with the mean score of 26.9 from the 10 DBT and CAT 
treatment completers between May and September 2012 at the same PD treatment 
clinic where the current trial was based. 
 
 
 CHAPTER VIII 
   
221 
8.4 Discussion 
8.4.1 Study Findings 
  Chapter VII reported an initial test of a group-based ACT intervention for 
DBT graduates with poor personality functioning, which indicated that the 
intervention was both feasible and acceptable to the patient group. Some increases in 
valued action and engagement in life were reported, but overall, the outcomes were 
mixed, particularly in terms of change in psychiatric symptomology. Several 
modifications were made to the treatment protocol and the current study was 
designed to test the feasibility, acceptability and impact of the modified protocol, in a 
second, small-scale, uncontrolled trial. Given that the participants have highly 
complex and potentially risky presentations, both group and individual responses to 
the protocol will be discussed in detail. 
 
8.4.1.1 Impact on Valued Action and Engagement in Life 
  ACT aims primarily to increase valued action and engagement in life, rather 
than targeting symptom reduction. The current protocol had a positive impact on 
valued action, as measured by the VLQ, and flourishing/engagement in life, as 
measured by the FS. Despite the small sample size, a significant group increase in 
valued action was found. The timing of this change was interesting in that although 
valuing (the other VLQ variable) increased pre- to post-intervention, valued action 
did not increase at the same time. Rather, what appears to have happened is that a 
shift towards a greater connection with personal life values preceded the significant 
increase in valued action reported at the 6-month follow-up point. The design of the 
study and small sample size does not allow for any possible causal relationship 
between increases in valuing and action to be tested. 
  No statistically significant group effects were detected other than for valued 
action, but because the study was underpowered due to the small sample size, effect 
sizes were calculated. These showed medium to large positive effects, both post-
intervention and at 6-month follow-up, for changes in engagement in life (FS), and 
number of types of positive activities (LAS), as well as valuing (VLQ).  
  Although values-related activity increased significantly, there was no change 
in general levels of positive activity, as measured by the LAS. The protocol did target 
personal values-related action, specifically, but it is unexpected that changes in CHAPTER VIII 
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valued action were not reflected at all on the LAS amount of activity variable. Based 
on the effect size calculations, what did increase pre- to post-intervention was the 
number of different kinds of positive activities participants engaged in, an increase 
that was maintained at follow-up. So, although participants did not increase the 
overall amount of positive activities they engaged in, they did broadened their 
repertoire of such behaviours. None of the published studies using ACT to treat PD 
included measures of values or activity, so it is not possible to compare these findings 
with those from other relevant research. There was a very large positive effect for 
engagement in life (FS), pre- to post-intervention and, although this decreased 
somewhat over the follow-up period, the pre-intervention to follow-up effect was still 
medium sized. The only one of these engagement in life and values-related variables 
for which RCIs could be calculated was the FS, with the results indicating that two 
participants showed reliable changes, pre to post-intervention, with the majority of 
participants showing non-reliable positive changes.  
In summary, the ACT group intervention was associated with large increases 
in values-related activity, types of activity, and engagement in life, with these 
improvements for the most part being sustained or even increasing at 6-month follow-
up. Given that ACT is primarily designed to bring about these kinds of changes, 
rather than targeting reductions in symptomology, these are highly promising results. 
 
8.4.1.2 Parasuicidal Behaviour and Psychiatric Symptomology 
  Parasuicidal Behaviour This intervention was designed to increase valued 
living while maintaining progress made through DBT in relation to parasuicidal 
behaviour. No participants made suicide attempts or were hospitalised due to 
psychiatric issues during the intervention or follow-up period. Three of the nine 
completers engaged in episodic, relatively minor self-harm, with none of these 
episodes requiring medical attention. As discussed in Chapter VII, Section 7.4.1.2, 
some re-emergence of self-harm has been reported in the follow-up period in both 
DBT and TAU conditions in BPD trials (e.g. van den Bosch et al., 2005), but due to 
differences between the various studies, it is not possible to directly compare 
findings. To determine whether the level of self-harm reported in the present study 
indicates that the ACT protocol had a negative impact, or alternatively was somewhat 
protective in relation to parasuicidal behaviours, requires further research, based on a 
randomised, controlled design with a larger sample. CHAPTER VIII 
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  Participant 4, who self-harmed during both the intervention and follow-up 
periods, reported that the only reason she had managed to not harm herself during the 
6 months pre-intervention was because she knew that she would not be able to access 
ACT if she acted on her urges. It may be that potential participants require motivation 
to stay self-harm free beyond getting access to therapy. The other participant who 
self-harmed both during and after the intervention, participant 5, had been free from 
substance misuse for 6 months prior to the intervention, but episodic binge drinking 
during the life of the group appeared to have increased her risk of self-harm.  
  As discussed in relation to Study 4 (Section 7.4.1.2), some re-appearance of 
self-harm during follow-up has been reported in DBT trials for PD (e.g. van den 
Bosch et al., 2005), and further research in the form of an RCT would be needed to 
understand more fully, the impact, positive or otherwise, of ACT on self-harm for this 
patient group. 
  Psychiatric Symptomology ACT was not developed primarily to reduce 
psychiatric symptoms, but given that previous ACT for PD protocols have positively 
impacted such variables, it was predicted that this protocol would have a similar 
effect. There were no significant changes in group means on either Axis I or Axis II 
psychopathology measures. Effect size calculations indicated a small positive effect 
for the BDI-II (depression), pre to post-intervention, and a small negative effect for 
the SCL-90-R (general psychiatric symptomology) over the same time period. 
However, both measures were associated with large positive group effects at 6-month 
follow-up. For the BDI-II this was large enough to yield a large, positive pre-group to 
follow-up effect size. The RCI analyses support these findings, with the majority of 
participants, particularly during the follow-up period, reporting changes on the BDI-II 
and SCL-90-R in the direction of better functioning. For a third of the sample, these 
changes were statistically significant. 
  There were no such increases in Axis I functioning in the follow-up period in 
the test of the earlier version of this protocol. The improvement with the current 
version might be due to changes in the content of sessions, and/or the addition of two 
sessions during the follow-up period, designed to maintain the use of ACT and DBT 
skills to support on-going engagement in life, and to address any participant-
identified problems.   
  These changes in Axis I symptomology are smaller than those on the same 
measures reported by Clarke et al. (in prep), a trial of ACT for treatment resistant CHAPTER VIII 
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mental health problems including PD. However, their sample scored substantially 
lower on both measures prior to therapy (mean score of 24.23 on the BDI-II 
compared to 35.78 for the current sample; mean score of 1.27 on the SCL-90-R GSI 
compared to 1.77), and only 50% of their sample had a co-morbid PD, suggesting 
that the current sample had significantly more severe and complex symptomology, 
with more modest therapeutic improvements likely to be expected. In fact, in terms of 
Axis I symptomology, the current sample was comparable to behaviourally unstable, 
BPD samples included in CBT and DBT RCTs, prior to treatment; a point that will be 
discussed in relation to both clinical studies, in Chapter IX, Section 9.1.2. 
  In terms of measures of personality functioning, effect size calculations 
indicated that on the self-control and social concordance SIPP domains, there were 
medium to large positive effects, pre to post-intervention. The remaining SIPP 
domains, and the SCID-II showed small positive effects. All SIPP domains showed 
some changes in the direction of poorer functioning during the follow-up period, but 
all SIPP group mean changes, pre-intervention to follow-up, remained in the direction 
of better personality functioning. This pattern was echoed in the RCI analyses, where 
there were non-significant trends in the direction of better functioning, for the 
majority of participants on the majority of SIPP domains. Only participant 10 showed 
consistent statistically reliable positive change on the SIPP domains, a result that was 
echoed in a reduction in her number of PD diagnoses.  
Across the sample, over 40% of the participants who provided follow-up 
SCID-II data showed reductions in number of PD diagnoses. One participant showed 
an increase in PD diagnoses (participant 4). This was not consistent with her SIPP 
scores, where she showed no reliable negative changes. Pre-intervention, she reached 
the diagnostic threshold for just one PD. This did not fit with her pattern of (high) 
scores on other measures of psychopathology or the experience of the group 
therapists, who viewed her as one of the more complex participants in the trial. It is 
possible that she under-reported her personality symptomology in the face-to-face 
SCID-II assessment prior to the group. 
Overall, some positive changes in both Axis I and Axis II symptoms occurred 
in relation to this intervention, despite the relatively severe nature of the participants’ 
presentations, and the fact that ACT does not directly address symptomology. 
However, in many cases these gains were modest. Interestingly, the main 
improvements in Axis I symptoms occurred in the follow-up period; perhaps CHAPTER VIII 
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indicating how difficult and slow therapeutic change can be for this patient group. It 
should be noted that effect size calculations indicated a pattern of deterioration in 
functioning in the 3 months prior to the start of the ACT intervention. Therefore, the 
intervention may have served to reverse this trend and to produce modest 
improvements on study outcome measures, a hypothesis that will be discussed further 
in Section 8.4.3.4. 
ACT suggests itself as a good candidate for a post-DBT intervention for PD 
patients for several reasons, including its emphasis on engagement in a valued life, 
and the possibility of ACT addressing emotional avoidance (which was Linehan’s 
original intention for a Stage II DBT intervention). It is also a transdiagostic 
approach, designed to impact universal psychological processes, such as CF, and as 
such might be particularly suitable for people with complex patterns of personality 
pathology. It is, however, possible that, although ACT may positively address 
processes that are implicated in both Axis I and Axis II psychopathology, patients 
might also require therapeutic input that is tailored to their particular experiences. If 
that is the case, the relatively modest improvements in symptomology reported here 
may represent the limitations of this general approach. Of course ACT protocols are 
often tailored to suit a particular patient group, as Gratz and Gunderson (2006) did in 
their ACT/DBT group for BPD patients. Whether there would be a way of 
meaningfully subdividing the current sample, to enable some narrowing the focus of 
the ACT protocol is unclear, given the very broad nature of personality 
symptomology of the participants. Lynch and colleagues (see Lynch & Cheavens, 
2008) have successfully taken this type of approach in their treatment of chronic 
depression with co-morbid emotionally over-controlled PDs.  
 
8.4.1.3 Feasibility and Participant Satisfaction 
  The intervention performed well in terms of feasibility, with nine of the ten 
participants completing therapy, a result that is comparable or better than those from 
other ACT for PD pilot trials (e.g. Clarke et al., in prep, reported an attrition rate of 
13% in their ACT condition). Group attendance was good, and satisfaction with the 
intervention was very high. Participants rated this intervention slightly higher than 
other PD treatment-completers rated DBT and CAT; the therapies that are standard 
care for PD in the same clinic.  
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8.4.1.4 Other Study Findings  
  There were no significant changes in group mean scores on any of the process 
measures, and few participants showed reliable individual changes on these measures. 
Effect size calculations showed that for the ACT-relevant measures (the CFQ and the 
AAQII), there was a medium and large negative effect respectively, pre to post-
intervention. Both measures were associated with very large positive effects sizes 
when comparing post-intervention and follow-up scores. If these changes were in 
response to the intervention, then it appears as if, when invited to consider what a 
personally meaningful life might look like, and then to engage more fully in such a 
life, participants initially became less psychologically flexible and more fused. Over 
time, perhaps through continued, gradual experiential engagement with these ACT-
relevant processes, it appears as if a substantial positive shift occurred.  
  Although this interpretation is based on limited evidence and requires future 
investigation, it does fits with the therapists’ observations of participants experiences, 
in that, even with the modifications made to the ACT protocol outlined in Chapter 
VII, Section 7.2.4.6 and Section 8.2.4.1 of this chapter, some participants were still 
initially anxious about making changes in their lives, and found the focus in ACT on 
experiencing emotions, cognitions and so on, counter to their usual coping strategies, 
and somewhat challenging. However, with encouragement to make flexible choices 
about when to engage and when to avoid, and with repeated, small practice steps, the 
majority of participants appeared to increase in confidence and willingness, over 
time. It is possible that any intervention post-Stage I DBT, that addressed engagement 
in life (and therefore also engagement with private experiences such as emotions), 
would result in similar changes on these process measures. 
  Based on the limited data from this pilot study, the temporary increase in CF 
and inflexibility does not appear to necessarily be detrimental; Participant 10, for 
example, clearly benefitted from the ACT intervention, in terms of changes on 
outcome measures, and reported an increase in fusion and inflexibility pre- to post 
intervention, followed by a decrease in both variables, by 6-month follow-up. 
Changes on these ACT process measures with this patient group needs further 
investigation, as a similar increase in a related measure (the AAQI) has not been 
found in other ACT PD trials (e.g. Gratz and Gunderson, 2006). 
  The eventual increase in flexibility and defusion occurred during the same 
time period as the increases in valued action and improvements in Axis I CHAPTER VIII 
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symptomology discussed earlier. Due to the study design and small sample size, it is 
not possible to test if there is a causal link between changes in the ACT processes and 
changes in outcome measures, or what the direction is of any such link. ACT theory 
suggests that these processes are implicated in psychopathology, and published 
outcome trials have shown related processes mediating ACT-related outcomes in 
(non-PD) treatment trials (e.g. Zettle et al., 2011.) 
  Finally, as with the previous study, the majority of the participants in this trial 
(90%) met diagnostic criteria for PDs from two clusters, with 40% having PD 
diagnoses across all three clusters. These results support the view that PD diagnostic 
categories do not represent completely separate disorders, and that there appears to be 
shared personality pathology across clusters.  
 
8.4.2 Methodological Limitations 
  The majority of the limitations of this study, such as small sample size and 
lack of randomisation, are identical to those identified for the previous trial, and stem 
from design decisions appropriate to the initial testing of a new treatment for a 
potentially high risk patient group. These limitations are discussed in Chapter VII, 
Section 7.4.2. As with the previous study, the current sample did not include male 
participants, despite there being no gender difference in PD prevalence. This 
limitation means that generalising from the findings should be done with caution. 
A number of important questions about possible causal relationships amongst 
study variables have been raised in this study, which could only be answered through 
significant changes in study design. Several limitations of the previous treatment 
protocol were addressed in this study, and this appeared to have a positive impact in 
terms of outcomes. However, the psychopathology outcomes were still relatively 
modest, and it may be that further fine-tuning of the protocol is required. Several 
recommendations for further research, addressing the current limitations, are made in 
Section 8.4.3. 
8.4.3 Implications and Future Research 
  Although the number of participants in this trial was small, and so 
generalising from the findings should be done with this in mind, taking into CHAPTER VIII 
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consideration the results of the first trial of the protocol as well, a number of possible 
recommendations for future ACT outcome research with this patient group suggest 
themselves. 
 
8.4.3.1 Participant Selection 
1. It seems likely that a period free from self-harm of longer than 6-months 
(possibly 12 months) prior to intervention would decrease the likelihood of 
self-harm during ACT.  
2. Similarly, a period of more than 6-months free from substance misuse 
would be advisable.  
3. A minimum of 6 months between the end of DBT and the start of the ACT 
intervention would be advisable. 
4. Incidents of self-harm between DBT ending and ACT commencing may 
indicate the possibility of continued behavioural instability during the ACT 
intervention. 
5. A participant’s number of PD diagnoses did not appear to affect outcome, 
but specific diagnoses, (schizotypal and antisocial PD) might be associated 
with poor outcomes. Excluding people with these diagnoses might be 
advisable. 
 
8.4.3.2 ACT Protocol 
  Based on changes in study measures and anecdotal reports, a number of 
aspects of the intervention may have been particularly helpful. These features of the 
protocol should be retained in any future version.  
1. Connecting with personal values appears to have been motivating for many 
participants. 
2. Repeatedly coaching participants in taking small behavioural steps in a 
valued life direction, appears to have been effective in increasing valued 
action. 
3. A number of the participants who benefitted from the intervention appeared 
to bring about some change in their relationship with their private experiences 
such as thoughts, and cited both defusion and mindfulness practices as having 
been helpful in achieving this.  
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8.4.3.3 ACT Protocol Changes 
1. In this study, many of the positive changes occurred in the 6-month follow-
up period. This suggests that this patient group took a relatively long time to 
begin to make therapeutic gains, and therefore extending the intervention over 
a longer time period might optimise these improvements. Alternatively, it may 
be that extending the intervention is not required, but that the improvements 
might continue to develop beyond the current 6-month follow-up point, and 
that an extended follow-up period of 12 or 18 months is required. 
2. The finding that participants initially became more fused and less flexible 
requires further investigation. If this is found to be detrimental for some 
participants, then further modifications to the protocol might be necessary, 
along the lines of further emphasising the flexible use of both 
avoidance/control and acceptance strategies.  
 
8.4.3.4 Measures 
1. All measures included in the study were completed by all participants 
without difficulty, suggesting feasibility of use with this patient group. As this 
was the first time some of the measures had been used with a PD sample, this 
research has established that they all could be considered for inclusion in 
future trials. 
2. The VLQ was used in a simplified form and performed well with this 
patient group. There is no psychometric data available for this form of the 
measure, so a study examining its reliability and validity would be a useful 
development.   
3. The LAS was developed for use in this study because the ACT therapists 
were concerned in Study 4 that anecdotal reports of increased positive patient 
activity had not been fully reflected in the psychometric data for that study. 
However, the ‘amount of activity’ variable of the LAS showed no change 
between any of the study time points, while group change on the VLQ valued 
action variable was significant. It seems likely that the LAS was not sensitive 
enough to detect these important changes, and its exclusion from future trials 
should be considered, unless it is significantly modified and tested 
psychometrically.  
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8.4.3.5 Future Trial 
Although few significant results were found in this study, the effect size 
calculations suggested that an adequately powered study would have been likely to 
show several significant positive changes. The next step therefore should be an RCT, 
testing the protocol against a control condition of people with poor personality 
functioning who are receiving standard psychiatric care. The effect size calculations 
for the group changes in the 3 months prior to the start of the intervention suggest that 
participants were deteriorating. If this deterioration were to be observed in a control 
group, along with the improvements in functioning that would be predicted for the 
ACT condition, then large between-group differences, in favour of ACT, would be 
likely. 
   
8.4.4 Summary 
This study indicates that this ACT-based group intervention is a safe and 
acceptable treatment approach, post-DBT, for this potentially risky and difficult to 
treat group, and has the potential to help patients develop valued “lives worth living” 
(Linehan, 1993, p. 172). Taking into consideration the recommendations outlined 
above, the next step in testing the protocol would be to use an RCT design, with 
greater participant numbers and an extended follow-up period. 
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CHAPTER IX 
General Discussion 
 
As described in Chapter I, PDs are relatively common, chronic mental health 
problems, associated with risky behaviours and poor treatment outcomes. Although 
current diagnostic systems treat PDs as distinct disorders, there is evidence to suggest 
that there is personality pathology that cuts across PD diagnostic categories, and that 
PDs might be more helpfully be conceptualised dimensionally, in terms of poor 
personality functioning. There are some effective psychosocial interventions for PD, 
most notably DBT for BPD. DBT graduates however often continue to experience 
significant mental health problems, and report difficulties in engaging in life, and 
have been described as experiencing “quiet desperation” (Dimeff & Linehan, 2001, 
p.2). For other PD diagnoses, little treatment development research has been carried 
out and there are few evidence-based psychotherapy options.  
There are two plausible reasons for considering ACT as a possible candidate 
for a post-DBT intervention for people with poor personality functioning across 
diagnostic categories. First, it was developed to impact universal psychological 
processes such as CF, and is therefore hypothesised to be effective across mental 
health diagnostic categories. Second, ACT emphasises experiencing rather than 
avoiding private experiences, and engaging in a valued life, and is therefore 
consistent with Linehan’s (1993) views on what Stage II and III DBT interventions 
should address.  
Based on these considerations, this thesis had two main aims: firstly, to 
investigate CF, an important yet under-researched component of the ACT model of 
psychopathology, and secondly, to develop and test a novel ACT intervention for a 
post-DBT sample with poor personality functioning. The thesis focused on phases I 
and II of the complex interventions development model outlined in Chapter III 
(Campbell et al., 2000). Initially, analogue studies were used to investigate CF, a 
crucial aspect of the model underpinning ACT. This included testing its relevance to 
personality functioning. This was followed by small-scale treatment-development 
studies, designed to pilot a new ACT-based group intervention, for a heterogeneous 
post-DBT PD sample. CHAPTER IX 
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  This chapter provides a summary of the research findings, outlining the role 
of each study in the overall research programme. The thesis is also critically reviewed 
in terms of its main strengths and limitations. The implications of the study findings 
in relation to developing and refining ACT theory, and understanding and treating 
PDs, are also reviewed. Finally, recommendations for future research are made.  
 
9.1 Main Findings 
9.1.1 Analogue Research 
  ACT theory hypothesises that a number of linked psychological processes, 
including CF, underpin psychopathology. CF is a key component of the ACT 
psychopathology model, yet it remains relatively under-investigated, in large part due 
to the lack of a reliable and valid measure. Such a measure (the CFQ) has recently 
been developed, and Study 1 outlined its clinical validation. Based on a mixed, NHS, 
mental health sample (including people with PD diagnoses), and using CFA 
methodology, the CFQ was shown to have the same theory-consistent factor structure 
as had been identified with a non-clinical sample. Overall, it was found to be a 
reliable and valid self-report measure of CF, with the clinical sample. These findings 
allowed for the possibility of CF to be investigated with clinical and nonclinical 
samples.  
  Study 2 demonstrated one such application of the CFQ; testing the role played 
by CF in relation to personality functioning. The process was shown to fully mediate 
the relationships between known genetic (negative affectivity) and environmental 
(childhood trauma) risk factors for poor personality functioning, and actual 
personality functioning in adulthood. This model-testing study, although cross-
sectional in design and therefore not able to demonstrate causality, represented the 
first evidence that CF is associated with poor personality functioning. Given that it is 
not possible to change an individual’s history or genetics, it is important to identify 
mediating variables (CF in this case), to guide the development of interventions.  
The final analogue study in this thesis was designed to use the CFQ in the 
development of a measure of the behavioural aspects of EA, another key ACT 
process. Avoidant behaviour is common amongst PD patients, and along with CF 
appears to interfere with healthy psychological functioning and engagement in life. CHAPTER IX 
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The study was based on a non-clinical, student sample, as a safe, first step. A 
prototype computer-based task was developed, which—based on the study findings—
appeared to function as a behavioural measure of CF rather than EA. Although this 
result was unexpected, the availability of two measures of CF that utilise different 
methodologies, can only be advantageous in terms of increasing confidence CF as a 
construct, and the empirical evidence relating to CF. 
The results from these analogue studies, along with existing research (e.g. 
Gratz and Gunderson, 2006; Clarke, et al., in prep) suggest that ACT, designed as it 
is, to impact universal psychological processes such as CF, might be of benefit to 
people with poor personality functioning. A novel ACT-based intervention for post-
DBT patients with mixed PD presentations was therefore developed and initial testing 
of that protocol was carried out (see next section).  
 
9.1.2 Applied Research 
  Previous outcome trials (e.g. Gratz & Gunderson, 2006), indicated that ACT 
might be beneficial in relation to PD, but its applicability to people with broad, 
transdiagnostic PD symptomology had not been tested. Given the complexity and risk 
histories of the target participants, a cautious approach to treatment development was 
taken. 
  Study 4 used an uncontrolled, pre-post design to test an ACT-based (with 
some DBT features) group intervention. Although the protocol was found to be 
feasible, and participants reported high levels of satisfaction, outcomes were mixed. 
There were no significant pre to post group differences, possibly due to the small 
sample size. RCI calculations indicated that the protocol had a positive impact on 
some primary outcome measures such as valued action, engagement in life, and some 
personality domains, and on some key process variables including CF. However, a 
minority of participants showed no improvements or deteriorated on some measures, 
particularly those assessing Axis I symptomology. Following feedback from 
participants and the therapists’ experiences, several possible improvements to the 
protocol suggested themselves, and a second, small-scale trial was carried out to test 
the modified protocol. CHAPTER IX 
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  Study 5, used the same design to test the extended and refined intervention. 
The results suggested that the changes to the protocol had had a positive impact. 
Encouraging results from the first trial, such as increases in valued activity, were also 
found in this trial, and were maintained or improved at 6-months follow-up. 
Additionally, effect size and RCI calculations indicated that the second version of the 
protocol had a more positive impact than the first, on psychiatric symptomology such 
as depression and PD diagnoses. Nonetheless, these latter improvements were 
relatively modest, and not all participants benefitted.  
  Changes in CF and psychological flexibility were consistent with each other; 
initial increases in fusion and inflexibility were followed by large improvements 
during the follow-up period, with the protocol being associated with a reduction in 
CF, overall. The improvements in these processes occurred at the same time as 
improvements in psychiatric symptomology. 
  Participants from both studies had highly complex personality presentations, 
with, on average, four PD diagnoses. The severity of Axis I symptomology in the 
cohorts matched that of pre-treatment participants in published CBT and DBT PD 
trials. For example, the mean score on the BDI-II (depression) across the two clinical 
studies in this thesis was 33.43. Davidson et al. (2006) reported a pre-intervention 
mean of 31.30 in their CBT condition, while McMain et al. reported a mean BDI-II 
score of 37.19 in their DBT condition. This is interesting given that the thesis study 
participants were DBT graduates, and DBT outcome research suggests that they 
would have experienced some improvements in Axis I functioning as a result of 
DBT. There is some evidence from Study 5 that the participants had deteriorated in 
terms of psychological functioning in the 3 months prior to starting ACT. This might 
suggest that DBT had improved Axis I symptomology but that those improvements 
had not been sustained. It is also possible that this group represents a particularly 
severe sub-group of DBT graduates who did not benefit from DBT in terms of Axis I 
disorders. 
Both studies have limitations (discussed below), and should be viewed as the 
initial steps in the development of an effective treatment. Nonetheless, some 
provisional conclusions can be drawn from the findings, although generalising from 
these conclusions should be done with caution: CHAPTER IX 
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1. Based on the severity of pre-treatment symptoms, and verbally reported life 
difficulties, there is a need for a post-DBT psychosocial intervention for at least some 
DBT graduates. 
2. ACT can be delivered to this patient group in a format that is feasible, 
acceptable and safe. 
3. ACT can impact positively on engagement in life, valued action, and 
psychological functioning with this patient group. 
4. Some of these improvements are modest, and there are indications that the 
protocol was not beneficial to all participants. 
5. ACT-relevant processes such as CF appeared to be affected by the protocol, 
although not in a straightforward way, in the case of Study 5. 
   Taken together, the two clinical trials demonstrated the possibility of using an 
ACT-based group intervention to safely address post-DBT residual difficulties, for a 
particularly complex patient group. However, it is unclear whether the somewhat 
limited positive impact of the intervention might be improved by further refinement, 
or whether it indicates the limit of a non-specific, transdiagnostic approach, with 
further therapeutic gains only being possible with more focussed interventions. 
Alternatively, it may be the case that this particularly complex sub-group of people 
with PDs is especially difficult to treat, and these results, modest though they are, 
should be viewed as a validation of the approach taken. 
 
9.1.4 Main Strengths  
  This programme of research had several strengths. I identified gaps in the 
current ACT model-testing literature and the PD treatment literature, and a novel, 
theory-consistent approach was taken to address these gaps in a coherent and 
systematic fashion. The programme of research that ensued was designed to fit within 
a well-established model for the development of complex psychosocial interventions. 
A multi-method approach was used, involving both analogue and applied research, to 
allow for a broad investigation of ACT and its relevance to personality functioning, 
across a range of samples. Diverse and advanced statistical methods supported this 
approach. The thesis has enhanced understanding of common yet significantly under-
researched mental health difficulties, and involved the development of two measures CHAPTER IX 
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that have broad applicability, and a novel treatment approach for a patient group who 
are generally poorly served in terms of evidence-based interventions.  
 
9.1.5 Main Limitations 
  A number of limitations must be weighed against the strengths reviewed 
above.  
Analogue Studies Due to time and resource constraints, in Study 1, CFA was not 
preceded by EFA with a separate sample. Instead, the CFQ factor structure identified 
with non-clinical samples was used to suggest what factor structure should be 
modelled and tested with the clinical sample. This is the correct procedure when there 
are limited samples available, but ideally, two clinical samples would have been 
recruited. Similar constraints also meant that in Study 3, the computer-based task was 
not further developed to yield a measure of behavioural avoidance, as originally 
planned. This meant that although the study enhanced knowledge and resulted in the 
development of a behavioural measure of CF, some of the original aims of the study 
were not met. Finally, both for ethical and resource reasons, non-clinical samples 
were used in Studies 2 and 3 to investigate clinically-relevant phenomena. 
 
Applied Studies Because Studies 4 and 5 involved a previously untested protocol and 
participants with significant risk histories, the ACT intervention was tested on very 
small samples, and no RCT was conducted. This means that it is unclear how well the 
findings from these studies will generalise, and without the random allocation of 
participants, a causal relationship between the intervention and the observed 
outcomes cannot be certain. These studies should therefore be viewed as initial steps 
on the path to developing an evidence-based intervention (see Section 9.2.5 for 
recommendations for next steps).  
Also, in terms of limitations, as discussed in Section 9.1.2, the impact of the 
ACT protocol was somewhat limited, with some participants clearly not benefitting, 
suggesting that further development and testing is needed. 
 
General Limitations As with the majority of related published research, all the thesis 
studies relied to a large extent on self-report measures. There are sound ethical and CHAPTER IX 
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economic justifications for this, but nonetheless, the use of such measures carries the 
risk of demand bias, participant fatigue, and inaccurate memory of experiences. 
Attempts were made to minimise these risks, such as allowing participants to 
complete questionnaires in private, and anonymously where possible. Additionally, 
Study 3, in yielding a behavioural measure of CF, will help improve this issue in 
future research.  
  Finally, in terms of limitations across studies, there were biases in all study 
samples in terms of gender, ethnic background, and in the case of Study 3, age.  
 
 
9.2 Implications and Suggestions for Future Research 
 
9.2.1 CF, the CFQ, and the ACT Model 
  The ACT model implicates a set of related processes in psychopathology, 
cutting across syndromal categories. The way in which these processes, including CF, 
relate to each other, is currently imprecisely articulated in the ACT literature, and it 
will be difficult to examine this issue empirically until there are valid measures of all 
relevant processes. The development and validation of the CFQ, the first 
psychometrically sound, general measure of CF, is therefore an important 
development for the ACT research community because it will support the 
examination of the role and impact of CF in many settings, with clinical and non-
clinical populations. As with any psychometric measure, the CFQ itself should be 
subject to an on-going programme of testing and validation, including examining its 
performance with other physical and mental health populations, with samples from 
different ethnic backgrounds, and in a variety of settings. 
  There are several gaps in the ACT research literature in relation to CF that the 
CFQ could be used to address. For example, the role of CF as a possible mediator of 
therapeutic change in outcome trials is under-researched. Also, although the impact of 
stand-alone defusion practices has been tested (see Chapter II, Section 2.2.1.2), to 
date this work has relied on weak measures of CF. Replication of the findings from 
these studies using the CFQ, would be an important step in assessing the effect of 
defusion exercises.  CHAPTER IX 
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  Examination of the relationships within the ACT process model will require 
the development of good quality, distinct measures (such as the CFQ), for all of the 
processes involved. Related to this point, a new self-report measure of EA has been 
published since the studies in this thesis were planned (Gamez, Chmielewski, Kotov, 
Ruggero, & Watson, 2011). If it proves to perform well, it could contribute to the 
testing of the ACT model, as well as further validation of the CFQ and any 
behavioural measures of ACT processes such as the one developed in Study 3. 
It will also be important, in terms of theory refinement, to examine the 
relationship between CF and other related constructs, such as decentering, and 
metacognitive awareness. 
9.2.3 Additional Mediators of Poor Personality Functioning 
  Understanding mediating variables in relation to psychological difficulties is 
important because it can both increase theoretical understanding of those difficulties 
(through model-building), and guide treatment development. There is a paucity of 
modelling studies in relation to PD. Study 2 demonstrated that CF plays an important 
role in relation to poor personality functioning. Although CF fully meditated the 
relationship between risk factors and personality functioning, and accounted for 59% 
of the variance in the latter, other factors will also be relevant. Studies such as 
Cheavens et al., (2005) and Kingston et al., (2010), suggest that EA or a related 
construct such as thought suppression are likely candidates as additional mediators in 
relation to poor personality functioning. Also, given the hypothesised relationship 
between CF and EA whereby EA would not be necessary if fusion had not already 
occurred (e.g. Pistorello et al., 2000), the relationship between these constructs could 
be examined using a path model of personality functioning. Other constructs such as 
emotional regulation and self-compassion might also be expected to play a mediating 
role in relation to poor personality functioning, based on previous relevant research 
(e.g. Gratz & Tull, 2010; Gratz et al., 2006; Kuyken et al., 2010) and should be tested 
as part of a more comprehensive model of processes underpinning personality 
functioning. CHAPTER IX 
   
239 
9.2.4 Behavioural Measures of Psychological Processes 
  The potential risks associated with over-reliance on self-report measures have 
already been alluded to in this discussion. In clinically focussed ACT research in 
particular, behavioural measures that reflect hypothesised ACT processes are likely to 
increase the validity and utility of study findings. It can be a complex and time-
consuming process to develop such measures to a point where they function as 
required, as seen in Study 3. The potential benefits however suggest that the 
development of both self-report and behavioural measures of key ACT processes 
should be pursued.  
 
9.2.5 Psychosocial Treatment of Poor Personality Functioning 
  There are many gaps in our understanding of how to best treat PD, despite the 
pioneering work done by Linehan and others in the DBT research community, in 
particular. The studies in this thesis represent an attempt to address just one of those 
gaps: treating the continuing psychological difficulties of people with several PD 
diagnoses, post-DBT. The two linked treatment development studies have provided 
information about the impact of a novel ACT-based intervention for this patient 
group, as well as some indications of which patients might and might not benefit. In 
terms of the Rounsaville et al. (2001) treatment development stages, these studies 
have addressed Stage Ia. Stage Ib would involve an RCT with a larger sample, in 
order to assess the protocol’s impact in a better powered and controlled study. 
Options for control conditions include a waiting list, treatment-as-usual, or an active 
control such as continued DBT, perhaps in the form of a DBT graduates’ group. 
  This is of course not the only option for a post-DBT psychosocial 
intervention. Another possibility would be to include some features of ACT in a DBT 
Stage II intervention. Component studies testing specific aspects of ACT might aid 
clarification of which components of ACT to include. Based on clinical observation 
throughout the current clinical work, this is likely to include an emphasis on valued 
action, and the cultivation of a defused relationship to private experiences. A third 
option would be to develop and test a purely DBT Stage II intervention, as originally 
suggested by Linehan (1993). To date, no research testing such an intervention has 
been published. CHAPTER IX 
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The difficulty with the two latter possibilities is that DBT tends to be tailored 
to meet the needs of people with very specific PD presentations, usually BPD. Lynch 
and colleagues are in the process of testing a form of DBT for people with treatment 
resistant depression and co-morbid emotionally over-controlled PDs, cutting across 
several PD diagnoses (Lynch et al., 2011 – 2016). Their approach may well prove 
more effective for a heterogeneous PD patient group than the more general 
intervention tested in this programme of research (this would need testing 
empirically). However, there were several people in the current trials who 
simultaneously met the diagnostic criteria for both emotionally over- and under-
controlled PDs, and it is unclear which currently available form of DBT would best 
meet their needs. If more than one of the above treatment options were pursued, the 
resulting protocols could be tested against each other in an RCT.  
A significant advantage of an ACT-based protocol for a heterogeneous PD 
sample is that it is designed to impact universal psychological processes implicated in 
psychopathology. An alternative would be to develop a protocol based on a different 
approach, which is also thought to act through universal mechanisms. For example, 
Clarke et al. (2013) suggest that their CAT intervention for mixed PDs may have its 
impact through the therapeutic relationship and its impact on relationship with self 
and others. Based on their findings, this approach might have something to offer post-
DBT patients with poor personality functioning across PD categories. However, the 
disadvantage of using CAT as a post-DBT therapy is that the two approaches are so 
different to each other (theoretically and practically) that the transition for patients 
from one to the other might prove difficult. ACT and DBT have sufficient shared 
theoretical underpinnings and focus of content that the transition is manageable. 
  Studies 4 and 5 confirmed the need for a post-DBT intervention. There are 
several approaches including, but not limited to, ACT, that might be of benefit to 
people with complex PD presentations, post-DBT. A great deal more treatment 
development research will be needed in order to ascertain the most effective 
approaches. 
 
9.3 Concluding Remarks 
This thesis was designed to enhance understanding and measurement of a 
specific aspect of the ACT model, CF, and to test the applicability of ACT, both CHAPTER IX 
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theoretically and clinically, to poor personality functioning. This integrated 
programme of research, although clearly just the initial steps towards a 
comprehensive ACT-based understanding and treatment of PD, has demonstrated that 
CF can be measured successfully with mental health patients including those with 
PDs, has measurable behavioural consequences, and is relevant to the development of 
personality problems. An ACT-based protocol has also been shown to have some 
positive effects for this highly complex patient group. 
  Levin at al. (2012) argue that it is not sufficient to develop and test the 
efficacy of psychosocial interventions; researchers should also be testing and refining 
relevant theory in parallel, with each of these strands of empirical work 
complementing and informing the other. Only is this way can psychotherapeutic 
interventions have a coherent theoretical basis, with empirically demonstrated 
mechanisms of change. This thesis represents an attempt to bring basic and applied 
science together in exactly this way. One possible advantage of a focus on process-
orientated research alongside treatment development trials is that it might support an 
exploration of the commonalities (of action), between apparently differing therapeutic 
approaches, to the advantage of patients. Therapies such as ACT and DBT that have 
been hypothesised to have theoretical common ground (Hayes, 2004) might both be 
enhanced by joint empirical exploration. 
  The clinical trials in the thesis focused on an almost completely neglected 
sub-group of a relatively neglected patient group (people with PDs)—neglected both 
in terms of process and outcome research. They are a challenging group of people to 
include in research trials, but the suffering experienced by such patients and their 
loved-ones surely should motivate researchers to engage with this group. This thesis 
demonstrates that such work is possible. 
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APPENDICES 
Appendix A: Summary of principal methodological characteristics and results for all cognitive behavioural therapies RCTs for 
PD, organised by intervention type 
 
Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test 
Points 
Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
Behaviour  
Therapy 
         
 
     
 
Alden 
(1989) 
 
 
 
 
Avoidant PD 
20 - 40 years 
old 
All unmarried 
 
Graded 
exposure 
(GE). 
10 x weekly 
group 
sessions. 
N = 76 in total 
for across 
intervention 
and control 
groups - no N 
for specific 
conditions 
reported.  
 
GE + social skills 
training. 
 
GE + social skills 
training + focus 
on intimacy. 
 
Wait list control. 
 
All active 
conditions 
matched for 
frequency of 
contact/ number 
of sessions. 
 
 
Pre, 
post, 3-
month 
follow-
up. 
 
SORT 
SRI 
SQ 
Ideographic 
measure of 
social targets. 
Self-monitoring 
of social 
activity. 
Interviewer 
behavioural 
rating. 
 
 
No risk related 
information 
reported. 
 
Significant 
improvements 
on all 
measures for 
all active 
conditions 
compared 
with w/list 
control, 
maintained at 
follow-up. 
Addition of 
skills training 
made no 
difference to 
outcomes. 
 
Adherence-
rating not 
independent. 
Comparison of 
3 active, 
manualised 
conditions, 
and a w/list 
control. 
Short follow-
up. 
Small N. No 
power 
calculation. 
Focused on 
PD rarely 
investigated. 
Data not 
analysed on 
ITT basis. 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test 
Points 
Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
Cognitive 
Behaviour 
Therapy 
               
 
Davidson, 
Tyrer, Tata, 
Norrie, 
Palmer & 
Murray 
(2006) 
 
 
 
 
BPD: 100% 
DSH or 
hospitalisatio
n within 
previous  
12 months 
 
CBT + TAU. 
30 x 1-to1 
sessions over 
1 year. 
N = 54 
 
Non- 
Manualised, 
general UK NHS 
TAU. 
Not matched to 
test condition for 
frequency of 
contact/ number 
of sessions. 
N = 52. 
 
Pre, 
post, 6 
month, 
12 
month  
follow-
up. 
 
Suicidal acts, A 
& E visits, 
hospitalisations
. 
ADSHI 
BDI-II 
STAI 
BSI 
IIP 
SFQ 
YSQ 
EuroQol 
WAI 
 
 
Significant 
reduction in 
suicidal acts, 
A & E visits, 
hospitalisation
s for both 
conditions at 
follow-up. 
Significant 
between group 
difference for 
suicide acts, in 
favour of CBT. 
 
 
 
Significant 
improvement 
on all 
measures 
for both 
conditions at 
12 and 24 
months. 
CBT 
outperformed 
TAU on 
symptom 
distress, state 
anxiety, 
dysfunctional 
beliefs. 
 
Manualised 
and 
adherence 
rated 
treatment 
condition. 
Control 
condition 
neither 
manualised 
nor adherence 
rated. 
Controlled 
follow-up. 
Sufficiently 
powered. 
 
Emmelkamp
, et al., 
(2006) 
 
 
 
 
 
 
 
 
Avoidant PD 
Excluded 
suicide risk. 
 
Manualized 
CBT: 20 
sessions over 
6 months. 
N = 21 
 
1. Manualized 
brief dynamic 
therapy: 20 
sessions. 
N = 23 
 
2. Waiting list. 
N = 18 
 
Pre, 
post, 6 
month 
follow-
up. 
 
SCID-II 
PDBQ 
LWASQ 
SPAI 
AS 
 
Not applicable 
(high risk was 
an exclusion 
criteria). 
 
 
Significant 
improvements 
on all 
measures for 
both 
conditions. 
CBT 
outperformed 
BDT and WLC  
 
 
Manualised 
and 
adherence 
rated 
treatment and 
control 
condition, and 
WLC. 
Follow-up not 
including w/list 
control. APPENDICES 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test 
Points 
Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Emmelkamp 
et al., cont. 
             
on majority of 
measures; 
maintained at 
6-month 
follow-up. 
 
Small N. No 
power 
calculation. 
Focused on 
PD rarely 
investigated. 
Data not 
analysed on 
ITT basis. 
 
 
Evans, et al. 
(1999) 
 
 
 
Cluster B 
personality 
“disturbance” 
+ recent 
DSH. 
 
 
Brief, 
CBT/DBT 
hybrid 
bibliotherapy + 
up to 6 
sessions 
(MACT).  
N = 18. 
 
General, non-
manualized 
psychiatric TAU,  
Not matched to 
test condition for 
frequency of 
contact/ number 
of sessions. 
N = 16. 
 
 
Pre, 6-
months. 
 
Time to next 
DSH episode. 
Median DSH 
per month. 
HADS 
SFQ 
Financial cost 
of follow-up per 
month. 
 
 
Non-sig trend 
favouring 
MACT on time 
to next DSH 
episode and 
median DSH 
episodes. 
 
MACT 
outperformed 
TAU on HADS 
only 
 
Manualized 
treatment 
condition. 
Adherence not 
rated. 
No active 
control 
condition. 
Underpowered
. 
Data not 
analysed on 
an ITT basis. 
Easy to 
implement, 
low-cost 
intervention. 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test 
Points 
Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Svartberg, 
Stiles & 
Seltzer 
(2004) 
 
 
 
 
 
 
 
 
One or more 
Cluster C PD. 
Excluded all 
other PD 
diagnoses. 
Excluded  
parasuicidal 
behaviour. 
 
 
 
CBT (40 
weekly  
sessions). 
Conditions 
matched for  
frequency of 
contact/ 
number of 
sessions.  
N = 25. 
 
Short term (40 
weekly sessions) 
1-to-1 dynamic 
psychotherapy 
(STDP). 
N = 25. 
 
 
 
 
 
Pre, 
mid-
therapy, 
post, 6, 
12, and 
24-
month 
follow-
up. 
 
 
 
 
 
SCL-90 
IIP 
MCMI-III 
 
 
 
 
 
 
 
 
Not applicable 
(high risk was 
an exclusion 
criteria). 
 
 
 
 
 
 
 
Significant 
improvements 
on all 
measures for 
both 
conditions. No 
significant 
between 
group effects. 
Some  
trends in 
favour of 
STDP. 
 
Adherence 
independently 
rated. 
Comparison of 
2 active, 
manualised 
interventions. 
Controlled, 
long follow-up. 
Under 
powered. 
Focused on 
PDs rarely 
investigated. 
 
 
Blum, St. 
John, Pfohl, 
Stuart, 
McCormick, 
Allen et al. 
(2008) 
 
BPD: not 
required to 
have recent 
parasuicidal 
acts. 
 
Systems 
Training for 
Emotional 
Predictability 
and Problem 
Solving 
(STEPPS) 
20 x weekly 
group 
sessions. 
+ TAU. 
N = 65. 
 
General, non-
manualised TAU, 
could include 1-
to-1 therapy. 
Not matched to 
test condition for 
frequency of 
contact/ number 
of sessions. 
N = 59. 
 
Pre, 
post, 1 
year 
follow-
up. 
 
ZRSBPD 
BESOT 
PANAS 
CGI 
GAS 
BDI 
SCL-90 
BIS 
SAS 
 
Significant 
reduction in 
suicidal 
acts,self-harm, 
hospitalisation
s for both 
conditions, 
maintained at 
follow-up. 
No significant 
between group 
differences. 
 
Significant 
improvement 
on all 
measures 
for both 
conditions, 
maintained at 
follow-up. 
STEPPS 
outperformed 
TAU on 
ZRSBPD, 
PANAS, CGI, 
GAS, BDI, 
BIS 
 
Manualised/ 
adherence 
rated 
treatment 
condition. 
Non-
manualised 
TAU control. 
Controlled 
follow-up/ 
Sufficiently 
powered. 
High attrition 
in STEPPS 
condition. APPENDICES 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test 
Points 
Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
Dialectical 
Behaviour 
Therapy 
               
 
Linehan, 
Armstrong, 
Suarez, 
Allmon, & 
Heard 
(1991)  
 
 
 
 
BPD. 
Female. 
Parasuicidal 
act within 
previous 8 
weeks. 
 
 
DBT. Full 
programme. 
12 months. 
N = 24. 
 
Non-manualised, 
standard TAU. 
Not matched to 
test condition for 
frequency of 
contact/ number 
of sessions. 
N = 22. 
 
Pre, 4, 
8, 12 
months. 
 
 
PHI 
THI 
SSI 
BDI 
BHS 
RLISCS 
 
Significant 
between group 
differences in 
favour of DBT 
on number of 
parasuicidal 
acts, medical 
risk associated 
with those 
acts, 
psychiatric 
inpatient days. 
 
 
 
Significant 
improvement 
on all other 
measures 
for both 
conditions,  
No significant 
group 
differences.  
 
 
No therapist 
adherence 
reported. 
Manualised 
treatment 
condition. 
Non-
manualised 
TAU control. 
No follow-up 
reported. 
Underpowered
. 
Low attrition 
for DBT. 
Data not 
analysed  on 
ITT basis. 
 
 
Linehan, 
Schmidt, 
Dimeff, 
Craft, 
Kanter, & 
Comtois 
(1999) 
 
 
BPD + 
substance 
use disorder.  
Not required 
to have 
recent 
parasuicidal 
acts. 
 
DBT. Full 
programme + 
replacement 
medications. 
12 months. 
N = 12. 
 
Non-manualised, 
standard TAU. 
Not matched to 
test condition for 
frequency of 
contact/ number 
of sessions. 
N = 15. 
 
Pre, 4, 
8, 12, 16 
months. 
 
Structured 
clinical 
interview re 
drug abuse. 
Urinalysis. 
THI 
PHI 
SHI 
 
No between 
group 
difference on 
parasuicidal 
acts. 
 
Significant 
group 
differences 
favouring DBT 
on drug 
abuse, global 
+ social 
adjustment. 
 
No adherence 
reported. 
Manualised 
treatment 
condition. 
Non-
manualised 
control. APPENDICES 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test 
Points 
Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Linehan et 
al., cont. 
 
Female 
       
GSA 
GAS 
SAEI 
 
  No between 
group 
differences on 
other 
measures. 
 
 
Short, 
controlled 
follow-up. 
Underpowered
. 
 
Turner 
(2000) 
 
 
BPD. Recent 
history of 
suicide 
attempt. 
 
 
DBT-oriented 
therapy 
including 
psychodynami
c techniques. 
Skills training 
within 1-to-1 
sessions, not 
as separate 
groups. 
12 months. 
N = 12. 
 
 
Manualised client-
centred therapy. 
Matched to test 
condition for 
frequency of 
contact/number of 
sessions. 
N = 12. 
 
 
Pre, 6, 
12 
months. 
 
HRSD 
BPRS 
TBR 
BDI 
BAI 
BSSI 
 
Significant 
improvement 
for both 
conditions on 
parasuicidal 
behaviours 
and 
hospitalisation. 
Significant 
between group 
differences in 
favour of DBT. 
 
 
Significant 
improvement 
for both 
conditions on 
all other 
measures.  
Significant 
between 
group 
differences in 
favour of DBT 
on 
depression, 
global 
functioning, 
impulsivity 
and anger. 
 
Adherence not 
reported. 
Manualised, 
active control. 
No follow-up 
reported. 
Underpowered
. 
Naturalistic 
setting. 
DBT condition 
was not based 
on standard 
DBT. 
 
 
Koons, 
Robins, 
Tweed, 
Lynch, 
Gonzalez, 
Bishop et al. 
(2001) 
 
BPD. Female 
US veterans. 
40% 
parasuicidal 
act in 
previous 6 
months. 
 
DBT. Full 
prgramme. 
6-months. 
N = 13. 
 
 
 
 
Non-manualised 
TAU.  
1 x weekly 1-to-1 
non-specified 
psychotherapy + 
psychoeducationa
l groups. 
 
Pre, 3, 6 
months. 
 
 
 
 
 
 
PHI 
BSSI 
BHS 
BDI 
HAM-D 
HARS 
SAES 
 
Significant 
improvement 
for both 
conditions on 
parasuicidal 
behaviours. 
Significant  
 
Significant 
improvement 
for both 
conditions on 
all other 
measures 
except anxiety  
 
Manualised 
and 
adherence 
rated 
treatment 
condition. 
Non- APPENDICES 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test 
Points 
Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Koons, 
Robins, 
Tweed, 
Lynch, 
Gonzalez, 
Bishop et al. 
(2001) cont. 
 
 
Antisocial PD 
excluded. 
   
Partly matched to 
DBT for 
frequency of 
contact/number of 
sessions. 
N = 12. 
 
   
DES 
 
between group 
differences in 
favour of DBT. 
 
(neither group 
changed) and 
suicidal 
ideation and 
hopelessness 
(control did 
not change). 
Significant 
between 
group 
differences in 
favour of DBT 
on suicidal 
ideation, 
hopelessness, 
depression, 
and anger 
expression. 
 
manualised 
TAU control. 
Underpowered 
Data not 
analysed on 
ITT basis. 
 
 
Linehan, 
Dimeff, 
Reynolds, 
Comtois, 
Welsh, 
Heagerty et 
al. (2002) 
 
 
BPD + opiate 
dependance. 
Not required 
to have 
recent 
parasuicidal 
acts. 
Female. 
 
DBT. Full 
prgramme + 
replacement 
medications. 
12 months. 
N = 11. 
 
 
Comprehensive 
Validation 
Therapy + 12-
step programme 
+ replacement 
medications. 
Partly matched to 
DBT for 
frequency of 
contact/number of 
sessions. 
N = 12. 
 
Pre, 4, 
8, 12, 16 
months. 
 
Urinalysis. 
PHI 
SHI 
GAF 
BSI 
 
 
 
Significant 
reduction in 
suicidal acts, 
self-harm, 
hospitalisation
s for both 
conditions, 
maintained at 
follow-up. 
No significant 
between group 
differences. 
 
Significant 
improvement 
in all outcome 
measures for 
both groups. 
DBT: better 
maintenance 
of reduction in 
drug use. No 
other between 
group 
differences. 
 
Adherence not 
independently 
rated. 
Manualised 
conditions. 
Short, 
controlled 
follow-up. 
Underpowered 
Higher attrition 
in DBT (36%). APPENDICES 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test 
Points 
Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Van den 
Bosch, 
Schippers, 
Verheul, & 
van den 
Brink 
(2002); 
Verheul, van 
den Bosch, 
Koeter, de 
Ridder, 
Stijnen, & 
van den 
Brink 
(2003). 
 
 
BPD +/- 
substance 
abuse. 
Not required 
to have 
recent 
parasuicidal 
acts. 
Female. 
 
DBT. Full 
prgramme. 
12 months. 
N = 31. 
 
 
Non-manualised 
TAU. 
Not matched to 
test condition for 
frequency of 
contact/ number 
of sessions. 
N = 33 
 
 
Pre, 11, 
22, 33, 
44, 52 
weeks, 
6-month 
follow-
up. 
 
Treatment 
retention. 
BPDSI 
LPC 
 
Significant 
reduction in 
self-harm for 
both 
conditions. 
Significant 
between group 
difference in 
favour of DBT. 
  
 
No significant 
improvement 
for either 
condition on 
substance 
misuse. 
 
Manualised 
treatment 
condition. 
Adherence not 
reported. 
Non-
manualised 
control. 
Controlled 
follow-up. 
Power 
calculation not 
reported. 
High attrition 
rate (77%) in 
control. 
Naturalistic 
setting. 
 
Linehan et 
al. (2006);  
Harned, et 
al., (2008) 
 
BPD + recent 
parasuicidal 
acts. 
Female. 
 
 
DBT. Full 
programme. 
12 months. 
N = 52. 
 
 
Non-manualised 
Community 
Treatment by 
Experts. 
Not matched to 
test condition for 
frequency of 
contact/ number 
of sessions. 
N = 51. 
 
 
Pre, 4 
monthly, 
to 12-
month 
follow-
up. 
 
SASII 
SBQ 
RLI 
THI 
HRSD 
LIFE 
 
Significant 
reduction in 
suicide 
attempts, self-
harm and 
hospitalisation 
for both 
conditions. 
Significant 
between group 
differences in 
 
 
Significant 
improvement 
on 
depression, 
hopelessness,
, suicidal 
ideation, Axis-
I disorders, 
and reasons 
for living for 
both groups. 
No between  
 
Manualised/ 
adherence 
rated 
treatment 
condition. 
Non-
manualised 
control. 
Controlled 
follow-up. 
Sufficiently 
powered. APPENDICES 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test 
Points 
Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
             
favour of DBT 
on suicide 
attempts and 
hospitalisation. 
No significant 
between group 
differences on 
self-harm. 
 
 
group 
differences on 
these 
variables 
except for 
substance 
dependence 
(in favour of 
DBT). 
 
 
 
McMain, 
Links, 
Gnam, 
Guimond, 
Cardish, 
Korman et 
al. (2009) 
 
 
 
 
 
 
BPD + 
parasuicidal 
act within 
past 5 years. 
 
 
DBT. Full 
programme. 
12 months. 
N = 90. 
 
Non-manualised 
general 
psychiatric 
management 
TAU. 
Not matched to 
test condition for 
frequency of 
contact/ number 
of sessions. 
N = 90. 
 
 
Pre, 4-
monthly. 
No 
follow-
up 
reported
. 
 
SASII 
ZRSBPD 
SCL-90 
STAEI 
BDI 
IIP 
THI 
RETFTQ 
 
Significant 
reduction in 
suicide 
attempts, self-
harm and 
hospitalisation 
for both 
conditions. 
No significant 
between group 
differences on 
these 
variables. 
 
 
Significant 
reduction in 
BPD 
symptoms, 
depression, 
interpersonal 
functioning, 
symptom 
distress and 
anger for both 
conditions. 
No significant 
between 
group 
differences on 
these 
variables. 
 
 
Manualised 
and 
adherence 
rated 
treatment 
condition. 
Non-
manualised 
control. 
No follow-up 
reported. 
Sufficiently 
powered. 
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Measures abbreviations: 
     
SORT: Social Reticence Inventory                                                                SRI: Self-Report Inventory 
SQ: Shyness questionnaire  ADSHI: Acts of Deliberate Self-Harm Inventory  
BDI: Beck Depression Inventory  STAI: Spielberger State Trait Anxiety Inventory 
BSI: Brief Symptom Inventory  IIP: Inventory of Interpersonal Problems 
SFQ: Social Functioning Questionnaire  YSQ: Young Schema Questionnaire 
WAI: Working Alliance Inventory  ZRSBPD: Zanarini Rating Scale for BPD 
CGI: Clinical Global Impression  GAS: Global Assessment Scale 
SAS: Social Adjustment Scale   SCL-90: Symptom Checklist-90 
BESOT: Borderline Evaluation of Severity Over Time  PANAS: Positive and Negative Affect Schedule 
PSI: Parasuicide History Interview  THI: Treatment History Interview 
SSI: Scale for Suicidal Ideators  BHS: Beck Hopelessness Scale 
RLISCS: Reasons for Living Inventory, Survival and Coping Scale  SHI: Social History Interview 
SAEI: State-Trait Anger Expression Inventory  HRSD: Hamilton Rating Scale for Depression 
BSI: Borderline Syndrome Index   TBR: Target Behaviour Ratings 
BAI: Beck Anxiety Inventory  BSSI: Beck Scale for Suicidal Ideation 
HAM-D: Hamilton Depression Rating Scale  HARS: Hamilton Anxiety Rating Scale 
BPDSI: BPD Severity Index  LPC: Lifetime Parasuicidal Count 
SASII: Suicide Attempt Self-Injury Interview  SBQ: Suicidal Behaviours Questionnaire  
LIFE: Longitudinal Interval Follow-up Evaluation  RFETFTQ: Reasons for Early Termination from Treatment Questionnaire 
EQ-5D: EuroQol Quality of Life  DIB-R: Diagnostic Interview for Borderline Personality Disorders-
Revised.Interview  
BPRS: Brief Psychiatric Rating Scale                                                            for DSM-IV Axis II Disorders. 
SCID-II: Structured Clinical Interview for DSM-IV Axis II Disorders              PDBQ: Personality Disorder Belief Questionnaire 
LWASQ: Lehrer Woolfolk Anxiety Symptoms Questionnaire                        SPAI: Social Phobia Anxiety Inventory 
AS: Avoidance Scale 
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Summary of principal methodological characteristics and results for all psychodynamic and interpersonal RCTs for PD, organised by 
intervention type 
 
 
Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test Points  Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
Schema 
Therapy 
               
 
Giesen-Bloo, 
van Dyck, 
Spinhoven, van 
Tilburg, Dirksen, 
van Asselt, et al. 
(2006) 
 
 
 
 
BPD: 50% 
DSH within 
previous 
3 months. 
Antisocial PD 
excluded 
 
Schema 
Therapy (ST) 
2 x weekly 
individual 
sessions 
for 3 years 
N = 44 
 
Transference 
Focused 
Therapy (TFT) 
2 x weekly 
individual 
sessions 
for 3 years. 
Matched with 
test condition 
for frequency 
of contact/ 
number of 
sessions. 
N = 42 
 
3-monthly 
for 3 
years 
 
BPDSI-IV 
EuroQol 
WHOQOL 
Composite 
psycho- and 
personality 
pathology 
measure 
 
Significant 
reduction 
in para- 
suicidal acts 
for both 
conditions. 
ST superior 
to TFT 
 
Significant 
improvement 
on all measures 
for both 
conditions 
at 1, 2, 3 
years. 
ST superior to 
TFT on 
all variables 
except QoL 
 
 
Adherence & 
competence 
rated. 
Comparison of 
2 active, 
well-described 
interventions. 
Controlled 
follow-up. 
Underpowered. 
Hospitalisation 
not measured. 
 
 
Farrell, Shaw, & 
Webber 
(2009) 
 
 
 
 
BPD: 100% 
DSH within 
previous  
24 months 
 
Schema 
Therapy + TAU 
30 x group 
sessions over 
8 months  
N = 16 
 
Non- 
manualised 
TAU. 
Not matched 
with test 
condition for 
frequency of 
contact/ 
number of  
 
Pre, post, 6-
month 
follow-up. 
 
BSI 
SCL-90 
DIB-R 
GAFS 
 
Significant 
reduction in 
self-injurious 
and impulsive 
behaviours 
for ST. 
 
 
Significant 
improvement 
on all measures 
for ST, but not 
control condition 
Significant group 
differences on 
all measures 
 
 
Adherence not 
assessed 
independently. 
Poor quality 
TAU  
Controlled 
follow-up. 
Small N. No 
power  APPENDICES 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test Points  Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Farrell et al. 
cont. 
     
sessions. 
N = 12 
         
calculation. 
100% retention 
rate in ST 
 
CAT                 
 
Chenen, 
Jackson, 
McCutcheon, 
Jovel, Dudgeon, 
Yeun et al. 
(2008) 
 
 
 
 
Adolescents 
with 2 - 9 BPD 
diagnostic 
criteria 
 
 
CAT 
Maximum of 24 
weekly, 1-to-1 
sessions 
N = 44 
 
Manualised 
‘good clinical 
care’ (GCC). 
Matched to test 
condition for 
frequency of 
contact/ 
number of 
sessions. 
N = 42 
 
Pre, post, 6-
monthly for 
2 years 
follow-up. 
 
 
SCID-II 
YSR 
SOFAS 
Number of 
parasuicudal 
episodes 
 
Significant 
reduction in 
self-injurious 
and impulsive 
behaviours 
for both 
conditions. 
No significant 
group 
differences. 
 
 
Significant 
improvement 
on all measures 
for both 
conditions, 
maintained at 
24-months. 
No significant 
group 
differences. 
 
 
Adherence & 
competence 
rated. 
Good quality 
control, though 
not specifically 
designed for 
PD. 
Controlled 
follow-up. 
Underpowered. 
 
Clarke et 
al. (in prep) 
 
 
 
At least one 
PD diagnosis. 
Exclusion of 
current  
parasuicidal 
behaviour. 
 
CAT 
24 sessions  
1-to-1 over 10 
months. 
N = 50. 
 
Non-
manualised, 
standard NHS 
care 
TAU. 
Not matched to 
test condition 
for frequency 
of contact/ 
number of  
sessions. 
N = 49. 
 
 
Pre, post, 
and 
uncontrolled 
follow-up at 
9 and 18 
months. 
 
CORE 
IIP 
DISQ 
SCL-90 
DES 
PSQ 
SSS 
 
 
N/A (high risk 
was an 
exclusion 
criteria). 
 
Significant group 
differences 
favouring CAT 
on SCID-II, IIP, 
CORE, PSQ, 
DIS-Q. 
No group 
differences on 
other measures. 
 
 
Adherence & 
competence 
rated. 
TAU not 
specifically for 
PD. 
Uncontrolled 
follow-up. 
Underpowered. 
High attrition at  
follow-up. 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test Points  Primary 
Measures 
Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Clarke et al. 
cont. 
               
Naturalistic 
setting. 
Included PDs 
not often 
investigated. 
 
Psychodynamic                 
 
Munroe- 
Blum & 
Marziali 
(1995) 
 
 
 
 
 
 
 
 
BPD 
Parasuicidal 
behaviour not 
excluded 
> 1/3 made a 
suicide 
attempt in 6 
months prior 
to study. 
 
 
Interpersonal 
group. 
25 x weekly 
sessions. 
5 x biweekly 
sessions. 
N = 38. 
 
Individual 
psychodynamic 
psychotherapy. 
1 or 2 x 
weekly. 
Open ended. 
Greater 
number of 
sessions and 
frequency of 
sessions than 
test condition. 
N = 41. 
 
Pre, 6- 
monthly for 
24 months. 
 
OBI 
SAS 
BDI 
HSCL-90 
 
Significant 
reduction in 
risk 
behaviours 
for both 
groups, 
maintained at 
24 months. 
No between 
group 
differences. 
 
 
Significant 
reduction in 
depression, 
general 
psychopathology 
and 
improvement in 
social 
functioning for 
both groups, 
maintained at 24 
months. 
No between 
group 
differences. 
 
 
Adherence not 
assessed 
independently. 
Control 
condition: 
experienced 
therapists/non 
manualised, 
homogenous 
intervention. 
Controlled 
follow-up. 
High dropout 
rates post-
randomisation.  
 
Bateman 
& Fonagy 
(1999; 2001) 
 
BPD 
DSH not an 
inclusion  
 
Partial 
hospitalisation 
(PH).  
 
TAU 
Standard NHS 
psychiatric  
 
3-monthly 
for 36 
months. 
 
SSHI 
SCL-90 
BDI 
 
Significant 
reduction in 
self-harm,  
 
Significant 
improvement on 
all other  
 
Adherence 
rating based 
on self-report. 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test Points  Measures  Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Bateman & 
Fonagy cont. 
 
criteria. 
Median of 9 
episodes in 6 
months prior 
to study. 
95% suicide 
attempt in 6 
months prior 
to study. 
 
Psychodynamic 
group & 1-to-1 
Total of 6 x 
week contact 
minimum 
max. 18 months 
N = 19. 
 
care. 
Not matched to 
test condition 
for frequency 
of contact/ 
number of 
sessions. 
N = 19. 
   
STAI 
SAS 
IIP 
 
suicide 
attempts and 
days in 
hospital for 
PH, but not 
for control. 
 
measures for PH 
but not control. 
 
Less intensive, 
non-
manualised 
control. 
PH group had 
therapy during 
follow-up. 
Underpowered. 
Naturalistic 
setting. 
Compromised 
randomisation. 
Included high 
risk patients. 
 
 
Bateman 
& Fonagy 
(2009) 
 
BPD.  
Parasuicidal 
act within 
previous 6 
months. 
 
 
MBT: 
Psychodynamic 
group & 1-to-1 
over 18 months. 
N = 71. 
 
Structured 
clinical 
management 
(SCM). 
N = 63.  
 
Pre, 6, 12, 8 
months. 
 
Suicide 
attempts 
Life-
threatening 
DSH 
Hospital 
admission 
SCL-90 
BDI 
SAS 
GAF 
IIP 
 
Significant 
reduction in  
suicide 
attempts, 
DSH and 
days in 
hospital for 
both 
conditions, 
with MBT 
outperforming 
SCM on all 
measures at 
18 months. 
 
 
Significant 
improvement on 
all other 
measures for 
both conditions.  
MBT 
outperformed 
SCM on the 
GAF, IIP, SCL-
90, SAS. 
 
Manualised 
and adherence 
rated treatment 
and active 
condition 
condition. 
No follow-up 
reported. 
Sufficiently 
powered. 
Included high 
risk patients. 
 
 APPENDICES 
   
256 
Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test Points  Measures  Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Svartberg, Stiles 
& Seltzer (2004) 
 
 
 
One or more 
Cluster C PD. 
Excluded all 
other PD 
diagnoses. 
Excluded  
parasuicidal 
behaviour. 
 
 
Short term (40 
weekly 
sessions) 1-to-1 
dynamic 
psychotherapy 
(STDP). 
N = 25. 
 
 
CBT (40 
weekly  
sessions). 
Conditions 
matched for  
frequency of 
contact/ 
number of 
sessions.  
N = 25. 
 
 
Pre, mid-
therapy, 
post, 6, 12, 
and 24-
month 
follow-up. 
 
SCL-90 
IIP 
MCMI-III 
 
 
Not 
applicable 
(high risk was 
an exclusion 
criteria). 
 
Significant 
improvements 
on all measures 
for both 
conditions. No 
significant 
between group 
effects. Some 
trends in favour 
of STDP.  
 
Adherence 
independently 
rated. 
Comparison of 
2 active, 
manualised 
interventions. 
Controlled, 
long follow-up. 
Under 
powered. 
Focused on 
PDs rarely 
investigated. 
 
 
Vinnars, Barber, 
Noren, Gallop, & 
Weinryb (2005) 
 
 
At least one 
PD diagnosis. 
High risk not 
excluded. 
 
Supportive-
expressive 
dynamic 
therapy (SEDT). 
40 x 1-to-1 
sessions. 
N = 80. 
 
 
Non-
manualised 
community-
based 
psychodynamic 
therapy (CPT). 
Open number 
of sessions. 
Not matched to 
test condition 
for frequency 
of contact/ 
number of 
sessions. 
 
 
Pre, post 
SEDT, 1 
year follow-
up. 
 
SCID-II 
SCL-90 
GAFS 
 
 
Not reported. 
 
Significant 
improvements 
on all measures 
for both 
conditions. No 
significant 
between group 
effects. 
 
 
Manualised 
and adherence 
rated treatment 
condition. 
Control 
condition 
neither 
manualised nor 
adherence 
rated. 
Controlled 
follow-up. 
Sufficiently 
powered. 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test Points  Measures  Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Vinnars et al., 
cont. 
     
N = 76. 
 
         
Naturalistic  
setting. 
Included a 
range of PD 
diagnoses. 
 
 
Muran, Samstag, 
Safran & 
Winston (2005) 
 
 
 
 
 
 
 
 
At least one 
Cluster C  or 
NOS PD 
diagnosis.  
Excluded 
Cluster A and 
B PD.  
 
Alliance focused 
brief relational 
therapy (BRT). 
Manualised 30 x 
weekly 1-to-1 
sessions. 
N = 33. 
 
CBT.  
Manualised 30 
x weekly 1-to-1 
sessions. 
N = 29. 
 
Short-term 
dynamic 
therapy  
Manualised 30  
x weekly 1-to-1 
sessions. 
N = 22. 
 
All conditions 
matched for 
frequency and 
number of 
sessions 
 
Pre, post, 6-
month 
follow-up. 
 
SCL-90 
TC 
GAS 
IIP 
WPI 
 
 
Not reported. 
 
Significant 
improvements 
on all measures 
for both 
conditions. No 
significant 
between group 
effects. 
 
 
All conditions 
adherence-
rated. 
Comparison of 
3 active, 
manualised 
conditions. 
Controlled 
follow-up. 
Underpowered. 
Naturalistic 
setting. 
Focused on 
PDs rarely 
investigated. 
Compromised 
randomisation 
process. 
Data not 
analysed on 
ITT basis. 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test Points  Measures  Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
 
Clarkin, Levy, 
Lenzenweger & 
Kernberg (2007) 
 
 
BPD. 
Other PDs not 
reported. 
 
Transference-
focused 
psychotherapy 
(TFP). 
Manualised, 1 
year 2 x weekly 
1-to-1 sessions. 
N = 30. 
 
 
DBT: 
Manualised, 1 
year full 
programme. 
N = 30. 
Supportive 
psychotherapy: 
Manualised, 1 
year, 1 x 
weekly 1-to-1 
sessions. 
N = 30. 
Conditions not 
matched for   
frequency/ 
number of 
sessions. 
 
 
Pre, 4, 8, 12 
months. 
No follow-
up data 
reported. 
 
OAS-M 
AIAQ 
BAI-II 
BSI 
BDI 
GAFS 
SAS 
 
Significant 
reduction in 
suicidality for 
TFP and DBT 
only. 
 
Significant 
improvements in 
depression, 
anxiety, global 
functioning, 
social 
adjustment for 
all 3 conditions. 
Significant 
improvements in 
anger,  
impulsivity for 
TFP and SP 
only. 
 
All conditions 
adherence-
rated. 
Comparison of 
3 active, 
manualised, 
conditions. 
Controlled 
follow-up. 
Underpowered. 
Included males 
in sample. 
 
 
Gregory, 
Chlebowski, 
Kang, Remen, 
Soderberg, 
Stepkovitch et al. 
(2008) 
 
 
BPD with co-
morbid alcohol 
addiction or 
dependence. 
Other PDs, 
including 
Antisocial PD 
not excluded. 
 
Dynamic 
Deconstructive 
Psychotherapy 
(DDP). 
Manualised, 12 
- 18 months 1 x 
weekly 1-to-1 
sessions. 
N = 15.  
 
 
TAU. 
Non-
manualised, 
general 
psychiatric 
including 
referral to 
alcohol 
rehabilitation 
centre. 12-
months. 
 
 
Pre, 3, 6, 9, 
12 months. 
No follow-
up data 
reported. 
 
LPC 
ASI 
THI 
BDI 
DES 
SPS 
BEST 
 
 
Significant 
reduction in 
parasuicidal 
behaviour at 
12 months. 
No between 
group 
difference. 
 
Significant 
improvement on 
alcohol misuse, 
institautional 
care, BPD 
symptomology, 
depression, 
dissociation & 
perceived social 
support at 12 
months for DDP.  
 
 
Adherence not 
rated. 
Poor quality, 
non-
manualised 
control. 
No follow-up 
data reported. 
Underpowered. 
Naturalistic 
setting. 
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Author (s)  Participants  Intervention 
Group (IG) 
Comparison 
Group (CG) 
Test Points  Measures  Results: 
Risk 
Results: 
Axis I/ Other 
Strengths/ 
Limitations 
 
       
Not matched to 
test condition 
for frequency 
and number of 
sessions. 
N = 15. 
 
       
Significant 
between group 
differences on 
BPD 
symptomology, 
depression and 
perceived social 
support. 
 
 
Included 
participants 
with severe 
problems. 
 
 
Doering, Horz, 
Rentrop, 
Fischer-Kern, 
Schuster, 
Benecke et al. 
(2010) 
 
 
BPD. 
Antisocial PD 
excluded. 
 
 
Transference-
Focused 
Psychotherapy 
(TFP). 
Manualised 1 
year 2 x weekly 
1-to-1 sessions. 
N = 52. 
 
 
TAU. 
1-to-1 
psychotherapy 
by experienced 
community 
therapists. 
Not matched to 
test condition 
for frequency 
and number of  
sessions. 
N = 52. 
 
 
Pre, post. 
No follow-
up data 
reported.  
 
CISSB 
SCID-I 
SCID-II 
GAFS 
BDI 
STAI 
CRTHI 
STIPO 
 
Significant 
reduction in 
suicide 
attempts for 
TFP. 
Between 
group effect 
in favour of 
TFP.  
No  
significant 
reduction in 
self-harm for 
either 
condition. 
 
 
Significant group 
effect in favour 
of TFP on BPD 
symptomology, 
psychosocial 
functioning, 
personality 
organisation. 
Both conditions 
showed  
significant 
improvement on 
depression, 
anxiety, with no 
group 
differences. 
 
 
TFP 
adherence 
rated. 
Non-
manualised 
control 
condition. 
No follow-up 
data reported. 
 
Adequately  
powered. 
High dropout 
rates in both 
conditions. 
Naturalistic 
setting. 
 
 
 
 APPENDICES 
   
260 
Measures abbreviations:   
 
BPDSI-IV: Borderline Personality Disorder Severity Index, fourth edition.   
EuroQol: EuroQol quality of life thermometer measure. 
WHOQOL: World Health Organization Quality of Life measure.  BSI: Borderline Syndrome Index 
SCL-90: Symptom Checklist-90  DIB-R: Diagnostic Interview for Borderline Personality Disorders-
Revised. 
GAFS: Global Assessment of Function Scale.  SCID-II: Structured Clinical Interview for DSM-IV Axis II Disorders. 
SCID-I: Structured Clinical Interview for DSM-IV Axis I Disorders.  YSR: Youth Self-Report questionnaire 
SOFAS: Social and Occupational Functioning Assessment Scale  MCMI-III: Millon Clinical Multiaxial Inventory 
CORE: Clinical Outcomes in Routine Evaluation  IIP: Inventory of Interpersonal Problems 
DISQ: Dissociative Questionnaire  DES: Dissociative Experiences Scale 
PSQ: Personality Structure Questionnaire  SSS: Service Satisfaction Scale 
DIBP: Diagnostic Interview for Borderline Patients  SSHI: Suicide and Self-Harm Inventory 
BDI: Beck Depression Inventory  STAI: Spielberger State Trait Anxiety Inventory 
SAS: Social Adjustment Scale  OAS-M: Overt Aggression Scale-Modified 
AIAQ: Anger, Irritability and Assault Questionnaire  BIS-II: Barratt Impulsivity Scale-II 
BSI: Brief Symptom Inventory  LPC: Lifetime Parasuicidal Count 
ASI: Addiction Severity Index  THI: Treatment History Interview 
SPS: Social Provisions Scale  BEST: Borderline Evaluation of Severity over Time 
CISSB: Cornell Interview for Suicidal and Self-Harming Behaviour  CRTHI: Cornell Revised Treatment History Inventory 
STIPO: Structured Interview for Personality Organisation  OBI: Objective Behaviors Index 
HSCL-90: Hopkins Symptom Checklist   
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Appendix B: Cognitive Fusion Questionnaire 
 
 
Below you will find a list of statements. Please rate how true each statement is for you by circling a 
number next to it. Use the scale below to make your choice.  
 
1  2  3  4  5  6  7 
never 
 true 
very 
seldom 
true 
seldom  
true 
sometimes  
true 
frequently  
true 
almost always 
true 
always  
true 
             
1.  My thoughts cause me distress or emotional pain  1  2  3  4  5  6  7 
2.  I get so caught up in my thoughts that I am unable to 
do the things that I most want to do 
1  2  3  4  5  6  7 
3.  Even when I am having distressing thoughts, I know  
that they may become less important eventually 
1  2  3  4  5  6  7 
4.     I over-analyse situations to the point where it’s 
unhelpful to me 
1  2  3  4  5  6  7 
5.  I struggle with my thoughts  1  2  3  4  5  6  7 
6.  Even when I’m having upsetting thoughts, I can see 
that those thoughts may not be literally true 
1  2  3  4  5  6  7 
7.  I get upset with myself for having certain thoughts  1  2  3  4  5  6  7 
8.  I need to control the thoughts that come into my head  1  2  3  4  5  6  7 
9.  I find it easy to view my thoughts from a different 
perspective 
1  2  3  4  5  6  7 
10. I tend to get very entangled in my thoughts  1  2  3  4  5  6  7 
11. I tend to react very strongly to my thoughts  1  2  3  4  5  6  7 
12. Its possible for me to have negative thoughts about 
myself and still know that I am an OK person 
1  2  3  4  5  6  7 
13. It’s such a struggle to let go of upsetting thoughts 
even when I know that letting go would be helpful 
1  2  3  4  5  6  7 
 
 
Thank you for completing this questionnaire 
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Appendix C: Brief Demographics Questionnaire 
 
 
Please complete this questionnaire by ticking the appropriate options. All information 
you supply will remain confidential and will be stored anonymously. 
 
 
 
1. Are you male or female?                              Male _____    Female _____                                                                
 
 
2. How old are you?                                                  _____ years old 
    
 
3. What is your ethnic origin?                           White _____     Asian _____    
 
                                                                          Black _____    Mixed _____ 
                                                                       
                                                                          Other ethnic group     _____ 
 
 
4. Are you currently having psychological 
    treatment (e.g. counselling, psychotherapy)?       Yes _____    No _____ 
 
 
 
 
 
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE 
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Appendix D: Study 1 Research Ethics Committee Approval Letter  
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Appendix E:  Study 1 consent form, participant information sheet and debrief 
sheet 
 
 
CONSENT FORM 
 
Title of the project: Validation of a self-report measure of cognitive fusion. 
 
Name of Researcher: Prof. Sue Clarke  
                                                                                                    Please initial each 
box                       
1.  I confirm that I have read and understood the information sheet dated           
11/05/2009 (version 1) for the above study. I have had the opportunity to 
consider the information, ask questions by phone and have had these 
answered satisfactorily 
 
2.  I understand that my participation is voluntary and that I am free to 
withdraw at any time without my medical care or legal rights being affected 
 
3.  I understand that data collected throughout this study may be looked at by 
members of Prof. Sue Clark’s research team. I give permission for these 
individuals to have access to the data collected from this study, to store 
and to process it. 
 
4.  I agree that in order for me to participate in the study, members of Prof. 
Susan Clarke’s research team may have access to my contact details, 
which will be stored securely on an NHS, password-protected computer or 
locked in an NHS filing cabinet. 
 
5.  I agree for my GP to be informed about my participation in this study.   
6.  I agree that data obtained from this trial can be used, in anonymous form, 
for publication. 
 
 
 
 
____________________      ________________  ____________________ 
      Participant name                    Date      Signature 
 
____________________      ________________  ____________________ 
    Researcher name          Date                 Signature 
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Participant information sheet 
 
Validation of a self-report measure of cognitive fusion. 
You are being invited to take part in a research study. Before you decide whether 
you would like to take part, you need to understand why the research is being done 
and what it would involve. Please take time to read the following information carefully. 
Talk to others about the study if you so wish.  
 
•  Part 1 tells you the purpose of this study and what will happen to you if you take 
part.   
•  Part 2 gives you more detailed information about the conduct of the study.  
 
If there is anything that is not clear, or if you would like more information, please do 
not hesitate to contact Helen Bolderston or Sue Clarke on 01202 584120. 
 
 
Part 1 
 
What is the purpose of this study? 
This study is designed to help develop a new questionnaire. The questionnaire 
measures a psychological process called ‘cognitive fusion’. Cognitive fusion has 
been defined as: ‘the process by which thoughts about an event become merged 
with the actual event’, so that people experience, for example, thoughts about a 
possible loss as if the loss had actually occurred, feeling sadness and so on.  
This process, experienced by everyone to some extent, is thought to have a role in 
the development and maintenance of a range of psychological problems, so it is 
important to be able to examine, measure and understand cognitive fusion. 
However, currently there is no good quality questionnaire available to measure 
cognitive fusion, hence the current study. This study has been designed by senior 
clinicians and researchers (Prof. Susan Clarke; Helen Bolderston). 
Why have I been invited? 
We are recruiting participants who are currently receiving care from local community 
mental health teams (CMHTs), or who are involved in assessment or psychotherapy 
at the Intensive Psychological Therapies Service (IPTS). We would therefore like to 
invite you to participate in the study. We aim to recruit a maximum of 200 
participants. 
 
Do I have to take part? 
It is up to you whether you take part or not. If you do decide to take part, you will be 
asked to sign a consent form.  
 
Having signed the consent form, you are still free to withdraw at any time and 
without giving a reason.  A decision to withdraw, or a decision not to take part, 
will not affect the standard of care you receive, in any way.  
 
 
What will happen to me if I take part; what will I have to do? APPENDICES 
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If you decide to take part, you will need to fill out and sign both copies of the 
enclosed consent form, keeping one copy for your own records and returning the 
other in the envelope provided. You will then be sent the questionnaires to fill out, 
which should take between 40 and 45 minutes in total. These are for you to complete 
in your own time, but it is important, once you begin filling out the questionnaires, 
that you complete them all within five days.  
  Once you have completed the questionnaires, they should be posted to the 
research team, in the stamped, addressed envelope provided. This would probably 
mark the end of your participation in the study. However, a small number of 
participants will be contacted once more, three weeks after returning this set of 
questionnaires. They will be asked to complete the questionnaire under development 
but none of the other questionnaires. This will take approximately five minutes. 
If you are willing to participate, but would like help filling out the 
questionnaires, please contact Helen Bolderston or Sue Clarke on 01202 584120, as 
we would be happy to arrange this for you. 
 
What are the questionnaires like? 
There are eight questionnaires in total, which vary in length. There is a brief 
demographics questionnaire which asks about such things as your age and ethnic 
background. There are then seven further questionnaires, focussing on a range of 
psychological processes and problems. 
 
Reactions to the questionnaires 
All of the questionnaires except the one under development and the demographic 
questionnaire are widely used in research and clinical settings, and it is unlikely that 
you will experience distress or difficulty as a result of filling them out. However, some 
of them do ask questions about quite personal thoughts and feelings, so we suggest 
that you complete them somewhere private, where you feel safe and secure, and 
where you are unlikely to be interrupted. You can take your time filling them out, if 
this helps, as long as you complete them all with five days of starting them. 
 
If you do find that you are in any way adversely affected by participating in the study, 
there are a number of sources of help and support available, outlined in the enclosed 
Debrief Sheet. 
 
Handling of data  
In order to be able to analyse the data from the study, we will ask for your consent 
for members of the research team to have access to your questionnaire responses. 
All of your completed questionnaire responses will be anonymised by labelling them 
with a number rather than with your name. They will be stored securely at the IPTS.  
 
What are the possible risks or disadvantages of taking part? 
Although it is thought to be unlikely, it is possible that you could experience some 
emotional distress as a result of filling out the questionnaires. If you experience 
anything along these lines, we would encourage you to seek help and support from 
the sources outlined in the Debrief Sheet. 
 
A possible disadvantage of participating in the study is the inconvenience of the time 
it takes to complete the questionnaires. These have been kept to a minimum and 
there is some flexibility in how long you can take to complete them, as outlined 
above. 
 
 
What are the potential benefits of taking part? APPENDICES 
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This is not a study that involves treatment or therapy, so you will not benefit along 
those lines. However, you may experience a sense of satisfaction from having 
contributed to a piece of research designed to improve understanding of 
psychological health and ill-health. 
In addition, the research team is happy to give you feedback about the 
meaning of your questionnaire scores, and the study in general, if you would find this 
helpful. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this is 
given in Part 2. 
 
Confidentiality –who will know that I am taking part in this study? 
All the information about your participation in this study will be kept confidential.  The 
details are included in Part 2. 
 
For further information 
If you would like any further information about the trial, please do not hesitate to 
contact Professor Sue Clarke or Helen Bolderston (01202 584120). 
 
This completes Part 1 of the Information Sheet. If the information in Part 1 has 
interested you and you are considering participation, please continue to read 
the additional information in Part 2 before making any decision 
 
 
Part 2 
 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw from the study at any stage. You do not have to let anyone 
know that you do not intend to participate. 
 
What if there is a problem? 
It is unlikely that this research will cause you any harm. If you have a concern about 
any aspect of this study, you should phone Sue Clarke (01202 584120). If you 
remain unhappy, you have the right to complain to the NHS about any aspects of the 
way you have been approached or treated during the course of this study. In the 
event that something does go wrong and you are harmed during the research study 
there are no special compensation arrangements.  If you are harmed and this is due 
to someone’s negligence then you may have grounds for a legal action for 
compensation against Dorset Healthcare Foundation Trust, but you may have to pay 
your legal costs.  
 
Confidentiality – who will know that I am taking part in this study? 
All information relating to you participating in this study will be securely stored, either 
on a password-protected NHS computer, or locked in an NHS filing cabinet. No 
completed questionnaires will be labelled using your name or any other identifiable 
information. Instead, each questionnaire will be labelled with a unique identification 
number. 
 
If you consent to participate in the study, your GP will be informed. This is a 
precautionary measure, as in the very unlikely event of you experiencing emotional 
discomfort following completing the questionnaires, your GP could be a source of 
support. They will be given no information beyond the fact that you have agreed to 
participate. APPENDICES 
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The only people who will have access to any information about you will be the 
research team. Your contact details, completed questionnaires and consent forms 
will be accorded the same degree of care as confidential medical records. They will 
be kept for up to 15 years – the normal period for confidential research data – after 
which they will be destroyed. Any electronic versions of this information will be stored 
on password protected NHS hard-drives. 
 
What will happen to the results of this study? 
The data from approximately 90 participants will be statistically analysed and 
submitted to an academic journal for publication (all data will be reported completely 
anonymously). Publication of the study will enable clinicians and researchers, both 
nationally and internationally, to learn from the research and to use the new 
questionnaire to help develop a better understanding of mental health problems and 
to develop more effective psychotherapy interventions. 
 
Any participants who would like to know the general outcomes of the study, or who 
would like feedback on their own questionnaire responses are welcome to contact 
either Sue Clarke or Helen Bolderston on 01202 584120. 
  
Who is organising the study? 
The study has been organised by Professor Sue Clarke and her research team. Sue 
is a Consultant Clinical Psychologist and is the Head of the Intensive Psychological 
Therapies Service in Poole. The sponsors of this study will pay members of the 
research team for evaluating your participation in this study.  
 
LREC Approval 
This study has been approved by the Southampton and South West Hampshire 
Research Ethics Committee A. If you have questions about your rights as a 
participant in this research, or if you feel that you have been placed at risk, you can 
contact the Research Ethics Committee at: 1st Floor, Regents Park Surgery, Park 
Street, Shirley, Southampton, SO16 4RJ, Tel. 023 8036 2466	 ﾠ
 
 
Summary  
 
1.  Participation is voluntary. You have the right to choose not to participate, 
or to stop participating in the study at any point and without consequence. 
2.  All the information you provide throughout the trial will be completely 
confidential.  
3.  This information sheet is for you to keep, as is the enclosed Debrief Sheet 
4.  For any further information, please contact the IPTS (01202 584120). 
 
 
 
Thank you for taking time to read this information sheet. 
	 ﾠ
 APPENDICES 
   
269 
Participant Debrief Sheet 
 
  
Cognitive fusion, defined as taking the content of thoughts about a situation to be the 
literal reality of the situation, is thought to play a role in the development of some 
psychological difficulties. This study was designed to develop a new questionnaire to 
measure cognitive fusion, so that researchers can learn more about the process, and 
also be able to assess the effectiveness of some psychotherapeutic interventions. 
  
In the unlikely event that you are experiencing strong emotions or uncomfortable 
thoughts as a result of participating in this study, and would like some support, then 
please contact either members of the research team, Sue Clarke and Helen 
Bolderston, who are both experienced clinical psychologists. They can both be 
contacted on 01202 584120 and will be happy to offer appropriate help and support.  
 
If you are in any way distressed as a result of participating in this study, we would 
also encourage you to make contact with your CMHT care coordinator or IPTS 
clinician, and/or your family doctor. 
 
You can also contact the Samaritans via their website: www.samaritans.org The 
Samaritans UK phone number is: 08457 90 90 90. 
   
This study has been approved by the Southampton and South West Hampshire 
Research Ethics Committee A. If you have questions about your rights as a 
participant in this research, or if you feel that you have been placed at risk, you can 
contact the Research Ethics Committee at: 1st Floor, Regents Park Surgery, Park 
Street, Shirley, Southampton, SO16 4RJ, Tel. 023 8036 2466 
 
 
Thank you for participating 
 
 
	 ﾠ
	 ﾠ
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Appendix F: Public access websites where Study 2 was hosted 
 
http://psych.hanover.edu/research/exponnet.html  
 
http://www.onlinepsychresearch.co.uk 
 
http://www.socialpsychology.org.uk 
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Appendix G: Study 2 demographic questionnaire and participant 
information/debrief sheet 
 
 
 
Demographics questionnaire 
 
Please indicate your answers in the spaces provided 
 
1. Are you male or female?      M          F 
 
2. How old are you?    ________ 
 
 
3. What is your ethnic origin?                           White _____     Asian _____    
 
                                                                          Black _____    Mixed _____ 
                                                                       
                                                                          Other ethnic group     _____ 
 
4. What country do you live in?               _________________ 
 
 
5. Have you ever sought treatment for a psychological problem (for example 
depression, anxiety, relationship difficulties, substance misuse, eating disorder)?  
 
Y      N 
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Predictors of personality functioning in adulthood 
 
Information Sheet 
 
Welcome to my internet survey study. I am Helen Bolderston, a PhD student from 
the University of Southampton, UK. I am requesting your participation in an online 
study exploring the relationships between various psychological processes, 
predictors of personality functioning, and adult personality functioning itself. 
  
 
Taking part in the study 
  
Taking part in this study involves completing a set of questionnaires, which should 
take no more than 30 minutes. Some of the questions in these questionnaires relate 
to personal, potentially sensitive issues such as traumatic experiences in childhood 
and emotional and other difficulties in adulthood. When you complete these 
questionnaires, it is important to be somewhere where you feel comfortable and 
safe, and where you are unlikely to be disturbed. 
It is entirely up to you to decide whether you would like to participate in this study or 
not. Your consent to participate in the study will be assumed by completion of the 
questionnaires.  
If you decide to take part in the study you will be asked to complete a brief set of 
questions about yourself (e.g. your age and ethnic origin) and six other 
questionnaires of varying lengths. 
You are not obliged to complete all the questionnaires, and in fact you can stop 
taking part in the study at any stage. For example, having seen the content of 
some of the questions, you might decide that you do not wish to answer the 
questions and that you would prefer to stop taking part in the study. That 
would be fine. If you do decide to stop early, I recommend that you press the STOP 
button. This takes you to a final information page. Included in this final page is an 
exercise designed to help you manage any uncomfortable thoughts or feelings 
that might have arisen as a result of you thinking about the subject matter of 
the study.  
 
If you are happy to answer all the questions, please remember to click the 
CONTINUE button at the bottom of each page. 
  
  
Risk and benefits for participation 
  
The only risk of participation in this study is that some of the questionnaires are of a 
personal nature and invite you to reflect on potentially sensitive issues. Therefore, it 
is possible that you might find answering a small number of the questions upsetting. 
Although completing these questionnaires will be of no direct benefit to you 
personally, this study will help us understand more fully the various processes 
leading to and underlying problematic personality functioning in adult life. This in turn 
may provide information to help guide future psychological treatment development 
for people with these kinds of psychological difficulties. 
  
 
Anonymity 
  
Your participation in this study will be anonymous. All data are treated as confidential 
and will not be linked to any personally identifying information.   APPENDICES 
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Contact 
  
You may contact Helen Bolderston, the principal investigator, if you have any 
questions or concerns about the study. This can be done by email: 
heb1w07@soton.ac.uk. This study is supervised by Professor Bob Remington, who 
can also be contacted by email: R.E.Remington@soton.ac.uk 
 
   
Legal 
  
This study has been approved by the Ethics Committee, School of Psychology, 
University of Southampton (contact details below). 
Your participation is voluntary and you may withdraw your participation at any time 
without consequence. 
  
  
 Giving consent 
  
In consenting, I understand that I am not waiving any legal claims, rights, or 
remedies. I also understand that the data collected as part of this research project 
will be kept confidential and that published results of this research project will 
maintain that confidentiality. I finally understand that if I have any questions about my 
rights as a participant in this research, or feel that I have been placed at risk, I may 
contact the chair of the Ethics Committee, School of Psychology, University of 
Southampton, Southampton, S017 1BJ. Phone: +44 (0)23 8059 5578 
  
             
I confirm that I am 18 years or older. I have read the information above. By ticking 
(checking) the box below and clicking CONTINUE, I give my consent to participate in 
the study described above: 
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Predictors of personality functioning in adulthood 
 
Debrief Sheet 
 
  
Research has identified a number of possible predictors of personality problems in 
adult life. These include some traumatic experiences in childhood and certain 
temperamental factors. However, many people who experience these predictor 
factors do not go on to have personality problems in adult life, and little is known 
about why some people do go on to have such problems and others do not. 
This study was designed to shed some light on this question.  
 
If you are experiencing uncomfortable thoughts or emotions as a result of 
taking part in this study, you might wish to complete the following exercise, 
designed to help you manage such thoughts and emotions. The exercise takes 
between 5 and 10 minutes to complete. After the exercise there are also some 
suggestions of places to get support, if you feel that would be helpful. 
 
 
Exercise 
 
Please read the following guidance all the way through, to get the general idea 
of the exercise, then work through it again from the beginning, step-by-step, 
actually trying out each step as instructed before moving onto the next step. 
 
1. Sit in a fairly upright chair, sitting with your back upright, your feet flat on 
the ground and your hands resting on the arms of the chair or in your lap. 
Obviously you will need your eyes open to read the instructions, but it is fine if 
you decide to close your eyes briefly as you practice each step. 
 
2. Take your attention into your feet, noticing the sensations of contact 
between the soles of your feet and the solid floor. Perhaps you can notice 
sensations of temperature, texture, or pressure? Continue with this noticing 
for a minute or so. 
 
3. Similarly, next take your attention into the parts of your body that are in 
contact with the chair, perhaps your legs or hands, and again notice the 
physical sensations of this contact between your body and the solid chair. 
Again, continue with this noticing for a minute or so. 
 
4. Now redirect your attention to the sensations of breathing in your abdomen. 
Feel each in-breath and each out-breath as they happen. You do not have to 
change how you are breathing in any way. The aim is just to notice the 
sensations of breathing, however they are, as you sit here.  
 
If at any point you notice that your attention has wandered from your breathing 
(as it surely will - human minds were designed to wander!), just acknowledge 
what it is that has pulled your attention away and then bring your attention 
back to your breathing. If it is something uncomfortable that pulled your 
attention away, maybe label it in your mind by saying to yourself something 
like ‘anxiety is here at the moment’ or ‘uncomfortable memories are around 
right now’. Then bring your attention back to your breathing, noticing the 
details of how this in-breath or this out-breath feels. Continue this part of the APPENDICES 
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exercise for a couple of minutes, coming back to the breath every time your 
attention wanders. 
 
5. The exercise is not about making any uncomfortable thoughts or emotions 
disappear. It is designed to help you use the sensations of breathing as a 
place to hold your attention, somewhere to bring your attention back to 
whenever you notice that your mind has wandered. In this way, although there 
may be uncomfortable thoughts and emotions around for a little while, you are 
less likely to get caught up in them. You can use your breathing as an anchor, 
holding you steady in the present moment.  
6. When you are ready, finish the exercise, but remember that you can always 
use your breathing as a place to steady your attention, if that is helpful for you. 
 
 
  
Following the exercise, if you are still concerned about any issues that have been 
raised for you through taking part in this study, or if you are experiencing strong 
emotions or uncomfortable thoughts and would like some support, then you might 
want to contact your general practitioner/family doctor.  
 
You can also contact the Samaritans via their website: www.samaritans.org There is 
a link on the Samaritan’s website to similar support options for people living outside 
of the UK. The Samaritans UK phone number is: 08457 90 90 90. 
 
 The UK Mind website can also provide UK participants with details of where to seek 
help for emotional/psychological/mental health problems: Mind PO Box 277 
Manchester M60 3XN Tel. 0845 766 0163 Email: info@mind.org.uk Web: 
www.mind.org.uk 
   
Finally, if you have any questions about your rights as a participant in this research, 
or you feel that you have been placed at risk, please contact the Chair of the Ethics 
Committee, School of Psychology, University of Southampton, Southampton, SO17 
1BJ, Tel: +44 (0)23 8059 5578 
  
 
 
Thank you for participating 
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Appendix H: List of 48 self-referential adjectives used in Study 3 
 
Main trials: positive words 
Respectful 
Responsible 
Kind 
Optimistic 
Imaginative 
Humorous 
Courageous 
Considerate 
Competent 
Friendly 
Generous 
Creative 
Interesting 
Understanding 
Honest 
Intelligent 
 
Main trials: negative words 
Unpleasant 
Selfish 
Egotistical 
Irritable 
Impolite 
Thoughtless 
Unfriendly 
Hostile 
Ungrateful 
Intolerant 
Deceitful 
Unreliable 
Insincere 
Incompetent 
Offensive 
Insolent  
 
Recognition trials: Positive words 
Brilliant   
Positive   
Outstanding   
Imaginative   
Clever  
Skilled  
Sociable   
Cheerful 
   
Recognition trials: Negative words 
Moody  
Unreasonable   
Immature   
Irrational   
Belligerent   
Unappreciative   
Boring  
Cowardly APPENDICES 
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Appendix I: Study 3 Brief Demographics Questionnaire 
 
 
 
Please complete this questionnaire by ticking the appropriate options.  
 
 
 
1. Are you male or female?                              Male _____    Female _____                                                                
 
 
2. How old are you?                                                  _____ years old 
    
 
3. What country were you born in?                           ___________________ 
 
 
4. What is your ethnic origin?                           White _____     Asian _____    
 
                                                                          Black _____    Mixed _____ 
                                                                       
                                                                          Other ethnic group     _____ 
 
 
 
 
 
 
 
THANK YOU FOR COMPLETING THIS QUESTIONNAIRE 
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Appendix J: Study 3 consent form, participant information sheet and debrief 
sheet 
 
 
Consent Form 
 
 
Study title: Metacognition and cognitive-behavioural responses to visual stimuli 
Researcher name: Helen Bolderston 
Study reference: 
Ethics reference: 
 
 
Please initial the box(es) if you agree with the statement(s):   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data Protection 
I understand that information collected about me during my participation in this study will be stored 
on a password-protected computer and that this information will only be used for the purpose of this 
study. All files containing any personal data will be made anonymous. 
 
 
Name of participant (print name)…………………………………………………… 
 
 
 
Signature of participant…………………………………………………………….. 
 
 
 
Date…………………………………………………………………………………   
 
 
 
 
 
 
I have read and understood the information sheet (Version 1; 20/06/11) 
and have had the opportunity to ask questions about the study. 
 
I agree to take part in this research project and agree for my data to be 
used for the purpose of this study 
I understand my participation is voluntary and I may withdraw at any 
time without my legal rights being affected  
 APPENDICES 
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Information Sheet 
Metacognition and cognitive-behavioural responses to visual stimuli 
 
 I am Helen Bolderston, a PhD student from the University of Southampton. I am requesting your 
participation in a study exploring influences on performance on a computer-based memory task.  
  
 
Taking part in the study 
  
 
Taking part in this study involves completing some questionnaires, which should take no more than 15 
minutes. This will be followed by the rest of the study, which involves a computer-based task, and for 
some participants, a brief psychological exercise. This part of the study will take between 15 and 45 
minutes, depending on which aspect of the study you are assigned to. 
It is entirely up to you to decide whether you would like to participate in this study or not. You will be 
asked to provide written consent for participation. If you do consent, you are still not obliged to 
complete the study. 
  
 
Risk and benefits for participation 
  
There is no anticipated risk associated with this study. 
Although participating will be of no direct benefit to you personally, this study will help us understand 
more fully processes that may be implicated in the development and maintenance of good mental 
health. 
 
  
Anonymity 
  
All data will be stored in an anonymised form, will be treated as confidential and will not be linked to 
any personally identifying information.   
For psychology students from the University of Southampton: Although I ask for your student ID 
number in order to award participation credits, it will be deleted when the data have been coded. 
 
The study will be administered and data handled by five third year undergraduate project students from 
the School of Psychology, supervised by Professor Bob Remington and/or by me. They are: 
Esther Akinfenwa 
Charlotte Deveson 
Fay Roberts 
Alison Tama 
Rebecca Wastell 
 
 
Contact 
  
You may contact Helen Bolderston, the principal investigator, if you have any questions or concerns 
about the study. This can be done by email: heb1w07@soton.ac.uk. This study is supervised by 
Professor Bob Remington: R.E.Remington@soton.ac.uk  
 
  
Legal 
  
This study has been approved by the Ethics Committee, School of Psychology, University of 
Southampton. 
If you consent, your participation is voluntary and you may withdraw your participation at any time 
without consequence. If you consent, you will not be waiving any legal claims, rights, or remedies. 
If you have any questions about your rights as a participant in this research, or feel that you have been 
placed at risk, you may contact the chair of the Ethics Committee, School of Psychology, University of 
Southampton, Southampton, S017 1BJ. Phone: +44 (0)23 8059 5578. APPENDICES 
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Debriefing Statement 
 
 
Metacognition and cognitive-behavioural responses to visual 
stimuli 
 
 
The aim of this research was to examine the impact of cognitive fusion, a strong 
attachment to the literal content of human thought that can reduce psychological 
flexibility. Everyone experiences this to some extent but some people show more 
fusion than others. We measured your tendency towards fusion using a questionnaire.  
 
Although fusion may be important in determining how flexible we can be, so far 
there has been little empirical research testing this idea. Current theory suggests that 
more fusion will tend to be associated with more avoidance of negative self-
referential words, but that such words will be easier to recall if seen recently. This 
study tested that idea by presenting both negative and positive words and measuring 
how quickly you moved on after seeing them. Later, we also checked how well you 
recalled the words you had seen.  
 
In some conditions of the study, we carried out a task designed to lower fusion levels 
before the memory task. Whether or not you took part in this exercise, a similar 
distraction exercise, or just did the memory task was determined by the design of the 
study. 
 
Your data will help us understand more about cognitive fusion.  
 
Once again, any reporting of this study will not include your name or any other 
identifying characteristics. If you would like a copy of the summary of research 
findings once the project is completed, please email me. If you have any further 
questions or concerns please contact me Helen Bolderston: heb1w07@soton.ac.uk 
 
 
If you have been adversely affected in any way by participating in this study, support 
is available. You could contact me, as I am an experienced clinical psychologist. 
Alternatively, you could seek support through the following resources:  
 
-  University of Southampton: the University Counselling Service, Nightline, on 023 
8059 5236 (free from halls on (78)25236) or visit http://nline.susu.org/ 
-   Non-university option: find a counsellor at www.bacp.org 
 
 
The study could produce different results if you had been fully aware of what 
you have just read before you took part. For this reason, it is very important to 
us that you do not disclose the ideas behind the research to your friends or other 
students, some of whom are likely to take part in the study later on. APPENDICES 
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Just to remind you, the data from this study may be handled by any of the following 
3
rd year undergraduate psychology project students: 
Esther Akinfenwa 
Charlotte Deveson 
Fay Roberts 
Alison Tama 
Rebecca Wastell 
 
 
If you would like to find out more about cognitive fusion and psychological 
flexibility, the following articles provide more detailed information: 
 
Blackledge, J. T. (2007). Disrupting verbal processes: Cognitive defusion in  
acceptance and commitment therapy and other mindfulness-based psychotherapies. 
The Psychological Record, 57, 555-576. 
 
Hayes, S. C., Luoma, J. B., Bond, F. W., Masuda, A., and Lillis, J. (2006). 
Acceptance and Commitment Therapy: Model, processes and outcomes.   Behaviour 
Research and Therapy 44, 1–25. 
 
 
 
If you have questions about your rights as a participant in this research, or if you feel 
that you have been placed at risk, you may contact the Chair of the Ethics Committee, 
Department of Psychology, University of Southampton, Southampton, SO17 1BJ. 
Phone: +44 (0)23 8059 5578. 
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Appendix K: Study 4: Details of protocol development 
 
  The content and structure of sessions was based on the successful ACT group 
protocol developed by SC and HB for the treatment of patients with treatment 
resistant mental health problems (see Clark et al., 2012, and Clarke et al., in prep, for 
more details). That original 16-week protocol had in turn been informed by the self-
help book “Get Out Of Your Mind And Into Your Life” (Hayes & Smith, 2005), 
though the content had been substantially modified to be suitable for UK-based 
mental health patients and for use in a group setting. 
  Significant changes were made to the Clarke et al. 16-week protocol to render 
it more suitable for a patient group with high levels of PD psychopathology. These 
changes were to both the structure of the intervention and the content. In terms of 
structural changes, the group was extended to 20 sessions, to allow longer for 
participants to adjust to this new therapeutic approach, to engage with the work, and 
begin to make changes in their lives. The new protocol included two review sessions, 
where no new material was introduced. The sessions were used to revisit topics and 
exercises already covered, as requested by group participants. Also, two hours of 1-
to-1 session time with either therapist was made available to each participant, in 
addition to the group session time. This time could be used as two, 1-hour sessions, or 
in the form of more frequent, brief sessions. This 1-to-1 time was included to serve 
the following functions: 
1. To aid transition from DBT (which has both group and individual therapy 
elements). 
 2. To offer appropriate support and intervention if increased risk of self-harm 
or increased suicidal ideation was reported, as well as support with difficult 
emotions, memories and other private experiences.  
3. To allow additional clarification and explanation of new, potentially 
confusing ACT concepts. 
4. To provide the opportunity to catch up on missed session content if 
participants missed sessions and/or were in danger of dropping out of the trial. 
   
 
In terms of the content of the sessions, changes were made to the original 
protocol for treatment-resistant mental health problems, by adding some DBT-APPENDICES 
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oriented content, and by modifying some of the existing ACT content (see Chapter 
VII, Sections 7.2.4.5 and 7.2.4.6 respectively, for an outline of these changes). 
As well as changing the structure and content of the protocol as outlined 
above, some modifications were made to the original 16-session protocol based on 
what was learned from the Clarke et al. RCT. For example, the original protocol had 
relatively little content directly addressing behavioural change, so this aspect of the 
intervention was enhanced. Also, it was decided to introduce the topic of values, in a 
relatively brief and unchallenging way, very early in the life of the group, to enhance 
patient motivation to engage with the intervention.  
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APPENDIX L: Studies 4 and 5 NHS Research Ethics Committee Approval 
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Appendix M: Studies 4 and 5 consent form, participant information sheet, and 
GP/CMHT information sheet 
 
 
CONSENT FORM 
 
Title of the project: 
 
Evaluation of Acceptance and Commitment Therapy for post-DBT clients 
 
Name of Researcher: Prof. Sue Clarke  
                                                                                                    Please initial each 
box                       
1.  I confirm that I have read and understood the information sheet dated          
14/12/2009 (version 1) for the above study. I have had the opportunity to 
consider the information, ask questions by phone and have had these 
answered satisfactorily 
 
2.  I understand that my participation is voluntary and that I am free to 
withdraw at any time without my medical care or legal rights being affected 
 
3.  I understand that data collected throughout this study may be looked at by 
members of Prof. Sue Clark’s research team. I give permission for these 
individuals to have access to the data collected from this study, to store 
and to process it. 
 
4.  I agree that in order for me to participate in the study, members of Prof. 
Susan Clarke’s research team may have access to my contact details, 
which will be stored securely on an NHS, password-protected computer or 
locked in an NHS filing cabinet. 
 
5.  I agree to take part in pre and post research assessment phases 
(questionnaires and interviews) as well as therapy. 
 
6.  I consent to the interviews and therapy sessions being audio-taped.   
7.   I agree for my GP and other healthcare professionals involved in my care 
to be informed about my participation in this research trial. 
 
8.   I agree that data obtained from this trial can be used, in anonymous form, 
for publication and for a PhD thesis. 
 
 
____________________      ________________  ____________________ 
      Paticipant name                     Date      Signature 
 
 
____________________      ________________  ____________________ 
    Researcher name          Date                 Signature APPENDICES 
   
286 
 
Participant information sheet 
Evaluation of Acceptance and Commitment Therapy for post-DBT clients 
 
You are being invited to take part in a research study. Before you decide whether 
you would like to take part, you need to understand why the research is being done 
and what it would involve. Please take time to read the following information carefully. 
Talk to others about the study if you so wish.  
 - Part 1 tells you the purpose of this study and what will happen to you if you take 
part.   
 - Part 2 gives you more detailed information about the conduct of the study.  
If there is anything that is not clear, or if you would like more information, please do 
not hesitate to contact Helen Bolderston or Sue Clarke on 01202 584120. 
 
Part 1 
 
What is the purpose of this study? 
This is a small scale, pilot research trial, which is designed to make some preliminary 
investigations into the effectiveness of Acceptance and Commitment Therapy (ACT) 
for people who have stopped engaging in self-harming behaviours following 
Dialectical Behaviour Therapy (DBT). This study has been designed by senior 
clinicians and researchers (Prof. Susan Clarke; Prof. Bob Remington; Helen 
Bolderston). 
Why have I been invited? 
We are recruiting people who have received at least 12 months of DBT at the 
Intensive Psychological Therapies Service (IPTS), who have not self-harmed in the 
last six months, and who are still experiencing some psychological distress or 
difficulty. Your DBT therapist thought that you meet these criteria and that you might 
benefit from this therapy and discussed the research trial with you. You indicated 
that you would be interested in meeting with one of the therapists/researchers (Sue 
Clarke and Helen Bolderston) for an assessment interview and to hear more about 
the study in general.  
We will be running two ACT therapy groups and aim to recruit a maximum of 10 
clients per group. The first group will start in Spring 2010, followed by the second 
group, which will start in Autumn 2010. 
 
Do I have to take part? 
It is up to you whether you take part or not. If you do decide to take part, you will be 
asked to sign a consent form.  
Having signed the consent form, you are still free to withdraw at any time and 
without giving a reason.  A decision to withdraw, or a decision not to take part, 
will not affect the standard of care you receive, in any way.  
 
 
What will happen to me if I take part; what will I have to do? 
 
Before therapy 
Initially, you will be invited to an interview with one of the therapists/researchers to 
discuss the study and to assess if the intervention might be suitable for you. 
Following the interview, if you are offered a place in the study and decide to accept 
it, you will be invited for a pre-therapy interview at the IPTS, which will take 
approximately 45 minutes. You will also be asked to complete a set of 
questionnaires, which will also take approximately 45 minutes.  
 APPENDICES 
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Therapy 
The therapy will be in the form of a 20-week ACT group. There will also be two one-
to-one sessions for each client, during the life of the group. ACT is a relatively new 
therapy that suggests that when people try to avoid difficult thoughts, memories, 
feelings and so on, they can get into a battle with themselves, and in fact can end up 
feeling worse. ACT uses exercises such as mindfulness meditation to help people 
accept difficult thoughts, memories, feelings and so on, so that they can step back 
from this internal battle. ACT attempts to help people clarify what they really value in 
life, and to begin to take action in accordance with these values, even if difficult 
thoughts and feelings are present. 
  There have been some international ACT studies that have shown promising 
results in terms of improving the lives of people with difficulties such as depression 
and anxiety. Over the last few years, there has been research at the IPTS examining 
the effectiveness of ACT groups for people with entrenched mental health difficulties. 
This work is on-going, but to date, the majority of patients have experienced a 
reduction in anxiety and depression levels, as well as an increase in quality of life. 
 
After therapy 
Immediately after the therapy group has finished, you will be asked to complete 
another set of questionnaires and come to a second, shorter interview (that will last 
approximately 20 minutes). In this interview you will be asked for feedback about 
your experience of the group, including what was helpful and not so helpful. Six 
months after the end of the group you will be asked to complete a final set of 
questionnaires and to attend a final interview. 
 
Data and audio taping  
In order to be able to analyse the data from the study, we will ask for your consent 
for members of the research team to have access to your questionnaire responses. 
All of your completed questionnaire responses will be anonymised by labelling them 
with a number rather than with your name. They will be stored securely at the IPTS. 
We will also ask your permission to audio record the therapy and assessment 
sessions, for therapist supervision and therapy planning purposes. 
 
Restrictions during and after therapy 
If you take part, you can continue taking any medication. We ask that for six months 
after the end of the ACT group you do not attend any other form of therapy. This is 
routine practice and is referred to as a consolidation phase. After we collect the six 
month follow-up data, you can consider any other therapy or intervention available, 
as appropriate. 
 
Attendance 
We ask you to come to all scheduled visits and to complete all questionnaires. If you 
are going to miss a group session, we ask you to let the clinic know beforehand. If 
you miss four sessions in a row, you will not be able to continue coming to the group. 
This is to help you not unintentionally drift out of therapy. It also helps group morale.  
 
What are the alternatives for treatment? 
You are free to choose not to participate in this research trial. If you do not want to 
participate in the trial, you will continue to be able to seek other available treatment, 
as appropriate.  
 
What are the possible risks or disadvantages of taking part? 
As with any therapy, you may sometimes feel emotionally distressed. Your well-
being will be monitored by the therapists during every session, and they will 
endeavour to ensure that no one leaves a session significantly distressed. Clients APPENDICES 
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who struggle with problems that cannot be addressed adequately in the group will be 
provided with an individual therapy session. The clinicians are both trained and well 
experienced in running ACT groups.  
As with any therapy, it is possible that a participant might actually deteriorate as a 
result of participating in the study. It is thought that this is highly unlikely, based on 
the results of similar ACT studies run at the IPTS. Every attempt will be made to 
ensure that this does not occur. 
A possible disadvantage is the inconvenience of the questionnaires and interviews. 
These have been kept to a minimum and will be done in a way that is as convenient 
for you as possible. It is also possible, though unlikely, that you might experience 
some emotional discomfort as a result of completing some of the questionnaires. 
Support will be available to you in this event.  
We will offer you feedback on the questionnaires and interviews at the end of the 
study.  
 
What are the potential benefits of taking part? 
If you are offered a place in one of the ACT groups and decide to participate, you will 
be offered 20 weeks of ACT-based psychotherapy. ACT is a relatively new and 
promising therapy, and there is evidence to suggest that participants might benefit 
from this intervention. This study provides participants with a therapeutic opportunity 
that is not currently available in the NHS. On the basis of previous research we 
anticipate that participants may be more able to build a life that is engaging and 
satisfying for them by the end of the intervention.    
Although group based therapy can seem daunting, it has many benefits. For 
example, you can develop both from active participation and from observation; you 
have the opportunity to give and receive immediate feedback; and you have the 
opportunity for support from people who are experiencing similar difficulties. Many 
patients find that group-based delivery can actually enhance their experience during 
therapy.  Participation in group therapy does not require you to share personal 
information.  
Whilst we expect these groups to be of benefit to you, we cannot guarantee this. 
Each participant will receive a £5 gift token at the end of the study as a small gesture 
to acknowledge the time and effort they have put into being a participant.   
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this is 
given in Part 2. 
 
Confidentiality –who will know that I am taking part in this study? 
All the information about your participation in this study will be kept confidential.  The 
details are included in Part 2. 
 
For further information 
If you would like any further information about the trial, please do not hesitate to 
contact Professor Sue Clarke or Helen Bolderston (01202 584120). 
 
This completes Part 1 of the Information Sheet. If the information in Part 1 has 
interested you and you are considering participation, please continue to read 
the additional information in Part 2 before making any decision 
 
 
 
Part 2 
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What if relevant new information becomes available?   
Members of Sue Clarke’s research team are currently monitoring and will continue to 
monitor the relevant research literature and websites. If any evidence comes to light 
that there are any adverse effects of this intervention, your clinician will inform you of 
these details and ask you whether you would like to continue with the trial. If you 
decide to continue in the study you will be asked to sign an updated consent form. If 
you decide not to continue with the trial your continuing care will be arranged. It is 
also possible that, on receiving new information, the clinician feels that it is in your 
best interests to withdraw from the study. In the unlikely event that this happens, she 
will explain the reasons and facilitate the continuation of your care. If the study is 
stopped for any other reason, you will be told why and your continuing care will be 
arranged. 
 
What will happen if I don’t want to carry on with the study? 
You are free to withdraw from treatment at any stage. If you withdraw, we will need 
to use the data collected up to your point of withdrawal, but this will only be available 
to members of the research team and will not be stored with information that can 
identify you. With your permission, we would also like you to complete post-
intervention questionnaires and attend the interview despite you not completing the 
group. However, you will retain the right not to do this if you so choose. 
 
What if there is a problem? 
It is unlikely that this therapy will cause you any harm. Trained clinicians will be 
available at every stage of your involvement. If you have a concern about any aspect 
of this study, you should phone Sue Clarke (01202 584120). If you remain unhappy, 
you have the right to complain to the NHS about any aspects of the way you have 
been approached or treated during the course of this clinical trial. In the event that 
something does go wrong and you are harmed during the research study there are 
no special compensation arrangements.  If you are harmed and this is due to 
someone’s negligence then you may have grounds for a legal action for 
compensation against Dorset Healthcare NHS Foundation Trust, but you may have 
to pay your legal costs.  
 
Confidentiality – who will know that I am taking part in this study? 
All information relating to you participating in this study will be securely stored, either 
on a password-protected NHS computer, or locked in an NHS filing cabinet. No 
completed questionnaires will be labelled using your name or any other identifiable 
information. Instead, each questionnaire will be labelled with a unique identification 
number. 
If you consent to participate in the study, your GP and other health professionals 
involved in your care will be informed. We will ask for your consent to do this. 
The only people who will have access to your data from the study will be the 
research team.  
 
Who is organising the study? 
The study has been organised by Professor Sue Clarke and her research team. Sue 
is a Consultant Clinical Psychologist and is the Head of the Intensive Psychological 
Therapies Service in Poole.  
The sponsors of this study will pay members of the research team for evaluating 
your participation in this study.  
 
 
LREC Approval 
This study has been approved by the Southampton A Research Ethics Committee APPENDICES 
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and by the University of Southampton School of Psychology Ethics Committee. If 
you have questions about your rights as a participant in this research, or if you feel 
that you have been placed at risk, you can contact the Chair of the Ethics 
Committee, Department of Psychology, University of Southampton, Southampton, 
SO17 1BJ. Phone:  (023) 8059 3995, or you can contact the Research Ethics 
Committee at: 1st Floor, Regents Park Surgery, Park Street, Shirley, Southampton, 
SO16 4RJ, Tel. 023 8036 2466. 
Thank you for taking time to read this information pack. 
 
Summary 
 
•  Participation is voluntary. You have the right to choose not to 
participate, or to stop participating in the trial at any point and without 
consequence. 
•  All the information you provide throughout the trial will be completely 
confidential. However, if a member of the team is given reason to 
believe that you may harm yourself or others, confidentiality may be 
breached.  
•  This information sheet is for you to keep. If you decide to participate, 
you will also be provided with a copy of the signed consent form. 
•  For any further information, please contact The IPTS (01202 584120). 
 
 
The following flowchart outlines what you will be asked of you if you decide to take 
part: 
 
 
 
 
 
 
 
 
 
 
 
GP information sheet 
 
 
Before you start therapy we ask you to: 
(1) Fill out a set of questionnaires. This takes about 45 minutes to complete. 
(2) Come to an interview at the IPTS. This also takes about 45 minutes. 
  
Therapy 
(1) Group therapy sessions will be held weekly for 20 weeks and will last up to 2 ½ 
hours (with a break).  
(2) There will be two one-to-one therapy sessions 
 
After the 20 weeks of therapy, we will ask you to: 
(1) Fill out a set of questionnaires (the same questionnaires as before therapy) 
(2) Attend a 20 minute interview on your experiences of the group 
 
 
6-months after therapy, we will ask you to: 
(1) Fill out a final set of questionnaires (same questionnaires as before therapy). 
(2) Attend a 45 minute interview at the clinic to see how you are 6 months after therapy APPENDICES 
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GP and CMHT Study Information Sheet 
 
Evaluation of Acceptance and Commitment Therapy for post-DBT clients 
 
Research Background 
Personality disorders are common, difficult to treat disorders that can have a 
profoundly negative impact on the sufferer. Dialectical Behaviour Therapy (DBT; 
Linehan, 1993) is currently the treatment of choice for many personality disorder 
clients, enabling many clients to reduce life-threatening behaviours. However, once 
behaviourally stable, many DBT graduates continue to have a range of psychological 
difficulties, and live limited and unfulfilling lives. 
Acceptance and Commitment Therapy (ACT; Hayes et al., 1999) has shown promise 
with clients with severe, entrenched mental health problems and may represent an 
effective post-DBT intervention for behaviourally stable personality disorder clients. 
For example, Clarke, Kingston et al., (in prep) found that in an RCT comparing ACT 
with treatment-as-usual for treatment resistant clients (some of whom had 
personality disorder diagnoses), immediately post therapy participants in both 
conditions showed improvement on outcome measures of depression, general 
psychological distress and quality of life. However, at six-month follow-up, the mean 
score of the control group had deteriorated, whereas in the mean score of the ACT 
group continued to show improvement.  
  
Research Aim 
Despite promising outcomes generally, data from Clarke, Kingston et al. suggests 
that the hardest-to-help clients remained those previously diagnosed with personality 
disorders. Although the Clarke, Kingston et al. protocol showed variable outcomes 
for this group, the results showed enough promise to justify an adaptation of the 
protocol to target problems associated severe personality disorder.   
The purpose of the current study is to develop and test the effectiveness of this new, 
adapted ACT-based group protocol for clients with personality disorder who have 
become behaviourally stable through DBT. Although an uncontrolled pre-post 
intervention, this study is an essential first step to developing an effective and 
acceptable treatment for this client group, allowing as it does, the opportunity to 
refine an ACT protocol specifically for personality disorder, and to fine-tune our 
process and outcome measures and determine effect sizes in preparation for a 
Randomised Control Trial (RCT).  
 
Methodology 
Participants 
Participants for this study will be recruited from the Intensive Psychological 
Therapies Service (IPTS), a specialist NHS personality disorder service based in 
Poole. 
Inclusion criteria 
(i) 18 years old and above. APPENDICES 
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(ii) Personality disorder diagnosis at initial IPTS assessment. 
(iii) Minimum of 12 months DBT input prior to this study. 
(iv) No parasuicidal behaviour during the six months prior to the study (parasuicidal 
behaviour defined as deliberate self-harm with or without intent to kill oneself).  
(iv) Continued significant psychological difficulties. 
Exclusion criteria 
 (i) Under the age of 18. 
(ii) Currently, or in the six months prior to this study, engaged in parasuicidal 
behaviour. 
(iii) Currently meets DSM-IV diagnostic criteria for a psychotic disorder. 
(iv) Eating disorder with BMI currently below 17.5. 
(v) Currently meets DSM-IV diagnostic criteria for substance dependence. 
(iv) Learning disability. 
(v) Other organic disorder that might impair capacity to give informed consent, or to 
participate. 
 
Procedure 
Participants will be recruited via DBT therapists at the IPTS. Assessments will be 
carried out by the CI, Prof. Sue Clarke, or Helen Bolderston, both experienced 
clinical psychologists. The assessment session will evaluate the client’s suitability for 
the study, and provide the client with the opportunity to discuss the study in detail. If 
they are offered a place in the study, and if they decide to participate, participants 
will be asked to provide written consent. 
Participants will attend a 20-week ACT group, as well as being offered two one-to-
one sessions during the life of the group. Group sessions will be weekly, each will 
last for 2 ½ hours (including a short break), and will be based at the IPTS. The aims 
of the group intervention will be to help participants: 
(i) Maintain behavioural stability (in terms of not engaging in parasuicidal behaviours) 
(ii) Begin to develop a life that they value, which is more satisfying and less defined 
by mental health problems. 
Participants will be asked to complete a questionnaire pack pre-intervention, post-
intervention, and at six-month follow-up. They will also have a personality disorder 
diagnostic interview pre-intervention and at six-month follow-up. 
 
Ethical considerations 
As with all forms of psychotherapy, it is possible that some participants might 
experience emotional discomfort or distress at times during the ACT group 
intervention. The (very experienced) therapists will monitor the wellbeing of APPENDICES 
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participants in every group session and will vary the content and intensity of 
interventions accordingly. 
As with all psychotherapy interventions, it is possible that a participant might actually 
deteriorate as a result of participating in the study. It is thought that this is unlikely, 
based on previous outcomes with a similar client group in a study by the same 
research group (Clarke, Kingston et al., in prep). Every attempt will be made to 
ensure that this does not occur, through weekly monitoring of DBT skills use and risk 
issues, through directly addressing any participant difficulties as soon as they arise, 
and through the use of one-to-one sessions where needed. All participants will 
continue to have access to whatever general forms of support (such as community 
mental health team care-coordinators) they were receiving prior to the ACT 
intervention. 
It is possible that participants might experience some fatigue, or feel inconvenienced, 
by completing the questionnaire packs and attending the interviews.  The 
questionnaires included have been kept to the minimum to evaluate the intervention 
as efficiently as possible. The participant information sheet will include an estimate of 
the amount of time it will take to complete the questionnaires (approximately 45 
minutes), and participants will be informed that it is acceptable to complete the 
questionnaires over a small number of days, rather than in one sitting. Participants 
will be offered the opportunity to receive feedback on their questionnaire responses 
at the end of the study.  
Other ethical concerns are limited to issues from research practice such as informed 
consent, right to withdraw, use of personal data and confidentiality. These will be 
addressed through research governance practices as follows. Participants will 
receive full information about all procedures regarding these issues before 
recruitment and will take part having provided written consent of their participation 
and data use. It will be emphasised that even following consent, participants are free 
to withdraw from the study at any point, with no negative consequences. 
All data will be labelled with a unique identification number for each participant. 
Questionnaires will not have any participant identifying information on them and will 
be kept locked in a filing cabinet at the IPTS. The only people who will have access 
to any material from participants will be the researchers. All participant completed 
questionnaires and consent forms will be accorded the same degree of care as 
confidential medical records.  
Following consent from participants, other NHS professionals involved in the care of 
each individual will be informed about the study. In line with good NHS practice, they 
will also receive brief clinical reports after assessment, post-intervention, and at 
discharge at six-month follow-up. 
This study is being conducted by Professor Sue Clarke, Consultant Clinical 
Psychologist, Head of the Intensive Psychological Therapies Service, Dorset 
Healthcare NHS Foundation Trust. This trial has been approved by the Southampton 
and South West Hampshire Research Ethics Committee A. 
 
Thank you for taking your time to read this information. 
 If you have any questions please do not hesitate to contact either Sue Clarke or 
Helen Bolderston (01202 584120)	 ﾠ
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Appendix N: Study 4: Details of treatment protocol 
 
The first of the six treatment phases was designed to support participants in 
the transition from DBT to ACT, and to motivate them to engage with the new ACT 
content and style. Group members were encouraged to reflect on the ways in which 
they had benefitted from DBT, and why it was important to continue using DBT 
skills to maintain stability. The possibility was introduced of a life that is not 
completely dominated by self-harm urges and behaviour, and each participant was 
supported to think about a life that had personal meaning for them. ACT was 
introduced as a possible way of enabling participants clarify what steps in the 
direction of a personally-valued life might look like, and then gradually and safely to 
take those first steps. Common ground between ACT and DBT was identified, such 
as mindfulness as a central process, attention to both acceptance and change, and the 
basic structure of the weekly group session. At the same time, differences in style 
(e.g. slower pace and less directive therapists), content (new skills to learn and new 
ways of thinking about personal experience to consider), and therapeutic goals (more 
emphasis on a life beyond self-harm) were also identified.   
The second phase of treatment addressed creative hopelessness, a common 
theme early in ACT protocols. In this phase, participants were offered a simple, RFT-
consistent account of the costs and benefits of human language and cognitive 
capacities, particularly in relation to psychological suffering. The universal and 
wholly understandable coping strategy of EA was discussed, with group members 
reflecting on the personal, short-term advantages and long-term disadvantages of 
over-reliance on EA. Willingness was introduced as a possible alternative to EA, with 
group discussions about how to distinguish when to use each strategy, based on 
current situation and emotional resources. A ‘dipping your toe in the water of 
acceptance rather than diving in head first’ approach was encouraged, to help deal 
with understandable nervousness about ‘having to’ ‘give up’ EA, the predominant 
psychological coping strategy for all group members. 
  The third phase of the protocol focused on cognitive defusion. Through 
several experiential practices as well as didactic teaching, the possibility of 
cultivating a radically different relationship to cognitive processes was introduced. 
Group members were encouraged to become more aware of their thoughts as they 
were arising, something that requires the willingness, at least momentarily, to ‘turn APPENDICES 
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towards’ these private experiences rather than attempting to avoid them. Participants 
were then coached to view thoughts as just thoughts, regardless of content; to relate 
to them as mental events that may or may not be accurate reflections of reality. The 
ACT principle of workability was used to help participants consider how helpful or 
not it might be to take seriously the content of particular thoughts, particularly 
thoughts about themselves. 
  The fourth treatment phase built on this exploration of cognitive defusion by 
using mindfulness, willingness and self-as-context as ways of cultivating more 
accepting and effective relationships with private experiences in general (not just 
thoughts), aversive life history, and sense of self. Experiential exercises and 
exploration of metaphors such as the chessboard representation of self-as-context 
were used to support participants to develop a sense of self not merely as the sum of 
self-referential thoughts. The on-going experience of this sense of self aided the 
maintenance of a less identified and less avoidant stance towards aversive memories 
of difficult historic experiences and related emotions.   
  Having dedicated three months to the gradual cultivation of the ability to 
relate to private experiences in a less reactive and avoidant manner, the protocol next 
revisited values, and specifically taking values-consistent action in life. The rationale 
for this order of content was that although ACT is a behavioural therapy, in that 
values-consistent behavioural change is the primary aim, a fused and avoidant 
relationship with thoughts, emotions, sensations, urges, and self can act as a barrier to 
such behavioural change, no matter how much the individual wishes to see the quality 
of their life improve. The ability to respond in a defused and open way to the 
thoughts, emotions and so on that arise as the individual begins to attempt 
behavioural change, is seen as vital to the individual’s ability to persist in taking such 
action. 
  A number of written exercises were included to aid group members clarify 
which aspects of life mattered to them personally, goals and actions related to these 
valued aspects of life, and the particular barriers preventing them take valued 
behavioural steps. This work was followed with values-consistent behavioural 
activation and exposure practices, which in fact formed the substantial part of the 
homework for the remaining weeks of the group. Emphasis in the protocol continued 
to be on making ‘wise-mind’ decisions about whether to use an acceptance or change APPENDICES 
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approach in each situation, and all behavioural change should be in the form of small, 
manageable steps. 
  The final three sessions of the protocol involved reviewing and revising the 
main themes of the material covered in the intervention, particularly the relationship 
between DBT and ACT, and acceptance and change, as well as planning for life after 
the group. The protocol emphasised that straying from valued life directions and 
falling back into old habits of over-reliance on avoidance and behavioural inertia 
were deeply human, pretty much guaranteed, and not reasons to give up. Instead, 
emphasis was placed on the value of ‘starting again’; the capacity to notice when you 
are no longer living life as you had planned or wanted, to use whatever DBT and 
ACT strategies are relevant to steady yourself emotionally and address the barriers 
that have got in the way, and then to begin again planning and carrying out values-
consistent steps, no matter how small.  
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Appendix O: Life Activities Schedule 
 
Please look through this list of activities and indicate which ones you have engaged 
in over the last week, and how many times you have done each activity. Please do 
this by using the following scale: 
 
               1                                    2                              3                                     4 
             Once                     More than once               Every day                   More than once a day 
      in the last week              in the last week             in the last week                 in the last week 
 
For example, if you have been to the beach once each day in the last week, you would write 3 by 
the side of that activity, in the rating column. 
 
If you have not done a particular activity in the last week, please do not write 
anything by the side of that activity. 
 
Excursions                                           
1. 
1. Going on a trip or holiday                                  _____ 
2. Shopping, car boot sales, flea markets                  _____ 
3. Going to the beach                                           _____ 
4. Going on a picnic                                              _____ 
5. Going out to dinner                                          _____ 
6. Going for a drive for pleasure                             _____ 
7. Riding in an airplane, hot air balloon, helicopter     _____ 
8. Staying at a hotel or b & b                                  _____ 
9. Camping                                                           _____ 
10. Going to a museum or exhibit                           _____ 
11. Going to a library or bookstore                         _____ 
12. Going to a fair, carnival, circus, zoo  
or amusement park                                               _____ 
13. Other:                                                            _____ 
 
Interactions with others/ 
social activities 
 
1. Going to or giving a party                                   _____ 
2. Giving or receiving physical affection                    _____ 
3. Reminiscing, talking about old times                     _____ 
4. Group activities                                                 _____ 
5. Having a frank and open conversation                 _____ 
6. Getting together with friends                             _____ 
7. Discussing a topic of interest                              _____ 
8. Having family visit or visiting family                      _____ 
9. Meeting someone new                                      _____ 
10. Eating out with friends or associate                   _____ 
11. Visiting friends or having friends visit                  _____          
12. Other:                                                           _____ 
 
Entertainment 
 
1. Watching TV or DVDs, or listening to the radio    _____ 
2. Bingo, gambling, playing the lottery          
 (including on-line)                                               _____ 
3. Going to the cinema                                         _____ 
4. Going to concerts                                            _____ 
5. Reading for pleasure                                         _____ 
6. Going to a play, musical, comedy show               _____ 
7. Going to a sporting event                                 _____ 
8. Going to the races                                           _____ 
9. Other:                                                            _____ 
Sports and games 
 
1. Swimming, snorkelling or scuba diving                _____ 
2. Cycling, skating or roller-blading                        _____ 
3. Jogging, hiking, or walking                                 _____ 
4.  Going to the gym                                           _____ 
5. Racquet sports (tennis, badminton, squash, 
 table tennis, racquetball, handball, volleyball)         _____ 
6. Computer or phone games                              _____ 
7. Playing board games                                        _____ 
8. Playing card games                                          _____ 
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9. Puzzles, crosswords, Sudoku etc.                       _____ 
10. Golf or putting                                              _____ 
11. Fishing                                                        _____ 
12. Bird watching                                               _____ 
13. Rock climbing or mountaineering                   _____ 
14. Boating, canoeing, kayaking, sailing                  _____ 
15. Pool, snooker or billiards                               _____ 
16. Hunting or shooting                                      _____ 
17. Others:                                                        _____ 
 
Hobbies, crafts, and the arts 
 
1. Playing a musical instrument                               _____ 
2. Singing                                                            _____ 
3. Dancing                                                          _____ 
4. Craft and artwork (drawing, painting,  
sculpting, pottery, movie making)                          _____ 
5. Needlework (knitting, crocheting, embroidery)    _____ 
6. Writing stories, novels, plays, poetry, essays, 
reports etc                                                        _____ 
7. Restoring antiques or refinishing furniture          _____ 
8. Photography                                                  _____ 
9. Woodworking or carpentry                             _____ 
10. Collecting things                                           _____ 
11. Other:                                                         _____ 
 
Education 
 
1. Learning something new (a language, how to  
play a musical instrument etc)                             _____ 
2. Learning something artistic (painting, pottery,  
crocheting etc)                                                  _____ 
3. Educational reading                                        _____ 
4. Taking a course on something interesting          _____ 
5. Reading a ‘how to do it’ book or article            _____ 
6. Going to a lecture or to listen to a speaker       _____ 
7. Going back to school, college etc.                    _____ 
8. Taking a course in computers                          _____ 
9. Other:                                                          _____ 
 
Health and appearance 
 
1. Getting new clothes, shoes or jewellery            _____ 
2. Putting on makeup or purchasing it                  _____ 
3. Getting haircut, going to the hairdressers          _____ 
4. Getting a manicure or pedicure                       _____ 
5. Getting a massage                                         _____ 
6. Putting on perfume or cologne                       _____ 
7. Improving one’s health (e.g. having teeth fixed, 
 new glasses, eating healthier, starting an exercise 
programme, having a health check)                     _____ 
8. Getting a makeover or facial                           _____ 
9. Other:                                                         _____ 
 
Pampering self and other leisure activities 
 
1. Making free time for yourself                           _____ 
2. Playing with or having a pet                             _____ 
3. Meditating or doing yoga                                 _____ 
4. Taking a bubble bath or soothing bath              _____ 
5. Making time to be alone                                  _____ 
6. Writing a journal or diary or keeping a 
scrapbook or photo album                                  _____ 
7. Having a lie in                                                 _____ 
8. Reading the newspaper or magazine                 _____ 
9. Listening to music                                           _____ 
10. Sunbathing                                                   _____ 
11. Enjoying nature                                            _____ APPENDICES 
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12. Telling and listening to jokes                          _____ 
13. Going to a spa                                             _____ 
14. Daydreaming                                               _____ 
15. Walking barefoot in the sand                          _____ 
16. Sitting around a fire                                        _____ 
17. Other:                                                          _____ 
                       
Domestic activities 
 
1. Cleaning the house                                        _____ 
2. Baking                                                          _____ 
3. Cooking                                                       _____ 
4. Gardening                                                     _____ 
5. Washing the car, maintaining the car                _____ 
6. Sewing                                                         _____ 
7. Buying flowers and plants                               _____ 
8. Re-arranging a room or the house                   _____ 
9. Painting and decorating                                  _____ 
10. Freshening up the house with potpourri,  
flowers, scented candles etc                               _____ 
11. Fixing things around the house                      _____ 
12. Other:                                                        _____ 
 
Treats 
 
1. Chocolate                                                       _____ 
2. Favourite sweets                                              _____ 
3. Ice cream                                                        _____ 
4. Dessert                                                           _____ 
5. A favourite drink                                              _____ 
6. Favourite meal                                                 _____ 
7. Other:                                                            _____  
                   
Altruistic acts 
 
1. Volunteering for a special cause                      _____ 
2. Charity work                                                _____ 
3. Doing favours for others                                _____ 
4. Making contributions to religious, charitable     
or other groups                                                _____ 
5. Giving gifts                                                    _____ 
6. Helping or listening to someone                      _____ 
7. Defending or protecting someone                   _____ 
8. Other:                                                          _____ 
 
Religious activities 
 
1. Going to a place of worship                              _____ 
2. Attending a wedding, baptism, bar mitzvah,  
religious ceremony or function                              _____ 
3. Joining a prayer or spiritual group                       _____ 
4. Praying                                                            _____ 
5. Reading sacred works                                       _____ 
6. Participating in a religious fellowship function       _____ 
7. Other:                                                            _____ 
Miscellaneous pleasant activities 
 
1. 
2. 
3. 
Miscellaneous pleasant activities 
 
4. 
5. 
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